1	JACC	NN	O	jacc	_	0	SENT_1	[p1l192t81r259b96],
2	:	:	O	:	_	0	SENT_1	[p1l192t81r259b96],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_1	[p1l276t81r498b96],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_1	[p1l516t81r709b96],
5	VOL	NNP	O	VOL	dep	4	SENT_1	[p1l1697t81r1751b96],
6	.	.	O	.	_	0	SENT_1	[p1l1697t81r1751b96],

1	5	CD	NUMBER	5	nsubj	12	SENT_2	[p1l1768t82r1786b98],
2	,	,	O	,	_	0	SENT_2	[p1l1768t82r1786b98],
3	NO.	NNP	DATE	NO.	appos	1	SENT_2	[p1l1804t81r1844b96],
4	12	CD	DATE	12	num	3	SENT_2	[p1l1863t81r1895b98],
5	,	,	DATE	,	_	0	SENT_2	[p1l1863t81r1895b98],
6	2012	CD	DATE	2012	num	3	SENT_2	[p1l1912t81r1967b96],
7	©	CD	DATE	©	num	8	SENT_2	[p1l193t113r206b127],
8	2012	CD	DATE	2012	dep	3	SENT_2	[p1l223t113r278b127],
9	BY	NNP	O	BY	dep	3	SENT_2	[p1l297t112r322b127],
10	THE	DT	O	the	det	12	SENT_2	[p1l338t112r381b127],
11	AMERICAN	NNP	MISC	AMERICAN	nn	12	SENT_2	[p1l398t112r523b127],
12	COLLEGE	NNP	O	COLLEGE	_	0	SENT_2	[p1l541t112r648b127],
13	OF	IN	O	of	_	0	SENT_2	[p1l665t112r693b127],
14	CARDIOLOGY	NNP	O	CARDIOLOGY	nn	16	SENT_2	[p1l710t112r869b127],
15	FOUNDATION	NNP	O	FOUNDATION	nn	16	SENT_2	[p1l886t112r1047b127],
16	lSSN1936-8798	NN	O	lssn1936-8798	prep_of	12	SENT_2	[p1l1675t111r1968b129],
17	/	:	O	/	punct	18	SENT_2	[p1l1675t111r1968b129],
18	$	$	MONEY	$	dep	12	SENT_2	[p1l1675t111r1968b129],
19	36.00	CD	MONEY	36.00	num	18	SENT_2	[p1l1675t111r1968b129],
20	PUBLISHED	VBN	O	publish	partmod	18	SENT_2	[p1l194t142r327b157],
21	BY	IN	O	by	_	0	SENT_2	[p1l345t142r371b157],
22	ELSEVIER	NNP	ORGANIZATION	ELSEVIER	agent	20	SENT_2	[p1l388t142r497b157],
23	INC.	NNP	ORGANIZATION	INC.	dep	22	SENT_2	[p1l515t142r562b157],
24	http	VB	O	http	rcmod	23	SENT_2	[p1l1397t142r1967b161],
25	:	:	O	:	_	0	SENT_2	[p1l1397t142r1967b161],
26	/	:	O	/	punct	18	SENT_2	[p1l1397t142r1967b161],
27	/	:	O	/	punct	30	SENT_2	[p1l1397t142r1967b161],
28	d	NN	O	d	dep	30	SENT_2	[p1l1397t142r1967b161],
29	>	JJR	O	>	npadvmod	30	SENT_2	[p1l1397t142r1967b161],
30	<	JJR	O	<	parataxis	12	SENT_2	[p1l1397t142r1967b161],
31	.	.	O	.	_	0	SENT_2	[p1l1397t142r1967b161],

1	dol.org/10.1016/j.jcin.2012.07.015	NN	O	dol.org/10.1016/j.jcin.2012.07.015	_	0	SENT_3	[p1l1397t142r1967b161],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_4	[p1l197t236r573b295],
2	*	NN	O	*	nsubj	8	SENT_4	[p1l197t236r573b295],
3	2	CD	NUMBER	2	dep	2	SENT_4	[p1l197t236r573b295],
4	and	CC	O	and	_	0	SENT_4	[p1l595t237r707b295],
5	*	CD	NUMBER	*	number	6	SENT_4	[p1l746t237r859b294],
6	17	CD	NUMBER	17	num	7	SENT_4	[p1l746t237r859b294],
7	Alleles	NNS	O	allele	conj_and	2	SENT_4	[p1l879t237r1086b295],
8	Have	VBP	O	have	_	0	SENT_4	[p1l1116t237r1266b295],
9	a	DT	O	a	det	11	SENT_4	[p1l1294t253r1329b295],
10	Significant	JJ	O	significant	amod	11	SENT_4	[p1l1357t236r1696b306],
11	Impact	NN	O	impact	dobj	8	SENT_4	[p1l196t337r412b406],
12	on	IN	O	on	_	0	SENT_4	[p1l440t353r513b395],
13	Platelet	NN	O	platelet	nn	14	SENT_4	[p1l546t337r786b395],
14	Response	NN	O	response	prep_on	11	SENT_4	[p1l816t337r1114b406],
15	and	CC	O	and	_	0	SENT_4	[p1l1142t337r1255b395],
16	Bleeding	NN	O	bleeding	nn	17	SENT_4	[p1l1288t337r1560b406],
17	Risk	NN	O	risk	prep_on	11	SENT_4	[p1l1589t337r1721b395],
18	in	IN	O	in	_	0	SENT_4	[p1l1749t337r1802b394],
19	Patients	NNS	O	patient	prep_in	14	SENT_4	[p1l196t436r453b494],
20	Treated	VBN	O	treat	partmod	19	SENT_4	[p1l479t436r718b494],
21	With	IN	O	with	_	0	SENT_4	[p1l748t436r892b494],
22	Prasugrel	NNP	O	Prasugrel	prep_with	20	SENT_4	[p1l925t436r1223b505],
23	After	IN	O	after	_	0	SENT_4	[p1l1252t435r1409b494],
24	Acute	JJ	O	acute	amod	26	SENT_4	[p1l1433t436r1614b494],
25	Coronary	JJ	O	coronary	amod	26	SENT_4	[p1l193t534r479b604],
26	Syndrome	NN	O	syndrome	prep_after	20	SENT_4	[p1l504t534r818b604],

1	Thomas	NNP	PERSON	Thomas	dep	119	SENT_5	[p1l192t679r330b711],
2	Cuisset	NNP	PERSON	Cuisset	dep	119	SENT_5	[p1l347t680r478b718],
3	,	,	O	,	_	0	SENT_5	[p1l347t680r478b718],
4	MD	NNP	O	MD	dep	119	SENT_5	[p1l494t680r577b718],
5	,	,	O	,	_	0	SENT_5	[p1l494t680r577b718],
6	PHD	NNP	O	PHD	dep	119	SENT_5	[p1l594t680r742b718],
7	,	,	O	,	_	0	SENT_5	[p1l594t680r742b718],
8	*	CD	NUMBER	*	dep	119	SENT_5	[p1l594t680r742b718],
9	”	CD	NUMBER	”	dep	119	SENT_5	[p1l594t680r742b718],
10	l'	NN	O	l'	dep	119	SENT_5	[p1l594t680r742b718],
11	:	:	O	:	_	0	SENT_5	[p1l594t680r742b718],
12	l	NN	O	l	dep	119	SENT_5	[p1l594t680r742b718],
13	=	JJ	O	=	dep	119	SENT_5	[p1l594t680r742b718],
14	Marie	NNP	PERSON	Marie	dep	119	SENT_5	[p1l757t680r857b711],
15	Loosveld	NNP	PERSON	Loosveld	dep	119	SENT_5	[p1l874t680r1033b718],
16	,	,	O	,	_	0	SENT_5	[p1l874t680r1033b718],
17	MD	NNP	O	MD	dep	119	SENT_5	[p1l1049t680r1195b718],
18	,	,	O	,	_	0	SENT_5	[p1l1049t680r1195b718],
19	'	''	O	'	_	0	SENT_5	[p1l1049t680r1195b718],
20	l'	NN	O	l'	dep	119	SENT_5	[p1l1049t680r1195b718],
21	:	:	O	:	_	0	SENT_5	[p1l1049t680r1195b718],
22	l	NN	O	l	dep	119	SENT_5	[p1l1049t680r1195b718],
23	:	:	O	:	_	0	SENT_5	[p1l1049t680r1195b718],
24	§	CD	NUMBER	§	dep	119	SENT_5	[p1l1049t680r1195b718],
25	Pierre	NNP	PERSON	Pierre	dep	119	SENT_5	[p1l194t733r292b763],
26	Emmanuel	NNP	PERSON	Emmanuel	dep	119	SENT_5	[p1l308t732r492b763],
27	Morange	NNP	PERSON	Morange	dep	119	SENT_5	[p1l506t733r668b774],
28	,	,	O	,	_	0	SENT_5	[p1l506t733r668b774],
29	MD	NNP	O	MD	dep	119	SENT_5	[p1l684t733r768b770],
30	,	,	O	,	_	0	SENT_5	[p1l684t733r768b770],
31	PHD	NNP	O	PHD	dep	119	SENT_5	[p1l784t732r939b770],
32	,1	CD	NUMBER	,1	dep	119	SENT_5	[p1l784t732r939b770],
33	'	''	O	'	_	0	SENT_5	[p1l784t732r939b770],
34	:	:	O	:	_	0	SENT_5	[p1l784t732r939b770],
35	l2	NN	O	l2	dep	119	SENT_5	[p1l784t732r939b770],
36	§	CD	NUMBER	§	dep	119	SENT_5	[p1l784t732r939b770],
37	Jacques	NNP	O	Jacques	dep	119	SENT_5	[p1l953t733r1078b774],
38	Ch	NNP	O	Ch	dep	119	SENT_5	[p1l1096t732r1219b771],
39	}	CD	NUMBER	}	dep	119	SENT_5	[p1l1096t732r1219b771],
40	ll_lCl	NN	O	ll_lcl	dep	119	SENT_5	[p1l1096t732r1219b771],
41	,	,	O	,	_	0	SENT_5	[p1l1096t732r1219b771],
42	MD	NN	O	md	dep	119	SENT_5	[p1l1234t732r1353b770],
43	,	,	O	,	_	0	SENT_5	[p1l1234t732r1353b770],
44	*	NN	O	*	dep	119	SENT_5	[p1l1234t732r1353b770],
45	'	''	O	'	_	0	SENT_5	[p1l1234t732r1353b770],
46	l'	NN	O	l'	dep	119	SENT_5	[p1l1234t732r1353b770],
47	Pierre	NNP	PERSON	Pierre	dep	119	SENT_5	[p1l194t783r292b814],
48	Julien	NNP	PERSON	Julien	dep	119	SENT_5	[p1l303t783r403b823],
49	Moro	NNP	PERSON	Moro	dep	119	SENT_5	[p1l417t783r522b821],
50	,	,	O	,	_	0	SENT_5	[p1l417t783r522b821],
51	MD	NNP	O	MD	dep	119	SENT_5	[p1l538t783r657b821],
52	,	,	O	,	_	0	SENT_5	[p1l538t783r657b821],
53	*	CD	NUMBER	*	dep	119	SENT_5	[p1l538t783r657b821],
54	:	:	O	:	_	0	SENT_5	[p1l538t783r657b821],
55	l	NN	O	l	dep	119	SENT_5	[p1l538t783r657b821],
56	:	:	O	:	_	0	SENT_5	[p1l538t783r657b821],
57	Noémie	NNP	O	Noémie	dep	119	SENT_5	[p1l673t783r805b814],
58	Saut	NNP	O	Saut	dep	119	SENT_5	[p1l823t783r904b821],
59	,	,	O	,	_	0	SENT_5	[p1l823t783r904b821],
60	PHD	NNP	O	PHD	dep	119	SENT_5	[p1l920t783r1055b821],
61	,	,	O	,	_	0	SENT_5	[p1l920t783r1055b821],
62	'	''	O	'	_	0	SENT_5	[p1l920t783r1055b821],
63	l'Il	NNP	O	l'Il	dep	119	SENT_5	[p1l920t783r1055b821],
64	:	:	O	:	_	0	SENT_5	[p1l920t783r1055b821],
65	Bénédicte	NNP	PERSON	Bénédicte	dep	119	SENT_5	[p1l1071t783r1235b814],
66	Gaborit	NNP	PERSON	Gaborit	dep	119	SENT_5	[p1l1252t783r1391b821],
67	,	,	O	,	_	0	SENT_5	[p1l1252t783r1391b821],
68	MD	NNP	O	MD	dep	119	SENT_5	[p1l1407t783r1533b821],
69	,	,	O	,	_	0	SENT_5	[p1l1407t783r1533b821],
70	'	''	O	'	_	0	SENT_5	[p1l1407t783r1533b821],
71	l‘Il	NN	O	l‘il	dep	119	SENT_5	[p1l1407t783r1533b821],
72	:	:	O	:	_	0	SENT_5	[p1l1407t783r1533b821],
73	Christel	NNP	PERSON	Christel	dep	119	SENT_5	[p1l194t835r328b866],
74	Castelli	NNP	PERSON	Castelli	dep	119	SENT_5	[p1l344t835r478b873],
75	,	,	O	,	_	0	SENT_5	[p1l344t835r478b873],
76	PHD	NNP	O	PHD	dep	119	SENT_5	[p1l494t831r600b876],
77	,	,	O	,	_	0	SENT_5	[p1l494t831r600b876],
78	”	NNP	O	”	dep	119	SENT_5	[p1l494t831r600b876],
79	Shirley	NNP	PERSON	Shirley	dep	119	SENT_5	[p1l618t835r734b877],
80	Beguin	NNP	PERSON	Beguin	dep	119	SENT_5	[p1l748t835r875b877],
81	,	,	O	,	_	0	SENT_5	[p1l748t835r875b877],
82	PHD	NNP	O	PHD	dep	119	SENT_5	[p1l892t835r1009b873],
83	,	,	O	,	_	0	SENT_5	[p1l892t835r1009b873],
84	ﬁl	NN	O	ﬁl	dep	119	SENT_5	[p1l892t835r1009b873],
85	Charlotte	NNP	PERSON	Charlotte	dep	119	SENT_5	[p1l1026t835r1184b866],
86	Grosdidier	NNP	PERSON	Grosdidier	dep	119	SENT_5	[p1l1201t835r1389b873],
87	,	,	O	,	_	0	SENT_5	[p1l1201t835r1389b873],
88	MD	NNP	O	MD	dep	119	SENT_5	[p1l1405t835r1552b873],
89	,	,	O	,	_	0	SENT_5	[p1l1405t835r1552b873],
90	l'	NNP	O	l'	dep	119	SENT_5	[p1l1405t835r1552b873],
91	:	:	O	:	_	0	SENT_5	[p1l1405t835r1552b873],
92	l	NN	O	l	dep	119	SENT_5	[p1l1405t835r1552b873],
93	:	:	O	:	_	0	SENT_5	[p1l1405t835r1552b873],
94	§	CD	NUMBER	§	dep	119	SENT_5	[p1l1405t835r1552b873],
95	Laurent	NNP	PERSON	Laurent	dep	119	SENT_5	[p1l194t887r326b918],
96	Fourcade	NNP	PERSON	Fourcade	dep	119	SENT_5	[p1l341t887r504b924],
97	,	,	O	,	_	0	SENT_5	[p1l341t887r504b924],
98	MD	NNP	O	MD	dep	119	SENT_5	[p1l520t887r627b924],
99	,	,	O	,	_	0	SENT_5	[p1l520t887r627b924],
100	#	#	O	#	dep	119	SENT_5	[p1l520t887r627b924],
101	Jean-Louis	NNP	PERSON	Jean-Louis	dep	119	SENT_5	[p1l637t887r823b926],
102	Bonnet	NNP	PERSON	Bonnet	dep	119	SENT_5	[p1l839t887r970b924],
103	,	,	O	,	_	0	SENT_5	[p1l839t887r970b924],
104	MD	NNP	O	MD	dep	119	SENT_5	[p1l986t887r1126b924],
105	,	,	O	,	_	0	SENT_5	[p1l986t887r1126b924],
106	*	CD	NUMBER	*	dep	119	SENT_5	[p1l986t887r1126b924],
107	1Li	NN	O	1lus	dep	119	SENT_5	[p1l986t887r1126b924],
108	Marie-Christine	NNP	PERSON	Marie-Christine	dep	119	SENT_5	[p1l1141t887r1416b918],
109	Alessi	NNP	PERSON	Alessi	dep	119	SENT_5	[p1l1431t886r1540b924],
110	,	,	O	,	_	0	SENT_5	[p1l1431t886r1540b924],
111	MD	NNP	O	MD	dep	119	SENT_5	[p1l1556t887r1639b924],
112	,	,	O	,	_	0	SENT_5	[p1l1556t887r1639b924],
113	PHD	NNP	O	PHD	dep	119	SENT_5	[p1l1656t887r1800b923],
114	’	CD	NUMBER	’	dep	119	SENT_5	[p1l1656t887r1800b923],
115	r	NN	O	r	dep	119	SENT_5	[p1l1656t887r1800b923],
116	:	:	O	:	_	0	SENT_5	[p1l1656t887r1800b923],
117	l	NN	O	l	dep	119	SENT_5	[p1l1656t887r1800b923],
118	:	:	O	:	_	0	SENT_5	[p1l1656t887r1800b923],
119	§	CD	NUMBER	§	_	0	SENT_5	[p1l1656t887r1800b923],

1	Marseille	NNP	LOCATION	Marseille	_	0	SENT_6	[p1l192t971r341b1000],
2	and	CC	O	and	_	0	SENT_6	[p1l355t971r418b1000],
3	Nimes	NNP	ORGANIZATION	Nimes	conj_and	1	SENT_6	[p1l427t972r535b1005],
4	,	,	O	,	_	0	SENT_6	[p1l427t972r535b1005],
5	France	NNP	LOCATION	France	appos	1	SENT_6	[p1l553t971r662b1000],

1	Objectives	NNS	MISC	objective	nsubjpass	6	SENT_7	[p1l194t1115r368b1148],
2	The	DT	MISC	the	det	4	SENT_7	[p1l387t1114r445b1141],
3	present	JJ	DATE	present	amod	4	SENT_7	[p1l461t1118r577b1149],
4	study	NN	O	study	dep	1	SENT_7	[p1l591t1114r677b1149],
5	was	VBD	O	be	auxpass	6	SENT_7	[p1l690t1122r748b1141],
6	designed	VBN	O	design	_	0	SENT_7	[p1l763t1114r905b1149],
7	to	TO	O	to	aux	8	SENT_7	[p1l920t1118r952b1142],
8	assess	VB	O	assess	xcomp	6	SENT_7	[p1l967t1122r1061b1142],
9	the	DT	O	the	det	10	SENT_7	[p1l1075t1114r1125b1141],
10	effect	NN	O	effect	dobj	8	SENT_7	[p1l1140t1114r1227b1141],
11	of	IN	O	of	_	0	SENT_7	[p1l1241t1114r1273b1142],
12	genetic	JJ	O	genetic	amod	13	SENT_7	[p1l1285t1115r1401b1149],
13	variants	NNS	O	variant	prep_of	10	SENT_7	[p1l1415t1115r1536b1141],
14	on	IN	O	on	_	0	SENT_7	[p1l1551t1122r1589b1141],
15	chronic	JJ	O	chronic	amod	17	SENT_7	[p1l1605t1114r1720b1141],
16	biological	JJ	O	biological	amod	17	SENT_7	[p1l1735t1114r1795b1142, p1l195t1163r293b1198],
17	response	NN	O	response	prep_on	8	SENT_7	[p1l310t1171r449b1198],
18	to	TO	O	to	_	0	SENT_7	[p1l463t1167r494b1191],
19	prasugrel	NN	O	prasugrel	nn	22	SENT_7	[p1l511t1163r654b1198],
20	and	CC	O	and	_	0	SENT_7	[p1l670t1163r726b1191],
21	bleeding	NN	O	bleeding	conj_and	19	SENT_7	[p1l744t1163r878b1198],
22	complications	NNS	O	complication	prep_to	8	SENT_7	[p1l895t1163r1120b1198],
23	.	.	O	.	_	0	SENT_7	[p1l895t1163r1120b1198],

1	Background	NN	O	background	nn	6	SENT_8	[p1l195t1251r392b1285],
2	CYP2C19	NN	O	cyp2c19	nn	6	SENT_8	[p1l414t1252r581b1278],
3	*	NN	O	*	nn	6	SENT_8	[p1l414t1252r581b1278],
4	2	CD	NUMBER	2	num	6	SENT_8	[p1l414t1252r581b1278],
5	loss-of-function	JJ	O	loss-of-function	amod	6	SENT_8	[p1l597t1250r837b1278],
6	allele	NN	O	allele	nsubjpass	15	SENT_8	[p1l853t1251r933b1278],
7	and	CC	O	and	_	0	SENT_8	[p1l948t1251r1005b1278],
8	CYP2C19	NN	O	cyp2c19	nsubjpass	15	SENT_8	[p1l1021t1252r1209b1278],
9	*	CD	NUMBER	*	number	10	SENT_8	[p1l1021t1252r1209b1278],
10	77	CD	NUMBER	77	num	12	SENT_8	[p1l1021t1252r1209b1278],
11	gain-of-function	NN	O	gain-of-function	nn	12	SENT_8	[p1l1221t1250r1472b1286],
12	allele	NN	O	allele	dep	8	SENT_8	[p1l1488t1251r1568b1278],
13	have	VBP	O	have	aux	15	SENT_8	[p1l1584t1251r1657b1278],
14	been	VBN	O	be	auxpass	15	SENT_8	[p1l1673t1251r1748b1278],
15	linked	VBN	O	link	_	0	SENT_8	[p1l195t1301r286b1328],
16	with	IN	O	with	_	0	SENT_8	[p1l302t1301r368b1328],
17	response	NN	O	response	prep_with	15	SENT_8	[p1l385t1309r524b1336],
18	to	TO	O	to	_	0	SENT_8	[p1l538t1305r570b1328],
19	clopidogrel	NN	O	clopidogrel	prep_to	15	SENT_8	[p1l585t1301r769b1336],
20	,	,	O	,	_	0	SENT_8	[p1l585t1301r769b1336],
21	but	CC	O	but	_	0	SENT_8	[p1l785t1301r836b1328],
22	preliminary	JJ	O	preliminary	amod	23	SENT_8	[p1l852t1301r1028b1336],
23	data	NNS	O	datum	nsubj	26	SENT_8	[p1l1042t1301r1109b1328],
24	did	VBD	O	do	aux	26	SENT_8	[p1l1124t1301r1172b1328],
25	not	RB	O	not	neg	26	SENT_8	[p1l1189t1305r1240b1328],
26	show	VB	O	show	conj_but	15	SENT_8	[p1l1254t1301r1336b1328],
27	any	DT	O	any	det	29	SENT_8	[p1l1351t1309r1406b1336],
28	signiﬁcant	JJ	O	signiﬁcant	amod	29	SENT_8	[p1l1420t1300r1580b1336],
29	inﬂuence	NN	O	inﬂuence	dobj	26	SENT_8	[p1l1595t1300r1737b1328],
30	of	IN	O	of	_	0	SENT_8	[p1l1752t1300r1784b1328],
31	these	DT	O	these	det	32	SENT_8	[p1l193t1351r277b1378],
32	alleles	NNS	O	allele	prep_of	29	SENT_8	[p1l292t1351r386b1378],
33	on	IN	O	on	_	0	SENT_8	[p1l401t1359r439b1378],
34	prasugrel	NN	O	prasugrel	nn	35	SENT_8	[p1l456t1351r600b1386],
35	effect	NN	O	effect	prep_on	26	SENT_8	[p1l616t1350r710b1378],
36	.	.	O	.	_	0	SENT_8	[p1l616t1350r710b1378],

1	Methods	NNS	O	method	nsubjpass	23	SENT_9	[p1l195t1439r338b1466],
2	A	DT	O	a	det	3	SENT_9	[p1l359t1440r380b1466],
3	total	NN	O	total	dep	1	SENT_9	[p1l394t1439r463b1466],
4	of	IN	O	of	_	0	SENT_9	[p1l480t1438r512b1466],
5	213	CD	NUMBER	213	num	6	SENT_9	[p1l524t1440r578b1466],
6	patients	NNS	O	patient	prep_of	3	SENT_9	[p1l595t1440r719b1474],
7	undergoing	VBG	O	undergo	dep	1	SENT_9	[p1l735t1439r916b1474],
8	successful	JJ	O	successful	amod	10	SENT_9	[p1l933t1438r1087b1466],
9	coronary	JJ	O	coronary	amod	10	SENT_9	[p1l1103t1447r1241b1474],
10	stenting	NN	O	stenting	dobj	7	SENT_9	[p1l1255t1440r1381b1474],
11	for	IN	O	for	_	0	SENT_9	[p1l1396t1438r1439b1466],
12	acute	JJ	O	acute	amod	14	SENT_9	[p1l1453t1443r1538b1466],
13	coronary	JJ	O	coronary	amod	14	SENT_9	[p1l1552t1447r1690b1474],
14	syndrome	NN	O	syndrome	prep_for	10	SENT_9	[p1l1704t1447r1767b1474, p1l194t1488r295b1516],
15	and	CC	O	and	_	0	SENT_9	[p1l310t1488r367b1516],
16	discharged	VBN	O	discharge	dep	1	SENT_9	[p1l383t1488r553b1523],
17	with	IN	O	with	_	0	SENT_9	[p1l568t1488r635b1515],
18	prasugrel	NN	O	prasugrel	nn	20	SENT_9	[p1l652t1488r795b1523],
19	10	CD	NUMBER	10	num	20	SENT_9	[p1l814t1490r848b1515],
20	mg	NN	O	mg	prep_with	16	SENT_9	[p1l864t1496r911b1523],
21	daily	JJ	SET	daily	advmod	23	SENT_9	[p1l927t1488r1000b1523],
22	were	VBD	O	be	auxpass	23	SENT_9	[p1l1014t1496r1089b1515],
23	included	VBN	O	include	_	0	SENT_9	[p1l1105t1488r1247b1516],
24	.	.	O	.	_	0	SENT_9	[p1l1105t1488r1247b1516],

1	Prasugrel	NN	O	prasugrel	nn	2	SENT_10	[p1l1263t1488r1405b1523],
2	response	NN	O	response	nsubjpass	4	SENT_10	[p1l1422t1496r1561b1523],
3	was	VBD	O	be	auxpass	4	SENT_10	[p1l1575t1496r1634b1515],
4	assessed	VBN	O	assess	_	0	SENT_10	[p1l1649t1488r1781b1515],
5	at	IN	O	at	_	0	SENT_10	[p1l194t1541r222b1565],
6	1	CD	DURATION	1	num	7	SENT_10	[p1l239t1539r248b1564],
7	month	NN	NUMBER	month	prep_at	4	SENT_10	[p1l269t1537r371b1564],
8	with	IN	O	with	_	0	SENT_10	[p1l386t1537r453b1564],
9	the	DT	O	the	det	12	SENT_10	[p1l468t1537r519b1564],
10	platelet	NN	O	platelet	nn	12	SENT_10	[p1l535t1537r651b1572],
11	reactivity	NN	O	reactivity	nn	12	SENT_10	[p1l667t1538r808b1572],
12	index	NN	O	index	prep_with	7	SENT_10	[p1l823t1537r907b1565],
13	(	CD	NUMBER	(	num	14	SENT_10	[p1l922t1538r988b1569],
14	PRI	NNP	ORGANIZATION	PRI	tmod	4	SENT_10	[p1l922t1538r988b1569],
15	)	CD	NUMBER	)	num	14	SENT_10	[p1l922t1538r988b1569],
16	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	17	SENT_10	[p1l1003t1537r1353b1565],
17	phosphoprotein	NN	O	phosphoprotein	nsubj	29	SENT_10	[p1l1370t1537r1621b1572],
18	(	CD	NUMBER	(	num	20	SENT_10	[p1l1638t1538r1737b1569],
19	VASP	NN	ORGANIZATION	vasp	nn	20	SENT_10	[p1l1638t1538r1737b1569],
20	)	NN	O	)	dep	17	SENT_10	[p1l1638t1538r1737b1569],
21	and	CC	O	and	_	0	SENT_10	[p1l1753t1537r1810b1564],
22	high	JJ	O	high	amod	24	SENT_10	[p1l195t1586r261b1622],
23	on-treatment	JJ	O	on-treatment	amod	24	SENT_10	[p1l278t1591r486b1614],
24	platelet	NN	O	platelet	nsubj	29	SENT_10	[p1l501t1586r618b1621],
25	reactivity	NN	O	reactivity	nn	28	SENT_10	[p1l633t1588r775b1622],
26	(	CD	NUMBER	(	num	28	SENT_10	[p1l790t1587r890b1619],
27	HTPR	NN	O	htpr	nn	28	SENT_10	[p1l790t1587r890b1619],
28	)	NN	O	)	dep	24	SENT_10	[p1l790t1587r890b1619],
29	deﬁned	VBN	O	deﬁned	rcmod	14	SENT_10	[p1l906t1586r1022b1614],
30	as	IN	O	as	_	0	SENT_10	[p1l1039t1595r1069b1614],
31	PRI	NNP	O	PRI	nn	32	SENT_10	[p1l1085t1588r1129b1614],
32	VASP	NN	O	vasp	prep_as	29	SENT_10	[p1l1144t1587r1225b1614],
33	>	JJR	O	>	amod	46	SENT_10	[p1l1242t1590r1267b1612],
34	50	CD	PERCENT	50	num	35	SENT_10	[p1l1284t1588r1350b1614],
35	%	NN	PERCENT	%	dep	33	SENT_10	[p1l1284t1588r1350b1614],
36	and	CC	O	and	_	0	SENT_10	[p1l1365t1586r1421b1614],
37	hyper-response	NN	O	hyper-response	npadvmod	41	SENT_10	[p1l1439t1586r1680b1622],
38	as	IN	O	as	_	0	SENT_10	[p1l1694t1595r1725b1614],
39	PRI	NNP	O	PRI	nn	40	SENT_10	[p1l1741t1588r1785b1614],
40	VASP	NN	O	vasp	prep_as	37	SENT_10	[p1l192t1637r273b1664],
41	<	JJR	O	<	conj_and	33	SENT_10	[p1l290t1636r388b1664],
42	75th	JJ	ORDINAL	75th	amod	46	SENT_10	[p1l290t1636r388b1664],
43	percentile	NN	O	percentile	nn	46	SENT_10	[p1l405t1636r559b1671],
44	(	CD	NUMBER	(	num	46	SENT_10	[p1l575t1637r630b1669],
45	PRI	NNP	O	PRI	nn	46	SENT_10	[p1l575t1637r630b1669],
46	VASP	NN	O	vasp	dobj	29	SENT_10	[p1l645t1637r726b1664],
47	<	JJR	O	<	amod	14	SENT_10	[p1l743t1640r768b1662],
48	17	CD	PERCENT	17	num	49	SENT_10	[p1l787t1637r869b1669],
49	%	NN	PERCENT	%	dep	47	SENT_10	[p1l787t1637r869b1669],
50	)	CD	NUMBER	)	dep	14	SENT_10	[p1l787t1637r869b1669],
51	.	.	O	.	_	0	SENT_10	[p1l787t1637r869b1669],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_11	[p1l884t1637r1051b1664],
2	*	NN	O	*	nsubjpass	10	SENT_11	[p1l884t1637r1051b1664],
3	2	CD	NUMBER	2	dep	2	SENT_11	[p1l884t1637r1051b1664],
4	and	CC	O	and	_	0	SENT_11	[p1l1066t1636r1122b1664],
5	CYP2C19	NN	O	cyp2c19	conj_and	2	SENT_11	[p1l1139t1637r1326b1664],
6	*	CD	NUMBER	*	number	7	SENT_11	[p1l1139t1637r1326b1664],
7	17	CD	NUMBER	17	num	8	SENT_11	[p1l1139t1637r1326b1664],
8	genotyping	NN	O	genotyping	dep	5	SENT_11	[p1l1339t1638r1518b1672],
9	were	VBD	O	be	auxpass	10	SENT_11	[p1l1534t1645r1609b1664],
10	performed	VBN	O	perform	_	0	SENT_11	[p1l1625t1636r1797b1671],
11	.	.	O	.	_	0	SENT_11	[p1l1625t1636r1797b1671],

1	Results	NNS	O	result	nn	2	SENT_12	[p1l195t1725r318b1752],
2	Carriers	NNS	O	carrier	nsubj	8	SENT_12	[p1l339t1725r451b1752],
3	of	IN	O	of	_	0	SENT_12	[p1l464t1724r495b1752],
4	loss-of-function	JJ	O	loss-of-function	amod	7	SENT_12	[p1l507t1724r737b1752],
5	*	NN	O	*	nn	7	SENT_12	[p1l753t1726r783b1752],
6	2	CD	NUMBER	2	num	7	SENT_12	[p1l753t1726r783b1752],
7	allele	NN	O	allele	prep_of	2	SENT_12	[p1l796t1724r872b1752],
8	had	VBD	O	have	_	0	SENT_12	[p1l887t1724r940b1752],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_12	[p1l955t1724r1134b1760],
10	higher	JJR	O	higher	amod	12	SENT_12	[p1l1148t1724r1244b1760],
11	PRI	NNP	O	PRI	nn	12	SENT_12	[p1l1257t1726r1300b1752],
12	VASP	NN	O	vasp	dobj	8	SENT_12	[p1l1313t1725r1392b1752],
13	than	IN	O	than	_	0	SENT_12	[p1l1405t1724r1472b1752],
14	noncarriers	JJ	O	noncarriers	amod	15	SENT_12	[p1l1488t1726r1653b1752],
15	(	NN	O	(	prep_than	12	SENT_12	[p1l1668t1725r1711b1757],
16	33	CD	NUMBER	33	dep	15	SENT_12	[p1l1668t1725r1711b1757],
17	:	:	O	:	_	0	SENT_12	[p1l1729t1728r1751b1751],
18	15	CD	PERCENT	15	num	19	SENT_12	[p1l196t1776r258b1802],
19	%	NN	PERCENT	%	dep	15	SENT_12	[p1l196t1776r258b1802],
20	vs.	CC	O	vs.	prep	19	SENT_12	[p1l271t1783r308b1802],
21	27	CD	NUMBER	27	dep	20	SENT_12	[p1l322t1776r357b1802],
22	:	:	O	:	_	0	SENT_12	[p1l373t1778r396b1801],
23	14	CD	PERCENT	14	num	24	SENT_12	[p1l415t1776r484b1807],
24	%	NN	PERCENT	%	dep	15	SENT_12	[p1l415t1776r484b1807],
25	,	,	O	,	_	0	SENT_12	[p1l415t1776r484b1807],
26	p	NN	O	p	appos	24	SENT_12	[p1l499t1783r516b1809],
27	=	JJ	O	=	amod	29	SENT_12	[p1l533t1785r555b1794],
28	0.03	CD	NUMBER	0.03	tmod	27	SENT_12	[p1l572t1775r642b1807],
29	)	NN	O	)	dep	26	SENT_12	[p1l572t1775r642b1807],
30	and	CC	O	and	_	0	SENT_12	[p1l656t1774r711b1802],
31	higher	JJR	O	higher	amod	32	SENT_12	[p1l727t1774r823b1810],
32	rate	NN	O	rate	prep_than	12	SENT_12	[p1l837t1779r893b1802],
33	of	IN	O	of	_	0	SENT_12	[p1l906t1774r937b1802],
34	HTPR	NN	O	htpr	prep_of	32	SENT_12	[p1l949t1776r1027b1802],
35	(	CD	PERCENT	(	num	34	SENT_12	[p1l1041t1775r1114b1807],
36	16	CD	PERCENT	16	number	37	SENT_12	[p1l1041t1775r1114b1807],
37	%	NN	PERCENT	%	amod	12	SENT_12	[p1l1041t1775r1114b1807],
38	vs.	CC	O	vs.	prep	12	SENT_12	[p1l1127t1783r1164b1802],
39	4	CD	PERCENT	4	num	40	SENT_12	[p1l1177t1776r1231b1807],
40	%	NN	PERCENT	%	dep	38	SENT_12	[p1l1177t1776r1231b1807],
41	,	,	O	,	_	0	SENT_12	[p1l1177t1776r1231b1807],
42	p	NN	O	p	appos	40	SENT_12	[p1l1245t1783r1263b1809],
43	=	JJ	O	=	amod	45	SENT_12	[p1l1279t1785r1302b1794],
44	0.01	CD	NUMBER	0.01	tmod	43	SENT_12	[p1l1318t1775r1396b1807],
45	)	NN	O	)	dep	42	SENT_12	[p1l1318t1775r1396b1807],
46	.	.	O	.	_	0	SENT_12	[p1l1318t1775r1396b1807],

1	Conversely	RB	O	conversely	dep	103	SENT_13	[p1l1410t1774r1580b1810],
2	,	,	O	,	_	0	SENT_13	[p1l1410t1774r1580b1810],
3	carriers	NNS	O	carrier	dep	103	SENT_13	[p1l1594t1776r1700b1802],
4	of	IN	O	of	dep	103	SENT_13	[p1l1714t1774r1745b1802],
5	*	NN	O	*	dep	103	SENT_13	[p1l195t1826r245b1852],
6	17	CD	NUMBER	17	dep	103	SENT_13	[p1l195t1826r245b1852],
7	gain-of-function	NN	O	gain-of-function	dep	103	SENT_13	[p1l256t1824r496b1860],
8	allele	NN	O	allele	dep	103	SENT_13	[p1l511t1824r587b1852],
9	had	VBD	O	have	dep	103	SENT_13	[p1l601t1824r655b1852],
10	signiﬁcantly	RB	O	signiﬁcantly	dep	103	SENT_13	[p1l670t1824r849b1860],
11	lower	JJR	O	lower	dep	103	SENT_13	[p1l862t1824r945b1852],
12	PRI	NNP	O	PRI	dep	103	SENT_13	[p1l959t1826r1001b1852],
13	VASP	NN	O	vasp	dep	103	SENT_13	[p1l1015t1825r1094b1852],
14	than	IN	O	than	dep	103	SENT_13	[p1l1106t1824r1173b1852],
15	noncarriers	JJ	O	noncarriers	dep	103	SENT_13	[p1l1189t1826r1355b1852],
16	(	NN	O	(	dep	103	SENT_13	[p1l1369t1825r1412b1857],
17	25	CD	NUMBER	25	dep	103	SENT_13	[p1l1369t1825r1412b1857],
18	:	:	O	:	_	0	SENT_13	[p1l1430t1828r1453b1851],
19	13	CD	PERCENT	13	dep	103	SENT_13	[p1l1472t1826r1534b1852],
20	%	NN	PERCENT	%	dep	103	SENT_13	[p1l1472t1826r1534b1852],
21	vs.	CC	O	vs.	dep	103	SENT_13	[p1l1546t1833r1584b1852],
22	31	CD	NUMBER	31	dep	103	SENT_13	[p1l1597t1826r1627b1852],
23	:	:	O	:	_	0	SENT_13	[p1l1649t1828r1672b1851],
24	15	CD	PERCENT	15	dep	103	SENT_13	[p1l1691t1826r1760b1857],
25	%	NN	PERCENT	%	dep	103	SENT_13	[p1l1691t1826r1760b1857],
26	,	,	O	,	_	0	SENT_13	[p1l1691t1826r1760b1857],
27	p	NN	O	p	dep	103	SENT_13	[p1l195t1883r213b1909],
28	=	JJ	O	=	dep	103	SENT_13	[p1l229t1885r252b1894],
29	0.03	CD	NUMBER	0.03	dep	103	SENT_13	[p1l268t1876r336b1907],
30	,	,	O	,	_	0	SENT_13	[p1l268t1876r336b1907],
31	p	NN	O	p	dep	103	SENT_13	[p1l351t1883r369b1909],
32	=	JJ	O	=	dep	103	SENT_13	[p1l385t1885r408b1894],
33	0.03	CD	NUMBER	0.03	dep	103	SENT_13	[p1l424t1875r502b1907],
34	)	NN	O	)	dep	103	SENT_13	[p1l424t1875r502b1907],
35	,	,	O	,	_	0	SENT_13	[p1l424t1875r502b1907],
36	lower	JJR	O	lower	dep	103	SENT_13	[p1l517t1874r599b1902],
37	rate	NN	O	rate	dep	103	SENT_13	[p1l613t1879r669b1902],
38	of	IN	O	of	dep	103	SENT_13	[p1l682t1874r713b1902],
39	HTPR	NN	O	htpr	dep	103	SENT_13	[p1l725t1876r803b1902],
40	(	NN	O	(	dep	103	SENT_13	[p1l817t1875r872b1907],
41	1	CD	PERCENT	1	dep	103	SENT_13	[p1l817t1875r872b1907],
42	%	NN	PERCENT	%	dep	103	SENT_13	[p1l817t1875r872b1907],
43	vs.	CC	O	vs.	dep	103	SENT_13	[p1l884t1883r922b1902],
44	10	CD	PERCENT	10	dep	103	SENT_13	[p1l938t1876r1007b1907],
45	%	NN	PERCENT	%	dep	103	SENT_13	[p1l938t1876r1007b1907],
46	,	,	O	,	_	0	SENT_13	[p1l938t1876r1007b1907],
47	p	NN	O	p	dep	103	SENT_13	[p1l1021t1883r1039b1909],
48	=	JJ	O	=	dep	103	SENT_13	[p1l1056t1885r1078b1894],
49	0.02	CD	NUMBER	0.02	dep	103	SENT_13	[p1l1095t1875r1173b1907],
50	)	NN	O	)	dep	103	SENT_13	[p1l1095t1875r1173b1907],
51	,	,	O	,	_	0	SENT_13	[p1l1095t1875r1173b1907],
52	higher	JJR	O	higher	dep	103	SENT_13	[p1l1187t1874r1283b1910],
53	rate	NN	O	rate	dep	103	SENT_13	[p1l1297t1879r1353b1902],
54	of	IN	O	of	dep	103	SENT_13	[p1l1366t1874r1397b1902],
55	hyper-response	JJ	O	hyper-response	dep	103	SENT_13	[p1l1409t1874r1641b1910],
56	(	NN	O	(	dep	103	SENT_13	[p1l1655t1875r1729b1907],
57	34	CD	PERCENT	34	dep	103	SENT_13	[p1l1655t1875r1729b1907],
58	%	NN	PERCENT	%	dep	103	SENT_13	[p1l1655t1875r1729b1907],
59	vs.	CC	O	vs.	dep	103	SENT_13	[p1l1741t1883r1779b1902],
60	21	CD	PERCENT	21	dep	103	SENT_13	[p1l194t1926r265b1956],
61	%	NN	PERCENT	%	dep	103	SENT_13	[p1l194t1926r265b1956],
62	,	,	O	,	_	0	SENT_13	[p1l194t1926r265b1956],
63	p	NN	O	p	dep	103	SENT_13	[p1l280t1933r297b1959],
64	=	JJ	O	=	dep	103	SENT_13	[p1l314t1935r337b1944],
65	0.02	CD	NUMBER	0.02	dep	103	SENT_13	[p1l353t1925r431b1956],
66	)	NN	O	)	dep	103	SENT_13	[p1l353t1925r431b1956],
67	,	,	O	,	_	0	SENT_13	[p1l353t1925r431b1956],
68	and	CC	O	and	dep	103	SENT_13	[p1l444t1924r499b1952],
69	higher	JJR	O	higher	dep	103	SENT_13	[p1l515t1924r611b1959],
70	rate	NN	O	rate	dep	103	SENT_13	[p1l625t1929r681b1952],
71	of	IN	O	of	dep	103	SENT_13	[p1l694t1924r725b1952],
72	bleeding	VBG	O	bleed	dep	103	SENT_13	[p1l737t1924r867b1959],
73	complications	NNS	O	complication	dep	103	SENT_13	[p1l881t1924r1090b1959],
74	than	IN	O	than	dep	103	SENT_13	[p1l1103t1924r1170b1952],
75	noncarriers	NNS	O	noncarrier	dep	103	SENT_13	[p1l1186t1926r1358b1952],
76	:	:	O	:	_	0	SENT_13	[p1l1186t1926r1358b1952],
77	23	CD	PERCENT	23	dep	103	SENT_13	[p1l1372t1926r1436b1952],
78	%	NN	PERCENT	%	dep	103	SENT_13	[p1l1372t1926r1436b1952],
79	versus	CC	O	versus	dep	103	SENT_13	[p1l1448t1933r1542b1952],
80	11	CD	PERCENT	11	dep	103	SENT_13	[p1l1559t1926r1627b1956],
81	%	NN	PERCENT	%	dep	103	SENT_13	[p1l1559t1926r1627b1956],
82	,	,	O	,	_	0	SENT_13	[p1l1559t1926r1627b1956],
83	(	JJ	O	(	dep	103	SENT_13	[p1l1642t1924r1724b1956],
84	odds	NNS	O	odds	dep	103	SENT_13	[p1l1642t1924r1724b1956],
85	ratio	NN	O	ratio	dep	103	SENT_13	[p1l1738t1926r1804b1952],
86	[	CD	PERCENT	[	dep	103	SENT_13	[p1l195t1974r268b2005],
87	95	CD	PERCENT	95	dep	103	SENT_13	[p1l195t1974r268b2005],
88	%	NN	PERCENT	%	dep	103	SENT_13	[p1l195t1974r268b2005],
89	conﬁdence	NN	O	conﬁdence	dep	103	SENT_13	[p1l281t1973r447b2001],
90	interval	NN	O	interval	dep	103	SENT_13	[p1l462t1973r588b2005],
91	]	CD	NUMBER	]	dep	103	SENT_13	[p1l462t1973r588b2005],
92	:	:	O	:	_	0	SENT_13	[p1l462t1973r588b2005],
93	2.5	CD	NUMBER	2.5	dep	103	SENT_13	[p1l602t1975r643b2001],
94	[	CD	NUMBER	[	dep	103	SENT_13	[p1l659t1974r709b2005],
95	1.2	CD	NUMBER	1.2	dep	103	SENT_13	[p1l659t1974r709b2005],
96	to	TO	O	to	dep	103	SENT_13	[p1l722t1978r753b2001],
97	5.4	CD	NUMBER	5.4	dep	103	SENT_13	[p1l767t1974r826b2006],
98	]	CD	NUMBER	]	dep	103	SENT_13	[p1l767t1974r826b2006],
99	;	:	O	;	_	0	SENT_13	[p1l767t1974r826b2006],
100	p	NN	O	p	dep	103	SENT_13	[p1l840t1982r858b2008],
101	=	JJ	O	=	dep	103	SENT_13	[p1l875t1984r897b1993],
102	0.02	CD	NUMBER	0.02	dep	103	SENT_13	[p1l914t1974r992b2006],
103	)	NN	O	)	_	0	SENT_13	[p1l914t1974r992b2006],
104	.	.	O	.	_	0	SENT_13	[p1l914t1974r992b2006],

1	No	DT	O	no	det	3	SENT_14	[p1l1006t1975r1047b2001],
2	signiﬁcant	NN	O	signiﬁcant	nn	3	SENT_14	[p1l1061t1973r1214b2009],
3	inﬂuence	NN	O	inﬂuence	nsubj	14	SENT_14	[p1l1228t1973r1364b2001],
4	of	IN	O	of	_	0	SENT_14	[p1l1378t1973r1409b2001],
5	genotypes	NNS	O	genotype	prep_of	3	SENT_14	[p1l1420t1978r1578b2009],
6	on	IN	O	on	_	0	SENT_14	[p1l1591t1982r1628b2001],
7	platelet	NN	O	platelet	nn	8	SENT_14	[p1l1644t1973r1755b2008],
8	reactivity	NN	O	reactivity	prep_on	5	SENT_14	[p1l195t2024r330b2058],
9	assessed	VBN	O	assess	partmod	8	SENT_14	[p1l342t2023r470b2050],
10	by	IN	O	by	_	0	SENT_14	[p1l485t2023r521b2058],
11	adenosine	NN	O	adenosine	nn	13	SENT_14	[p1l533t2023r688b2050],
12	diphosphate	NN	O	diphosphate	nn	13	SENT_14	[p1l701t2023r1030b2057],
13	—	NN	O	—	agent	9	SENT_14	[p1l701t2023r1030b2057],
14	induced	VBD	O	induce	_	0	SENT_14	[p1l701t2023r1030b2057],
15	platelet	NN	O	platelet	nn	16	SENT_14	[p1l1046t2023r1158b2057],
16	aggregation	NN	O	aggregation	nsubjpass	18	SENT_14	[p1l1170t2024r1352b2058],
17	was	VBD	O	be	auxpass	18	SENT_14	[p1l1366t2031r1424b2050],
18	obsen/ed	VBN	O	obsen/ed	ccomp	14	SENT_14	[p1l1437t2023r1582b2050],
19	.	.	O	.	_	0	SENT_14	[p1l1437t2023r1582b2050],

1	Conclusions	NNS	O	conclusion	nsubj	5	SENT_15	[p1l194t2111r395b2138],
2	The	DT	O	the	det	4	SENT_15	[p1l414t2110r470b2138],
3	present	JJ	DATE	present	amod	4	SENT_15	[p1l485t2115r597b2145],
4	study	NN	O	study	dep	1	SENT_15	[p1l610t2110r692b2146],
5	shows	VBZ	O	show	_	0	SENT_15	[p1l705t2110r798b2138],
6	a	DT	O	a	det	8	SENT_15	[p1l811t2119r826b2138],
7	signiﬁcant	JJ	O	signiﬁcant	amod	8	SENT_15	[p1l840t2110r994b2146],
8	inﬂuence	NN	O	inﬂuence	dobj	5	SENT_15	[p1l1007t2110r1144b2138],
9	of	IN	O	of	_	0	SENT_15	[p1l1158t2110r1189b2138],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_15	[p1l1200t2111r1361b2138],
11	*	NN	O	*	prep_of	8	SENT_15	[p1l1200t2111r1361b2138],
12	2	CD	NUMBER	2	num	11	SENT_15	[p1l1200t2111r1361b2138],
13	and	CC	O	and	_	0	SENT_15	[p1l1374t2110r1429b2138],
14	*	CD	NUMBER	*	number	15	SENT_15	[p1l1445t2112r1495b2138],
15	17	CD	NUMBER	17	num	16	SENT_15	[p1l1445t2112r1495b2138],
16	alleles	NNS	O	allele	dobj	5	SENT_15	[p1l1505t2110r1596b2138],
17	on	IN	O	on	_	0	SENT_15	[p1l1609t2119r1646b2138],
18	response	NN	O	response	prep_on	16	SENT_15	[p1l1662t2119r1796b2145],
19	to	TO	O	to	_	0	SENT_15	[p1l193t2165r224b2188],
20	chronic	JJ	O	chronic	amod	21	SENT_15	[p1l237t2160r347b2188],
21	treatment	NN	O	treatment	prep_to	5	SENT_15	[p1l360t2165r510b2188],
22	by	IN	O	by	_	0	SENT_15	[p1l524t2160r560b2196],
23	prasugrel	NN	O	prasugrel	nn	25	SENT_15	[p1l573t2160r711b2196],
24	10	CD	NUMBER	10	num	25	SENT_15	[p1l728t2162r761b2188],
25	mg	NN	O	mg	prep_by	21	SENT_15	[p1l775t2169r822b2196],
26	daily	JJ	SET	daily	advmod	25	SENT_15	[p1l837t2160r907b2196],
27	and	CC	O	and	_	0	SENT_15	[p1l919t2160r974b2188],
28	occurrence	NN	O	occurrence	conj_and	21	SENT_15	[p1l989t2169r1155b2188],
29	of	IN	O	of	_	0	SENT_15	[p1l1168t2160r1199b2188],
30	bleeding	VBG	O	bleed	amod	31	SENT_15	[p1l1211t2160r1341b2196],
31	complications	NNS	O	complication	prep_of	28	SENT_15	[p1l1355t2160r1571b2195],
32	.	.	O	.	_	0	SENT_15	[p1l1355t2160r1571b2195],

1	(	NN	O	(	nn	2	SENT_16	[p1l1613t2161r1632b2192],
2	J	NN	O	j	nsubj	5	SENT_16	[p1l1613t2161r1632b2192],
3	Am	VBP	O	be	cop	5	SENT_16	[p1l1647t2162r1697b2188],
4	Coll	NNP	PERSON	Coll	nn	5	SENT_16	[p1l1711t2160r1766b2188],
5	Cardiol	NNP	PERSON	Cardiol	_	0	SENT_16	[p1l194t2210r297b2238],
6	lntv	NN	O	lntv	dep	5	SENT_16	[p1l313t2212r368b2238],
7	2012	CD	DATE	2012	num	6	SENT_16	[p1l381t2211r610b2242],
8	;	:	O	;	_	0	SENT_16	[p1l381t2211r610b2242],
9	5:1280	CD	NUMBER	5:1280	num	10	SENT_16	[p1l381t2211r610b2242],
10	—	NN	O	—	dep	5	SENT_16	[p1l381t2211r610b2242],
11	7	CD	NUMBER	7	num	12	SENT_16	[p1l381t2211r610b2242],
12	)	NN	O	)	dep	10	SENT_16	[p1l381t2211r610b2242],
13	©	CD	NUMBER	©	num	14	SENT_16	[p1l624t2213r647b2237],
14	2012	CD	DATE	2012	dep	5	SENT_16	[p1l661t2212r732b2238],
15	by	IN	O	by	dep	14	SENT_16	[p1l748t2210r783b2246],
16	the	DT	O	the	det	18	SENT_16	[p1l795t2210r844b2238],
17	American	NNP	ORGANIZATION	American	nn	18	SENT_16	[p1l857t2212r998b2238],
18	College	NNP	ORGANIZATION	College	pobj	15	SENT_16	[p1l1013t2210r1125b2246],
19	of	IN	ORGANIZATION	of	dep	14	SENT_16	[p1l1138t2210r1169b2238],
20	Cardiology	NNP	ORGANIZATION	Cardiology	nn	21	SENT_16	[p1l1180t2210r1343b2246],
21	Foundation	NNP	ORGANIZATION	Foundation	pobj	19	SENT_16	[p1l1356t2210r1527b2238],

1	From	IN	O	from	dep	9	SENT_17	[p1l193t2364r257b2385],
2	the	DT	O	the	det	6	SENT_17	[p1l268t2364r304b2385],
3	*	CD	NUMBER	*	num	6	SENT_17	[p1l314t2364r479b2393],
4	Département	NNP	MISC	Département	nn	6	SENT_17	[p1l314t2364r479b2393],
5	de	IN	MISC	de	amod	6	SENT_17	[p1l489t2364r515b2385],
6	Cardiologie	NNP	MISC	Cardiologie	pobj	1	SENT_17	[p1l526t2364r669b2393],
7	,	,	O	,	_	0	SENT_17	[p1l526t2364r669b2393],
8	CHU	NNP	PERSON	CHU	nn	9	SENT_17	[p1l680t2364r747b2386],
9	Timone	NNP	PERSON	Timone	_	0	SENT_17	[p1l756t2363r857b2390],
10	,	,	O	,	_	0	SENT_17	[p1l756t2363r857b2390],
11	Marseille	NNP	LOCATION	Marseille	appos	9	SENT_17	[p1l867t2364r982b2390],
12	,	,	O	,	_	0	SENT_17	[p1l867t2364r982b2390],
13	France	NNP	LOCATION	France	dep	9	SENT_17	[p1l993t2364r1078b2390],
14	;	:	O	;	_	0	SENT_17	[p1l993t2364r1078b2390],
15	TINSERM	NNP	LOCATION	TINSERM	dep	9	SENT_17	[p1l1089t2364r1228b2390],
16	,	,	O	,	_	0	SENT_17	[p1l1089t2364r1228b2390],
17	UMR1062	NN	O	umr1062	appos	15	SENT_17	[p1l1239t2364r1374b2390],
18	,	,	O	,	_	0	SENT_17	[p1l1239t2364r1374b2390],
19	Nutrition	NNP	O	Nutrition	appos	15	SENT_17	[p1l1385t2364r1502b2390],
20	,	,	O	,	_	0	SENT_17	[p1l1385t2364r1502b2390],
21	Obesity	NNP	O	Obesity	appos	15	SENT_17	[p1l1514t2364r1605b2393],
22	and	CC	O	and	_	0	SENT_17	[p1l1614t2364r1656b2385],
23	Risk	NN	O	risk	appos	15	SENT_17	[p1l1666t2364r1719b2385],
24	of	IN	O	of	_	0	SENT_17	[p1l193t2400r220b2422],
25	Thrombosis	NN	O	thrombosis	prep_of	23	SENT_17	[p1l236t2399r388b2427],
26	,	,	O	,	_	0	SENT_17	[p1l236t2399r388b2427],
27	Marseille	NNP	LOCATION	Marseille	appos	25	SENT_17	[p1l409t2400r527b2427],
28	,	,	O	,	_	0	SENT_17	[p1l409t2400r527b2427],
29	France	NNP	LOCATION	France	appos	25	SENT_17	[p1l549t2400r636b2427],
30	;	:	O	;	_	0	SENT_17	[p1l549t2400r636b2427],
31	:	:	O	:	_	0	SENT_17	[p1l658t2400r760b2426],
32	l	NN	O	l	dep	23	SENT_17	[p1l658t2400r760b2426],
33	:	:	O	:	_	0	SENT_17	[p1l658t2400r760b2426],
34	Faculté	NNP	O	Faculté	nn	36	SENT_17	[p1l658t2400r760b2426],
35	de	NNP	O	de	nn	36	SENT_17	[p1l781t2400r808b2422],
36	Médecine	NNP	O	Médecine	dep	32	SENT_17	[p1l828t2400r953b2427],
37	,	,	O	,	_	0	SENT_17	[p1l828t2400r953b2427],
38	Aix-Marseille	NNP	PERSON	Aix-Marseille	nn	39	SENT_17	[p1l974t2399r1141b2422],
39	Université	NNP	PERSON	Université	appos	36	SENT_17	[p1l1162t2400r1291b2427],
40	,	,	O	,	_	0	SENT_17	[p1l1162t2400r1291b2427],
41	Marseille	NNP	LOCATION	Marseille	appos	36	SENT_17	[p1l1313t2400r1431b2427],
42	,	,	O	,	_	0	SENT_17	[p1l1313t2400r1431b2427],
43	France	NNP	LOCATION	France	appos	36	SENT_17	[p1l1453t2400r1540b2427],
44	;	:	O	;	_	0	SENT_17	[p1l1453t2400r1540b2427],
45	§	CD	NUMBER	§	num	47	SENT_17	[p1l1563t2400r1717b2426],
46	Laboratoire	NNP	ORGANIZATION	Laboratoire	nn	47	SENT_17	[p1l1563t2400r1717b2426],
47	d’Hématologie	NNP	ORGANIZATION	d’Hématologie	dep	23	SENT_17	[p1l193t2436r373b2465],
48	,	,	O	,	_	0	SENT_17	[p1l193t2436r373b2465],
49	CHU	NNP	PERSON	CHU	nn	50	SENT_17	[p1l386t2436r454b2458],
50	Timone	NNP	PERSON	Timone	appos	47	SENT_17	[p1l464t2435r565b2462],
51	,	,	O	,	_	0	SENT_17	[p1l464t2435r565b2462],
52	Marseille	NNP	LOCATION	Marseille	appos	47	SENT_17	[p1l577t2436r693b2462],
53	,	,	O	,	_	0	SENT_17	[p1l577t2436r693b2462],
54	France	NNP	LOCATION	France	appos	47	SENT_17	[p1l706t2436r791b2462],
55	;	:	O	;	_	0	SENT_17	[p1l706t2436r791b2462],
56	|	CD	NUMBER	|	number	57	SENT_17	[p1l805t2433r970b2465],
57	|	CD	NUMBER	|	dep	23	SENT_17	[p1l805t2433r970b2465],
58	Departement	NNP	ORGANIZATION	Departement	nn	63	SENT_17	[p1l805t2433r970b2465],
59	BESPIM	NNP	ORGANIZATION	BESPIM	nn	63	SENT_17	[p1l981t2436r1099b2462],
60	,	,	O	,	_	0	SENT_17	[p1l981t2436r1099b2462],
61	CHU	NNP	ORGANIZATION	CHU	appos	63	SENT_17	[p1l1113t2436r1180b2458],
62	de	IN	ORGANIZATION	de	amod	63	SENT_17	[p1l1192t2436r1218b2458],
63	Nimes	NNP	ORGANIZATION	Nimes	dep	57	SENT_17	[p1l1230t2436r1313b2462],
64	,	,	O	,	_	0	SENT_17	[p1l1230t2436r1313b2462],
65	Nimes	NNP	ORGANIZATION	Nimes	nn	67	SENT_17	[p1l1326t2436r1409b2462],
66	,	,	O	,	_	0	SENT_17	[p1l1326t2436r1409b2462],
67	France	NNP	LOCATION	France	appos	15	SENT_17	[p1l1422t2436r1508b2462],
68	;	:	O	;	_	0	SENT_17	[p1l1422t2436r1508b2462],
69	1	CD	NUMBER	1	number	70	SENT_17	[p1l1521t2436r1621b2465],
70	[	CD	NUMBER	[	dep	67	SENT_17	[p1l1521t2436r1621b2465],
71	Equipe	NNP	ORGANIZATION	Equipe	nn	73	SENT_17	[p1l1521t2436r1621b2465],
72	Mobile	NNP	ORGANIZATION	Mobile	nn	73	SENT_17	[p1l1633t2436r1718b2458],
73	d’Aide	NNP	O	d’Aide	dep	79	SENT_17	[p1l193t2471r269b2494],
74	a	DT	O	a	det	76	SENT_17	[p1l281t2474r293b2494],
75	1	CD	NUMBER	1	num	76	SENT_17	[p1l303t2472r468b2501],
76	’	CD	NUMBER	’	dep	73	SENT_17	[p1l303t2472r468b2501],
77	Investigation	NNP	O	Investigation	dep	79	SENT_17	[p1l303t2472r468b2501],
78	(	CD	NUMBER	(	num	79	SENT_17	[p1l480t2471r585b2498],
79	EMAI	NNP	O	EMAI	dep	67	SENT_17	[p1l480t2471r585b2498],
80	)	CD	NUMBER	)	num	79	SENT_17	[p1l480t2471r585b2498],
81	,	,	O	,	_	0	SENT_17	[p1l480t2471r585b2498],
82	Assistance	NNP	O	Assistance	nn	85	SENT_17	[p1l596t2471r718b2494],
83	Publique-Hopitaux	NNP	O	Publique-Hopitaux	nn	85	SENT_17	[p1l730t2472r957b2501],
84	de	IN	O	de	amod	85	SENT_17	[p1l967t2472r994b2494],
85	Marseille	NNP	ORGANIZATION	Marseille	appos	79	SENT_17	[p1l1004t2472r1119b2498],
86	,	,	O	,	_	0	SENT_17	[p1l1004t2472r1119b2498],
87	Marseille	NNP	LOCATION	Marseille	appos	79	SENT_17	[p1l1131t2472r1246b2498],
88	,	,	O	,	_	0	SENT_17	[p1l1131t2472r1246b2498],
89	France	NNP	LOCATION	France	appos	79	SENT_17	[p1l1258t2472r1343b2498],
90	;	:	O	;	_	0	SENT_17	[p1l1258t2472r1343b2498],
91	and	CC	O	and	_	0	SENT_17	[p1l1355t2472r1397b2494],
92	#HIA	NNP	O	#HIA	nn	97	SENT_17	[p1l1407t2471r1480b2494],
93	Laveran	NNP	O	Laveran	nn	97	SENT_17	[p1l1491t2472r1591b2498],
94	,	,	O	,	_	0	SENT_17	[p1l1491t2472r1591b2498],
95	Marseille	NNP	LOCATION	Marseille	appos	97	SENT_17	[p1l1602t2472r1717b2498],
96	,	,	O	,	_	0	SENT_17	[p1l1602t2472r1717b2498],
97	France	NNP	LOCATION	France	dep	9	SENT_17	[p1l193t2507r278b2529],
98	.	.	O	.	_	0	SENT_17	[p1l193t2507r278b2529],

1	Dr.	NNP	O	Dr.	nn	2	SENT_18	[p1l290t2508r329b2529],
2	Cuisset	NNP	PERSON	Cuisset	nsubj	4	SENT_18	[p1l341t2507r427b2530],
3	has	VBZ	O	have	aux	4	SENT_18	[p1l437t2507r474b2529],
4	received	VBN	O	receive	_	0	SENT_18	[p1l485t2507r580b2529],
5	consultant	NN	O	consultant	nn	6	SENT_18	[p1l591t2507r711b2529],
6	fees	NNS	O	fee	dobj	4	SENT_18	[p1l721t2507r764b2529],
7	from	IN	O	from	_	0	SENT_18	[p1l775t2507r831b2529],
8	Daiichi-Sankyo	NNP	LOCATION	Daiichi-Sankyo	nn	11	SENT_18	[p1l842t2507r1025b2537],
9	and	CC	O	and	_	0	SENT_18	[p1l1037t2507r1079b2529],
10	Eli	NNP	PERSON	Eli	nn	11	SENT_18	[p1l1090t2507r1124b2529],
11	Lilly	NNP	PERSON	Lilly	prep_from	4	SENT_18	[p1l1135t2507r1195b2537],
12	,	,	O	,	_	0	SENT_18	[p1l1135t2507r1195b2537],
13	and	CC	O	and	_	0	SENT_18	[p1l1207t2507r1249b2529],
14	lectu	NN	O	lectu	prep_from	4	SENT_18	[p1l1259t2507r1337b2529],
15	.	.	O	.	_	0	SENT_18	[p1l1259t2507r1337b2529],

1	re	NN	O	re	nn	2	SENT_19	[p1l1259t2507r1337b2529],
2	fees	NNS	O	fee	_	0	SENT_19	[p1l1347t2507r1390b2529],
3	from	IN	O	from	_	0	SENT_19	[p1l1401t2507r1458b2529],
4	Astrazeneca	NNP	ORGANIZATION	Astrazeneca	prep_from	2	SENT_19	[p1l1467t2507r1623b2534],
5	,	,	O	,	_	0	SENT_19	[p1l1467t2507r1623b2534],
6	Abbott	NNP	ORGANIZATION	Abbott	nn	7	SENT_19	[p1l1634t2507r1718b2529],
7	Vascular	NNP	ORGANIZATION	Vascular	appos	2	SENT_19	[p1l193t2543r299b2570],
8	,	,	O	,	_	0	SENT_19	[p1l193t2543r299b2570],
9	Biotronik	NNP	ORGANIZATION	Biotronik	appos	2	SENT_19	[p1l311t2543r430b2570],
10	,	,	O	,	_	0	SENT_19	[p1l311t2543r430b2570],
11	Boston	NNP	ORGANIZATION	Boston	nn	12	SENT_19	[p1l442t2544r524b2565],
12	Scientiﬁc	NNP	ORGANIZATION	Scientiﬁc	appos	2	SENT_19	[p1l537t2543r650b2570],
13	,	,	O	,	_	0	SENT_19	[p1l537t2543r650b2570],
14	Cordis	NNP	ORGANIZATION	Cordis	appos	2	SENT_19	[p1l663t2543r747b2570],
15	,	,	O	,	_	0	SENT_19	[p1l663t2543r747b2570],
16	Daiichi	NNP	ORGANIZATION	Daiichi	appos	2	SENT_19	[p1l760t2543r950b2573],
17	.	.	O	.	_	0	SENT_19	[p1l760t2543r950b2573],

1	—	NN	O	—	_	0	SENT_20	[p1l760t2543r950b2573],
2	.	.	O	.	_	0	SENT_20	[p1l760t2543r950b2573],

1	Sa	NN	O	sa	_	0	SENT_21	[p1l760t2543r950b2573],
2	.	.	O	.	_	0	SENT_21	[p1l760t2543r950b2573],

1	nkyo	NN	O	nkyo	_	0	SENT_22	[p1l760t2543r950b2573],
2	,	,	O	,	_	0	SENT_22	[p1l760t2543r950b2573],
3	Edwards	NNP	PERSON	Edwards	appos	1	SENT_22	[p1l963t2543r1071b2570],
4	,	,	O	,	_	0	SENT_22	[p1l963t2543r1071b2570],
5	Eli	NNP	PERSON	Eli	nn	6	SENT_22	[p1l1084t2543r1118b2565],
6	Lilly	NNP	PERSON	Lilly	appos	1	SENT_22	[p1l1129t2543r1189b2573],
7	,	,	O	,	_	0	SENT_22	[p1l1129t2543r1189b2573],
8	Sanoﬁ-Aventis	NNP	PERSON	Sanoﬁ-Aventis	appos	1	SENT_22	[p1l1203t2543r1383b2570],
9	,	,	O	,	_	0	SENT_22	[p1l1203t2543r1383b2570],
10	and	CC	O	and	_	0	SENT_22	[p1l1396t2543r1438b2565],
11	Servier	NNP	ORGANIZATION	Servier	appos	1	SENT_22	[p1l1450t2543r1535b2566],
12	.	.	O	.	_	0	SENT_22	[p1l1450t2543r1535b2566],

1	Dr.	NNP	O	Dr.	nn	2	SENT_23	[p1l1548t2544r1587b2565],
2	Alessi	NNP	PERSON	Alessi	nsubj	8	SENT_23	[p1l1599t2543r1669b2565],
3	has	VBZ	O	have	aux	8	SENT_23	[p1l1680t2543r1717b2565],
4	been	VBN	O	be	cop	8	SENT_23	[p1l193t2580r247b2602],
5	a	DT	O	a	det	8	SENT_23	[p1l257t2588r268b2602],
6	regional	JJ	O	regional	amod	8	SENT_23	[p1l277t2580r371b2609],
7	board	NN	O	board	nn	8	SENT_23	[p1l379t2580r445b2602],
8	member	NN	O	member	_	0	SENT_23	[p1l454t2580r550b2602],
9	of	IN	O	of	_	0	SENT_23	[p1l559t2580r585b2602],
10	Eli	NNP	ORGANIZATION	Eli	nn	11	SENT_23	[p1l591t2580r625b2601],
11	Lilly	NNP	ORGANIZATION	Lilly	prep_of	8	SENT_23	[p1l634t2580r689b2609],
12	and	CC	O	and	_	0	SENT_23	[p1l697t2580r739b2602],
13	received	VBD	O	receive	conj_and	8	SENT_23	[p1l748t2580r842b2602],
14	research	NN	O	research	nn	15	SENT_23	[p1l851t2580r946b2602],
15	funding	NN	O	funding	dobj	13	SENT_23	[p1l954t2580r1046b2609],
16	from	IN	O	from	_	0	SENT_23	[p1l1054t2580r1111b2602],
17	Sanoﬁ	NNP	LOCATION	Sanoﬁ	prep_from	13	SENT_23	[p1l1121t2579r1301b2602],
18	.	.	O	.	_	0	SENT_23	[p1l1121t2579r1301b2602],

1	—	NN	O	—	_	0	SENT_24	[p1l1121t2579r1301b2602],
2	.	.	O	.	_	0	SENT_24	[p1l1121t2579r1301b2602],

1	Aventis	NNP	O	Aventis	_	0	SENT_25	[p1l1121t2579r1301b2602],
2	.	.	O	.	_	0	SENT_25	[p1l1121t2579r1301b2602],

1	The	DT	O	the	det	3	SENT_26	[p1l1310t2579r1359b2602],
2	other	JJ	O	other	amod	3	SENT_26	[p1l1368t2580r1430b2602],
3	authors	NNS	O	author	nsubj	5	SENT_26	[p1l1439t2580r1524b2602],
4	have	VBP	O	have	aux	5	SENT_26	[p1l1533t2580r1585b2602],
5	stated	VBN	O	state	_	0	SENT_26	[p1l1595t2580r1663b2602],
6	that	IN	O	that	complm	8	SENT_26	[p1l1672t2580r1718b2602],
7	they	PRP	O	they	nsubj	8	SENT_26	[p1l193t2616r244b2645],
8	have	VBP	O	have	ccomp	5	SENT_26	[p1l253t2616r305b2638],
9	no	DT	O	no	det	10	SENT_26	[p1l316t2624r345b2638],
10	relationships	NNS	O	relationship	nsubj	11	SENT_26	[p1l355t2616r503b2645],
11	relevant	JJ	O	relevant	xcomp	8	SENT_26	[p1l514t2616r606b2638],
12	to	TO	O	to	_	0	SENT_26	[p1l616t2621r638b2638],
13	the	DT	O	the	det	14	SENT_26	[p1l650t2616r686b2638],
14	contents	NNS	O	contents	prep_to	11	SENT_26	[p1l697t2621r794b2638],
15	of	IN	O	of	_	0	SENT_26	[p1l806t2616r832b2638],
16	this	DT	O	this	det	17	SENT_26	[p1l839t2616r880b2638],
17	paper	NN	O	paper	prep_of	14	SENT_26	[p1l891t2624r956b2645],
18	to	TO	O	to	aux	19	SENT_26	[p1l966t2621r989b2638],
19	disclose	VB	O	disclose	infmod	17	SENT_26	[p1l1000t2616r1095b2638],
20	.	.	O	.	_	0	SENT_26	[p1l1000t2616r1095b2638],

1	Manuscript	NN	O	manuscript	nsubj	2	SENT_27	[p1l192t2652r328b2681],
2	received	VBD	O	receive	_	0	SENT_27	[p1l338t2652r433b2674],
3	June	NNP	DATE	June	tmod	2	SENT_27	[p1l440t2652r494b2680],
4	4	CD	DATE	4	num	3	SENT_27	[p1l505t2653r525b2678],
5	,	,	DATE	,	_	0	SENT_27	[p1l505t2653r525b2678],
6	2012	CD	DATE	2012	num	3	SENT_27	[p1l536t2653r601b2678],
7	;	:	O	;	_	0	SENT_27	[p1l536t2653r601b2678],
8	revised	VBN	O	revise	amod	9	SENT_27	[p1l612t2652r692b2674],
9	manuscript	NN	O	manuscript	nsubj	16	SENT_27	[p1l703t2653r833b2681],
10	received	VBN	O	receive	partmod	9	SENT_27	[p1l843t2652r937b2674],
11	July	NNP	DATE	July	tmod	10	SENT_27	[p1l945t2652r993b2681],
12	10	CD	DATE	10	num	11	SENT_27	[p1l1004t2653r1037b2678],
13	,	,	DATE	,	_	0	SENT_27	[p1l1004t2653r1037b2678],
14	2012	CD	DATE	2012	num	11	SENT_27	[p1l1048t2653r1112b2678],
15	,	,	O	,	_	0	SENT_27	[p1l1048t2653r1112b2678],
16	accepted	VBN	O	accept	parataxis	2	SENT_27	[p1l1125t2652r1224b2681],
17	July	NNP	DATE	July	tmod	16	SENT_27	[p1l1231t2652r1280b2681],
18	19	CD	DATE	19	num	17	SENT_27	[p1l1290t2653r1324b2678],
19	,	,	DATE	,	_	0	SENT_27	[p1l1290t2653r1324b2678],
20	2012	CD	DATE	2012	num	17	SENT_27	[p1l1335t2653r1399b2674],
21	.	.	O	.	_	0	SENT_27	[p1l1335t2653r1399b2674],

1	JACC	NN	O	jacc	_	0	SENT_28	[p1l8t2841r158b2872],
2	:	:	O	:	_	0	SENT_28	[p1l8t2841r158b2872],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_28	[p1l193t2841r692b2872],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_28	[p1l728t2841r1187b2877],
5	,	,	O	,	_	0	SENT_28	[p1l728t2841r1187b2877],
6	VOL	NNP	O	VOL	appos	4	SENT_28	[p1l1221t2841r1344b2872],
7	.	.	O	.	_	0	SENT_28	[p1l1221t2841r1344b2872],

1	5	CD	NUMBER	5	_	0	SENT_29	[p1l1380t2842r1422b2877],
2	,	,	O	,	_	0	SENT_29	[p1l1380t2842r1422b2877],
3	NO.	NNP	DATE	NO.	appos	1	SENT_29	[p1l1459t2841r1549b2872],
4	12	CD	DATE	12	num	3	SENT_29	[p1l1587t2842r1662b2877],
5	,	,	DATE	,	_	0	SENT_29	[p1l1587t2842r1662b2877],
6	2012	CD	DATE	2012	num	3	SENT_29	[p1l1698t2842r1822b2872],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_29	[p1l11t2905r295b2937],
8	2012:1280	CD	NUMBER	2012:1280	num	7	SENT_29	[p1l327t2906r682b2937],
9	—	CD	NUMBER	—	number	10	SENT_29	[p1l327t2906r682b2937],
10	7	CD	NUMBER	7	dep	7	SENT_29	[p1l327t2906r682b2937],

1	Dual	JJ	O	dual	amod	3	SENT_30	[p1l10t3098r180b3164],
2	antiplatelet	JJ	O	antiplatelet	amod	3	SENT_30	[p1l204t3097r580b3187],
3	therapy	NN	O	therapy	nsubj	13	SENT_30	[p1l601t3097r858b3187],
4	with	IN	O	with	_	0	SENT_30	[p1l873t3097r1029b3164],
5	aspirin	NN	O	aspirin	prep_with	3	SENT_30	[p1l1053t3100r1279b3187],
6	and	CC	O	and	_	0	SENT_30	[p1l1303t3097r1427b3164],
7	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_30	[p1l1450t3097r1827b3187],
8	has	VBZ	O	have	aux	13	SENT_30	[p1l1848t3097r1957b3164],
9	been	VBN	O	be	cop	13	SENT_30	[p1l1979t3097r2140b3164],
10	the	DT	O	the	det	13	SENT_30	[p1l10t3205r116b3271],
11	gold	JJ	O	gold	amod	13	SENT_30	[p1l147t3205r297b3294],
12	standard	NN	O	standard	nn	13	SENT_30	[p1l329t3205r619b3271],
13	therapy	NN	O	therapy	_	0	SENT_30	[p1l649t3205r906b3294],
14	for	IN	O	for	_	0	SENT_30	[p1l933t3205r1030b3271],
15	patients	NNS	O	patient	prep_for	13	SENT_30	[p1l1059t3208r1323b3294],
16	undergoing	VBG	O	undergo	partmod	15	SENT_30	[p1l1355t3205r1747b3294],
17	percutane	NN	O	percutane	nn	18	SENT_30	[p1l1775t3222r2137b3294],
18	—	NN	O	—	dobj	16	SENT_30	[p1l1775t3222r2137b3294],
19	ous	JJ	O	ous	amod	21	SENT_30	[p1l11t3337r122b3377],
20	coronary	JJ	O	coronary	amod	21	SENT_30	[p1l158t3336r455b3400],
21	interventions	NNS	O	intervention	nsubj	22	SENT_30	[p1l485t3314r925b3377],
22	(	VBP	O	(	rcmod	18	SENT_30	[p1l963t3309r1158b3391],
23	PCI	NN	O	pcus	nn	24	SENT_30	[p1l963t3309r1158b3391],
24	)	NN	O	)	dobj	22	SENT_30	[p1l963t3309r1158b3391],
25	and	CC	O	and	_	0	SENT_30	[p1l1196t3311r1350b3377],
26	/	:	O	/	punct	33	SENT_30	[p1l1196t3311r1350b3377],
27	or	CC	O	or	cc	33	SENT_30	[p1l1351t3336r1422b3377],
28	after	IN	O	after	_	0	SENT_30	[p1l1454t3311r1606b3377],
29	acute	JJ	O	acute	amod	31	SENT_30	[p1l1639t3328r1812b3377],
30	coronary	JJ	O	coronary	amod	31	SENT_30	[p1l1847t3336r2145b3400],
31	syndrome	NN	O	syndrome	prep_after	33	SENT_30	[p1l11t3416r342b3505],
32	(	CD	NUMBER	(	num	33	SENT_30	[p1l368t3414r591b3496],
33	ACS	NN	ORGANIZATION	ac	dep	24	SENT_30	[p1l368t3414r591b3496],
34	)	CD	NUMBER	)	number	35	SENT_30	[p1l368t3414r591b3496],
35	(	CD	NUMBER	(	dep	33	SENT_30	[p1l620t3414r816b3496],
36	1-3	CD	NUMBER	1-3	num	37	SENT_30	[p1l620t3414r816b3496],
37	)	NN	O	)	conj_and	24	SENT_30	[p1l620t3414r816b3496],
38	.	.	O	.	_	0	SENT_30	[p1l620t3414r816b3496],

1	The	DT	O	the	det	3	SENT_31	[p1l840t3414r983b3482],
2	large	JJ	O	large	amod	3	SENT_31	[p1l1005t3416r1168b3505],
3	Variability	NN	O	variability	nsubjpass	10	SENT_31	[p1l1188t3416r1525b3505],
4	of	IN	O	of	_	0	SENT_31	[p1l1545t3416r1623b3482],
5	the	DT	O	the	det	7	SENT_31	[p1l1633t3416r1740b3482],
6	clopidogrel	NN	O	clopidogrel	nn	7	SENT_31	[p1l1765t3416r2141b3505],
7	response	NN	O	response	prep_of	3	SENT_31	[p1l10t3548r300b3611],
8	has	VBZ	O	have	aux	10	SENT_31	[p1l343t3522r451b3588],
9	been	VBN	O	be	auxpass	10	SENT_31	[p1l492t3522r654b3588],
10	described	VBN	O	describe	_	0	SENT_31	[p1l696t3522r1014b3588],
11	with	IN	O	with	_	0	SENT_31	[p1l1051t3522r1207b3588],
12	clinical	JJ	O	clinical	amod	13	SENT_31	[p1l1249t3522r1486b3588],
13	consequences	NNS	O	consequence	prep_with	10	SENT_31	[p1l1527t3548r1980b3611],
14	+	CC	O	+	_	0	SENT_31	[p1l2026t3520r2136b3602],
15	After	IN	O	after	_	0	SENT_31	[p1l8t3627r192b3694],
16	intestinal	JJ	O	intestinal	amod	17	SENT_31	[p1l217t3628r528b3694],
17	absorption	NN	O	absorption	prep_after	27	SENT_31	[p1l556t3628r931b3717],
18	,	,	O	,	_	0	SENT_31	[p1l556t3628r931b3717],
19	clopidogrel	NN	O	clopidogrel	nn	20	SENT_31	[p1l962t3628r1339b3718],
20	biotransformation	NN	O	biotransformation	appos	17	SENT_31	[p1l1363t3628r1978b3694],
21	into	IN	O	into	_	0	SENT_31	[p1l2005t3631r2138b3694],
22	its	PRP$	O	its	poss	24	SENT_31	[p1l10t3737r85b3800],
23	active	JJ	O	active	amod	24	SENT_31	[p1l112t3737r300b3800],
24	metabolite	NN	O	metabolite	prep_into	20	SENT_31	[p1l326t3734r683b3800],
25	is	VBZ	O	be	auxpass	27	SENT_31	[p1l707t3737r756b3800],
26	mainly	RB	O	mainly	advmod	27	SENT_31	[p1l782t3734r1015b3823],
27	mediated	VBN	O	mediate	conj_+	10	SENT_31	[p1l1036t3734r1350b3800],
28	by	IN	O	by	_	0	SENT_31	[p1l1371t3734r1455b3823],
29	hepatic	JJ	O	hepatic	amod	30	SENT_31	[p1l1475t3734r1720b3824],
30	cytochrome	NN	O	cytochrome	agent	27	SENT_31	[p1l1744t3734r2139b3823],

1	P450	NN	O	p450	nn	2	SENT_32	[p2l10t17r187b83],
2	1H	NN	O	1h	nsubj	6	SENT_32	[p2l224t15r466b97],
3	+	CC	O	+	_	0	SENT_32	[p2l224t15r466b97],
4	Recent	JJ	O	recent	amod	5	SENT_32	[p2l505t18r742b83],
5	data	NNS	O	datum	nsubj	6	SENT_32	[p2l775t17r917b83],
6	showed	VBD	O	show	_	0	SENT_32	[p2l950t17r1206b83],
7	that	IN	O	that	complm	19	SENT_32	[p2l1238t17r1374b83],
8	the	DT	O	the	det	10	SENT_32	[p2l1405t17r1512b83],
9	C'YP	NN	O	c'yp	nn	10	SENT_32	[p2l1552t20r1838b83],
10	2C1	NN	O	2c1	nsubjpass	19	SENT_32	[p2l1552t20r1838b83],
11	9	CD	NUMBER	9	num	12	SENT_32	[p2l1847t20r1952b83],
12	*	NN	O	*	dep	10	SENT_32	[p2l1847t20r1952b83],
13	2	CD	NUMBER	2	num	15	SENT_32	[p2l1847t20r1952b83],
14	lossof	JJ	O	lossof	amod	15	SENT_32	[p2l1983t17r2137b83, p2l11t122r397b188],
15	—	NN	O	—	dep	10	SENT_32	[p2l1983t17r2137b83, p2l11t122r397b188],
16	function	NN	O	function	nn	17	SENT_32	[p2l1983t17r2137b83, p2l11t122r397b188],
17	allele	NN	O	allele	dep	15	SENT_32	[p2l448t122r615b188],
18	is	VBZ	O	be	auxpass	19	SENT_32	[p2l666t125r714b188],
19	associated	VBN	O	associate	ccomp	6	SENT_32	[p2l767t122r1104b188],
20	with	IN	O	with	_	0	SENT_32	[p2l1149t122r1305b188],
21	a	DT	O	a	det	23	SENT_32	[p2l1356t148r1390b188],
22	marked	JJ	O	marked	amod	23	SENT_32	[p2l1439t122r1695b188],
23	decrease	NN	O	decrease	prep_with	19	SENT_32	[p2l1745t122r2024b188],
24	in	IN	O	in	_	0	SENT_32	[p2l2074t125r2140b187],
25	platelet	NN	O	platelet	nn	26	SENT_32	[p2l9t228r258b318],
26	response	NN	O	response	prep_in	23	SENT_32	[p2l282t254r572b318],
27	to	TO	O	to	_	0	SENT_32	[p2l599t245r665b294],
28	clopidogrel	NN	O	clopidogrel	prep_to	19	SENT_32	[p2l694t228r1072b318],
29	in	IN	O	in	_	0	SENT_32	[p2l1097t231r1162b294],
30	unstable	JJ	O	unstable	amod	31	SENT_32	[p2l1188t228r1468b294],
31	patients	NNS	O	patient	prep_in	28	SENT_32	[p2l1494t231r1759b318],
32	(	IN	O	(	_	0	SENT_32	[p2l1790t226r1879b309],
33	5	CD	NUMBER	5	num	34	SENT_32	[p2l1790t226r1879b309],
34	)	NN	O	)	prep_(	19	SENT_32	[p2l1790t226r1879b309],
35	and	CC	O	and	_	0	SENT_32	[p2l1911t228r2035b294],
36	an	DT	O	a	det	46	SENT_32	[p2l2062t255r2140b294],
37	impaired	JJ	O	impaired	dep	38	SENT_32	[p2l10t371r312b461],
38	prognosis	NN	O	prognosis	amod	46	SENT_32	[p2l353t374r677b461],
39	in	IN	O	in	_	0	SENT_32	[p2l721t374r787b437],
40	clopidogrel	NN	O	clopidogrel	nn	41	SENT_32	[p2l830t371r1476b461],
41	—	NN	O	—	prep_in	38	SENT_32	[p2l830t371r1476b461],
42	treated	VBN	O	treat	partmod	41	SENT_32	[p2l830t371r1476b461],
43	patients	NNS	O	patient	dobj	42	SENT_32	[p2l1516t374r1781b461],
44	(	CD	NUMBER	(	number	45	SENT_32	[p2l1828t369r2001b452],
45	6,7	CD	NUMBER	6,7	num	46	SENT_32	[p2l1828t369r2001b452],
46	)	NN	O	)	conj_and	34	SENT_32	[p2l1828t369r2001b452],
47	.	.	O	.	_	0	SENT_32	[p2l1828t369r2001b452],

1	By	IN	O	by	_	0	SENT_33	[p2l2048t372r2144b461],
2	contrast	NN	O	contrast	prep_by	53	SENT_33	[p2l11t495r297b558],
3	,	,	O	,	_	0	SENT_33	[p2l11t495r297b558],
4	the	DT	O	the	det	6	SENT_33	[p2l346t477r453b544],
5	gain	NN	O	gain	nn	6	SENT_33	[p2l499t477r1066b567],
6	—	NN	O	—	nsubj	53	SENT_33	[p2l499t477r1066b567],
7	of	IN	O	of	_	0	SENT_33	[p2l499t477r1066b567],
8	—	CD	NUMBER	—	num	11	SENT_33	[p2l499t477r1066b567],
9	function	NN	O	function	nn	11	SENT_33	[p2l499t477r1066b567],
10	allele	NN	O	allele	nn	11	SENT_33	[p2l1114t477r1282b544],
11	CYP2C19	NN	O	cyp2c19	prep_of	6	SENT_33	[p2l1336t481r1732b545],
12	*	CD	NUMBER	*	nsubjpass	17	SENT_33	[p2l1336t481r1732b545],
13	J	NN	O	j	amod	12	SENT_33	[p2l1336t481r1732b545],
14	7	CD	NUMBER	7	number	13	SENT_33	[p2l1745t482r1782b544],
15	has	VBZ	O	have	aux	17	SENT_33	[p2l1824t477r1933b544],
16	been	VBN	O	be	auxpass	17	SENT_33	[p2l1979t477r2140b544],
17	linked	VBN	O	link	rcmod	11	SENT_33	[p2l9t583r221b650],
18	with	IN	O	with	_	0	SENT_33	[p2l243t583r394b650],
19	a	DT	O	a	det	21	SENT_33	[p2l421t610r455b650],
20	better	JJR	O	better	amod	21	SENT_33	[p2l477t583r667b650],
21	response	NN	O	response	prep_with	17	SENT_33	[p2l690t609r968b673],
22	to	TO	O	to	_	0	SENT_33	[p2l994t601r1059b650],
23	clopidogrel	NN	O	clopidogrel	nn	24	SENT_33	[p2l1086t583r1445b673],
24	(	NN	O	(	prep_to	21	SENT_33	[p2l1472t581r1558b664],
25	8	CD	NUMBER	8	num	26	SENT_33	[p2l1472t581r1558b664],
26	)	NN	O	)	dobj	17	SENT_33	[p2l1472t581r1558b664],
27	and	CC	O	and	_	0	SENT_33	[p2l1589t583r1724b664],
28	,	,	O	,	_	0	SENT_33	[p2l1589t583r1724b664],
29	accordingly	RB	O	accordingly	dep	26	SENT_33	[p2l1754t583r2137b673],
30	,	,	O	,	_	0	SENT_33	[p2l1754t583r2137b673],
31	a	DT	O	a	det	33	SENT_33	[p2l11t716r46b756],
32	higher	JJR	O	higher	amod	33	SENT_33	[p2l72t690r283b779],
33	risk	NN	O	risk	dobj	17	SENT_33	[p2l309t690r429b756],
34	of	IN	O	of	_	0	SENT_33	[p2l453t690r530b756],
35	bleeding	VBG	O	bleed	prepc_of	33	SENT_33	[p2l543t690r822b779],
36	4	CD	NUMBER	4	dobj	35	SENT_33	[p2l851t688r955b770],
37	`	``	O	`	_	0	SENT_33	[p2l851t688r955b770],
38	H	NN	O	h	dobj	35	SENT_33	[p2l851t688r955b770],
39	+	CC	O	+	_	0	SENT_33	[p2l851t688r955b770],
40	Recently	RB	DATE	recently	advmod	17	SENT_33	[p2l989t690r1286b779],
41	,	,	O	,	_	0	SENT_33	[p2l989t690r1286b779],
42	a	DT	O	a	det	45	SENT_33	[p2l1318t716r1352b756],
43	third	JJ	ORDINAL	third	amod	45	SENT_33	[p2l1378t690r1913b779],
44	—	NN	O	—	nn	45	SENT_33	[p2l1378t690r1913b779],
45	generation	NN	O	generation	nsubj	48	SENT_33	[p2l1378t690r1913b779],
46	thien	JJ	O	thien	amod	48	SENT_33	[p2l1940t690r2137b756],
47	—	NN	O	—	nn	48	SENT_33	[p2l1940t690r2137b756],
48	opyridine	NN	O	opyridine	conj_+	17	SENT_33	[p2l11t797r332b886],
49	,	,	O	,	_	0	SENT_33	[p2l11t797r332b886],
50	prasugrel	NN	O	prasugrel	appos	48	SENT_33	[p2l353t797r663b886],
51	,	,	O	,	_	0	SENT_33	[p2l353t797r663b886],
52	has	VBZ	O	have	aux	53	SENT_33	[p2l685t797r790b863],
53	provided	VBN	O	provide	_	0	SENT_33	[p2l810t797r1096b886],
54	faster	RBR	O	faster	advmod	53	SENT_33	[p2l1114t797r1303b878],
55	,	,	O	,	_	0	SENT_33	[p2l1114t797r1303b878],
56	more	RBR	O	more	advmod	57	SENT_33	[p2l1326t822r1494b863],
57	potent	JJ	O	potent	amod	61	SENT_33	[p2l1513t814r1727b886],
58	and	CC	O	and	_	0	SENT_33	[p2l1745t797r1865b863],
59	predictable	JJ	O	predictable	amod	61	SENT_33	[p2l1882t797r2137b886, p2l11t902r138b968],
60	platelet	NN	O	platelet	nn	61	SENT_33	[p2l169t902r405b991],
61	inhibition	NN	O	inhibition	dobj	53	SENT_33	[p2l434t902r754b968],
62	compared	VBN	O	compare	prep	61	SENT_33	[p2l785t902r1107b991],
63	vvith	NN	O	vvith	nn	64	SENT_33	[p2l1134t902r1284b968],
64	clopidogrel	NN	O	clopidogrel	dep	62	SENT_33	[p2l1316t902r1675b991],
65	(	CD	NUMBER	(	number	66	SENT_33	[p2l1707t900r1954b983],
66	10,11	CD	NUMBER	10,11	num	67	SENT_33	[p2l1707t900r1954b983],
67	)	NN	O	)	dep	64	SENT_33	[p2l1707t900r1954b983],
68	.	.	O	.	_	0	SENT_33	[p2l1707t900r1954b983],

1	This	DT	O	this	det	3	SENT_34	[p2l1986t900r2138b968],
2	higher	JJR	O	higher	amod	3	SENT_34	[p2l10t1008r222b1097],
3	degree	NN	O	degree	nsubjpass	16	SENT_34	[p2l268t1008r479b1097],
4	of	IN	O	of	_	0	SENT_34	[p2l528t1008r604b1074],
5	platelet	NN	O	platelet	nn	6	SENT_34	[p2l638t1008r874b1097],
6	inhibition	NN	O	inhibition	prep_of	3	SENT_34	[p2l920t1008r1240b1074],
7	resulting	VBG	O	result	partmod	6	SENT_34	[p2l1287t1008r1568b1097],
8	in	IN	O	in	_	0	SENT_34	[p2l1613t1011r1677b1073],
9	a	DT	O	a	det	11	SENT_34	[p2l1726t1034r1761b1074],
10	signiﬁcant	JJ	O	signiﬁcant	amod	11	SENT_34	[p2l1808t1008r2142b1097],
11	reduction	NN	O	reduction	prep_in	7	SENT_34	[p2l10t1113r318b1179],
12	of	IN	O	of	_	0	SENT_34	[p2l351t1113r427b1179],
13	ischemic	JJ	O	ischemic	amod	14	SENT_34	[p2l447t1113r729b1179],
14	events	NNS	O	event	prep_of	11	SENT_34	[p2l762t1130r959b1179],
15	was	VBD	O	be	auxpass	16	SENT_34	[p2l989t1139r1111b1179],
16	associated	VBN	O	associate	_	0	SENT_34	[p2l1147t1113r1467b1179],
17	with	IN	O	with	_	0	SENT_34	[p2l1495t1113r1646b1179],
18	an	DT	O	a	det	19	SENT_34	[p2l1679t1139r1756b1179],
19	increase	NN	O	increase	prep_with	16	SENT_34	[p2l1788t1116r2042b1179],
20	of	IN	O	of	_	0	SENT_34	[p2l2076t1113r2152b1179],
21	bleeding	VBG	O	bleed	prepc_of	19	SENT_34	[p2l8t1219r288b1308],
22	complications	NNS	O	complication	dobj	21	SENT_34	[p2l314t1219r759b1309],
23	in	IN	O	in	_	0	SENT_34	[p2l788t1222r852b1285],
24	the	DT	O	the	det	27	SENT_34	[p2l879t1219r982b1285],
25	overall	JJ	O	overall	amod	27	SENT_34	[p2l1011t1219r1222b1285],
26	TRITON	NNP	ORGANIZATION	TRITON	nn	27	SENT_34	[p2l1244t1217r1588b1286],
27	TIMI	NNP	O	TIMI	prep_in	22	SENT_34	[p2l1614t1217r1816b1285],
28	38	CD	NUMBER	38	number	29	SENT_34	[p2l1847t1222r1924b1286],
29	(	CD	NUMBER	(	num	30	SENT_34	[p2l1958t1217r2141b1299],
30	Trial	NN	O	trial	tmod	21	SENT_34	[p2l1958t1217r2141b1299],
31	to	TO	O	to	aux	32	SENT_34	[p2l10t1343r74b1392],
32	Assess	VB	O	assess	infmod	30	SENT_34	[p2l94t1325r305b1392],
33	Improvement	NN	O	improvement	dobj	32	SENT_34	[p2l327t1327r777b1416],
34	in	IN	O	in	_	0	SENT_34	[p2l796t1329r860b1391],
35	Therapeutic	JJ	O	therapeutic	amod	36	SENT_34	[p2l878t1324r1277b1416],
36	Outcomes	NNS	O	outcome	prep_in	33	SENT_34	[p2l1300t1326r1636b1393],
37	by	IN	O	by	_	0	SENT_34	[p2l1657t1326r1739b1415],
38	Optimizing	VBG	O	optimize	prepc_by	32	SENT_34	[p2l1758t1326r2142b1416],
39	Platelet	NN	O	platelet	nn	40	SENT_34	[p2l10t1432r254b1499],
40	Inhibition	NN	O	inhibition	dobj	38	SENT_34	[p2l288t1432r617b1498],
41	with	IN	O	with	_	0	SENT_34	[p2l650t1432r801b1499],
42	Prasugrel-Thrombolysis	NN	PERSON	prasugrel-thrombolysis	prep_with	38	SENT_34	[p2l839t1431r1630b1521],
43	in	IN	O	in	_	0	SENT_34	[p2l1669t1435r1733b1498],
44	Myocardial	JJ	O	myocardial	amod	47	SENT_34	[p2l1768t1432r2141b1521],
45	Infarction	NN	O	infarction	nn	47	SENT_34	[p2l9t1536r353b1619],
46	)	NN	O	)	nn	47	SENT_34	[p2l9t1536r353b1619],
47	study	NN	O	study	prep_in	42	SENT_34	[p2l404t1538r579b1627],
48	(	CD	NUMBER	(	num	50	SENT_34	[p2l624t1536r769b1619],
49	12	CD	NUMBER	12	num	50	SENT_34	[p2l624t1536r769b1619],
50	)	NN	O	)	dep	30	SENT_34	[p2l624t1536r769b1619],
51	.	.	O	.	_	0	SENT_34	[p2l624t1536r769b1619],

1	Like	IN	O	like	_	0	SENT_35	[p2l821t1538r969b1604],
2	clopidogrel	NN	O	clopidogrel	prep_like	7	SENT_35	[p2l1017t1538r1391b1628],
3	,	,	O	,	_	0	SENT_35	[p2l1017t1538r1391b1628],
4	it	PRP	O	it	nsubj	7	SENT_35	[p2l1440t1541r1487b1604],
5	is	VBZ	O	be	cop	7	SENT_35	[p2l1531t1541r1577b1604],
6	a	DT	O	a	det	7	SENT_35	[p2l1627t1565r1661b1604],
7	prodrug	NN	O	prodrug	_	0	SENT_35	[p2l1705t1538r1968b1628],
8	that	WDT	O	that	nsubj	10	SENT_35	[p2l2012t1538r2142b1604],
9	irreversibly	RB	O	irreversibly	advmod	10	SENT_35	[p2l10t1644r362b1734],
10	blocks	VBZ	O	block	rcmod	7	SENT_35	[p2l379t1644r582b1711],
11	the	DT	O	the	det	14	SENT_35	[p2l606t1644r709b1711],
12	P2Y12	NN	O	p2y12	nn	14	SENT_35	[p2l733t1645r960b1712],
13	platelet	NN	O	platelet	nn	14	SENT_35	[p2l984t1644r1220b1734],
14	receptor	NN	O	receptor	dobj	10	SENT_35	[p2l1241t1662r1506b1734],
15	after	IN	O	after	_	0	SENT_35	[p2l1528t1644r1672b1711],
16	hepatic	JJ	O	hepatic	amod	17	SENT_35	[p2l1694t1644r1928b1734],
17	transformation	NN	O	transformation	prep_after	10	SENT_35	[p2l1949t1661r2137b1711, p2l10t1750r334b1817],
18	and	CC	O	and	_	0	SENT_35	[p2l376t1750r496b1817],
19	could	MD	O	could	aux	21	SENT_35	[p2l537t1750r714b1817],
20	be	VB	O	be	auxpass	21	SENT_35	[p2l751t1750r828b1817],
21	affected	VBN	O	affect	conj_and	10	SENT_35	[p2l871t1750r1114b1817],
22	by	IN	O	by	_	0	SENT_35	[p2l1152t1750r1235b1840],
23	CYP450	NN	O	cyp450	nn	25	SENT_35	[p2l1273t1750r1562b1817],
24	genetic	JJ	O	genetic	amod	25	SENT_35	[p2l1602t1753r1834b1840],
25	variants	NNS	O	variant	agent	21	SENT_35	[p2l1870t1753r2136b1817],
26	.	.	O	.	_	0	SENT_35	[p2l1870t1753r2136b1817],

1	However	RB	O	however	advmod	7	SENT_36	[p2l11t1858r327b1938],
2	,	,	O	,	_	0	SENT_36	[p2l11t1858r327b1938],
3	previous	JJ	O	previous	amod	4	SENT_36	[p2l347t1860r615b1946],
4	studies	NNS	O	study	nsubj	7	SENT_36	[p2l637t1857r854b1923],
5	did	VBD	O	do	aux	7	SENT_36	[p2l875t1857r981b1923],
6	not	RB	O	not	neg	7	SENT_36	[p2l1000t1874r1110b1923],
7	ﬁnd	VB	O	ﬁnd	conj_and	7	SENT_36	[p2l1127t1857r1259b1923],
8	any	DT	O	any	det	10	SENT_36	[p2l1279t1883r1395b1946],
9	signiﬁcant	JJ	O	signiﬁcant	amod	10	SENT_36	[p2l1411t1857r1744b1946],
10	inﬂuence	NN	O	inﬂuence	dobj	7	SENT_36	[p2l1761t1857r2056b1923],
11	of	IN	O	of	_	0	SENT_36	[p2l2076t1857r2152b1923],
12	CYP	NNP	O	CYP	nn	14	SENT_36	[p2l12t1963r179b2029],
13	genetic	JJ	O	genetic	amod	14	SENT_36	[p2l200t1966r433b2052],
14	variants	NNS	O	variant	prep_of	10	SENT_36	[p2l451t1966r700b2029],
15	on	IN	O	on	_	0	SENT_36	[p2l725t1989r809b2029],
16	pharmacokinetic	JJ	O	pharmacokinetic	amod	19	SENT_36	[p2l830t1963r1373b2052],
17	and	CC	O	and	_	0	SENT_36	[p2l1397t1963r1517b2029],
18	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	16	SENT_36	[p2l1538t1963r2141b2052],
19	response	NN	O	response	prep_on	14	SENT_36	[p2l10t2095r288b2159],
20	to	TO	O	to	_	0	SENT_36	[p2l310t2087r374b2136],
21	prasugrel	NN	O	prasugrel	prep_to	7	SENT_36	[p2l395t2070r691b2159],
22	and	CC	O	and	_	0	SENT_36	[p2l712t2070r833b2136],
23	on	IN	O	on	_	0	SENT_36	[p2l854t2096r937b2136],
24	clinical	JJ	O	clinical	amod	25	SENT_36	[p2l959t2070r1183b2136],
25	outcome	NN	O	outcome	prep_on	7	SENT_36	[p2l1204t2087r1485b2136],
26	in	IN	O	in	_	0	SENT_36	[p2l1508t2073r1572b2135],
27	prasugrel	NN	O	prasugrel	nn	28	SENT_36	[p2l1592t2070r2141b2159],
28	—	NN	O	—	prep_in	25	SENT_36	[p2l1592t2070r2141b2159],
29	treated	VBN	O	treat	partmod	28	SENT_36	[p2l1592t2070r2141b2159],
30	patients	NNS	O	patient	dobj	29	SENT_36	[p2l9t2178r261b2264],
31	(	CD	NUMBER	(	number	32	SENT_36	[p2l290t2173r537b2256],
32	13,14	CD	NUMBER	13,14	num	33	SENT_36	[p2l290t2173r537b2256],
33	)	NN	O	)	dep	30	SENT_36	[p2l290t2173r537b2256],
34	,	,	O	,	_	0	SENT_36	[p2l290t2173r537b2256],
35	although	IN	O	although	mark	39	SENT_36	[p2l566t2175r866b2264],
36	a	DT	O	a	det	37	SENT_36	[p2l894t2201r928b2241],
37	trend	NN	O	trend	nsubjpass	39	SENT_36	[p2l953t2175r1133b2241],
38	was	VBD	O	be	auxpass	39	SENT_36	[p2l1155t2201r1281b2241],
39	observed	VBN	O	observe	dep	30	SENT_36	[p2l1309t2175r1605b2241],
40	in	IN	O	in	_	0	SENT_36	[p2l1630t2178r1696b2240],
41	the	DT	O	the	det	45	SENT_36	[p2l1722t2175r1829b2241],
42	Mega	JJ	O	mega	amod	45	SENT_36	[p2l1854t2176r2054b2264],
43	et	FW	O	et	nn	45	SENT_36	[p2l2080t2192r2142b2241],
44	al.	FW	O	al.	nn	45	SENT_36	[p2l11t2281r82b2347],
45	study	NN	O	study	prep_in	39	SENT_36	[p2l117t2281r299b2370],
46	(	CD	NUMBER	(	number	47	SENT_36	[p2l328t2279r480b2361],
47	13	CD	NUMBER	13	num	48	SENT_36	[p2l328t2279r480b2361],
48	)	NN	O	)	dep	45	SENT_36	[p2l328t2279r480b2361],
49	.	.	O	.	_	0	SENT_36	[p2l328t2279r480b2361],

1	These	DT	O	these	det	2	SENT_37	[p2l511t2279r721b2347],
2	studies	NNS	O	study	nsubj	21	SENT_37	[p2l752t2281r980b2347],
3	included	VBD	O	include	_	0	SENT_37	[p2l1011t2281r1302b2347],
4	both	CC	O	both	preconj	6	SENT_37	[p2l1329t2281r1488b2347],
5	ACS	NN	ORGANIZATION	ac	nn	6	SENT_37	[p2l1515t2279r1688b2347],
6	patients	NNS	O	patient	tmod	3	SENT_37	[p2l1720t2284r1984b2370],
7	and	CC	O	and	_	0	SENT_37	[p2l2017t2281r2141b2347],
8	healthy	JJ	O	healthy	amod	9	SENT_37	[p2l10t2387r262b2476],
9	subjects	NNS	O	subject	tmod	3	SENT_37	[p2l283t2387r562b2476],
10	,	,	O	,	_	0	SENT_37	[p2l283t2387r562b2476],
11	assessed	VBN	O	assess	partmod	6	SENT_37	[p2l590t2387r861b2453],
12	response	NN	O	response	dobj	11	SENT_37	[p2l884t2413r1174b2477],
13	to	TO	O	to	_	0	SENT_37	[p2l1199t2404r1265b2453],
14	60	CD	NUMBER	60	number	15	SENT_37	[p2l1292t2390r1522b2476],
15	—	CD	NUMBER	—	prep_to	11	SENT_37	[p2l1292t2390r1522b2476],
16	mg	NN	O	mg	nn	18	SENT_37	[p2l1292t2390r1522b2476],
17	loading	NN	O	loading	nn	18	SENT_37	[p2l1543t2387r1798b2476],
18	dose	NN	O	dose	dep	6	SENT_37	[p2l1821t2387r1989b2468],
19	,	,	O	,	_	0	SENT_37	[p2l1821t2387r1989b2468],
20	and	CC	O	and	_	0	SENT_37	[p2l2018t2387r2142b2453],
21	used	VBD	O	use	conj_and	3	SENT_37	[p2l9t2494r163b2560],
22	light	JJ	O	light	amod	26	SENT_37	[p2l196t2494r354b2583],
23	transmittance	JJ	O	transmittance	amod	26	SENT_37	[p2l387t2497r849b2560],
24	aggregometry	NN	O	aggregometry	nn	26	SENT_37	[p2l886t2511r1352b2583],
25	(	NN	O	(	nn	26	SENT_37	[p2l1386t2492r1615b2575],
26	LTA	NN	ORGANIZATION	lta	dobj	21	SENT_37	[p2l1386t2492r1615b2575],
27	)	RB	O	)	advmod	21	SENT_37	[p2l1386t2492r1615b2575],
28	as	IN	O	as	mark	73	SENT_37	[p2l1655t2520r1716b2560],
29	the	DT	O	the	det	31	SENT_37	[p2l1753t2494r1859b2560],
30	platelet	NN	O	platelet	nn	31	SENT_37	[p2l1893t2494r2142b2584],
31	test	NN	O	test	nsubj	73	SENT_37	[p2l10t2617r145b2681],
32	,	,	O	,	_	0	SENT_37	[p2l10t2617r145b2681],
33	though	IN	O	though	mark	66	SENT_37	[p2l174t2600r419b2689],
34	the	DT	O	the	det	35	SENT_37	[p2l445t2600r551b2666],
35	inﬂuence	NN	O	inﬂuence	nsubj	66	SENT_37	[p2l578t2600r886b2666],
36	of	IN	O	of	_	0	SENT_37	[p2l913t2600r992b2666],
37	such	JJ	O	such	amod	39	SENT_37	[p2l1007t2600r1158b2666],
38	genetic	JJ	O	genetic	amod	39	SENT_37	[p2l1182t2603r1425b2689],
39	variants	NNS	O	variant	prep_of	35	SENT_37	[p2l1447t2603r1709b2666],
40	on	IN	O	on	_	0	SENT_37	[p2l1738t2626r1823b2666],
41	response	NN	O	response	prep_on	39	SENT_37	[p2l1849t2626r2139b2690],
42	to	TO	O	to	_	0	SENT_37	[p2l10t2724r76b2773],
43	maintenance	NN	O	maintenance	nn	44	SENT_37	[p2l131t2710r562b2773],
44	therapy	NN	O	therapy	prep_to	41	SENT_37	[p2l614t2707r871b2797],
45	in	IN	O	in	_	0	SENT_37	[p2l920t2710r985b2773],
46	ACS	NN	ORGANIZATION	ac	nn	47	SENT_37	[p2l1035t2706r1209b2774],
47	patients	NNS	O	patient	prep_in	44	SENT_37	[p2l1263t2710r1527b2797],
48	using	VBG	O	use	partmod	47	SENT_37	[p2l1580t2710r1763b2796],
49	the	DT	O	the	det	52	SENT_37	[p2l1814t2707r1920b2773],
50	most	RBS	O	most	advmod	51	SENT_37	[p2l1974t2724r2142b2773],
51	speciﬁc	JJ	O	speciﬁc	amod	52	SENT_37	[p2l11t2813r258b2903],
52	test	NN	O	test	dobj	48	SENT_37	[p2l289t2830r409b2879],
53	of	IN	O	of	_	0	SENT_37	[p2l441t2813r519b2879],
54	P2Y12	NN	O	p2y12	nn	55	SENT_37	[p2l540t2814r774b2881],
55	inhibition	NN	O	inhibition	prep_of	52	SENT_37	[p2l809t2813r1162b2894],
56	,	,	O	,	_	0	SENT_37	[p2l809t2813r1162b2894],
57	the	DT	O	the	det	60	SENT_37	[p2l1198t2813r1305b2879],
58	platelet	NN	O	platelet	nn	60	SENT_37	[p2l1338t2813r1587b2903],
59	reactivity	NN	O	reactivity	nn	60	SENT_37	[p2l1618t2816r1927b2902],
60	index	NN	O	index	appos	55	SENT_37	[p2l1956t2813r2141b2879],
61	(	CD	NUMBER	(	num	65	SENT_37	[p2l13t2917r204b3000],
62	PRI	NNP	ORGANIZATION	PRI	nn	65	SENT_37	[p2l13t2917r204b3000],
63	)	CD	NUMBER	)	num	65	SENT_37	[p2l13t2917r204b3000],
64	vasodilator	NN	O	vasodilator	nn	65	SENT_37	[p2l262t2919r1028b2986],
65	—	NN	O	—	dep	60	SENT_37	[p2l262t2919r1028b2986],
66	stimulated	VBD	O	stimulate	dep	31	SENT_37	[p2l262t2919r1028b2986],
67	phosphoprotein	NN	O	phosphoprotein	iobj	66	SENT_37	[p2l1083t2919r1626b3009],
68	(	CD	NUMBER	(	num	70	SENT_37	[p2l1687t2917r1981b3000],
69	VASP	NN	ORGANIZATION	vasp	nn	70	SENT_37	[p2l1687t2917r1981b3000],
70	)	NN	O	)	dobj	66	SENT_37	[p2l1687t2917r1981b3000],
71	,	,	O	,	_	0	SENT_37	[p2l1687t2917r1981b3000],
72	remained	VBD	O	remain	cop	73	SENT_37	[p2l2042t2945r2137b2986, p2l11t3025r263b3092],
73	unknown	JJ	O	unknown	advcl	21	SENT_37	[p2l287t3025r627b3092],
74	.	.	O	.	_	0	SENT_37	[p2l287t3025r627b3092],

1	We	PRP	O	we	nsubj	3	SENT_38	[p2l653t3026r782b3092],
2	therefore	RB	O	therefore	advmod	3	SENT_38	[p2l808t3025r1113b3092],
3	designed	VBD	O	design	_	0	SENT_38	[p2l1141t3025r1439b3115],
4	the	DT	O	the	det	6	SENT_38	[p2l1464t3025r1570b3092],
5	present	JJ	DATE	present	amod	6	SENT_38	[p2l1595t3042r1844b3115],
6	study	NN	O	study	dobj	3	SENT_38	[p2l1869t3025r2051b3115],
7	to	TO	O	to	aux	8	SENT_38	[p2l2073t3043r2139b3092],
8	assess	VB	O	assess	xcomp	3	SENT_38	[p2l11t3158r198b3198],
9	the	DT	O	the	det	10	SENT_38	[p2l225t3132r332b3198],
10	inﬂuence	NN	O	inﬂuence	dobj	8	SENT_38	[p2l358t3132r665b3198],
11	of	IN	O	of	_	0	SENT_38	[p2l692t3132r770b3198],
12	CYP2CZ9	NN	O	cyp2cz9	nn	13	SENT_38	[p2l789t3135r1189b3199],
13	*	NN	O	*	prep_of	10	SENT_38	[p2l789t3135r1189b3199],
14	2	CD	NUMBER	2	num	13	SENT_38	[p2l789t3135r1189b3199],
15	and	CC	O	and	_	0	SENT_38	[p2l1215t3132r1339b3198],
16	*	CD	NUMBER	*	number	17	SENT_38	[p2l1369t3135r1477b3198],
17	17	CD	NUMBER	17	num	18	SENT_38	[p2l1369t3135r1477b3198],
18	alleles	NNS	O	allele	conj_and	10	SENT_38	[p2l1498t3132r1695b3198],
19	on	IN	O	on	_	0	SENT_38	[p2l1722t3158r1808b3198],
20	prasugrel	NN	O	prasugrel	nn	21	SENT_38	[p2l1832t3132r2141b3221],
21	response	NN	O	response	prep_on	18	SENT_38	[p2l10t3264r300b3328],
22	and	CC	O	and	_	0	SENT_38	[p2l337t3239r461b3305],
23	bleeding	NN	O	bleeding	nn	24	SENT_38	[p2l492t3239r784b3328],
24	complications	NNS	O	complication	conj_and	21	SENT_38	[p2l818t3239r1285b3328],
25	in	IN	O	in	_	0	SENT_38	[p2l1321t3242r1387b3304],
26	patients	NNS	O	patient	prep_in	8	SENT_38	[p2l1420t3242r1685b3328],
27	treated	VBN	O	treat	partmod	26	SENT_38	[p2l1721t3239r1955b3305],
28	with	IN	O	with	_	0	SENT_38	[p2l1985t3239r2140b3305],
29	prasugrel	NN	O	prasugrel	prep_with	27	SENT_38	[p2l9t3345r319b3434],
30	10	CD	NUMBER	10	num	31	SENT_38	[p2l351t3348r430b3411],
31	mg	NN	O	mg	npadvmod	32	SENT_38	[p2l461t3371r571b3434],
32	daily	RB	SET	daily	advmod	27	SENT_38	[p2l600t3345r762b3434],
33	after	IN	O	after	_	0	SENT_38	[p2l789t3345r941b3411],
34	PCI	NNP	O	PCI	prep_after	27	SENT_38	[p2l969t3345r1113b3411],
35	for	IN	O	for	_	0	SENT_38	[p2l1145t3345r1242b3411],
36	ACS	NNP	O	ACS	prep_for	34	SENT_38	[p2l1267t3343r1460b3411],
37	.	.	O	.	_	0	SENT_38	[p2l1267t3343r1460b3411],

1	Methods	NNS	O	method	_	0	SENT_39	[p2l13t3594r377b3656],

1	Study	NNP	O	Study	_	0	SENT_40	[p3l11t46r209b122],
2	population	NN	O	population	dep	1	SENT_40	[p3l258t46r654b120],
3	.	.	O	.	_	0	SENT_40	[p3l258t46r654b120],

1	Consecutive	JJ	O	consecutive	amod	2	SENT_41	[p3l705t39r1119b106],
2	patients	NNS	O	patient	nsubj	17	SENT_41	[p3l1164t42r1428b129],
3	admitted	VBN	O	admit	partmod	2	SENT_41	[p3l1477t39r1781b105],
4	for	IN	O	for	_	0	SENT_41	[p3l1825t39r1922b105],
5	nonST-segment	JJ	O	nonst-segment	amod	7	SENT_41	[p3l1967t65r2142b105, p3l13t144r437b234],
6	elevation	NN	O	elevation	nn	7	SENT_41	[p3l462t145r762b212],
7	ACS	NN	O	ac	nn	12	SENT_41	[p3l785t144r959b212],
8	or	CC	O	or	_	0	SENT_41	[p3l987t171r1058b212],
9	ST-segment	NN	O	st-segment	nn	10	SENT_41	[p3l1085t143r1509b234],
10	elevation	NN	O	elevation	nn	12	SENT_41	[p3l1533t145r1833b212],
11	myocardial	JJ	O	myocardial	amod	12	SENT_41	[p3l1860t171r2137b234, p3l11t252r133b319],
12	infarction	NN	O	infarction	prep_for	3	SENT_41	[p3l159t252r487b319],
13	in	IN	O	in	_	0	SENT_41	[p3l513t255r579b318],
14	our	PRP$	O	we	poss	15	SENT_41	[p3l607t278r721b319],
15	institution	NN	O	institution	prep_in	12	SENT_41	[p3l745t255r1096b319],
16	were	VBD	O	be	cop	17	SENT_41	[p3l1119t278r1281b319],
17	eligible	JJ	O	eligible	_	0	SENT_41	[p3l1309t252r1548b342],
18	for	IN	O	for	_	0	SENT_41	[p3l1576t252r1673b319],
19	this	DT	O	this	det	21	SENT_41	[p3l1698t252r1819b319],
20	prospective	JJ	O	prospective	amod	21	SENT_41	[p3l1847t278r2137b342, p3l10t361r129b425],
21	study	NN	O	study	prep_for	17	SENT_41	[p3l175t358r357b448],
22	if	IN	O	if	mark	25	SENT_41	[p3l397t358r456b424],
23	they	PRP	O	they	nsubjpass	30	SENT_41	[p3l488t358r636b448],
24	had	VBD	O	have	aux	25	SENT_41	[p3l676t358r802b425],
25	undergone	VBN	O	undergo	advcl	17	SENT_41	[p3l844t358r1207b448],
26	successful	JJ	O	successful	amod	27	SENT_41	[p3l1253t358r1580b425],
27	PCI	NN	O	pcus	dobj	25	SENT_41	[p3l1623t358r1767b425],
28	and	CC	O	and	_	0	SENT_41	[p3l1815t358r1938b425],
29	were	VBD	O	be	auxpass	30	SENT_41	[p3l1978t384r2139b425],
30	treated	VBN	O	treat	advcl	17	SENT_41	[p3l10t464r244b531],
31	at	IN	O	at	_	0	SENT_41	[p3l294t481r355b531],
32	discharge	NN	O	discharge	prep_at	30	SENT_41	[p3l404t464r720b554],
33	with	IN	O	with	_	0	SENT_41	[p3l766t464r922b531],
34	prasugrel	NN	O	prasugrel	nn	36	SENT_41	[p3l970t464r1279b554],
35	10	CD	NUMBER	10	num	36	SENT_41	[p3l1332t468r1410b531],
36	mg	NN	O	mg	prep_with	30	SENT_41	[p3l1461t491r1586b554],
37	.	.	O	.	_	0	SENT_41	[p3l1461t491r1586b554],

1	The	DT	O	the	det	3	SENT_42	[p3l1637t463r1780b531],
2	exclusion	NN	O	exclusion	nn	3	SENT_42	[p3l1831t465r2140b531],
3	criteria	NNS	O	criterion	nsubj	6	SENT_42	[p3l11t573r245b637],
4	were	VBD	O	be	cop	6	SENT_42	[p3l280t596r441b637],
5	a	DT	O	a	det	6	SENT_42	[p3l485t597r519b637],
6	history	NN	O	history	_	0	SENT_42	[p3l559t570r793b660],
7	of	IN	O	of	_	0	SENT_42	[p3l831t570r910b637],
8	bleeding	VBG	O	bleed	amod	9	SENT_42	[p3l936t570r1228b660],
9	diathesis	NN	O	diathesis	prep_of	6	SENT_42	[p3l1268t570r1577b651],
10	,	,	O	,	_	0	SENT_42	[p3l1268t570r1577b651],
11	prior	RB	O	prior	advmod	6	SENT_42	[p3l1620t573r1786b660],
12	stroke	NN	O	stroke	dep	6	SENT_42	[p3l1827t570r2029b637],
13	or	CC	O	or	_	0	SENT_42	[p3l2072t596r2142b637],
14	transient	JJ	O	transient	amod	16	SENT_42	[p3l10t679r307b743],
15	ischemic	JJ	O	ischemic	amod	16	SENT_42	[p3l326t676r620b743],
16	attack	NN	O	attack	dep	6	SENT_42	[p3l641t677r859b757],
17	,	,	O	,	_	0	SENT_42	[p3l641t677r859b757],
18	contraindications	NNS	O	contraindication	conj_and	6	SENT_42	[p3l883t676r1464b743],
19	to	TO	O	to	_	0	SENT_42	[p3l1486t694r1552b743],
20	antiplatelet	JJ	O	antiplatelet	amod	21	SENT_42	[p3l1575t676r1952b766],
21	therapy	NN	O	therapy	prep_to	18	SENT_42	[p3l1970t676r2137b743, p3l11t809r144b872],
22	,	,	O	,	_	0	SENT_42	[p3l1970t676r2137b743, p3l11t809r144b872],
23	platelet	NN	O	platelet	nn	24	SENT_42	[p3l165t783r414b872],
24	count	NN	O	count	conj_and	6	SENT_42	[p3l433t800r625b849],
25	<	JJR	O	<	npadvmod	28	SENT_42	[p3l649t787r841b849],
26	10O	CD	NUMBER	10o	npadvmod	27	SENT_42	[p3l649t787r841b849],
27	>	JJR	O	>	amod	25	SENT_42	[p3l871t792r923b845],
28	<	JJR	O	<	amod	24	SENT_42	[p3l871t792r923b845],
29	109/1	CD	NUMBER	109/1	dep	24	SENT_42	[p3l957t770r1137b864],
30	,	,	O	,	_	0	SENT_42	[p3l957t770r1137b864],
31	and	CC	O	and	_	0	SENT_42	[p3l1161t783r1285b849],
32	creatinine	NN	O	creatinine	nn	33	SENT_42	[p3l1305t786r1635b849],
33	clearance	NN	O	clearance	dep	34	SENT_42	[p3l1657t783r1963b849],
34	<	JJR	O	<	conj_and	6	SENT_42	[p3l1989t783r2137b850],
35	25	CD	NUMBER	25	num	36	SENT_42	[p3l1989t783r2137b850],
36	ml/min	NN	O	ml/min	dep	34	SENT_42	[p3l11t889r282b956],
37	.	.	O	.	_	0	SENT_42	[p3l11t889r282b956],

1	Patients	NNS	O	patient	nsubj	2	SENT_43	[p3l312t890r583b956],
2	received	VBD	O	receive	_	0	SENT_43	[p3l609t889r883b956],
3	loading	VBG	O	load	xcomp	2	SENT_43	[p3l906t889r1160b979],
4	doses	NNS	O	dose	dobj	3	SENT_43	[p3l1184t889r1363b956],
5	of	IN	O	of	_	0	SENT_43	[p3l1389t889r1467b956],
6	aspirin	NN	O	aspirin	nn	8	SENT_43	[p3l1481t892r1706b979],
7	250	CD	NUMBER	250	num	8	SENT_43	[p3l1729t889r1856b957],
8	mg	NN	O	mg	prep_of	4	SENT_43	[p3l1882t916r1993b979],
9	and	CC	O	and	_	0	SENT_43	[p3l2017t889r2141b956],
10	prasugrel	NN	O	prasugrel	nn	12	SENT_43	[p3l9t996r319b1086],
11	60	CD	NUMBER	60	num	12	SENT_43	[p3l341t1000r422b1063],
12	mg	NN	O	mg	conj_and	4	SENT_43	[p3l446t1023r557b1086],
13	and	CC	O	and	_	0	SENT_43	[p3l579t996r720b1077],
14	,	,	O	,	_	0	SENT_43	[p3l579t996r720b1077],
15	as	IN	O	as	dep	12	SENT_43	[p3l747t1023r808b1063],
16	discharge	NN	O	discharge	nn	17	SENT_43	[p3l833t996r1149b1086],
17	therapy	NN	O	therapy	pobj	15	SENT_43	[p3l1173t996r1444b1086],
18	,	,	O	,	_	0	SENT_43	[p3l1173t996r1444b1086],
19	oral	JJ	O	oral	amod	20	SENT_43	[p3l1469t996r1597b1063],
20	doses	NNS	O	dose	conj_and	4	SENT_43	[p3l1619t996r1798b1063],
21	of	IN	O	of	_	0	SENT_43	[p3l1822t996r1900b1063],
22	75	CD	NUMBER	75	number	23	SENT_43	[p3l1912t996r1991b1063],
23	—	CD	NUMBER	—	num	25	SENT_43	[p3l1998t1023r2142b1086],
24	mg	NN	O	mg	nn	25	SENT_43	[p3l1998t1023r2142b1086],
25	aspirin	NN	O	aspirin	prep_of	20	SENT_43	[p3l11t1141r236b1228],
26	and	CC	O	and	_	0	SENT_43	[p3l280t1138r404b1205],
27	10	CD	NUMBER	10	conj_and	25	SENT_43	[p3l449t1142r560b1205],
28	-	:	O	-	_	0	SENT_43	[p3l449t1142r560b1205],
29	mg	NN	O	mg	nn	30	SENT_43	[p3l605t1165r716b1228],
30	prasugrel	NN	O	prasugrel	dep	27	SENT_43	[p3l754t1138r1064b1228],
31	daily	RB	SET	daily	advmod	3	SENT_43	[p3l1105t1138r1280b1228],
32	.	.	O	.	_	0	SENT_43	[p3l1105t1138r1280b1228],

1	Prasugrel	NN	O	prasugrel	nn	2	SENT_44	[p3l1327t1139r1643b1228],
2	response	NN	O	response	nsubj	3	SENT_44	[p3l1684t1164r1974b1228],
3	was	VBD	O	be	_	0	SENT_44	[p3l2012t1165r2138b1205],

1	Cuisset	NNP	O	Cuisset	_	0	SENT_45	[p3l1469t1388r1659b1432],
2	et	FW	O	et	nn	3	SENT_45	[p3l1685t1391r1737b1432],
3	al.	FW	O	al.	dep	1	SENT_45	[p3l1760t1389r1818b1432],
4	1281	CD	DATE	1281	dep	1	SENT_45	[p3l1999t1388r2141b1432],

1	Genetic	JJ	O	genetic	nsubj	9	SENT_46	[p3l946t1470r1146b1513],
2	and	CC	O	and	_	0	SENT_46	[p3l1169t1471r1264b1513],
3	Prasugrel	NNP	O	Prasugrel	nn	4	SENT_46	[p3l1292t1471r1538b1524],
4	Response	NNP	O	Response	nsubj	9	SENT_46	[p3l1565t1471r1821b1523],
5	assessed	VBN	O	assess	partmod	4	SENT_46	[p3l12t1685r282b1752],
6	at	IN	O	at	_	0	SENT_46	[p3l310t1702r371b1752],
7	1-month	JJ	DURATION	1-month	amod	8	SENT_46	[p3l399t1685r701b1752],
8	clinical	JJ	O	clinical	prep_at	5	SENT_46	[p3l728t1685r964b1752],
9	follow	VBP	O	follow	_	0	SENT_46	[p3l989t1685r1319b1775],
10	—	CD	NUMBER	—	dobj	9	SENT_46	[p3l989t1685r1319b1775],
11	up	RP	O	up	prt	9	SENT_46	[p3l989t1685r1319b1775],
12	by	IN	O	by	_	0	SENT_46	[p3l1344t1685r1429b1775],
13	PRI	NNP	ORGANIZATION	PRI	nn	14	SENT_46	[p3l1451t1686r1591b1751],
14	VASP	NN	ORGANIZATION	vasp	prep_by	9	SENT_46	[p3l1619t1684r1858b1752],
15	.	.	O	.	_	0	SENT_46	[p3l1619t1684r1858b1752],

1	Adherence	NN	O	adherence	nsubjpass	4	SENT_47	[p3l1886t1684r2138b1752, p3l12t1818r161b1858],
2	was	VBD	O	be	auxpass	4	SENT_47	[p3l187t1818r312b1858],
3	systematically	RB	O	systematically	advmod	4	SENT_47	[p3l344t1791r809b1881],
4	assessed	VBN	O	assess	_	0	SENT_47	[p3l835t1791r1105b1858],
5	during	IN	O	during	_	0	SENT_47	[p3l1134t1791r1358b1881],
6	this	DT	O	this	det	7	SENT_47	[p3l1385t1792r1506b1858],
7	consultation	NN	O	consultation	prep_during	4	SENT_47	[p3l1537t1792r1968b1858],
8	.	.	O	.	_	0	SENT_47	[p3l1537t1792r1968b1858],

1	The	DT	O	the	det	3	SENT_48	[p3l1997t1790r2141b1858],
2	study	NN	O	study	nn	3	SENT_48	[p3l12t1897r194b1987],
3	protocol	NN	O	protocol	nsubjpass	5	SENT_48	[p3l224t1897r507b1987],
4	was	VBD	O	be	auxpass	5	SENT_48	[p3l537t1924r663b1964],
5	approved	VBN	O	approve	_	0	SENT_48	[p3l701t1897r1012b1987],
6	by	IN	O	by	_	0	SENT_48	[p3l1043t1898r1128b1987],
7	the	DT	O	the	det	9	SENT_48	[p3l1159t1897r1265b1964],
8	ethics	NNS	O	ethic	nn	9	SENT_48	[p3l1302t1897r1493b1964],
9	committee	NN	O	committee	agent	5	SENT_48	[p3l1530t1900r1892b1964],
10	of	IN	O	of	_	0	SENT_48	[p3l1928t1897r2006b1964],
11	our	PRP$	O	we	poss	12	SENT_48	[p3l2029t1923r2143b1964],
12	institution	NN	O	institution	prep_of	9	SENT_48	[p3l11t2006r380b2084],
13	,	,	O	,	_	0	SENT_48	[p3l11t2006r380b2084],
14	and	CC	O	and	_	0	SENT_48	[p3l428t2003r552b2070],
15	patients	NNS	O	patient	nsubj	16	SENT_48	[p3l595t2006r859b2093],
16	gave	VBD	O	give	conj_and	5	SENT_48	[p3l904t2030r1053b2093],
17	Written	VBN	O	write	dep	16	SENT_48	[p3l1095t2006r1341b2070],
18	informed	VBN	O	inform	amod	19	SENT_48	[p3l1385t2003r1699b2070],
19	consent	NN	O	consent	dobj	17	SENT_48	[p3l1743t2020r2004b2070],
20	for	IN	O	for	_	0	SENT_48	[p3l2046t2003r2143b2070],
21	participation	NN	O	participation	prep_for	19	SENT_48	[p3l10t2111r456b2197],
22	.	.	O	.	_	0	SENT_48	[p3l10t2111r456b2197],

1	Platelet	NN	O	platelet	nn	2	SENT_49	[p3l14t2221r273b2280],
2	parameters	NNS	O	parameter	_	0	SENT_49	[p3l314t2230r722b2296],
3	.	.	O	.	_	0	SENT_49	[p3l314t2230r722b2296],

1	Blood	NN	O	blood	nn	2	SENT_50	[p3l772t2214r984b2281],
2	samples	NNS	O	sample	nsubjpass	8	SENT_50	[p3l1023t2214r1296b2304],
3	for	IN	O	for	_	0	SENT_50	[p3l1335t2214r1436b2281],
4	testing	NN	O	testing	nn	6	SENT_50	[p3l1472t2217r1711b2304],
5	clopidogrel	NN	O	clopidogrel	nn	6	SENT_50	[p3l1748t2214r2143b2304],
6	response	NN	O	response	prep_for	2	SENT_50	[p3l11t2346r313b2410],
7	were	VBD	O	be	auxpass	8	SENT_50	[p3l353t2346r519b2387],
8	drawn	VBN	O	draw	_	0	SENT_50	[p3l563t2320r781b2387],
9	at	IN	O	at	_	0	SENT_50	[p3l825t2337r888b2387],
10	1-month	JJ	DURATION	1-month	amod	11	SENT_50	[p3l933t2320r1245b2387],
11	folloW	NN	O	follow	prep_at	8	SENT_50	[p3l1287t2320r1651b2410],
12	—	CD	NUMBER	—	dep	13	SENT_50	[p3l1287t2320r1651b2410],
13	up	RP	O	up	advmod	8	SENT_50	[p3l1287t2320r1651b2410],
14	.	.	O	.	_	0	SENT_50	[p3l1287t2320r1651b2410],

1	For	IN	O	for	_	0	SENT_51	[p3l1698t2321r1823b2387],
2	patients	NNS	O	patient	prep_for	27	SENT_51	[p3l1863t2323r2139b2410],
3	who	WP	O	who	nsubj	4	SENT_51	[p3l8t2427r156b2493],
4	experienced	VBD	O	experience	rcmod	2	SENT_51	[p3l214t2426r613b2516],
5	significant	JJ	O	significant	amod	6	SENT_51	[p3l669t2426r1018b2516],
6	bleeding	NN	O	bleeding	dobj	4	SENT_51	[p3l1070t2426r1362b2516],
7	(	CD	NUMBER	(	dep	13	SENT_51	[p3l1418t2424r1747b2516],
8	Bleeding	NNP	O	Bleeding	nn	13	SENT_51	[p3l1418t2424r1747b2516],
9	Academic	NNP	O	Academic	nn	13	SENT_51	[p3l1798t2425r2142b2493],
10	Research	NNP	O	Research	nn	13	SENT_51	[p3l13t2533r318b2599],
11	Consortium	NNP	O	Consortium	nn	13	SENT_51	[p3l350t2532r761b2599],
12	[	CD	NUMBER	[	num	13	SENT_51	[p3l798t2530r1090b2613],
13	BARC	NNP	O	BARC	dep	4	SENT_51	[p3l798t2530r1090b2613],
14	]	CD	NUMBER	]	num	16	SENT_51	[p3l798t2530r1090b2613],
15	Z2	NN	O	z2	nn	16	SENT_51	[p3l1132t2530r1264b2613],
16	)	NN	O	)	dep	13	SENT_51	[p3l1132t2530r1264b2613],
17	and	CC	O	and	_	0	SENT_51	[p3l1300t2532r1424b2599],
18	who	WP	O	who	nsubj	19	SENT_51	[p3l1450t2533r1598b2599],
19	needed	VBD	O	need	dep	4	SENT_51	[p3l1631t2532r1872b2599],
20	to	TO	O	to	aux	21	SENT_51	[p3l1902t2549r1968b2599],
21	stop	VB	O	stop	xcomp	19	SENT_51	[p3l2001t2549r2139b2622],
22	prasugrel	NN	O	prasugrel	dobj	21	SENT_51	[p3l10t2638r336b2728],
23	,	,	O	,	_	0	SENT_51	[p3l10t2638r336b2728],
24	platelet	NN	O	platelet	nn	25	SENT_51	[p3l370t2638r619b2728],
25	testing	NN	O	testing	nsubjpass	27	SENT_51	[p3l649t2641r877b2728],
26	was	VBD	O	be	auxpass	27	SENT_51	[p3l904t2665r1030b2705],
27	performed	VBN	O	perform	_	0	SENT_51	[p3l1063t2638r1418b2728],
28	in	IN	O	in	_	0	SENT_51	[p3l1450t2641r1516b2704],
29	our	PRP$	O	we	poss	30	SENT_51	[p3l1549t2664r1662b2705],
30	center	NN	O	center	prep_in	27	SENT_51	[p3l1693t2655r1900b2705],
31	before	IN	O	before	_	0	SENT_51	[p3l1929t2638r2140b2705],
32	discontinuation	NN	O	discontinuation	prep_before	27	SENT_51	[p3l12t2744r555b2811],
33	.	.	O	.	_	0	SENT_51	[p3l12t2744r555b2811],

1	Blood	NN	O	blood	nsubjpass	3	SENT_52	[p3l582t2744r788b2811],
2	was	VBD	O	be	auxpass	3	SENT_52	[p3l806t2771r932b2811],
3	sent	VBN	O	send	_	0	SENT_52	[p3l956t2761r1093b2811],
4	immediately	RB	O	immediately	advmod	3	SENT_52	[p3l1114t2744r1537b2834],
5	to	TO	O	to	_	0	SENT_52	[p3l1555t2762r1621b2811],
6	the	DT	O	the	det	8	SENT_52	[p3l1644t2744r1751b2811],
7	hemostasis	NN	O	hemostasis	nn	8	SENT_52	[p3l1774t2744r2139b2811],
8	laboratory	NN	O	laboratory	prep_to	3	SENT_52	[p3l10t2850r401b2940],
9	to	TO	O	to	aux	10	SENT_52	[p3l463t2867r535b2917],
10	determine	VB	O	determine	xcomp	3	SENT_52	[p3l604t2850r987b2917],
11	the	DT	O	the	det	14	SENT_52	[p3l1054t2850r1171b2917],
12	VASP	NN	ORGANIZATION	vasp	nn	14	SENT_52	[p3l11t2956r234b3024],
13	Dhosnhorvlation	NN	O	dhosnhorvlation	nn	14	SENT_52	[p3l288t2958r842b3029],
14	state	NN	O	state	dobj	10	SENT_52	[p3l898t2975r1050b3024],
15	of	IN	O	of	_	0	SENT_52	[p3l1106t2957r1185b3024],
16	i	FW	O	i	nn	17	SENT_52	[p3l1271t2940r1274b3029],
17	Abbreviathns	FW	MISC	abbreviathns	prep_of	14	SENT_52	[p3l1378t2940r1836b2995],
18	whole	JJ	O	whole	amod	19	SENT_52	[p3l7t3118r214b3184],
19	b1Lood	NN	O	b1lood	dep	17	SENT_52	[p3l234t3082r595b3185],
20	.	.	O	.	_	0	SENT_52	[p3l234t3082r595b3185],

1	LWe	NN	O	lwe	nsubj	2	SENT_53	[p3l234t3082r595b3185],
2	iised	VBD	O	iise	dep	13	SENT_53	[p3l610t3082r771b3184],
3	a	DT	O	a	det	5	SENT_53	[p3l793t3144r827b3184],
4	standard	JJ	O	standard	amod	5	SENT_53	[p3l849t3118r1169b3184],
5	—	NN	O	—	nsubj	8	SENT_53	[p3l849t3118r1169b3184],
6	and	CC	O	and	_	0	SENT_53	[p3l1380t3092r1497b3145],
7	Acronyms	NNS	MISC	acronym	conj_and	5	SENT_53	[p3l1526t3092r1856b3158],
8	ized	VBD	O	ize	ccomp	2	SENT_53	[p3l11t3225r150b3291],
9	ﬂow	NN	O	ﬂow	nn	11	SENT_53	[p3l179t3224r329b3291],
10	cytometric	JJ	O	cytometric	amod	11	SENT_53	[p3l356t3228r713b3314],
11	assay	NN	O	assay	dobj	8	SENT_53	[p3l744t3251r914b3314],
12	(	RB	O	(	advmod	8	SENT_53	[p3l943t3223r1169b3305],
13	Plate	VBP	O	plate	_	0	SENT_53	[p3l943t3223r1169b3305],
14	—	CD	NUMBER	—	num	15	SENT_53	[p3l943t3223r1169b3305],
15	Acs	NNS	O	ac	dobj	13	SENT_53	[p3l1378t3251r1485b3292],
16	=	JJ	O	=	amod	17	SENT_53	[p3l1513t3265r1549b3283],
17	acute	JJ	O	acute	tmod	13	SENT_53	[p3l1576t3253r1719b3293],
18	coronary	JJ	O	coronary	advmod	17	SENT_53	[p3l1741t3261r1962b3302],
19	let	VB	O	let	dep	13	SENT_53	[p4l10t36r98b102],
20	VASP	NN	ORGANIZATION	vasp	dobj	19	SENT_53	[p4l155t35r402b117],
21	;	:	O	;	_	0	SENT_53	[p4l155t35r402b117],
22	Diagnostica	NNP	ORGANIZATION	Diagnostica	nn	23	SENT_53	[p4l464t37r885b126],
23	Stago	NNP	ORGANIZATION	Stago	dep	20	SENT_53	[p4l947t36r1174b126],
24	/	:	ORGANIZATION	/	punct	30	SENT_53	[p4l947t36r1174b126],
25	Biocytex	NNP	ORGANIZATION	Biocytex	nn	30	SENT_53	[p4l11t144r363b233],
26	,	,	O	,	_	0	SENT_53	[p4l11t144r363b233],
27	Asniéres	NNP	LOCATION	Asniéres	appos	30	SENT_53	[p4l431t142r785b224],
28	,	,	O	,	_	0	SENT_53	[p4l431t142r785b224],
29	France	NNP	LOCATION	France	appos	30	SENT_53	[p4l856t141r1169b224],
30	)	NNP	O	)	dep	19	SENT_53	[p4l856t141r1169b224],
31	,	,	O	,	_	0	SENT_53	[p4l856t141r1169b224],
32	which	WDT	O	which	nsubj	35	SENT_53	[p4l7t250r219b317],
33	is	VBZ	O	be	cop	35	SENT_53	[p4l276t253r325b317],
34	an	DT	O	a	det	35	SENT_53	[p4l385t277r464b317],
35	adaptation	NN	O	adaptation	rcmod	30	SENT_53	[p4l523t250r883b340],
36	of	IN	O	of	_	0	SENT_53	[p4l940t250r1019b317],
37	the	DT	O	the	det	38	SENT_53	[p4l1064t251r1171b317],
38	method	NN	O	method	prep_of	35	SENT_53	[p4l12t357r276b423],
39	of	IN	O	of	_	0	SENT_53	[p4l329t357r407b423],
40	Schwarz	NNP	PERSON	Schwarz	prep_of	38	SENT_53	[p4l452t357r738b423],
41	et	FW	O	et	nn	43	SENT_53	[p4l790t374r852b423],
42	al.	FW	O	al.	nn	43	SENT_53	[p4l905t357r976b423],
43	(	FW	O	(	dobj	19	SENT_53	[p4l1036t355r1168b437],
44	15	CD	NUMBER	15	number	45	SENT_53	[p4l1036t355r1168b437],
45	)	CD	NUMBER	)	nsubj	13	SENT_53	[p4l1036t355r1168b437],
46	Dreviouslv	NNP	PERSON	Dreviouslv	dep	45	SENT_53	[p4l11t464r354b535],
47	described	VBN	O	describe	partmod	45	SENT_53	[p4l391t464r724b530],
48	.	.	O	.	_	0	SENT_53	[p4l391t464r724b530],

1	PRI	NNP	O	PRI	_	0	SENT_54	[p4l768t465r908b529],
2	VASP	NN	O	vasp	dep	1	SENT_54	[p4l950t462r1172b530],

1	was	VBD	O	be	auxpass	2	SENT_55	[p4l7t627r133b667],
2	calculated	VBN	O	calculate	_	0	SENT_55	[p4l181t600r513b667],
3	from	IN	O	from	_	0	SENT_55	[p4l557t601r722b667],
4	the	DT	O	the	det	7	SENT_55	[p4l767t601r874b667],
5	median	JJ	O	median	amod	7	SENT_55	[p4l920t601r1172b667],
6	ﬂuorescence	NN	O	ﬂuorescence	nn	7	SENT_55	[p4l11t707r423b774],
7	intensity	NN	O	intensity	prep_from	2	SENT_55	[p4l480t711r774b797],
8	(	CD	NUMBER	(	num	9	SENT_55	[p4l830t706r1045b788],
9	MFI	NNP	ORGANIZATION	MFI	nsubjpass	2	SENT_55	[p4l830t706r1045b788],
10	)	CD	NUMBER	)	num	9	SENT_55	[p4l830t706r1045b788],
11	of	IN	O	of	_	0	SENT_55	[p4l1106t707r1184b774],
12	samples	NNS	O	sample	prep_of	9	SENT_55	[p4l12t814r275b904],
13	incubated	VBN	O	incubate	partmod	12	SENT_55	[p4l334t814r665b880],
14	with	IN	O	with	_	0	SENT_55	[p4l718t814r874b880],
15	prostaglandin	NN	O	prostaglandin	nn	16	SENT_55	[p4l930t831r1169b904, p4l10t921r265b1010],
16	E1	NN	O	e1	prep_with	13	SENT_55	[p4l294t922r378b1006],
17	(	CD	NUMBER	(	num	16	SENT_55	[p4l411t919r683b1001],
18	PGE1	NN	O	pge1	tmod	13	SENT_55	[p4l411t919r683b1001],
19	)	CD	NUMBER	)	num	18	SENT_55	[p4l411t919r683b1001],
20	or	CC	O	or	_	0	SENT_55	[p4l714t946r784b987],
21	PGE1	NN	O	pge1	nn	24	SENT_55	[p4l809t921r1017b1006],
22	and	CC	O	and	_	0	SENT_55	[p4l1049t921r1173b987],
23	adenosine	NN	O	adenosine	nn	24	SENT_55	[p4l13t1027r347b1093],
24	diphosphate	NN	O	diphosphate	tmod	13	SENT_55	[p4l370t1027r785b1117],
25	(	CD	NUMBER	(	num	26	SENT_55	[p4l810t1025r1044b1107],
26	ADP	NN	ORGANIZATION	adp	dep	13	SENT_55	[p4l810t1025r1044b1107],
27	)	CD	NUMBER	)	nsubj	35	SENT_55	[p4l810t1025r1044b1107],
28	according	VBG	O	accord	_	0	SENT_55	[p4l1070t1054r1170b1093, p4l12t1134r287b1223],
29	to	TO	O	to	prepc_according_to	27	SENT_55	[p4l348t1151r417b1200],
30	the	DT	O	the	det	31	SENT_55	[p4l480t1134r593b1200],
31	formula	NN	O	formulum	pobj	27	SENT_55	[p4l656t1134r957b1200],
32	:	:	O	:	_	0	SENT_55	[p4l656t1134r957b1200],
33	PRI	NNP	O	PRI	nn	34	SENT_55	[p4l1025t1135r1170b1199],
34	VASP	NN	O	vasp	dep	31	SENT_55	[p4l11t1239r264b1307],
35	=	JJ	O	=	rcmod	26	SENT_55	[p4l350t1266r403b1287],
36	[	CD	NUMBER	[	number	37	SENT_55	[p4l495t1238r1022b1336],
37	(	CD	NUMBER	(	num	40	SENT_55	[p4l495t1238r1022b1336],
38	MFI	NNP	O	MFI	nn	40	SENT_55	[p4l495t1238r1022b1336],
39	(	CD	NUMBER	(	num	40	SENT_55	[p4l495t1238r1022b1336],
40	PGE1	NN	O	pge1	dobj	35	SENT_55	[p4l495t1238r1022b1336],
41	)	CD	NUMBER	)	number	42	SENT_55	[p4l495t1238r1022b1336],
42	—	CD	NUMBER	—	num	45	SENT_55	[p4l1110t1274r1163b1279],
43	MFI	NNP	O	MFI	nn	45	SENT_55	[p4l9t1345r1032b1442],
44	(	CD	NUMBER	(	num	45	SENT_55	[p4l9t1345r1032b1442],
45	PGE1	NN	O	pge1	dep	40	SENT_55	[p4l9t1345r1032b1442],
46	+	CC	O	+	_	0	SENT_55	[p4l9t1345r1032b1442],
47	ADP	NN	O	adp	dobj	35	SENT_55	[p4l9t1345r1032b1442],
48	)	CD	NUMBER	)	num	47	SENT_55	[p4l9t1345r1032b1442],
49	/	:	O	/	punct	51	SENT_55	[p4l9t1345r1032b1442],
50	MFIPGE1	NN	O	mfipge1	nn	51	SENT_55	[p4l9t1345r1032b1442],
51	]	NN	O	]	dep	47	SENT_55	[p4l9t1345r1032b1442],
52	X	NN	O	x	amod	51	SENT_55	[p4l1110t1357r1162b1409],
53	100	CD	NUMBER	100	number	52	SENT_55	[p4l15t1458r154b1520],
54	.	.	O	.	_	0	SENT_55	[p4l15t1458r154b1520],

1	High	JJ	O	high	nsubjpass	11	SENT_56	[p4l203t1454r385b1543],
2	on	IN	O	on	_	0	SENT_56	[p4l430t1471r883b1520],
3	—	NN	O	—	nn	5	SENT_56	[p4l430t1471r883b1520],
4	treatment	NN	O	treatment	nn	5	SENT_56	[p4l430t1471r883b1520],
5	platelet	NN	O	platelet	prep_on	1	SENT_56	[p4l925t1454r1174b1543],
6	reactivity	NN	O	reactivity	nn	9	SENT_56	[p4l11t1564r320b1650],
7	(	CD	NUMBER	(	num	9	SENT_56	[p4l348t1559r642b1641],
8	HTPR	NN	O	htpr	nn	9	SENT_56	[p4l348t1559r642b1641],
9	)	NN	O	)	dep	5	SENT_56	[p4l348t1559r642b1641],
10	was	VBD	O	be	auxpass	11	SENT_56	[p4l671t1587r796b1627],
11	deﬁned	VBN	O	deﬁned	_	0	SENT_56	[p4l828t1561r1080b1627],
12	as	IN	O	as	_	0	SENT_56	[p4l1110t1587r1171b1627],
13	PRI	NNP	ORGANIZATION	PRI	nn	14	SENT_56	[p4l11t1668r153b1732],
14	VASP	NN	O	vasp	dep	15	SENT_56	[p4l213t1666r438b1734],
15	>	JJR	O	>	prep_as	11	SENT_56	[p4l502t1667r720b1733],
16	50	CD	PERCENT	50	number	17	SENT_56	[p4l502t1667r720b1733],
17	%	NN	PERCENT	%	amod	15	SENT_56	[p4l502t1667r720b1733],
18	as	IN	O	as	advmod	20	SENT_56	[p4l780t1694r842b1733],
19	recently	RB	DATE	recently	advmod	18	SENT_56	[p4l902t1667r1176b1757],
20	proposed	VBN	O	propose	partmod	15	SENT_56	[p4l10t1774r372b1864],
21	(	NN	O	(	nn	23	SENT_56	[p4l445t1772r628b1855],
22	16	CD	NUMBER	16	num	23	SENT_56	[p4l445t1772r628b1855],
23	)	NN	O	)	dobj	20	SENT_56	[p4l445t1772r628b1855],
24	,	,	O	,	_	0	SENT_56	[p4l445t1772r628b1855],
25	and	CC	O	and	_	0	SENT_56	[p4l703t1774r842b1840],
26	hyperresponse	NN	O	hyperresponse	prep_as	11	SENT_56	[p4l912t1774r1169b1864, p4l11t1906r301b1970],
27	as	IN	O	as	_	0	SENT_56	[p4l330t1907r391b1947],
28	PRI	NNP	O	PRI	nn	29	SENT_56	[p4l420t1882r560b1946],
29	VASP	NN	ORGANIZATION	vasp	prep_as	26	SENT_56	[p4l588t1879r811b1948],
30	below	IN	O	below	_	0	SENT_56	[p4l836t1881r1042b1947],
31	the	DT	O	the	det	33	SENT_56	[p4l1065t1881r1171b1947],
32	75th	JJ	ORDINAL	75th	amod	33	SENT_56	[p4l13t1987r167b2054],
33	percentile	NN	O	percentile	prep_below	26	SENT_56	[p4l200t1987r530b2077],
34	by	IN	O	by	_	0	SENT_56	[p4l563t1988r647b2077],
35	quartile	JJ	O	quartile	amod	36	SENT_56	[p4l678t1988r932b2077],
36	repartition	NN	O	repartition	prep_by	33	SENT_56	[p4l966t2013r1169b2077, p4l11t2097r219b2160],
37	.	.	O	.	_	0	SENT_56	[p4l966t2013r1169b2077, p4l11t2097r219b2160],

1	Blood	NN	O	blood	nsubjpass	17	SENT_57	[p4l283t2094r495b2160],
2	was	VBD	O	be	auxpass	4	SENT_57	[p4l550t2120r678b2160],
3	immediately	RB	O	immediately	advmod	4	SENT_57	[p4l739t2094r1176b2183],
4	collected	VBN	O	collect	_	0	SENT_57	[p4l12t2201r308b2267],
5	in	IN	O	in	_	0	SENT_57	[p4l357t2204r422b2266],
6	an	DT	O	a	det	10	SENT_57	[p4l473t2227r552b2267],
7	evacuated	VBN	O	evacuate	amod	10	SENT_57	[p4l603t2201r931b2267],
8	blood	NN	O	blood	nn	10	SENT_57	[p4l978t2201r1173b2267],
9	sample	NN	O	sample	nn	10	SENT_57	[p4l12t2308r261b2397],
10	tube	NN	O	tube	prep_in	4	SENT_57	[p4l324t2308r480b2374],
11	containing	VBG	O	contain	partmod	10	SENT_57	[p4l544t2311r933b2397],
12	3.8	CD	PERCENT	3.8	number	13	SENT_57	[p4l995t2311r1172b2374],
13	%	NN	PERCENT	%	amod	15	SENT_57	[p4l995t2311r1172b2374],
14	trisodium	NN	O	trisodium	nn	15	SENT_57	[p4l11t2414r338b2480],
15	citrate	NN	O	citrate	dobj	11	SENT_57	[p4l372t2417r579b2480],
16	and	CC	O	and	_	0	SENT_57	[p4l614t2414r738b2480],
17	ﬁlled	VBN	O	ﬁlled	conj_and	4	SENT_57	[p4l769t2414r938b2480],
18	to	TO	O	to	_	0	SENT_57	[p4l969t2431r1035b2480],
19	capacity	NN	O	capacity	prep_to	17	SENT_57	[p4l1069t2440r1169b2480, p4l10t2524r227b2610],
20	.	.	O	.	_	0	SENT_57	[p4l1069t2440r1169b2480, p4l10t2524r227b2610],

1	The	DT	O	the	det	5	SENT_58	[p4l255t2519r399b2587],
2	blood	NN	O	blood	nn	5	SENT_58	[p4l425t2521r663b2587],
3	—	NN	O	—	nn	5	SENT_58	[p4l425t2521r663b2587],
4	citrate	NN	O	citrate	nn	5	SENT_58	[p4l675t2524r882b2587],
5	mixture	NN	O	mixture	nsubjpass	7	SENT_58	[p4l911t2524r1172b2587],
6	was	VBD	O	be	auxpass	7	SENT_58	[p4l7t2654r133b2693],
7	centriﬁiged	VBN	O	centriﬁiged	_	0	SENT_58	[p4l185t2627r568b2717],
8	at	IN	O	at	_	0	SENT_58	[p4l618t2644r679b2693],
9	120	CD	NUMBER	120	num	10	SENT_58	[p4l731t2631r852b2694],
10	g	NN	O	g	prep_at	7	SENT_58	[p4l895t2655r943b2719],
11	for	IN	O	for	_	0	SENT_58	[p4l987t2627r1083b2693],
12	5	CD	DURATION	5	num	13	SENT_58	[p4l1131t2628r1169b2693],
13	min	NN	DURATION	min	prep_for	10	SENT_58	[p4l12t2737r163b2800],
14	.	.	O	.	_	0	SENT_58	[p4l12t2737r163b2800],

1	The	DT	O	the	det	4	SENT_59	[p4l218t2732r361b2800],
2	resulting	VBG	O	result	amod	4	SENT_59	[p4l415t2734r709b2823],
3	platelet	NN	O	platelet	nn	4	SENT_59	[p4l760t2734r1173b2823],
4	—	NN	O	—	nsubjpass	8	SENT_59	[p4l760t2734r1173b2823],
5	rich	JJ	O	rich	dep	6	SENT_59	[p4l760t2734r1173b2823],
6	plasma	NN	O	plasma	amod	4	SENT_59	[p4l10t2841r248b2930],
7	was	VBD	O	be	auxpass	8	SENT_59	[p4l270t2867r396b2907],
8	kept	VBN	O	keep	_	0	SENT_59	[p4l426t2841r575b2930],
9	at	IN	O	at	_	0	SENT_59	[p4l602t2858r663b2907],
10	room	NN	O	room	nn	11	SENT_59	[p4l689t2866r870b2907],
11	temperature	NN	O	temperature	prep_at	8	SENT_59	[p4l898t2858r1169b2930, p4l13t2965r179b3013],
12	for	IN	O	for	_	0	SENT_59	[p4l234t2947r331b3013],
13	use	NN	O	use	prep_for	11	SENT_59	[p4l381t2973r489b3013],
14	within	IN	O	within	_	0	SENT_59	[p4l540t2947r764b3013],
15	1	CD	NUMBER	1	num	16	SENT_59	[p4l822t2951r853b3012],
16	h.	NN	O	h.	prep_within	8	SENT_59	[p4l912t2947r972b3013],
17	The	DT	O	the	det	18	SENT_59	[p4l1028t2946r1171b3013],
18	syndrome	NN	O	syndrome	dep	16	SENT_59	[p4l1378t41r1625b92],

1	ADP	NN	O	adp	_	0	SENT_60	[p4l1378t161r1488b202],
2	=	JJ	O	=	amod	4	SENT_60	[p4l1514t174r1550b193],
3	adenosine	NN	O	adenosine	nn	4	SENT_60	[p4l1577t161r1836b202],
4	diphosphate	NN	O	diphosphate	dep	1	SENT_60	[p4l1380t246r1692b296],

1	ADP-Ag	NN	O	adp-ag	nsubj	6	SENT_61	[p4l1378t366r1573b417],
2	=	JJ	O	=	amod	5	SENT_61	[p4l1597t379r1633b398],
3	adenosine	NN	O	adenosine	nn	5	SENT_61	[p4l1660t366r1920b407],
4	diphosphate	NN	O	diphosphate	nn	5	SENT_61	[p4l1380t450r1922b501],
5	—	NN	O	—	dep	1	SENT_61	[p4l1380t450r1922b501],
6	induced	VBD	O	induce	_	0	SENT_61	[p4l1380t450r1922b501],
7	platelet	NN	O	platelet	nn	8	SENT_61	[p4l1947t451r2141b501],
8	aggregation	NN	O	aggregation	dobj	6	SENT_61	[p4l1380t565r1685b616],

1	BARC	NN	ORGANIZATION	barc	_	0	SENT_62	[p4l1382t685r1527b726],
2	=	JJ	O	=	amod	6	SENT_62	[p4l1555t699r1591b717],
3	Bleeding	NNP	O	Bleeding	nn	6	SENT_62	[p4l1619t685r1842b736],
4	Academic	NNP	O	Academic	nn	6	SENT_62	[p4l1861t685r2114b727],
5	Research	NNP	O	Research	nn	6	SENT_62	[p4l1382t770r1618b811],
6	Consortium	NNP	O	Consortium	dep	1	SENT_62	[p4l1641t769r1933b811],

1	CI	NN	O	ci	_	0	SENT_63	[p4l1380t890r1429b930],
2	=	JJ	O	=	amod	4	SENT_63	[p4l1459t903r1495b921],
3	confidence	NN	O	confidence	nn	4	SENT_63	[p4l1521t889r1801b930],
4	interval	NN	O	interval	dep	1	SENT_63	[p4l1824t889r2011b930],

1	CYP	NN	O	cyp	_	0	SENT_64	[p4l1380t1009r1485b1051],
2	=	JJ	O	=	amod	4	SENT_64	[p4l1512t1023r1548b1041],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_64	[p4l1575t1010r1876b1060],
4	P450	NN	O	p450	dep	1	SENT_64	[p4l1900t1009r2035b1051],

1	HTPR	NN	O	htpr	_	0	SENT_65	[p4l1382t1130r1519b1170],
2	=	JJ	O	=	amod	5	SENT_65	[p4l1547t1143r1583b1161],
3	high	JJ	O	high	amod	5	SENT_65	[p4l1611t1129r1715b1180],
4	on-treatment	JJ	O	on-treatment	amod	5	SENT_65	[p4l1738t1131r2070b1170],
5	platelet	NN	O	platelet	dep	1	SENT_65	[p4l1381t1214r1576b1264],
6	reactivity	NN	O	reactivity	dep	1	SENT_65	[p4l1599t1214r1838b1265],

1	LTA	NN	ORGANIZATION	lta	_	0	SENT_66	[p4l1381t1334r1475b1374],
2	=	JJ	O	=	amod	5	SENT_66	[p4l1500t1347r1537b1365],
3	light	JJ	O	light	amod	5	SENT_66	[p4l1565t1334r1676b1385],
4	transmittance	NN	O	transmittance	nn	5	SENT_66	[p4l1696t1334r2059b1375],
5	aggregometry	NN	O	aggregometry	dep	1	SENT_66	[p4l1380t1420r1736b1469],

1	OR	NN	O	or	_	0	SENT_67	[p4l1380t1538r1452b1579],
2	=	JJ	O	=	amod	3	SENT_67	[p4l1480t1552r1516b1570],
3	odds	NNS	O	odds	dep	1	SENT_67	[p4l1543t1539r1662b1580],
4	ratio	NN	O	ratio	dep	1	SENT_67	[p4l1686t1538r1801b1580],

1	MFI	NN	O	mfus	_	0	SENT_68	[p4l1382t1658r1474b1699],
2	=	JJ	O	=	amod	5	SENT_68	[p4l1503t1671r1539b1690],
3	median	JJ	O	median	amod	5	SENT_68	[p4l1567t1658r1749b1699],
4	fluorescence	NN	O	fluorescence	nn	5	SENT_68	[p4l1771t1658r2100b1699],
5	intensity	NN	O	intensity	dep	1	SENT_68	[p4l1381t1742r1602b1793],

1	PCI	NN	O	pcus	_	0	SENT_69	[p4l1382t1863r1466b1904],
2	=	JJ	O	=	amod	5	SENT_69	[p4l1495t1876r1531b1895],
3	percutaneous	JJ	O	percutaneous	amod	5	SENT_69	[p4l1559t1864r1906b1914],
4	coronary	JJ	O	coronary	amod	5	SENT_69	[p4l1380t1957r1601b1998],
5	interventions	NNS	O	intervention	dep	1	SENT_69	[p4l1624t1947r1957b1988],

1	PCR	NN	O	pcr	_	0	SENT_70	[p4l1382t2067r1489b2108],
2	=	JJ	O	=	amod	3	SENT_70	[p4l1516t2081r1552b2099],
3	polymerase	NN	O	polymerase	dep	1	SENT_70	[p4l1580t2068r1871b2118],
4	chain	NN	O	chain	nn	5	SENT_70	[p4l1892t2067r2028b2108],
5	reaction	NN	O	reaction	dep	1	SENT_70	[p4l1382t2151r1589b2193],

1	PGE1	NN	O	pge1	_	0	SENT_71	[p4l1382t2272r1512b2326],
2	=	JJ	O	=	amod	4	SENT_71	[p4l1537t2285r1573b2304],
3	prostaglandin	NN	O	prostaglandin	nn	4	SENT_71	[p4l1601t2272r1947b2323],
4	E1	NN	O	e1	dep	1	SENT_71	[p4l1973t2272r2029b2326],

1	PRI	NNP	O	PRI	_	0	SENT_72	[p4l1381t2393r1465b2432],
2	=	JJ	O	=	amod	3	SENT_72	[p4l1495t2405r1530b2424],
3	platelet	NN	O	platelet	dep	1	SENT_72	[p4l1559t2392r1753b2443],
4	reactivity	NN	O	reactivity	nn	5	SENT_72	[p4l1777t2392r2016b2443],
5	index	NN	O	index	dep	1	SENT_72	[p4l1381t2476r1516b2517],

1	TIMI	NN	ORGANIZATION	timus	_	0	SENT_73	[p4l1378t2597r1491b2637],
2	=	JJ	O	=	amod	3	SENT_73	[p4l1520t2610r1556b2628],
3	Thrombolysis	NNPS	O	Thrombolysis	dep	1	SENT_73	[p4l1582t2596r1918b2647],
4	In	IN	O	in	_	0	SENT_73	[p4l1943t2596r1985b2637],
5	Myocardial	JJ	O	myocardial	amod	6	SENT_73	[p4l1381t2680r1659b2732],
6	Infarction	NN	O	infarction	prep_in	3	SENT_73	[p4l1685t2680r1926b2722],

1	VASP	NN	ORGANIZATION	vasp	nn	5	SENT_74	[p4l1378t2801r1519b2841],
2	=	JJ	O	=	amod	5	SENT_74	[p4l1545t2814r1581b2832],
3	vasodilatorstimulated	JJ	O	vasodilatorstimulated	amod	5	SENT_74	[p4l1607t2800r1905b2842, p4l1378t2885r1651b2926],
4	phosphoprotein	NN	O	phosphoprotein	nn	5	SENT_74	[p4l1675t2885r2067b2935],
5	platelet	NN	O	platelet	nsubjpass	17	SENT_74	[p4l10t3054r259b3144],
6	count	NN	O	count	dep	5	SENT_74	[p4l310t3071r501b3121],
7	was	VBD	O	be	auxpass	8	SENT_74	[p4l548t3081r673b3121],
8	determined	VBN	O	determine	_	0	SENT_74	[p4l727t3054r1116b3121],
9	in	IN	O	in	_	0	SENT_74	[p4l1166t3057r1232b3120],
10	the	DT	O	the	det	15	SENT_74	[p4l1284t3054r1390b3121],
11	platelet	NN	O	platelet	nn	15	SENT_74	[p4l1441t3054r1854b3144],
12	—	NN	O	—	nn	15	SENT_74	[p4l1441t3054r1854b3144],
13	rich	JJ	O	rich	amod	15	SENT_74	[p4l1441t3054r1854b3144],
14	plasma	NN	O	plasma	nn	15	SENT_74	[p4l1904t3054r2143b3144],
15	sample	NN	O	sample	prep_in	8	SENT_74	[p5l12t32r246b121],
16	and	CC	O	and	_	0	SENT_74	[p5l291t32r415b98],
17	adjusted	VBN	O	adjust	conj_and	8	SENT_74	[p5l458t32r737b121],
18	to	TO	O	to	_	0	SENT_74	[p5l779t49r845b98],
19	2.5	CD	NUMBER	2.5	num	20	SENT_74	[p5l887t32r990b99],
20	X	NN	O	x	prep_to	17	SENT_74	[p5l1045t41r1097b94],
21	108	CD	NUMBER	108	num	22	SENT_74	[p5l1154t19r1263b98],
22	ml_1	NN	O	ml_1	dobj	8	SENT_74	[p5l1309t19r1479b97],
23	with	IN	O	with	_	0	SENT_74	[p5l1522t32r1679b98],
24	homologous	JJ	O	homologous	amod	26	SENT_74	[p5l1721t32r2139b121],
25	platelet	NN	O	platelet	nn	26	SENT_74	[p5l10t138r451b228],
26	—	NN	O	—	prep_with	8	SENT_74	[p5l10t138r451b228],
27	poor	JJ	O	poor	amod	28	SENT_74	[p5l10t138r451b228],
28	plasma	NN	O	plasma	dep	26	SENT_74	[p5l475t138r728b228],
29	.	.	O	.	_	0	SENT_74	[p5l475t138r728b228],

1	Platelets	NNS	O	platelet	nsubjpass	3	SENT_75	[p5l760t139r1042b205],
2	were	VBD	O	be	auxpass	3	SENT_75	[p5l1067t164r1228b205],
3	stimulated	VBN	O	stimulate	dep	13	SENT_75	[p5l1258t138r1611b205],
4	with	IN	O	with	_	0	SENT_75	[p5l1634t139r1791b205],
5	ADP	NN	O	adp	prep_with	3	SENT_75	[p5l1815t137r2003b204],
6	(	CD	NUMBER	(	number	7	SENT_75	[p5l2033t136r2140b219],
7	10	CD	NUMBER	10	num	9	SENT_75	[p5l2033t136r2140b219],
8	pumol/l	NN	O	pumol/l	nn	9	SENT_75	[p5l14t242r275b328],
9	)	NN	O	)	dep	5	SENT_75	[p5l14t242r275b328],
10	and	CC	O	and	_	0	SENT_75	[p5l331t244r455b311],
11	aggregation	NN	O	aggregation	conj_and	5	SENT_75	[p5l507t247r902b334],
12	was	VBD	O	be	auxpass	13	SENT_75	[p5l950t271r1076b311],
13	assessed	VBN	O	assess	_	0	SENT_75	[p5l1130t245r1401b311],
14	with	IN	O	with	_	0	SENT_75	[p5l1448t245r1604b311],
15	a	DT	O	a	det	16	SENT_75	[p5l1657t271r1691b311],
16	PAP4	NN	O	pap4	prep_with	13	SENT_75	[p5l1742t243r1951b310],
17	Aggregometer	NNP	O	Aggregometer	nn	20	SENT_75	[p5l2000t243r2138b334, p5l10t368r398b440],
18	(	CD	NUMBER	(	num	20	SENT_75	[p5l434t348r723b431],
19	Biodata	NNP	ORGANIZATION	Biodata	nn	20	SENT_75	[p5l434t348r723b431],
20	Corporation	NNP	ORGANIZATION	Corporation	nsubjpass	13	SENT_75	[p5l759t350r1196b440],
21	,	,	O	,	_	0	SENT_75	[p5l759t350r1196b440],
22	Wellcome	NNP	ORGANIZATION	Wellcome	nn	26	SENT_75	[p5l1229t351r1602b431],
23	,	,	O	,	_	0	SENT_75	[p5l1229t351r1602b431],
24	Paris	NNP	LOCATION	Paris	appos	26	SENT_75	[p5l1640t351r1825b431],
25	,	,	O	,	_	0	SENT_75	[p5l1640t351r1825b431],
26	France	NNP	LOCATION	France	appos	20	SENT_75	[p5l1863t348r2137b431],
27	)	CD	NUMBER	)	num	26	SENT_75	[p5l1863t348r2137b431],
28	.	.	O	.	_	0	SENT_75	[p5l1863t348r2137b431],

1	Aggregation	NN	O	aggregation	nsubjpass	3	SENT_76	[p5l9t455r435b546],
2	was	VBD	O	be	auxpass	3	SENT_76	[p5l465t483r591b523],
3	expressed	VBN	O	express	_	0	SENT_76	[p5l627t456r947b546],
4	as	IN	O	as	_	0	SENT_76	[p5l982t483r1043b523],
5	the	DT	O	the	det	7	SENT_76	[p5l1078t456r1184b523],
6	percentage	NN	O	percentage	nn	7	SENT_76	[p5l1217t474r1581b546],
7	change	NN	O	change	prep_as	3	SENT_76	[p5l1616t457r1853b546],
8	in	IN	O	in	_	0	SENT_76	[p5l1887t459r1953b522],
9	light	JJ	O	light	amod	10	SENT_76	[p5l1985t456r2143b546],
10	transmittance	NN	O	transmittance	prep_in	7	SENT_76	[p5l11t565r473b629],
11	from	IN	O	from	_	0	SENT_76	[p5l527t562r693b629],
12	baseline	NN	O	baseline	prep_from	10	SENT_76	[p5l745t562r1033b643],
13	,	,	O	,	_	0	SENT_76	[p5l745t562r1033b643],
14	with	IN	O	with	_	0	SENT_76	[p5l1086t562r1242b629],
15	platelet	NN	O	platelet	nn	18	SENT_76	[p5l1295t562r1735b652],
16	—	NN	O	—	nn	18	SENT_76	[p5l1295t562r1735b652],
17	poor	JJ	O	poor	amod	18	SENT_76	[p5l1295t562r1735b652],
18	plasma	NN	O	plasma	prep_with	10	SENT_76	[p5l1786t562r2024b652],
19	as	IN	O	as	_	0	SENT_76	[p5l2078t589r2139b629],
20	reference	NN	O	reference	prep_as	3	SENT_76	[p5l11t668r334b735],
21	.	.	O	.	_	0	SENT_76	[p5l11t668r334b735],

1	Here	RB	O	here	advmod	4	SENT_77	[p5l375t669r566b749],
2	,	,	O	,	_	0	SENT_77	[p5l375t669r566b749],
3	we	PRP	O	we	nsubj	4	SENT_77	[p5l601t695r698b735],
4	report	VBP	O	report	dep	13	SENT_77	[p5l735t686r942b758],
5	data	NNS	O	datum	dobj	4	SENT_77	[p5l977t668r1120b735],
6	on	IN	O	on	_	0	SENT_77	[p5l1155t695r1241b735],
7	the	DT	O	the	det	9	SENT_77	[p5l1277t668r1384b735],
8	maximal	JJ	O	maximal	amod	9	SENT_77	[p5l1422t668r1713b735],
9	intensity	NN	O	intensity	prep_on	4	SENT_77	[p5l1748t671r2042b758],
10	of	IN	O	of	_	0	SENT_77	[p5l2075t668r2153b735],
11	ADP	NN	O	adp	nn	12	SENT_77	[p5l9t773r502b841],
12	—	NN	O	—	prep_of	9	SENT_77	[p5l9t773r502b841],
13	induced	VBD	O	induce	_	0	SENT_77	[p5l9t773r502b841],
14	platelet	NN	O	platelet	nn	15	SENT_77	[p5l523t774r772b864],
15	aggregation	NN	O	aggregation	dobj	13	SENT_77	[p5l794t777r1189b864],
16	(	CD	NUMBER	(	num	17	SENT_77	[p5l1215t772r1608b864],
17	ADP	NN	O	adp	nsubj	13	SENT_77	[p5l1215t772r1608b864],
18	.	.	O	.	_	0	SENT_77	[p5l1215t772r1608b864],

1	—	NN	O	—	_	0	SENT_78	[p5l1215t772r1608b864],
2	.	.	O	.	_	0	SENT_78	[p5l1215t772r1608b864],

1	Ag	NN	O	ag	_	0	SENT_79	[p5l1215t772r1608b864],
2	)	NN	O	)	dep	1	SENT_79	[p5l1215t772r1608b864],
3	.	.	O	.	_	0	SENT_79	[p5l1215t772r1608b864],

1	The	DT	O	the	det	2	SENT_80	[p5l1633t773r1776b841],
2	coefficient	NN	O	coefficient	nsubjpass	14	SENT_80	[p5l1801t774r2143b841],
3	of	IN	O	of	_	0	SENT_80	[p5l12t880r90b947],
4	variation	NN	O	variation	prep_of	2	SENT_80	[p5l107t883r405b947],
5	of	IN	O	of	_	0	SENT_80	[p5l439t880r516b947],
6	maximal	JJ	O	maximal	amod	7	SENT_80	[p5l538t880r829b947],
7	intensity	NN	O	intensity	prep_of	4	SENT_80	[p5l860t883r1154b970],
8	of	IN	O	of	_	0	SENT_80	[p5l1183t880r1261b947],
9	platelet	NN	O	platelet	nn	10	SENT_80	[p5l1280t880r1529b970],
10	aggregation	NN	O	aggregation	prep_of	7	SENT_80	[p5l1561t883r1956b970],
11	with	IN	O	with	_	0	SENT_80	[p5l1985t880r2141b947],
12	ADP	NN	ORGANIZATION	adp	prep_with	10	SENT_80	[p5l9t984r197b1050],
13	was	VBD	O	be	auxpass	14	SENT_80	[p5l222t1011r348b1051],
14	measured	VBN	O	measure	_	0	SENT_80	[p5l380t985r703b1051],
15	at	IN	O	at	_	0	SENT_80	[p5l733t1002r794b1051],
16	6.5	CD	PERCENT	6.5	num	17	SENT_80	[p5l824t985r1008b1051],
17	%	NN	PERCENT	%	prep_at	14	SENT_80	[p5l824t985r1008b1051],
18	.	.	O	.	_	0	SENT_80	[p5l824t985r1008b1051],

1	1282	CD	DATE	1282	num	2	SENT_81	[p5l11t1089r151b1133],
2	Cuisset	NNP	O	Cuisset	_	0	SENT_81	[p5l330t1089r520b1133],
3	et	FW	O	et	nn	4	SENT_81	[p5l542t1092r593b1133],
4	al.	FW	O	al.	dep	2	SENT_81	[p5l611t1090r669b1133],
5	.	.	O	.	_	0	SENT_81	[p5l611t1090r669b1133],

1	Genetic	JJ	O	genetic	_	0	SENT_82	[p5l330t1171r530b1214],
2	and	CC	O	and	_	0	SENT_82	[p5l551t1172r646b1214],
3	Prasugrel	NNP	O	Prasugrel	nn	4	SENT_82	[p5l672t1172r918b1224],
4	Response	NN	O	response	conj_and	1	SENT_82	[p5l944t1172r1200b1224],

1	Genotyping	NN	O	genotyping	_	0	SENT_83	[p5l11t1396r437b1469],
2	.	.	O	.	_	0	SENT_83	[p5l11t1396r437b1469],

1	Genomic	JJ	O	genomic	amod	2	SENT_84	[p5l488t1386r817b1453],
2	DNA	NN	O	dna	nsubjpass	4	SENT_84	[p5l845t1385r1053b1452],
3	was	VBD	O	be	auxpass	4	SENT_84	[p5l1077t1413r1205b1453],
4	extracted	VBN	O	extract	_	0	SENT_84	[p5l1237t1386r1556b1453],
5	from	IN	O	from	_	0	SENT_84	[p5l1584t1386r1754b1453],
6	peripheral	JJ	O	peripheral	amod	8	SENT_84	[p5l1783t1386r2141b1476],
7	blood	NN	O	blood	nn	8	SENT_84	[p5l8t1492r210b1559],
8	leukocytes	NNS	O	leukocyte	prep_from	4	SENT_84	[p5l254t1492r617b1582],
9	by	IN	O	by	_	0	SENT_84	[p5l663t1493r749b1582],
10	the	DT	O	the	det	12	SENT_84	[p5l791t1493r901b1559],
11	salting	VBG	O	salt	amod	12	SENT_84	[p5l950t1492r1334b1582],
12	—	NN	O	—	agent	4	SENT_84	[p5l950t1492r1334b1582],
13	out	IN	O	out	_	0	SENT_84	[p5l950t1492r1334b1582],
14	method	NN	O	method	prep_out	12	SENT_84	[p5l1380t1492r1670b1559],
15	.	.	O	.	_	0	SENT_84	[p5l1380t1492r1670b1559],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_85	[p5l1727t1496r2141b1560],
2	*	NN	O	*	nsubjpass	10	SENT_85	[p5l1727t1496r2141b1560],
3	2	CD	NUMBER	2	dep	2	SENT_85	[p5l1727t1496r2141b1560],
4	and	CC	O	and	_	0	SENT_85	[p5l11t1598r139b1665],
5	CYP2C19	NN	O	cyp2c19	conj_and	2	SENT_85	[p5l176t1602r639b1666],
6	*	CD	NUMBER	*	number	7	SENT_85	[p5l176t1602r639b1666],
7	17	CD	NUMBER	17	num	8	SENT_85	[p5l176t1602r639b1666],
8	genotyping	NN	O	genotyping	dep	5	SENT_85	[p5l665t1601r1063b1688],
9	was	VBD	O	be	auxpass	10	SENT_85	[p5l1090t1625r1219b1665],
10	done	VBN	O	do	_	0	SENT_85	[p5l1253t1598r1424b1665],
11	using	VBG	O	use	xcomp	10	SENT_85	[p5l1455t1601r1645b1688],
12	ampliﬁcation	NN	O	ampliﬁcation	nsubj	16	SENT_85	[p5l1677t1598r2140b1688],
13	refractory	JJ	O	refractory	amod	16	SENT_85	[p5l10t1704r353b1794],
14	mutation	NN	O	mutation	nn	16	SENT_85	[p5l374t1707r696b1771],
15	system	NN	O	system	nn	16	SENT_85	[p5l722t1722r957b1794],
16	PCR	NN	O	pcr	xcomp	11	SENT_85	[p5l982t1704r1163b1771],
17	in	IN	O	in	_	0	SENT_85	[p5l1185t1707r1252b1770],
18	duplex	JJ	O	duplex	amod	19	SENT_85	[p5l1278t1704r1511b1794],
19	reaction	NN	O	reaction	prep_in	16	SENT_85	[p5l1534t1707r1835b1771],
20	.	.	O	.	_	0	SENT_85	[p5l1534t1707r1835b1771],

1	Primers	NNS	O	primer	dep	121	SENT_86	[p5l1865t1705r2138b1771],
2	(	VBP	O	(	dep	121	SENT_86	[p5l13t1809r429b1900],
3	lnvitrogen	NN	O	lnvitrogen	dep	121	SENT_86	[p5l13t1809r429b1900],
4	,	,	O	,	_	0	SENT_86	[p5l13t1809r429b1900],
5	Carlsbad	NNP	LOCATION	Carlsbad	dep	121	SENT_86	[p5l459t1810r792b1891],
6	,	,	O	,	_	0	SENT_86	[p5l459t1810r792b1891],
7	California	NNP	LOCATION	California	dep	121	SENT_86	[p5l822t1809r1204b1891],
8	)	NN	O	)	dep	121	SENT_86	[p5l822t1809r1204b1891],
9	are	VBP	O	be	dep	121	SENT_86	[p5l1234t1836r1334b1877],
10	as	IN	O	as	dep	121	SENT_86	[p5l1362t1837r1425b1877],
11	follows	VBZ	O	follow	dep	121	SENT_86	[p5l1452t1810r1721b1877],
12	:	:	O	:	_	0	SENT_86	[p5l1452t1810r1721b1877],
13	*	NN	O	*	dep	121	SENT_86	[p5l1756t1814r1819b1877],
14	2	CD	NUMBER	2	dep	121	SENT_86	[p5l1756t1814r1819b1877],
15	forward	RB	O	forward	dep	121	SENT_86	[p5l1843t1810r2136b1877],
16	:	:	O	:	_	0	SENT_86	[p5l1843t1810r2136b1877],
17	cag	NN	O	cag	dep	121	SENT_86	[p5l11t1940r126b2003],
18	agc	NN	O	agc	dep	121	SENT_86	[p5l156t1940r269b2003],
19	ttg	NN	O	ttg	dep	121	SENT_86	[p5l298t1931r396b2003],
20	gca	NN	O	gca	dep	121	SENT_86	[p5l423t1940r540b2003],
21	tat	NN	O	tat	dep	121	SENT_86	[p5l568t1931r661b1980],
22	tgt	NN	O	tgt	dep	121	SENT_86	[p5l689t1931r787b2003],
23	atc	NN	O	atc	dep	121	SENT_86	[p5l817t1931r935b1994],
24	,	,	O	,	_	0	SENT_86	[p5l817t1931r935b1994],
25	*	NN	O	*	dep	121	SENT_86	[p5l973t1918r1036b1980],
26	2	CD	NUMBER	2	dep	121	SENT_86	[p5l973t1918r1036b1980],
27	reverse	NN	O	reverse	dep	121	SENT_86	[p5l1065t1939r1324b1980],
28	:	:	O	:	_	0	SENT_86	[p5l1065t1939r1324b1980],
29	tat	NN	O	tat	dep	121	SENT_86	[p5l1358t1931r1451b1980],
30	cgc	NN	O	cgc	dep	121	SENT_86	[p5l1480t1940r1593b2003],
31	aag	NN	O	aag	dep	121	SENT_86	[p5l1624t1940r1739b2003],
32	cag	NN	O	cag	dep	121	SENT_86	[p5l1768t1940r1883b2003],
33	tca	NN	O	tca	dep	121	SENT_86	[p5l1911t1931r2012b1980],
34	cat	NN	O	cat	dep	121	SENT_86	[p5l2042t1931r2142b1980],
35	aac	NN	O	aac	dep	121	SENT_86	[p5l11t2048r138b2102],
36	;	:	O	;	_	0	SENT_86	[p5l11t2048r138b2102],
37	*	NN	O	*	dep	121	SENT_86	[p5l175t2025r238b2088],
38	2	CD	NUMBER	2	dep	121	SENT_86	[p5l175t2025r238b2088],
39	G	NN	O	g	dep	121	SENT_86	[p5l267t2021r333b2088],
40	speciﬁc	NN	O	speciﬁc	dep	121	SENT_86	[p5l364t2021r620b2111],
41	(	NN	O	(	dep	121	SENT_86	[p5l651t2020r907b2102],
42	sense	NN	O	sense	dep	121	SENT_86	[p5l651t2020r907b2102],
43	)	CD	NUMBER	)	dep	121	SENT_86	[p5l651t2020r907b2102],
44	:	:	O	:	_	0	SENT_86	[p5l651t2020r907b2102],
45	act	VB	O	act	dep	121	SENT_86	[p5l941t2039r1041b2088],
46	atc	NN	O	atc	dep	121	SENT_86	[p5l1069t2039r1168b2088],
47	att	NN	O	att	dep	121	SENT_86	[p5l1196t2038r1287b2088],
48	gat	NN	O	gat	dep	121	SENT_86	[p5l1313t2039r1422b2111],
49	tat	NN	O	tat	dep	121	SENT_86	[p5l1448t2039r1541b2088],
50	ttc	NN	O	ttc	dep	121	SENT_86	[p5l1566t2039r1657b2088],
51	ccg	NN	O	ccg	dep	121	SENT_86	[p5l1686t2048r1799b2111],
52	and	CC	O	and	dep	121	SENT_86	[p5l1827t2021r1954b2088],
53	*	NN	O	*	dep	121	SENT_86	[p5l1987t2025r2050b2088],
54	2	CD	NUMBER	2	dep	121	SENT_86	[p5l1987t2025r2050b2088],
55	A	DT	O	a	dep	121	SENT_86	[p5l2075t2020r2142b2087],
56	speciﬁc	NN	O	speciﬁc	dep	121	SENT_86	[p5l11t2127r268b2217],
57	(	NN	O	(	dep	121	SENT_86	[p5l294t2125r688b2208],
58	antisense	JJ	O	antisense	dep	121	SENT_86	[p5l294t2125r688b2208],
59	)	NN	O	)	dep	121	SENT_86	[p5l294t2125r688b2208],
60	:	:	O	:	_	0	SENT_86	[p5l294t2125r688b2208],
61	gta	NN	O	gta	dep	121	SENT_86	[p5l715t2145r824b2217],
62	att	NN	O	att	dep	121	SENT_86	[p5l847t2145r939b2194],
63	tgt	NN	O	tgt	dep	121	SENT_86	[p5l961t2145r1060b2217],
64	tat	NN	O	tat	dep	121	SENT_86	[p5l1081t2144r1175b2194],
65	ggg	NN	O	ggg	dep	121	SENT_86	[p5l1195t2154r1324b2217],
66	ttc	NN	O	ttc	dep	121	SENT_86	[p5l1346t2145r1437b2194],
67	ct	NN	O	ct	dep	121	SENT_86	[p5l1461t2145r1541b2209],
68	;	:	O	;	_	0	SENT_86	[p5l1461t2145r1541b2209],
69	*	CD	NUMBER	*	dep	121	SENT_86	[p5l1573t2131r1633b2193],
70	1	CD	NUMBER	1	dep	121	SENT_86	[p5l1573t2131r1633b2193],
71	7	CD	NUMBER	7	dep	121	SENT_86	[p5l1648t2133r1685b2194],
72	forward	RB	O	forward	dep	121	SENT_86	[p5l1704t2127r1996b2194],
73	:	:	O	:	_	0	SENT_86	[p5l1704t2127r1996b2194],
74	aag	NN	O	aag	dep	121	SENT_86	[p5l2026t2154r2142b2217],
75	aag	NN	O	aag	dep	121	SENT_86	[p5l11t2258r127b2321],
76	cct	NN	O	cct	dep	121	SENT_86	[p5l151t2249r249b2298],
77	tag	NN	O	tag	dep	121	SENT_86	[p5l272t2249r380b2321],
78	ttt	NN	O	ttt	dep	121	SENT_86	[p5l403t2249r486b2298],
79	ctc	NN	O	ctc	dep	121	SENT_86	[p5l510t2249r608b2298],
80	aag	NN	O	aag	dep	121	SENT_86	[p5l633t2258r766b2321],
81	,	,	O	,	_	0	SENT_86	[p5l633t2258r766b2321],
82	*	NN	O	*	dep	121	SENT_86	[p5l799t2236r858b2297],
83	1	CD	NUMBER	1	dep	121	SENT_86	[p5l799t2236r858b2297],
84	7	CD	NUMBER	7	dep	121	SENT_86	[p5l874t2237r911b2298],
85	reverse	NN	O	reverse	dep	121	SENT_86	[p5l930t2257r1190b2298],
86	:	:	O	:	_	0	SENT_86	[p5l930t2257r1190b2298],
87	aaacacctttaccatttaaccc	NN	O	aaacacctttaccatttaaccc	dep	121	SENT_86	[p5l1220t2249r2001b2312],
88	;	:	O	;	_	0	SENT_86	[p5l1220t2249r2001b2312],
89	*	CD	NUMBER	*	dep	121	SENT_86	[p5l2033t2236r2092b2297],
90	1	CD	NUMBER	1	dep	121	SENT_86	[p5l2033t2236r2092b2297],
91	7	CD	NUMBER	7	dep	121	SENT_86	[p5l2108t2237r2145b2298],
92	T	NN	O	t	dep	121	SENT_86	[p5l7t2337r69b2404],
93	speciﬁc	JJ	O	speciﬁc	dep	121	SENT_86	[p5l96t2338r352b2428],
94	(	NN	O	(	dep	121	SENT_86	[p5l380t2336r637b2419],
95	sense	NN	O	sense	dep	121	SENT_86	[p5l380t2336r637b2419],
96	)	CD	NUMBER	)	dep	121	SENT_86	[p5l380t2336r637b2419],
97	:	:	O	:	_	0	SENT_86	[p5l380t2336r637b2419],
98	tgt	NN	O	tgt	dep	121	SENT_86	[p5l666t2355r765b2428],
99	ctt	NN	O	ctt	dep	121	SENT_86	[p5l790t2356r880b2405],
100	ctg	NN	O	ctg	dep	121	SENT_86	[p5l905t2356r1010b2428],
101	ttc	NN	O	ttc	dep	121	SENT_86	[p5l1034t2356r1124b2405],
102	tca	NN	O	tca	dep	121	SENT_86	[p5l1149t2356r1250b2405],
103	aag	NN	O	aag	dep	121	SENT_86	[p5l1275t2365r1391b2428],
104	ta	NN	O	ta	dep	121	SENT_86	[p5l1415t2356r1479b2405],
105	and	CC	O	and	dep	121	SENT_86	[p5l1505t2338r1632b2405],
106	*	NN	O	*	dep	121	SENT_86	[p5l1662t2342r1721b2404],
107	1	CD	NUMBER	1	dep	121	SENT_86	[p5l1662t2342r1721b2404],
108	7	CD	NUMBER	7	dep	121	SENT_86	[p5l1737t2344r1774b2405],
109	C	NN	O	c	dep	121	SENT_86	[p5l1797t2338r1856b2405],
110	speciﬁc	JJ	O	speciﬁc	dep	121	SENT_86	[p5l1884t2338r2141b2428],
111	(	NN	O	(	dep	121	SENT_86	[p5l13t2442r407b2525],
112	antisense	JJ	O	antisense	dep	121	SENT_86	[p5l13t2442r407b2525],
113	)	NN	O	)	dep	121	SENT_86	[p5l13t2442r407b2525],
114	:	:	O	:	_	0	SENT_86	[p5l13t2442r407b2525],
115	atta	NN	O	atta	dep	121	SENT_86	[p5l455t2461r583b2511],
116	tct	NN	O	tct	dep	121	SENT_86	[p5l624t2462r716b2511],
117	ctt	NN	O	ctt	dep	121	SENT_86	[p5l757t2462r847b2511],
118	aca	NN	O	aca	dep	121	SENT_86	[p5l889t2471r997b2511],
119	tca	NN	O	tca	dep	121	SENT_86	[p5l1038t2461r1139b2511],
120	gag	NN	O	gag	dep	121	SENT_86	[p5l1178t2471r1301b2534],
121	atg	NN	O	atg	_	0	SENT_86	[p5l1343t2462r1465b2534],
122	.	.	O	.	_	0	SENT_86	[p5l1343t2462r1465b2534],

1	Size	NN	O	size	nsubj	68	SENT_87	[p5l1515t2444r1656b2511],
2	of	IN	O	of	_	0	SENT_87	[p5l1700t2444r1780b2511],
3	the	DT	O	the	det	5	SENT_87	[p5l1809t2444r1919b2511],
4	PCR	NN	MISC	pcr	nn	5	SENT_87	[p5l1962t2444r2143b2511],
5	products	NNS	O	product	prep_of	1	SENT_87	[p5l9t2550r313b2640],
6	generated	VBN	O	generate	partmod	5	SENT_87	[p5l340t2550r703b2640],
7	:	:	O	:	_	0	SENT_87	[p5l340t2550r703b2640],
8	CYP2C19	NN	O	cyp2c19	nn	9	SENT_87	[p5l741t2554r1155b2618],
9	*	NN	O	*	nsubj	68	SENT_87	[p5l741t2554r1155b2618],
10	2	CD	NUMBER	2	num	11	SENT_87	[p5l741t2554r1155b2618],
11	forvvard/reverse	NN	O	forvvard/reverse	dep	9	SENT_87	[p5l1180t2550r1749b2617],
12	:	:	O	:	_	0	SENT_87	[p5l1180t2550r1749b2617],
13	373	CD	NUMBER	373	num	14	SENT_87	[p5l1781t2552r1905b2617],
14	bp	NN	O	bp	nsubj	68	SENT_87	[p5l1934t2551r2043b2640],
15	,	,	O	,	_	0	SENT_87	[p5l1934t2551r2043b2640],
16	*	NN	O	*	nn	19	SENT_87	[p5l2078t2554r2141b2617],
17	2	CD	NUMBER	2	num	19	SENT_87	[p5l2078t2554r2141b2617],
18	allele	NN	O	allele	nn	19	SENT_87	[p5l11t2656r187b2723],
19	G	NN	O	g	appos	14	SENT_87	[p5l214t2656r280b2723],
20	(	CD	NUMBER	(	num	22	SENT_87	[p5l308t2654r632b2737],
21	normal	JJ	O	normal	amod	22	SENT_87	[p5l308t2654r632b2737],
22	)	NN	O	)	dep	19	SENT_87	[p5l308t2654r632b2737],
23	:	:	O	:	_	0	SENT_87	[p5l308t2654r632b2737],
24	283	CD	NUMBER	283	nsubj	68	SENT_87	[p5l659t2660r787b2724],
25	bp	NN	O	bp	dep	24	SENT_87	[p5l812t2656r921b2746],
26	,	,	O	,	_	0	SENT_87	[p5l812t2656r921b2746],
27	and	CC	O	and	_	0	SENT_87	[p5l949t2657r1077b2723],
28	*	NN	O	*	nn	30	SENT_87	[p5l1105t2660r1168b2723],
29	2	CD	NUMBER	2	num	30	SENT_87	[p5l1105t2660r1168b2723],
30	allele	NN	O	allele	nsubj	68	SENT_87	[p5l1193t2656r1369b2723],
31	A	DT	O	a	det	32	SENT_87	[p5l1391t2655r1458b2722],
32	(	NN	O	(	nsubj	45	SENT_87	[p5l1483t2655r1848b2737],
33	mutated	VBN	O	mutate	partmod	32	SENT_87	[p5l1483t2655r1848b2737],
34	)	CD	NUMBER	)	dobj	33	SENT_87	[p5l1483t2655r1848b2737],
35	:	:	O	:	_	0	SENT_87	[p5l1483t2655r1848b2737],
36	129	CD	NUMBER	129	num	37	SENT_87	[p5l1881t2660r2004b2724],
37	bp	NN	O	bp	dep	32	SENT_87	[p5l2028t2656r2137b2746],
38	;	:	O	;	_	0	SENT_87	[p5l2028t2656r2137b2746],
39	CYP2C19	NN	O	cyp2c19	nn	40	SENT_87	[p5l16t2766r426b2830],
40	*	NN	O	*	dep	37	SENT_87	[p5l16t2766r426b2830],
41	1	CD	NUMBER	1	number	42	SENT_87	[p5l16t2766r426b2830],
42	7	CD	NUMBER	7	dep	40	SENT_87	[p5l442t2768r479b2829],
43	forward	RB	O	forward	advmod	42	SENT_87	[p5l498t2762r805b2829],
44	/	:	O	/	punct	37	SENT_87	[p5l498t2762r805b2829],
45	reverse	VB	O	reverse	rcmod	30	SENT_87	[p5l807t2788r1066b2829],
46	:	:	O	:	_	0	SENT_87	[p5l807t2788r1066b2829],
47	507	CD	NUMBER	507	num	48	SENT_87	[p5l1095t2762r1225b2829],
48	bp	NN	O	bp	dep	30	SENT_87	[p5l1246t2762r1355b2852],
49	,	,	O	,	_	0	SENT_87	[p5l1246t2762r1355b2852],
50	*	NN	O	*	appos	48	SENT_87	[p5l1388t2766r1447b2828],
51	1	CD	NUMBER	1	number	52	SENT_87	[p5l1388t2766r1447b2828],
52	7	CD	NUMBER	7	num	57	SENT_87	[p5l1462t2768r1499b2829],
53	allele	NN	O	allele	nn	57	SENT_87	[p5l1520t2762r1696b2829],
54	C	NN	O	c	nn	57	SENT_87	[p5l1723t2762r1782b2829],
55	(	CD	NUMBER	(	num	57	SENT_87	[p5l1811t2760r2136b2843],
56	normal	JJ	O	normal	amod	57	SENT_87	[p5l1811t2760r2136b2843],
57	)	NN	O	)	dep	50	SENT_87	[p5l1811t2760r2136b2843],
58	:	:	O	:	_	0	SENT_87	[p5l1811t2760r2136b2843],
59	330	CD	NUMBER	330	num	60	SENT_87	[p5l11t2872r139b2935],
60	bp	NN	O	bp	conj_and	1	SENT_87	[p5l167t2869r275b2958],
61	,	,	O	,	_	0	SENT_87	[p5l167t2869r275b2958],
62	and	CC	O	and	_	0	SENT_87	[p5l309t2868r436b2935],
63	*	NN	O	*	nn	66	SENT_87	[p5l470t2872r582b2935],
64	17	CD	NUMBER	17	num	66	SENT_87	[p5l470t2872r582b2935],
65	allele	NN	O	allele	nn	66	SENT_87	[p5l607t2868r784b2935],
66	T	NN	O	t	nsubj	68	SENT_87	[p5l810t2867r873b2934],
67	(	CD	NUMBER	(	dep	66	SENT_87	[p5l904t2866r1270b2949],
68	mutated	VBN	O	mutate	_	0	SENT_87	[p5l904t2866r1270b2949],
69	)	CD	NUMBER	)	dobj	68	SENT_87	[p5l904t2866r1270b2949],
70	:	:	O	:	_	0	SENT_87	[p5l904t2866r1270b2949],
71	218	CD	NUMBER	218	num	72	SENT_87	[p5l1302t2872r1430b2936],
72	bp	NN	O	bp	dep	69	SENT_87	[p5l1461t2869r1568b2958],
73	.	.	O	.	_	0	SENT_87	[p5l1461t2869r1568b2958],

1	Reactions	NNS	MISC	reaction	nsubjpass	3	SENT_88	[p5l1604t2869r1945b2935],
2	were	VBD	O	be	auxpass	3	SENT_88	[p5l1973t2894r2139b2935],
3	made	VBN	O	make	_	0	SENT_88	[p5l11t2974r199b3041],
4	in	IN	O	in	_	0	SENT_88	[p5l244t2977r312b3040],
5	a	DT	O	a	det	7	SENT_88	[p5l357t3001r391b3041],
6	ﬁnal	JJ	O	ﬁnal	amod	7	SENT_88	[p5l434t2974r589b3041],
7	Volume	NN	O	volume	prep_in	3	SENT_88	[p5l628t2974r887b3041],
8	of	IN	O	of	_	0	SENT_88	[p5l933t2974r1013b3041],
9	12.5	CD	NUMBER	12.5	num	10	SENT_88	[p5l1049t2974r1193b3042],
10	ul	NN	O	ul	prep_of	7	SENT_88	[p5l1244t2975r1339b3058],
11	,	,	O	,	_	0	SENT_88	[p5l1244t2975r1339b3058],
12	using	VBG	O	use	xcomp	3	SENT_88	[p5l1385t2977r1575b3064],
13	200	CD	NUMBER	200	num	14	SENT_88	[p5l1616t2978r1746b3042],
14	nmol/l	NN	O	nmol/l	dobj	12	SENT_88	[p5l1792t2974r2029b3041],
15	of	IN	O	of	_	0	SENT_88	[p5l2073t2974r2152b3041],
16	primer	NN	O	primer	prep_of	14	SENT_88	[p5l9t3083r248b3170],
17	except	IN	O	except	_	0	SENT_88	[p5l270t3098r493b3170],
18	for	IN	O	for	_	0	SENT_88	[p5l514t3080r615b3147],
19	*	NN	O	*	prep_except_for	12	SENT_88	[p5l642t3084r705b3147],
20	2	CD	NUMBER	2	num	19	SENT_88	[p5l642t3084r705b3147],
21	A	DT	O	a	det	26	SENT_88	[p5l725t3079r791b3146],
22	primer	NN	O	primer	nn	26	SENT_88	[p5l812t3083r1051b3170],
23	(	NN	O	(	nn	26	SENT_88	[p5l1076t3078r1231b3161],
24	300	CD	NUMBER	300	num	26	SENT_88	[p5l1076t3078r1231b3161],
25	nmol/l	NN	O	nmol/l	nn	26	SENT_88	[p5l1256t3078r1540b3162],
26	)	NN	O	)	dep	19	SENT_88	[p5l1256t3078r1540b3162],
27	,	,	O	,	_	0	SENT_88	[p5l1256t3078r1540b3162],
28	0.15	CD	NUMBER	0.15	num	29	SENT_88	[p5l1567t3080r1716b3147],
29	unit	NN	O	unit	appos	19	SENT_88	[p5l1741t3084r1885b3147],
30	of	IN	O	of	_	0	SENT_88	[p5l1908t3080r1987b3147],
31	Taq	NN	O	taq	nn	36	SENT_88	[p5l1995t3079r2141b3170],
32	DNA	NN	O	dna	nn	36	SENT_88	[p5l10t3185r217b3253],
33	polymerase	NN	O	polymerase	nn	36	SENT_88	[p5l239t3187r635b3276],
34	(	CD	NUMBER	(	num	36	SENT_88	[p5l664t3184r1003b3276],
35	(	NN	O	(	nn	36	SENT_88	[p5l664t3184r1003b3276],
36	ﬂ	NN	O	ﬂ	prep_of	29	SENT_88	[p5l664t3184r1003b3276],
37	)	CD	NUMBER	)	num	38	SENT_88	[p5l664t3184r1003b3276],
38	iotaq	NN	O	iotaq	dep	36	SENT_88	[p5l664t3184r1003b3276],
39	,	,	O	,	_	0	SENT_88	[p5l664t3184r1003b3276],
40	MP	NN	O	mp	nn	41	SENT_88	[p5l1030t3187r1169b3252],
41	Biomedicals	NNS	O	biomedical	appos	19	SENT_88	[p5l1195t3186r1646b3267],
42	,	,	O	,	_	0	SENT_88	[p5l1195t3186r1646b3267],
43	Solon	NNP	ORGANIZATION	Solon	appos	41	SENT_88	[p5l1678t3186r1897b3267],
44	,	,	O	,	_	0	SENT_88	[p5l1678t3186r1897b3267],
45	Ohio	NNP	LOCATION	Ohio	nn	46	SENT_88	[p5l1928t3184r2137b3267],
46	)	NN	O	)	appos	41	SENT_88	[p5l1928t3184r2137b3267],
47	in	IN	O	in	_	0	SENT_88	[p5l10t3296r78b3359],
48	its	PRP$	O	its	poss	50	SENT_88	[p5l137t3296r216b3360],
49	accompanying	VBG	O	accompany	amod	50	SENT_88	[p5l279t3296r787b3383],
50	buffer	NN	O	buffer	prep_in	46	SENT_88	[p5l842t3293r1065b3374],
51	,	,	O	,	_	0	SENT_88	[p5l842t3293r1065b3374],
52	200	CD	NUMBER	200	num	53	SENT_88	[p5l1127t3297r1257b3361],
53	um	NN	O	um	conj_and	46	SENT_88	[p5l1321t3320r1444b3377],
54	of	IN	O	of	_	0	SENT_88	[p5l1506t3293r1586b3360],
55	accompanying	VBG	O	accompany	amod	57	SENT_88	[p5l1634t3296r2142b3383],
56	deoxyribonucleotide	NN	O	deoxyribonucleotide	nn	57	SENT_88	[p6l11t33r725b123],
57	triphosphates	NNS	O	triphosphate	prep_of	53	SENT_88	[p6l766t33r1264b123],
58	,	,	O	,	_	0	SENT_88	[p6l766t33r1264b123],
59	and	CC	O	and	_	0	SENT_88	[p6l1309t33r1437b100],
60	25	CD	NUMBER	25	num	61	SENT_88	[p6l1474t33r1559b101],
61	ng	NN	O	ng	conj_and	46	SENT_88	[p6l1604t60r1691b123],
62	of	IN	O	of	_	0	SENT_88	[p6l1731t33r1811b100],
63	genomic	JJ	O	genomic	amod	64	SENT_88	[p6l1838t36r2141b123],
64	DNA	NN	O	dna	prep_of	61	SENT_88	[p6l10t138r234b206],
65	.	.	O	.	_	0	SENT_88	[p6l10t138r234b206],

1	Cycling	NNP	O	Cycling	nn	2	SENT_89	[p6l273t139r548b229],
2	conditions	NNS	O	condition	_	0	SENT_89	[p6l581t139r967b206],
3	:	:	O	:	_	0	SENT_89	[p6l581t139r967b206],
4	ﬁrst	NN	O	ﬁrst	dep	2	SENT_89	[p6l1005t139r1142b206],
5	denaturing	VBG	O	denature	partmod	4	SENT_89	[p6l1175t139r1559b229],
6	step	NN	O	step	dobj	5	SENT_89	[p6l1592t156r1749b229],
7	:	:	O	:	_	0	SENT_89	[p6l1592t156r1749b229],
8	90	CD	DURATION	90	num	9	SENT_89	[p6l1788t143r1871b206],
9	min	NN	DURATION	min	dep	2	SENT_89	[p6l1906t142r2044b205],
10	at	IN	O	at	_	0	SENT_89	[p6l2079t157r2142b206],
11	94	CD	NUMBER	94	number	12	SENT_89	[p6l11t245r208b326],
12	°	CD	NUMBER	°	num	13	SENT_89	[p6l11t245r208b326],
13	C	NN	O	c	prep_at	9	SENT_89	[p6l11t245r208b326],
14	,	,	O	,	_	0	SENT_89	[p6l11t245r208b326],
15	then	RB	O	then	advmod	17	SENT_89	[p6l235t246r393b312],
16	35	CD	NUMBER	35	num	17	SENT_89	[p6l418t245r499b312],
17	cycles	NNS	O	cycle	appos	2	SENT_89	[p6l527t245r725b335],
18	of	IN	O	of	_	0	SENT_89	[p6l752t245r832b312],
19	30	CD	DURATION	30	num	20	SENT_89	[p6l844t249r928b312],
20	min	NN	DURATION	min	prep_of	17	SENT_89	[p6l954t248r1092b311],
21	at	IN	O	at	_	0	SENT_89	[p6l1117t263r1181b312],
22	95	CD	NUMBER	95	number	23	SENT_89	[p6l1205t245r1401b326],
23	°	CD	NUMBER	°	num	24	SENT_89	[p6l1205t245r1401b326],
24	C	NN	O	c	prep_at	20	SENT_89	[p6l1205t245r1401b326],
25	,	,	O	,	_	0	SENT_89	[p6l1205t245r1401b326],
26	30	CD	DURATION	30	num	27	SENT_89	[p6l1429t249r1512b312],
27	min	NN	DURATION	min	appos	2	SENT_89	[p6l1538t248r1676b311],
28	at	IN	O	at	_	0	SENT_89	[p6l1702t262r1765b312],
29	60	CD	NUMBER	60	number	30	SENT_89	[p6l1789t245r1985b326],
30	°	CD	NUMBER	°	num	31	SENT_89	[p6l1789t245r1985b326],
31	C	NN	O	c	prep_at	27	SENT_89	[p6l1789t245r1985b326],
32	,	,	O	,	_	0	SENT_89	[p6l1789t245r1985b326],
33	and	CC	O	and	_	0	SENT_89	[p6l2014t245r2141b312],
34	50	CD	DURATION	50	num	35	SENT_89	[p6l10t351r95b418],
35	min	NN	DURATION	min	conj_and	31	SENT_89	[p6l128t354r266b417],
36	at	IN	O	at	_	0	SENT_89	[p6l299t369r362b418],
37	72	CD	NUMBER	72	number	38	SENT_89	[p6l394t351r590b432],
38	°	CD	NUMBER	°	num	39	SENT_89	[p6l394t351r590b432],
39	C	NN	O	c	prep_at	35	SENT_89	[p6l394t351r590b432],
40	,	,	O	,	_	0	SENT_89	[p6l394t351r590b432],
41	ﬁnal	JJ	O	ﬁnal	amod	43	SENT_89	[p6l625t351r779b418],
42	extension	NN	O	extension	nn	43	SENT_89	[p6l811t354r1144b418],
43	step	NN	O	step	appos	2	SENT_89	[p6l1177t369r1333b441],
44	:	:	O	:	_	0	SENT_89	[p6l1177t369r1333b441],
45	3	CD	NUMBER	3	num	46	SENT_89	[p6l1370t355r1406b418],
46	h	NN	O	h	dep	2	SENT_89	[p6l1442t352r1487b417],
47	at	IN	O	at	_	0	SENT_89	[p6l1519t369r1583b418],
48	72	CD	NUMBER	72	number	49	SENT_89	[p6l1614t351r1789b419],
49	°	CD	NUMBER	°	num	50	SENT_89	[p6l1614t351r1789b419],
50	C	NN	O	c	prep_at	46	SENT_89	[p6l1614t351r1789b419],
51	and	CC	O	and	_	0	SENT_89	[p6l1824t351r1952b418],
52	then	RB	O	then	conj_and	46	SENT_89	[p6l1982t351r2140b418],
53	cooling	VBG	O	cool	partmod	52	SENT_89	[p6l11t457r270b547],
54	to	TO	O	to	_	0	SENT_89	[p6l311t475r378b524],
55	15	CD	NUMBER	15	number	56	SENT_89	[p6l426t457r619b524],
56	°	CD	NUMBER	°	prep_to	53	SENT_89	[p6l426t457r619b524],
57	C.	NNP	O	C.	nn	59	SENT_89	[p6l426t457r619b524],
58	PCR	NN	O	pcr	nn	59	SENT_89	[p6l666t457r847b524],
59	products	NNS	O	product	nsubjpass	61	SENT_89	[p6l885t457r1189b547],
60	were	VBD	O	be	auxpass	61	SENT_89	[p6l1229t483r1396b524],
61	run	VBN	O	run	ccomp	53	SENT_89	[p6l1438t483r1558b524],
62	on	IN	O	on	_	0	SENT_89	[p6l1601t484r1688b524],
63	2	CD	PERCENT	2	number	64	SENT_89	[p6l1728t461r1838b525],
64	%	NN	PERCENT	%	amod	66	SENT_89	[p6l1728t461r1838b525],
65	agarose	NN	O	agarose	nn	66	SENT_89	[p6l1882t483r2139b547],
66	gels	NNS	O	gel	prep_on	61	SENT_89	[p6l9t564r162b654],
67	,	,	O	,	_	0	SENT_89	[p6l9t564r162b654],
68	and	CC	O	and	_	0	SENT_89	[p6l208t564r336b631],
69	genotypes	NNS	O	genotype	nsubjpass	71	SENT_89	[p6l375t582r726b654],
70	were	VBD	O	be	auxpass	71	SENT_89	[p6l766t590r933b631],
71	assigned	VBN	O	assign	ccomp	53	SENT_89	[p6l977t564r1272b654],
72	according	VBG	O	accord	_	0	SENT_89	[p6l1315t564r1658b654],
73	to	TO	O	to	prepc_according_to	71	SENT_89	[p6l1698t582r1766b631],
74	the	DT	O	the	det	77	SENT_89	[p6l1808t564r1919b631],
75	PCR	NN	MISC	pcr	nn	77	SENT_89	[p6l1962t564r2143b631],
76	products	NNS	O	product	nn	77	SENT_89	[p6l9t670r313b760],
77	sizes	NNS	O	size	pobj	71	SENT_89	[p6l345t673r502b737],
78	observed	VBN	O	observe	partmod	77	SENT_89	[p6l534t670r859b737],
79	.	.	O	.	_	0	SENT_89	[p6l534t670r859b737],

1	CYP2CJ9	NN	O	cyp2cj9	nn	2	SENT_90	[p6l899t674r1313b738],
2	*	NN	O	*	nsubjpass	8	SENT_90	[p6l899t674r1313b738],
3	2	CD	NUMBER	2	dep	2	SENT_90	[p6l899t674r1313b738],
4	and	CC	O	and	_	0	SENT_90	[p6l1342t670r1470b737],
5	*	CD	NUMBER	*	num	6	SENT_90	[p6l1503t674r1615b737],
6	17	CD	NUMBER	17	conj_and	2	SENT_90	[p6l1503t674r1615b737],
7	are	VBP	O	be	auxpass	8	SENT_90	[p6l1641t696r1741b737],
8	deﬁned	VBN	O	deﬁned	_	0	SENT_90	[p6l1772t670r2032b737],
9	by	IN	O	by	_	0	SENT_90	[p6l2058t670r2145b760],
10	rs4244285	NN	O	rs4244285	agent	8	SENT_90	[p6l10t776r376b844],
11	and	CC	O	and	_	0	SENT_90	[p6l418t776r546b843],
12	rs12248560	NN	O	rs12248560	agent	8	SENT_90	[p6l582t776r1015b857],
13	,	,	O	,	_	0	SENT_90	[p6l582t776r1015b857],
14	respectively	RB	O	respectively	advmod	8	SENT_90	[p6l1055t776r1479b866],
15	.	.	O	.	_	0	SENT_90	[p6l1055t776r1479b866],

1	I-Iardy-Weinberg	NN	O	i-iardy-weinberg	nn	2	SENT_91	[p6l1521t776r2142b866],
2	equilibrium	NN	O	equilibrium	nsubjpass	4	SENT_91	[p6l11t884r420b973],
3	was	VBD	O	be	auxpass	4	SENT_91	[p6l464t910r594b950],
4	tested	VBN	O	test	_	0	SENT_91	[p6l643t883r851b950],
5	for	IN	O	for	_	0	SENT_91	[p6l897t883r998b950],
6	each	DT	O	each	det	7	SENT_91	[p6l1045t884r1201b950],
7	polymorphism	NN	O	polymorphism	prep_for	4	SENT_91	[p6l1248t883r1763b973],
8	to	TO	O	to	aux	9	SENT_91	[p6l1811t901r1879b950],
9	detect	VB	O	detect	xcomp	4	SENT_91	[p6l1930t883r2142b950],
10	potential	JJ	O	potential	amod	12	SENT_91	[p6l9t1025r324b1115],
11	stratiﬁcation	NN	O	stratiﬁcation	nn	12	SENT_91	[p6l358t1025r800b1092],
12	bias	NN	O	bias	dobj	9	SENT_91	[p6l831t1025r966b1092],
13	or	CC	O	or	_	0	SENT_91	[p6l1001t1051r1073b1092],
14	genotyping	JJ	O	genotyping	amod	15	SENT_91	[p6l1103t1028r1503b1115],
15	errors	NNS	O	error	conj_or	12	SENT_91	[p6l1534t1051r1753b1092],
16	.	.	O	.	_	0	SENT_91	[p6l1534t1051r1753b1092],

1	Clinical	JJ	O	clinical	amod	2	SENT_92	[p6l11t1138r254b1197],
2	follow-up	NN	O	follow-up	_	0	SENT_92	[p6l312t1138r662b1213],
3	.	.	O	.	_	0	SENT_92	[p6l312t1138r662b1213],

1	Clinical	JJ	O	clinical	nsubjpass	6	SENT_93	[p6l712t1131r977b1198],
2	follow	VBP	O	follow	dep	1	SENT_93	[p6l1029t1131r1359b1221],
3	—	CD	NUMBER	—	dobj	2	SENT_93	[p6l1029t1131r1359b1221],
4	up	RP	O	up	prt	2	SENT_93	[p6l1029t1131r1359b1221],
5	was	VBD	O	be	auxpass	6	SENT_93	[p6l1410t1158r1536b1198],
6	planned	VBN	O	plan	_	0	SENT_93	[p6l1590t1131r1863b1221],
7	for	IN	O	for	_	0	SENT_93	[p6l1915t1131r2012b1198],
8	all	DT	O	all	det	9	SENT_93	[p6l2065t1131r2141b1198],
9	patients	NNS	O	patient	prep_for	6	SENT_93	[p6l9t1240r274b1327],
10	at	IN	O	at	_	0	SENT_93	[p6l303t1255r365b1304],
11	1	CD	DURATION	1	prep_at	9	SENT_93	[p6l393t1241r425b1303],
12	month	NN	NUMBER	month	tmod	6	SENT_93	[p6l457t1238r702b1304],
13	.	.	O	.	_	0	SENT_93	[p6l457t1238r702b1304],

1	The	DT	O	the	det	3	SENT_94	[p6l730t1236r873b1304],
2	clinical	JJ	O	clinical	amod	3	SENT_94	[p6l901t1237r1137b1304],
3	endpoint	NN	O	endpoint	nsubj	6	SENT_94	[p6l1163t1237r1469b1327],
4	was	VBD	O	be	cop	6	SENT_94	[p6l1490t1264r1616b1304],
5	the	DT	O	the	det	6	SENT_94	[p6l1643t1238r1750b1304],
6	occurrence	NN	O	occurrence	dep	30	SENT_94	[p6l1778t1263r2139b1304],
7	of	IN	O	of	_	0	SENT_94	[p6l11t1343r89b1410],
8	bleeding	VBG	O	bleed	prepc_of	6	SENT_94	[p6l106t1343r399b1433],
9	events	NNS	O	event	dobj	8	SENT_94	[p6l429t1361r636b1410],
10	according	VBG	O	accord	_	0	SENT_94	[p6l671t1343r1000b1433],
11	to	TO	O	to	prepc_according_to	8	SENT_94	[p6l1030t1360r1096b1410],
12	the	DT	O	the	det	15	SENT_94	[p6l1130t1344r1236b1410],
13	BARC	NN	ORGANIZATION	barc	nn	15	SENT_94	[p6l1269t1342r1511b1410],
14	consensus	NN	O	consensus	nn	15	SENT_94	[p6l1546t1370r1879b1410],
15	deﬁnitions	NNS	O	deﬁnitions	pobj	8	SENT_94	[p6l1914t1343r2137b1410, p6l10t1453r173b1516],
16	with	IN	O	with	_	0	SENT_94	[p6l202t1449r358b1516],
17	Type	NN	O	type	prep_with	15	SENT_94	[p6l386t1448r564b1539],
18	1	CD	NUMBER	1	num	17	SENT_94	[p6l601t1453r632b1515],
19	and	CC	O	and	_	0	SENT_94	[p6l670t1450r794b1516],
20	2	CD	NUMBER	2	pobj	8	SENT_94	[p6l822t1453r863b1517],
21	or	CC	O	or	_	0	SENT_94	[p6l897t1475r967b1516],
22	3	CD	NUMBER	3	conj_or	20	SENT_94	[p6l997t1453r1033b1516],
23	or	CC	O	or	_	0	SENT_94	[p6l1069t1475r1140b1516],
24	5	CD	NUMBER	5	number	25	SENT_94	[p6l1169t1449r1207b1516],
25	(	CD	NUMBER	(	conj_and	15	SENT_94	[p6l1244t1447r1444b1539],
26	Type	NN	O	type	dep	20	SENT_94	[p6l1244t1447r1444b1539],
27	4	CD	NUMBER	4	num	26	SENT_94	[p6l1475t1453r1517b1515],
28	was	VBD	O	be	auxpass	30	SENT_94	[p6l1544t1476r1670b1516],
29	not	RB	O	not	neg	30	SENT_94	[p6l1703t1467r1817b1516],
30	expected	VBN	O	expect	_	0	SENT_94	[p6l1848t1449r2141b1539],
31	because	IN	O	because	mark	35	SENT_94	[p6l8t1557r267b1623],
32	no	DT	O	no	det	33	SENT_94	[p6l301t1583r385b1623],
33	patient	NN	O	patient	nsubj	35	SENT_94	[p6l418t1559r656b1646],
34	had	VBD	O	have	aux	35	SENT_94	[p6l687t1556r813b1623],
35	planned	VBN	O	plan	advcl	30	SENT_94	[p6l843t1556r1117b1646],
36	coronary	JJ	O	coronary	amod	38	SENT_94	[p6l1149t1582r1446b1646],
37	artery	NN	O	artery	nn	38	SENT_94	[p6l1477t1574r1670b1646],
38	bypass	NN	O	bypass	dobj	35	SENT_94	[p6l1696t1557r1915b1646],
39	grafting	VBG	O	graft	partmod	38	SENT_94	[p6l1948t1556r2137b1646, p6l10t1660r141b1752],
40	)	CD	NUMBER	)	number	41	SENT_94	[p6l1948t1556r2137b1646, p6l10t1660r141b1752],
41	(	CD	NUMBER	(	dobj	39	SENT_94	[p6l173t1661r325b1743],
42	17	CD	NUMBER	17	num	43	SENT_94	[p6l173t1661r325b1743],
43	)	NN	O	)	nsubjpass	30	SENT_94	[p6l173t1661r325b1743],
44	.	.	O	.	_	0	SENT_94	[p6l173t1661r325b1743],

1	Bleeding	VBG	O	bleed	dep	18	SENT_95	[p6l355t1662r658b1752],
2	complications	NNS	O	complication	dobj	1	SENT_95	[p6l682t1662r1149b1752],
3	according	VBG	O	accord	_	0	SENT_95	[p6l1177t1662r1506b1752],
4	to	TO	O	to	prepc_according_to	1	SENT_95	[p6l1529t1679r1595b1729],
5	the	DT	O	the	det	8	SENT_95	[p6l1621t1663r1728b1729],
6	Thrombol	NNP	O	Thrombol	nn	8	SENT_95	[p6l1751t1661r2137b1729],
7	—	NN	O	—	nn	8	SENT_95	[p6l1751t1661r2137b1729],
8	ysis	NN	O	ysis	pobj	1	SENT_95	[p6l7t1771r125b1858],
9	In	IN	O	in	_	0	SENT_95	[p6l174t1769r250b1834],
10	Myocardial	JJ	O	myocardial	amod	11	SENT_95	[p6l296t1768r686b1858],
11	Infarction	NN	O	infarction	prep_in	8	SENT_95	[p6l732t1768r1070b1835],
12	(	CD	NUMBER	(	num	15	SENT_95	[p6l1121t1766r1376b1849],
13	TIMI	NNP	ORGANIZATION	TIMI	nn	15	SENT_95	[p6l1121t1766r1376b1849],
14	)	CD	NUMBER	)	num	15	SENT_95	[p6l1121t1766r1376b1849],
15	deﬁnition	NN	O	deﬁnition	nsubjpass	18	SENT_95	[p6l1429t1768r1758b1835],
16	were	VBD	O	be	auxpass	18	SENT_95	[p6l1802t1794r1963b1835],
17	also	RB	O	also	advmod	18	SENT_95	[p6l2014t1769r2139b1835],
18	collected	VBN	O	collect	_	0	SENT_95	[p6l11t1874r307b1941],
19	(	RB	O	(	advmod	18	SENT_95	[p6l345t1872r498b1955],
20	12	CD	NUMBER	12	num	21	SENT_95	[p6l345t1872r498b1955],
21	)	NN	O	)	dobj	18	SENT_95	[p6l345t1872r498b1955],
22	.	.	O	.	_	0	SENT_95	[p6l345t1872r498b1955],

1	Ischemic	JJ	O	ischemic	amod	2	SENT_96	[p6l538t1875r842b1941],
2	events	NNS	O	event	nsubjpass	5	SENT_96	[p6l879t1892r1086b1941],
3	were	VBD	O	be	auxpass	5	SENT_96	[p6l1120t1900r1282b1941],
4	also	RB	O	also	advmod	5	SENT_96	[p6l1321t1874r1446b1941],
5	collected	VBN	O	collect	_	0	SENT_96	[p6l1485t1874r1780b1941],
6	using	VBG	O	use	xcomp	5	SENT_96	[p6l1815t1877r1998b1964],
7	the	DT	O	the	det	9	SENT_96	[p6l2032t1875r2139b1941],
8	combined	JJ	O	combined	amod	9	SENT_96	[p6l11t1980r347b2047],
9	endpoint	NN	O	endpoint	dobj	6	SENT_96	[p6l372t1980r678b2070],
10	of	IN	O	of	_	0	SENT_96	[p6l700t1980r778b2047],
11	cardiovascular	JJ	O	cardiovascular	amod	12	SENT_96	[p6l791t1980r1266b2047],
12	death	NN	O	death	prep_of	9	SENT_96	[p6l1289t1980r1493b2062],
13	,	,	O	,	_	0	SENT_96	[p6l1289t1980r1493b2062],
14	myocardial	JJ	O	myocardial	amod	15	SENT_96	[p6l1521t1981r1893b2070],
15	infarction	NN	O	infarction	conj_and	12	SENT_96	[p6l1915t1980r2137b2047, p6l10t2089r163b2168],
16	,	,	O	,	_	0	SENT_96	[p6l1915t1980r2137b2047, p6l10t2089r163b2168],
17	deﬁnite	NN	O	deﬁnite	nn	21	SENT_96	[p6l187t2086r441b2153],
18	or	CC	O	or	_	0	SENT_96	[p6l463t2112r533b2153],
19	probable	JJ	O	probable	conj_or	17	SENT_96	[p6l551t2086r844b2176],
20	stent	NN	O	stent	nn	21	SENT_96	[p6l866t2103r1029b2153],
21	thrombosis	NN	O	thrombosis	conj_and	12	SENT_96	[p6l1048t2086r1445b2168],
22	,	,	O	,	_	0	SENT_96	[p6l1048t2086r1445b2168],
23	and	CC	O	and	_	0	SENT_96	[p6l1470t2086r1593b2153],
24	stroke	NN	O	stroke	conj_and	12	SENT_96	[p6l1614t2086r1833b2153],
25	.	.	O	.	_	0	SENT_96	[p6l1614t2086r1833b2153],

1	Deﬁnite	NN	O	deﬁnite	nsubjpass	7	SENT_97	[p6l1858t2086r2139b2153],
2	or	CC	O	or	_	0	SENT_97	[p6l11t2218r81b2259],
3	probable	JJ	O	probable	amod	5	SENT_97	[p6l131t2193r424b2282],
4	stent	NN	O	stent	nn	5	SENT_97	[p6l479t2209r642b2259],
5	thrombosis	NN	O	thrombosis	conj_or	1	SENT_97	[p6l693t2192r1071b2259],
6	was	VBD	O	be	auxpass	7	SENT_97	[p6l1122t2219r1248b2259],
7	deﬁned	VBN	O	deﬁned	_	0	SENT_97	[p6l1303t2192r1555b2259],
8	as	IN	O	as	_	0	SENT_97	[p6l1608t2219r1669b2259],
9	the	DT	O	the	det	11	SENT_97	[p6l1724t2192r1830b2259],
10	deﬁnite	JJ	O	deﬁnite	amod	11	SENT_97	[p6l1885t2192r2139b2259],
11	occurrence	NN	O	occurrence	prep_as	7	SENT_97	[p6l11t2324r372b2365],
12	of	IN	O	of	_	0	SENT_97	[p6l404t2298r482b2365],
13	a	DT	O	a	det	15	SENT_97	[p6l502t2325r536b2365],
14	thrombotic	JJ	O	thrombotic	amod	15	SENT_97	[p6l564t2298r946b2365],
15	event	NN	O	event	prep_of	11	SENT_97	[p6l976t2315r1173b2379],
16	,	,	O	,	_	0	SENT_97	[p6l976t2315r1173b2379],
17	according	VBG	O	accord	_	0	SENT_97	[p6l1207t2298r1536b2388],
18	to	TO	O	to	prepc_according_to	7	SENT_97	[p6l1564t2316r1630b2365],
19	the	DT	O	the	det	23	SENT_97	[p6l1661t2299r1768b2365],
20	Academic	NNP	ORGANIZATION	Academic	nn	23	SENT_97	[p6l1797t2297r2141b2365],
21	Research	NNP	ORGANIZATION	Research	nn	23	SENT_97	[p6l12t2404r316b2469],
22	Consortium	NNP	ORGANIZATION	Consortium	nn	23	SENT_97	[p6l353t2403r765b2469],
23	classiﬁcation	NN	O	classiﬁcation	pobj	7	SENT_97	[p6l802t2403r1227b2469],
24	(	CD	NUMBER	(	number	25	SENT_97	[p6l1265t2401r1418b2483],
25	18	CD	NUMBER	18	num	26	SENT_97	[p6l1265t2401r1418b2483],
26	)	NN	O	)	dep	23	SENT_97	[p6l1265t2401r1418b2483],
27	.	.	O	.	_	0	SENT_97	[p6l1265t2401r1418b2483],

1	To	TO	O	to	aux	3	SENT_98	[p6l1455t2402r1558b2469],
2	be	VB	O	be	auxpass	3	SENT_98	[p6l1593t2403r1671b2469],
3	considered	VBN	O	consider	purpcl	14	SENT_98	[p6l1708t2404r2071b2469],
4	a	DT	O	a	det	7	SENT_98	[p6l2107t2430r2142b2469],
5	primary	JJ	O	primary	amod	7	SENT_98	[p6l9t2513r278b2600],
6	endpoint	NN	O	endpoint	nn	7	SENT_98	[p6l330t2510r636b2600],
7	event	NN	O	event	dobj	3	SENT_98	[p6l690t2528r886b2591],
8	,	,	O	,	_	0	SENT_98	[p6l690t2528r886b2591],
9	a	DT	O	a	det	11	SENT_98	[p6l945t2537r979b2577],
10	myocardial	JJ	O	myocardial	amod	11	SENT_98	[p6l1033t2510r1405b2600],
11	infarction	NN	O	infarction	nsubj	14	SENT_98	[p6l1458t2510r1786b2577],
12	must	MD	O	must	aux	14	SENT_98	[p6l1841t2528r2010b2577],
13	be	VB	O	be	cop	14	SENT_98	[p6l2061t2510r2139b2577],
14	distinct	JJ	O	distinct	_	0	SENT_98	[p6l11t2615r262b2681],
15	from	IN	O	from	_	0	SENT_98	[p6l295t2615r459b2681],
16	the	DT	O	the	det	18	SENT_98	[p6l494t2615r601b2681],
17	index	NN	O	index	nn	18	SENT_98	[p6l636t2615r821b2681],
18	event	NN	O	event	prep_from	14	SENT_98	[p6l855t2633r1035b2681],
19	and	CC	O	and	_	0	SENT_98	[p6l1070t2615r1194b2681],
20	deﬁned	VBN	O	deﬁned	conj_and	14	SENT_98	[p6l1228t2615r1480b2681],
21	with	IN	O	with	_	0	SENT_98	[p6l1511t2615r1666b2681],
22	the	DT	O	the	det	24	SENT_98	[p6l1701t2615r1807b2681],
23	universal	JJ	O	universal	amod	24	SENT_98	[p6l1841t2615r2141b2681],
24	deﬁnition	NN	O	deﬁnition	prep_with	20	SENT_98	[p6l11t2721r340b2788],
25	of	IN	O	of	_	0	SENT_98	[p6l367t2721r446b2788],
26	myocardial	JJ	O	myocardial	amod	27	SENT_98	[p6l461t2722r833b2811],
27	infarction	NN	O	infarction	prep_of	24	SENT_98	[p6l858t2721r1186b2788],
28	(	CD	NUMBER	(	number	29	SENT_98	[p6l1215t2720r1368b2802],
29	19	CD	NUMBER	19	num	30	SENT_98	[p6l1215t2720r1368b2802],
30	)	NN	O	)	dobj	20	SENT_98	[p6l1215t2720r1368b2802],
31	.	.	O	.	_	0	SENT_98	[p6l1215t2720r1368b2802],

1	Stroke	NN	O	stroke	nsubjpass	3	SENT_99	[p6l1402t2721r1619b2788],
2	was	VBD	O	be	auxpass	3	SENT_99	[p6l1643t2748r1769b2788],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_99	[p6l1798t2721r2050b2788],
4	as	IN	O	as	_	0	SENT_99	[p6l2077t2748r2139b2788],
5	a	DT	O	a	det	7	SENT_99	[p6l11t2855r46b2895],
6	rapid	JJ	O	rapid	amod	7	SENT_99	[p6l70t2829r245b2918],
7	onset	NN	O	onset	prep_as	3	SENT_99	[p6l271t2845r451b2895],
8	of	IN	O	of	_	0	SENT_99	[p6l476t2828r554b2895],
9	a	DT	O	a	det	14	SENT_99	[p6l569t2855r603b2895],
10	new	JJ	O	new	amod	14	SENT_99	[p6l629t2855r771b2895],
11	persistent	JJ	O	persistent	amod	14	SENT_99	[p6l792t2831r1135b2918],
12	,	,	O	,	_	0	SENT_99	[p6l792t2831r1135b2918],
13	neurological	JJ	O	neurological	amod	14	SENT_99	[p6l1165t2828r1578b2918],
14	deﬁcit	NN	O	deﬁcit	prep_of	7	SENT_99	[p6l1604t2828r1814b2895],
15	that	WDT	O	that	nsubj	16	SENT_99	[p6l1838t2828r1974b2895],
16	lasts	VBZ	O	last	rcmod	14	SENT_99	[p6l1997t2829r2138b2895],
17	for	IN	O	for	_	0	SENT_99	[p6l10t2933r107b2999],
18	more	JJR	O	more	mwe	19	SENT_99	[p6l136t2959r309b2999],
19	than	IN	O	than	quantmod	20	SENT_99	[p6l340t2933r493b2999],
20	24	CD	NUMBER	24	num	21	SENT_99	[p6l520t2937r606b3000],
21	h.	NN	O	h.	prep_for	16	SENT_99	[p6l635t2933r696b2999],

1	Endpoints	NNS	O	endpoint	_	0	SENT_100	[p6l13t3046r377b3121],
2	.	.	O	.	_	0	SENT_100	[p6l13t3046r377b3121],

1	The	DT	O	the	det	3	SENT_101	[p6l423t3038r570b3106],
2	primary	JJ	O	primary	amod	3	SENT_101	[p6l603t3042r883b3129],
3	endpoint	NN	O	endpoint	nsubj	10	SENT_101	[p6l912t3039r1231b3129],
4	of	IN	O	of	_	0	SENT_101	[p6l1262t3039r1342b3106],
5	the	DT	O	the	det	7	SENT_101	[p6l1362t3040r1472b3106],
6	present	JJ	DATE	present	amod	7	SENT_101	[p6l1505t3056r1763b3129],
7	study	NN	O	study	prep_of	3	SENT_101	[p6l1796t3040r1985b3129],
8	was	VBD	O	be	cop	10	SENT_101	[p6l2010t3066r2139b3106],
9	the	DT	O	the	det	10	SENT_101	[p6l10t3146r120b3212],
10	effect	NN	O	effect	_	0	SENT_101	[p6l146t3145r331b3212],
11	of	IN	O	of	_	0	SENT_101	[p6l354t3145r434b3212],
12	CYP2CJ	NN	O	cyp2cj	nn	14	SENT_101	[p6l452t3149r746b3213],
13	9	CD	NUMBER	9	num	14	SENT_101	[p6l758t3149r866b3212],
14	*	NN	O	*	prep_of	10	SENT_101	[p6l758t3149r866b3212],
15	2	CD	NUMBER	2	num	14	SENT_101	[p6l758t3149r866b3212],
16	and	CC	O	and	_	0	SENT_101	[p6l890t3145r1018b3212],
17	*	CD	NUMBER	*	number	18	SENT_101	[p6l1047t3149r1106b3211],
18	1	CD	NUMBER	1	conj_and	10	SENT_101	[p6l1047t3149r1106b3211],
19	7	CD	NUMBER	7	num	20	SENT_101	[p6l1121t3150r1158b3212],
20	allele	NN	O	allele	dep	18	SENT_101	[p6l1179t3145r1355b3212],
21	on	IN	O	on	_	0	SENT_101	[p6l1381t3172r1468b3212],
22	prasugrel	NN	O	prasugrel	nn	23	SENT_101	[p6l1491t3146r1814b3235],
23	response	NN	O	response	prep_on	10	SENT_101	[p6l1837t3171r2139b3235],
24	assessed	VBN	O	assess	partmod	23	SENT_101	[p6l11t3253r294b3319],
25	by	IN	O	by	_	0	SENT_101	[p6l318t3252r404b3342],
26	PRI	NNP	ORGANIZATION	PRI	nn	27	SENT_101	[p6l428t3253r571b3318],
27	VASP	NN	ORGANIZATION	vasp	agent	24	SENT_101	[p6l601t3251r849b3333],
28	,	,	O	,	_	0	SENT_101	[p6l601t3251r849b3333],
29	incidence	NN	O	incidence	appos	27	SENT_101	[p6l879t3252r1211b3319],
30	of	IN	O	of	_	0	SENT_101	[p6l1241t3252r1320b3319],
31	HTPR	NN	O	htpr	prep_of	29	SENT_101	[p6l1336t3251r1589b3318],
32	deﬁned	VBN	O	deﬁned	partmod	31	SENT_101	[p6l1614t3252r1875b3319],
33	as	IN	O	as	_	0	SENT_101	[p6l1903t3279r1966b3319],
34	PRI	NNP	ORGANIZATION	PRI	nn	35	SENT_101	[p6l1995t3253r2139b3318],
35	VASP	NN	ORGANIZATION	vasp	prep_as	32	SENT_101	[p6l10t3357r238b3425],
36	>	JJR	O	>	amod	29	SENT_101	[p6l279t3369r339b3420],
37	50	CD	PERCENT	50	num	38	SENT_101	[p6l381t3359r552b3439],
38	%	NN	PERCENT	%	dep	36	SENT_101	[p6l381t3359r552b3439],
39	,	,	O	,	_	0	SENT_101	[p6l381t3359r552b3439],
40	and	CC	O	and	_	0	SENT_101	[p6l593t3358r721b3425],
41	hyper-response	JJ	O	hyper-response	conj_and	29	SENT_101	[p6l756t3359r1295b3448],
42	deﬁned	VBN	O	deﬁned	partmod	41	SENT_101	[p6l1332t3358r1593b3425],
43	as	IN	O	as	_	0	SENT_101	[p6l1630t3385r1692b3425],
44	PRI	NNP	O	PRI	nn	45	SENT_101	[p6l1731t3359r1874b3424],
45	VASP	NN	ORGANIZATION	vasp	prep_as	42	SENT_101	[p6l1912t3357r2140b3425],
46	below	IN	O	below	_	0	SENT_101	[p6l8t3464r221b3531],
47	the	DT	O	the	det	49	SENT_101	[p6l242t3464r352b3531],
48	75th	JJ	ORDINAL	75th	amod	49	SENT_101	[p6l380t3464r540b3531],
49	percentile	NN	O	percentile	prep_below	42	SENT_101	[p6l564t3465r928b3554],
50	.	.	O	.	_	0	SENT_101	[p6l564t3465r928b3554],

1	Secondary	JJ	O	secondary	amod	2	SENT_102	[p6l961t3464r1326b3554],
2	endpoints	NNS	O	endpoint	nsubj	3	SENT_102	[p6l1348t3464r1694b3554],
3	assessed	VBN	O	assess	_	0	SENT_102	[p6l1723t3464r2005b3531],
4	the	DT	O	the	det	6	SENT_102	[p6l2029t3464r2139b3531],
5	bleeding	NN	O	bleeding	nn	6	SENT_102	[p6l8t3570r312b3660],
6	complications	NNS	O	complication	dobj	3	SENT_102	[p6l368t3570r856b3660],
7	and	CC	O	and	_	0	SENT_102	[p6l916t3570r1043b3637],
8	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_102	[p6l1099t3570r1418b3637],
9	of	IN	O	of	_	0	SENT_102	[p6l1477t3570r1556b3637],
10	both	DT	O	both	det	12	SENT_102	[p6l1598t3570r1763b3637],
11	prasugrel	NN	O	prasugrel	nn	12	SENT_102	[p6l1818t3570r2142b3660],
12	response	NN	O	response	prep_of	6	SENT_102	[p6l10t3703r312b3767],
13	and	CC	O	and	_	0	SENT_102	[p6l348t3677r475b3744],
14	genotypes	NNS	O	genotype	conj_and	12	SENT_102	[p6l506t3695r857b3767],
15	on	IN	O	on	_	0	SENT_102	[p6l892t3704r980b3744],
16	bleeding	VBG	O	bleed	prepc_on	3	SENT_102	[p6l1011t3677r1315b3767],
17	risk	NN	O	risk	dobj	16	SENT_102	[p6l1346t3677r1491b3744],
18	.	.	O	.	_	0	SENT_102	[p6l1346t3677r1491b3744],

1	JACC	NN	O	jacc	_	0	SENT_103	[p7l316t133r466b164],
2	:	:	O	:	_	0	SENT_103	[p7l316t133r466b164],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_103	[p7l503t133r1002b164],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_103	[p7l1039t133r1498b169],
5	,	,	O	,	_	0	SENT_103	[p7l1039t133r1498b169],
6	VOL	NNP	O	VOL	appos	4	SENT_103	[p7l1534t133r1656b164],
7	.	.	O	.	_	0	SENT_103	[p7l1534t133r1656b164],

1	5	CD	NUMBER	5	_	0	SENT_104	[p7l1693t135r1736b169],
2	,	,	O	,	_	0	SENT_104	[p7l1693t135r1736b169],
3	NO.	NNP	DATE	NO.	appos	1	SENT_104	[p7l1774t133r1864b164],
4	12	CD	DATE	12	num	3	SENT_104	[p7l1903t134r1979b169],
5	,	,	DATE	,	_	0	SENT_104	[p7l1903t134r1979b169],
6	2012	CD	DATE	2012	num	3	SENT_104	[p7l2016t134r2141b164],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_104	[p7l1464t197r1749b229],
8	2012:1280	CD	NUMBER	2012:1280	num	7	SENT_104	[p7l1785t198r2141b229],
9	—	CD	NUMBER	—	number	10	SENT_104	[p7l1785t198r2141b229],
10	7	CD	NUMBER	7	dep	7	SENT_104	[p7l1785t198r2141b229],

1	Statistical	JJ	O	statistical	amod	2	SENT_105	[p7l12t396r342b455],
2	analysis	NN	O	analysis	_	0	SENT_105	[p7l378t396r667b472],
3	.	.	O	.	_	0	SENT_105	[p7l378t396r667b472],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_106	[p7l719t389r1062b456],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_106	[p7l1095t389r1360b479],
3	was	VBD	O	be	auxpass	4	SENT_106	[p7l1390t416r1519b456],
4	performed	VBN	O	perform	_	0	SENT_106	[p7l1552t389r1923b479],
5	using	VBG	O	use	xcomp	4	SENT_106	[p7l1953t392r2143b479],
6	the	DT	O	the	det	11	SENT_106	[p7l11t496r121b562],
7	GraphPad	NNP	MISC	GraphPad	nn	11	SENT_106	[p7l147t495r515b585],
8	Prism	NNP	MISC	Prism	nn	11	SENT_106	[p7l538t496r745b562],
9	Software	NNP	MISC	Software	nn	11	SENT_106	[p7l773t495r1080b562],
10	(	NNP	O	(	nn	11	SENT_106	[p7l1108t493r1188b576],
11	V.	NNP	O	V.	dobj	5	SENT_106	[p7l1108t493r1188b576],
12	4.00	CD	NUMBER	4.00	num	11	SENT_106	[p7l1214t499r1387b576],
13	,	,	O	,	_	0	SENT_106	[p7l1214t499r1387b576],
14	GraphPad	NNP	O	GraphPad	nn	15	SENT_106	[p7l1416t495r1784b585],
15	Software	NNP	O	Software	appos	11	SENT_106	[p7l1810t495r2138b576],
16	,	,	O	,	_	0	SENT_106	[p7l1810t495r2138b576],
17	La	NNP	LOCATION	La	nn	18	SENT_106	[p7l12t602r105b668],
18	Jolla	NNP	LOCATION	Jolla	appos	11	SENT_106	[p7l119t602r301b686],
19	,	,	O	,	_	0	SENT_106	[p7l119t602r301b686],
20	California	NNP	LOCATION	California	nn	21	SENT_106	[p7l329t599r733b682],
21	)	NN	O	)	appos	11	SENT_106	[p7l329t599r733b682],
22	.	.	O	.	_	0	SENT_106	[p7l329t599r733b682],

1	Continuous	JJ	O	continuous	amod	2	SENT_107	[p7l762t601r1178b668],
2	variables	NNS	O	variable	nsubjpass	14	SENT_107	[p7l1200t601r1504b668],
3	were	VBD	O	be	auxpass	4	SENT_107	[p7l1525t627r1691b668],
4	analyzed	VBN	O	analyze	_	0	SENT_107	[p7l1717t601r2020b691],
5	for	IN	O	for	_	0	SENT_107	[p7l2043t601r2143b668],
6	a	DT	O	a	det	8	SENT_107	[p7l13t734r47b774],
7	normal	JJ	O	normal	amod	8	SENT_107	[p7l106t707r357b774],
8	distribution	NN	O	distribution	prep_for	4	SENT_107	[p7l416t707r829b774],
9	with	IN	O	with	_	0	SENT_107	[p7l886t707r1047b774],
10	the	DT	O	the	det	12	SENT_107	[p7l1105t707r1216b774],
11	Shapiro-Wilk	NNP	MISC	Shapiro-Wilk	nn	12	SENT_107	[p7l1280t707r1775b797],
12	test	NN	O	test	prep_with	8	SENT_107	[p7l1830t724r1955b774],
13	and	CC	O	and	_	0	SENT_107	[p7l2014t707r2142b774],
14	expressed	VBN	O	express	conj_and	4	SENT_107	[p7l12t813r346b903],
15	as	IN	O	as	_	0	SENT_107	[p7l379t840r440b880],
16	mean	JJ	O	mean	amod	17	SENT_107	[p7l473t840r658b880],
17	i	FW	O	i	prep_as	14	SENT_107	[p7l696t823r749b876],
18	SD	NN	O	sd	dobj	4	SENT_107	[p7l792t813r921b880],
19	.	.	O	.	_	0	SENT_107	[p7l792t813r921b880],

1	Categorical	JJ	O	categorical	amod	2	SENT_108	[p7l957t813r1345b903],
2	variables	NNS	O	variable	nsubjpass	4	SENT_108	[p7l1370t813r1660b880],
3	are	VBP	O	be	auxpass	4	SENT_108	[p7l1693t839r1790b880],
4	expressed	VBN	O	express	_	0	SENT_108	[p7l1821t813r2142b903],
5	as	IN	O	as	_	0	SENT_108	[p7l13t947r74b987],
6	frequencies	NNS	O	frequency	prep_as	4	SENT_108	[p7l106t920r484b1010],
7	and	CC	O	and	_	0	SENT_108	[p7l518t920r642b987],
8	percentages	NNS	O	percentage	prep_as	4	SENT_108	[p7l671t938r1082b1010],
9	.	.	O	.	_	0	SENT_108	[p7l671t938r1082b1010],

1	Comparisons	NNS	O	comparison	nsubjpass	5	SENT_109	[p7l1119t920r1569b1010],
2	between	IN	O	between	_	0	SENT_109	[p7l1599t920r1883b987],
3	groups	NNS	O	group	prep_between	1	SENT_109	[p7l1913t946r2139b1010],
4	were	VBD	O	be	auxpass	5	SENT_109	[p7l8t1052r168b1093],
5	made	VBN	O	make	_	0	SENT_109	[p7l227t1027r410b1093],
6	with	IN	O	with	_	0	SENT_109	[p7l464t1027r620b1093],
7	the	DT	O	the	det	8	SENT_109	[p7l677t1026r783b1093],
8	chi-square	NN	O	chi-square	prep_with	5	SENT_109	[p7l842t1026r1193b1116],
9	or	CC	O	or	_	0	SENT_109	[p7l1252t1052r1321b1093],
10	Fisher	NNP	PERSON	Fisher	nn	12	SENT_109	[p7l1377t1026r1591b1093],
11	exact	JJ	O	exact	amod	12	SENT_109	[p7l1647t1043r1817b1093],
12	test	NN	O	test	prep_with	5	SENT_109	[p7l1871t1043r1991b1093],
13	for	IN	O	for	_	0	SENT_109	[p7l2046t1026r2143b1093],
14	categorical	JJ	O	categorical	amod	15	SENT_109	[p7l12t1132r371b1222],
15	variables	NNS	O	variable	prep_for	5	SENT_109	[p7l398t1132r688b1199],
16	and	CC	O	and	_	0	SENT_109	[p7l722t1132r847b1199],
17	1	CD	NUMBER	1	number	18	SENT_109	[p7l879t1148r907b1198],
18	‘	CD	NUMBER	‘	num	19	SENT_109	[p7l879t1148r907b1198],
19	test	NN	O	test	prep_for	5	SENT_109	[p7l933t1150r1052b1199],
20	for	IN	O	for	_	0	SENT_109	[p7l1082t1132r1179b1199],
21	continuous	JJ	O	continuous	amod	22	SENT_109	[p7l1210t1135r1582b1199],
22	variables	NNS	O	variable	prep_for	19	SENT_109	[p7l1612t1132r1920b1199],
23	.	.	O	.	_	0	SENT_109	[p7l1612t1132r1920b1199],

1	Oneway	NN	O	oneway	nn	2	SENT_110	[p7l1958t1132r2138b1199, p7l7t1266r146b1329],
2	analysis	NN	O	analysis	nsubjpass	6	SENT_110	[p7l188t1240r440b1329],
3	of	IN	O	of	_	0	SENT_110	[p7l488t1239r566b1306],
4	variance	NN	O	variance	prep_of	2	SENT_110	[p7l594t1242r871b1306],
5	was	VBD	O	be	auxpass	6	SENT_110	[p7l913t1266r1039b1306],
6	used	VBN	O	use	_	0	SENT_110	[p7l1084t1239r1238b1306],
7	for	IN	O	for	_	0	SENT_110	[p7l1281t1239r1379b1306],
8	comparison	NN	O	comparison	prep_for	6	SENT_110	[p7l1422t1242r1815b1329],
9	between	IN	O	between	_	0	SENT_110	[p7l1858t1240r2141b1306],
10	different	JJ	O	different	amod	11	SENT_110	[p7l12t1345r294b1412],
11	groups	NNS	O	group	prep_between	8	SENT_110	[p7l322t1371r567b1435],
12	.	.	O	.	_	0	SENT_110	[p7l322t1371r567b1435],

1	Values	NNS	O	value	nsubjpass	7	SENT_111	[p7l602t1345r826b1412],
2	of	IN	O	of	_	0	SENT_111	[p7l859t1345r937b1412],
3	p	NN	O	p	prep_of	1	SENT_111	[p7l954t1372r996b1435],
4	<	JJR	O	<	dep	3	SENT_111	[p7l1033t1356r1093b1407],
5	0.05	CD	NUMBER	0.05	dep	4	SENT_111	[p7l1129t1345r1273b1412],
6	were	VBD	O	be	auxpass	7	SENT_111	[p7l1303t1371r1464b1412],
7	considered	VBN	O	consider	_	0	SENT_111	[p7l1497t1345r1859b1412],
8	statistically	RB	O	statistically	advmod	9	SENT_111	[p7l1890t1348r2138b1412, p7l12t1451r163b1541],
9	significant	JJ	O	significant	acomp	7	SENT_111	[p7l197t1451r561b1541],
10	.	.	O	.	_	0	SENT_111	[p7l197t1451r561b1541],

1	Assuming	VBG	O	assume	ccomp	47	SENT_112	[p7l599t1450r948b1541],
2	that	DT	O	that	det	3	SENT_112	[p7l982t1452r1118b1518],
3	carriers	NNS	O	carrier	dobj	1	SENT_112	[p7l1153t1454r1393b1518],
4	of	IN	O	of	_	0	SENT_112	[p7l1432t1451r1510b1518],
5	*	NN	O	*	prep_of	3	SENT_112	[p7l1539t1455r1601b1518],
6	2	CD	NUMBER	2	number	10	SENT_112	[p7l1539t1455r1601b1518],
7	and	CC	O	and	_	0	SENT_112	[p7l1638t1451r1762b1518],
8	*	CD	NUMBER	*	conj_and	10	SENT_112	[p7l1802t1455r1860b1517],
9	1	CD	NUMBER	1	number	10	SENT_112	[p7l1802t1455r1860b1517],
10	7	CD	NUMBER	7	num	11	SENT_112	[p7l1873t1456r1910b1518],
11	alleles	NNS	O	allele	nsubj	12	SENT_112	[p7l1943t1451r2139b1518],
12	represent	VBP	O	represent	rcmod	3	SENT_112	[p7l11t1576r323b1648],
13	one-third	NN	ORDINAL	one-third	dobj	12	SENT_112	[p7l350t1558r675b1625],
14	of	IN	O	of	_	0	SENT_112	[p7l703t1558r782b1625],
15	the	DT	O	the	det	17	SENT_112	[p7l798t1558r904b1625],
16	entire	JJ	O	entire	amod	17	SENT_112	[p7l935t1561r1126b1625],
17	population	NN	O	population	prep_of	13	SENT_112	[p7l1155t1559r1540b1648],
18	,	,	O	,	_	0	SENT_112	[p7l1155t1559r1540b1648],
19	and	CC	O	and	_	0	SENT_112	[p7l1573t1558r1697b1625],
20	expecting	VBG	O	expect	conj_and	1	SENT_112	[p7l1726t1561r2049b1648],
21	in	IN	O	in	_	0	SENT_112	[p7l2075t1561r2141b1624],
22	these	DT	O	these	det	23	SENT_112	[p7l11t1664r183b1731],
23	patients	NNS	O	patient	prep_in	20	SENT_112	[p7l203t1667r468b1754],
24	a	DT	O	a	det	28	SENT_112	[p7l492t1691r526b1731],
25	5	CD	PERCENT	5	number	26	SENT_112	[p7l545t1664r651b1731],
26	%	NN	PERCENT	%	amod	28	SENT_112	[p7l545t1664r651b1731],
27	absolute	JJ	O	absolute	amod	28	SENT_112	[p7l673t1664r948b1731],
28	difference	NN	O	difference	dobj	20	SENT_112	[p7l970t1664r1294b1731],
29	in	IN	O	in	_	0	SENT_112	[p7l1315t1667r1381b1730],
30	PR1	NN	O	pr1	nn	31	SENT_112	[p7l1401t1665r1541b1730],
31	VASP	NN	ORGANIZATION	vasp	prep_in	20	SENT_112	[p7l1563t1663r1786b1731],
32	compared	VBN	O	compare	_	0	SENT_112	[p7l1807t1664r2142b1754],
33	with	IN	O	with	prepc_compared_with	20	SENT_112	[p7l7t1770r164b1837],
34	patients	NNS	O	patient	pobj	20	SENT_112	[p7l204t1773r469b1860],
35	who	WP	O	who	nsubj	37	SENT_112	[p7l509t1770r658b1837],
36	were	VBD	O	be	cop	37	SENT_112	[p7l698t1796r859b1837],
37	noncarriers	NNS	O	noncarrier	rcmod	34	SENT_112	[p7l903t1773r1297b1851],
38	,	,	O	,	_	0	SENT_112	[p7l903t1773r1297b1851],
39	a	DT	O	a	det	40	SENT_112	[p7l1343t1797r1378b1837],
40	total	NN	O	total	nsubjpass	47	SENT_112	[p7l1418t1770r1571b1837],
41	of	IN	O	of	_	0	SENT_112	[p7l1613t1770r1690b1837],
42	at	IN	O	at	quantmod	44	SENT_112	[p7l1722t1787r1784b1837],
43	least	JJS	O	least	mwe	42	SENT_112	[p7l1823t1770r1974b1837],
44	205	CD	NUMBER	205	num	45	SENT_112	[p7l2013t1770r2138b1838],
45	patients	NNS	O	patient	prep_of	40	SENT_112	[p7l10t1879r275b1966],
46	were	VBD	O	be	auxpass	47	SENT_112	[p7l299t1902r460b1943],
47	needed	VBN	O	need	_	0	SENT_112	[p7l488t1876r729b1943],
48	to	TO	O	to	aux	49	SENT_112	[p7l754t1894r821b1943],
49	detect	VB	O	detect	xcomp	47	SENT_112	[p7l849t1876r1053b1943],
50	the	DT	O	the	det	52	SENT_112	[p7l1078t1876r1184b1943],
51	expected	VBN	O	expect	amod	52	SENT_112	[p7l1212t1876r1506b1966],
52	difference	NN	O	difference	dobj	49	SENT_112	[p7l1532t1876r1856b1943],
53	with	IN	O	with	mark	64	SENT_112	[p7l1880t1876r2035b1943],
54	an	DT	O	a	det	56	SENT_112	[p7l2063t1903r2142b1943],
55	estimated	JJ	O	estimated	amod	56	SENT_112	[p7l12t1982r338b2049],
56	power	NN	O	power	nsubj	64	SENT_112	[p7l366t2008r578b2072],
57	of	IN	O	of	_	0	SENT_112	[p7l606t1982r684b2049],
58	80	CD	PERCENT	80	num	59	SENT_112	[p7l704t1986r850b2049],
59	%	NN	PERCENT	%	prep_of	56	SENT_112	[p7l704t1986r850b2049],
60	at	IN	O	at	_	0	SENT_112	[p7l881t2000r942b2049],
61	a	DT	O	a	det	63	SENT_112	[p7l972t2009r1006b2049],
62	2	CD	NUMBER	2	num	63	SENT_112	[p7l1032t1982r1287b2050],
63	—	NN	O	—	prep_at	59	SENT_112	[p7l1032t1982r1287b2050],
64	sided	VBD	O	side	advcl	49	SENT_112	[p7l1032t1982r1287b2050],
65	alpha	NN	O	alpha	acomp	64	SENT_112	[p7l1318t1982r1499b2072],
66	of	IN	O	of	_	0	SENT_112	[p7l1528t1982r1606b2049],
67	0.05	CD	NUMBER	0.05	prep_of	64	SENT_112	[p7l1624t1982r1787b2049],
68	.	.	O	.	_	0	SENT_112	[p7l1624t1982r1787b2049],

1	Results	NNS	O	result	_	0	SENT_113	[p7l13t2208r334b2270],

1	A	DT	O	a	det	2	SENT_114	[p7l9t2399r75b2466],
2	total	NN	O	total	nsubjpass	20	SENT_114	[p7l102t2401r262b2467],
3	of	IN	O	of	_	0	SENT_114	[p7l291t2400r370b2467],
4	213	CD	NUMBER	213	num	5	SENT_114	[p7l385t2404r513b2468],
5	patients	NNS	O	patient	prep_of	2	SENT_114	[p7l544t2403r821b2490],
6	undergoing	VBG	O	undergo	dep	5	SENT_114	[p7l851t2400r1258b2490],
7	successful	JJ	O	successful	amod	8	SENT_114	[p7l1287t2400r1630b2467],
8	PCI	NN	O	pcus	dobj	6	SENT_114	[p7l1658t2400r1805b2467],
9	for	IN	O	for	_	0	SENT_114	[p7l1836t2400r1936b2467],
10	ACS	NN	ORGANIZATION	ac	prep_for	6	SENT_114	[p7l1961t2399r2138b2467],
11	and	CC	O	and	_	0	SENT_114	[p7l13t2507r140b2574],
12	discharged	VBN	O	discharge	dep	5	SENT_114	[p7l180t2507r558b2597],
13	with	IN	O	with	_	0	SENT_114	[p7l592t2508r754b2574],
14	prasugrel	NN	O	prasugrel	nn	16	SENT_114	[p7l792t2507r1115b2597],
15	10	CD	NUMBER	10	num	16	SENT_114	[p7l1158t2511r1238b2574],
16	mg	NN	O	mg	prep_with	12	SENT_114	[p7l1279t2534r1391b2597],
17	daily	JJ	SET	daily	advmod	20	SENT_114	[p7l1430t2507r1599b2597],
18	were	VBD	O	be	auxpass	20	SENT_114	[p7l1630t2533r1797b2574],
19	prospectively	RB	O	prospectively	advmod	20	SENT_114	[p7l1835t2533r2138b2597, p7l11t2613r201b2703],
20	included	VBN	O	include	_	0	SENT_114	[p7l222t2613r543b2680],
21	.	.	O	.	_	0	SENT_114	[p7l222t2613r543b2680],

1	Characteristics	NNS	O	characteristic	nsubjpass	7	SENT_115	[p7l574t2613r1096b2680],
2	of	IN	O	of	_	0	SENT_115	[p7l1124t2613r1203b2680],
3	the	DT	O	the	det	5	SENT_115	[p7l1216t2613r1326b2680],
4	studied	VBN	O	study	amod	5	SENT_115	[p7l1353t2613r1608b2680],
5	population	NN	O	population	prep_of	1	SENT_115	[p7l1631t2614r2014b2703],
6	are	VBP	O	be	auxpass	7	SENT_115	[p7l2040t2639r2140b2680],
7	included	VBN	O	include	_	0	SENT_115	[p7l11t2719r314b2786],
8	in	IN	O	in	_	0	SENT_115	[p7l351t2722r419b2785],
9	Table	NNP	O	Table	prep_in	7	SENT_115	[p7l455t2718r659b2785],
10	1	CD	NUMBER	1	num	9	SENT_115	[p7l702t2723r757b2786],
11	.	.	O	.	_	0	SENT_115	[p7l702t2723r757b2786],

1	In	IN	O	in	_	0	SENT_116	[p7l799t2720r876b2785],
2	the	DT	O	the	det	4	SENT_116	[p7l914t2719r1025b2786],
3	whole	JJ	O	whole	amod	4	SENT_116	[p7l1060t2720r1273b2786],
4	population	NN	O	population	prep_in	19	SENT_116	[p7l1311t2720r1713b2809],
5	,	,	O	,	_	0	SENT_116	[p7l1311t2720r1713b2809],
6	the	DT	O	the	det	7	SENT_116	[p7l1754t2720r1864b2786],
7	rate	NN	O	rate	nsubj	19	SENT_116	[p7l1903t2737r2034b2786],
8	of	IN	O	of	_	0	SENT_116	[p7l2073t2719r2153b2786],
9	patients	NNS	O	patient	prep_of	7	SENT_116	[p7l10t2828r287b2915],
10	with	IN	O	with	_	0	SENT_116	[p7l319t2826r480b2892],
11	I-ITPR	NN	O	i-itpr	prep_with	9	SENT_116	[p7l515t2824r768b2891],
12	was	VBD	O	be	cop	19	SENT_116	[p7l796t2852r924b2892],
13	7	CD	PERCENT	7	num	14	SENT_116	[p7l962t2827r1068b2892],
14	%	NN	PERCENT	%	nn	19	SENT_116	[p7l962t2827r1068b2892],
15	(	CD	NUMBER	(	num	16	SENT_116	[p7l1105t2823r1176b2906],
16	n	NN	O	n	dep	14	SENT_116	[p7l1105t2823r1176b2906],
17	=	JJ	O	=	amod	19	SENT_116	[p7l1218t2851r1271b2872],
18	15	CD	NUMBER	15	tmod	17	SENT_116	[p7l1319t2824r1447b2906],
19	)	NN	O	)	_	0	SENT_116	[p7l1319t2824r1447b2906],
20	.	.	O	.	_	0	SENT_116	[p7l1319t2824r1447b2906],

1	The	DT	O	the	det	3	SENT_117	[p7l1483t2824r1630b2892],
2	present	JJ	DATE	present	amod	3	SENT_117	[p7l1664t2843r1922b2915],
3	study	NN	O	study	nsubj	4	SENT_117	[p7l1956t2825r2145b2915],
4	included	VBD	O	include	_	0	SENT_117	[p7l11t2932r314b2998],
5	15	CD	NUMBER	15	num	6	SENT_117	[p7l370t2932r448b2998],
6	patients	NNS	O	patient	dobj	4	SENT_117	[p7l502t2934r778b3021],
7	(	IN	O	(	_	0	SENT_117	[p7l835t2929r995b3012],
8	7	CD	PERCENT	7	number	9	SENT_117	[p7l835t2929r995b3012],
9	%	NN	PERCENT	%	amod	11	SENT_117	[p7l835t2929r995b3012],
10	)	CD	NUMBER	)	num	11	SENT_117	[p7l835t2929r995b3012],
11	older	JJR	O	older	prep_(	4	SENT_117	[p7l1051t2932r1230b2998],
12	than	IN	O	than	_	0	SENT_117	[p7l1280t2932r1439b2998],
13	75	CD	DURATION	75	num	14	SENT_117	[p7l1493t2932r1573b2998],
14	years	NNS	NUMBER	year	prep_than	11	SENT_117	[p7l1625t2957r1821b3021],
15	,	,	O	,	_	0	SENT_117	[p7l1625t2957r1821b3021],
16	and	CC	O	and	_	0	SENT_117	[p7l1877t2931r2004b2998],
17	13	CD	NUMBER	13	num	18	SENT_117	[p7l2060t2935r2137b2998],
18	patients	NNS	O	patient	conj_and	11	SENT_117	[p7l10t3040r287b3127],
19	(	CD	PERCENT	(	number	20	SENT_117	[p7l340t3035r500b3118],
20	6	CD	PERCENT	6	num	21	SENT_117	[p7l340t3035r500b3118],
21	%	NN	PERCENT	%	dep	18	SENT_117	[p7l340t3035r500b3118],
22	)	CD	NUMBER	)	npadvmod	4	SENT_117	[p7l340t3035r500b3118],
23	with	IN	O	with	_	0	SENT_117	[p7l549t3037r710b3104],
24	low	JJ	O	low	amod	26	SENT_117	[p7l757t3038r886b3104],
25	body	NN	O	body	nn	26	SENT_117	[p7l929t3038r1106b3127],
26	weight	NN	O	weight	prep_with	4	SENT_117	[p7l1147t3038r1407b3127],
27	.	.	O	.	_	0	SENT_117	[p7l1147t3038r1407b3127],

1	Prasugrel	NN	O	prasugrel	nn	2	SENT_118	[p7l1461t3038r1791b3127],
2	response	NN	O	response	_	0	SENT_118	[p7l1838t3063r2140b3127],
3	(	CD	NUMBER	(	num	6	SENT_118	[p7l14t3142r184b3224],
4	PRI	NNP	ORGANIZATION	PRI	nn	6	SENT_118	[p7l14t3142r184b3224],
5	VASP	NN	ORGANIZATION	vasp	nn	6	SENT_118	[p7l232t3141r485b3224],
6	)	NN	O	)	dep	2	SENT_118	[p7l232t3141r485b3224],
7	and	CC	O	and	_	0	SENT_118	[p7l536t3144r663b3210],
8	platelet	NN	O	platelet	nn	9	SENT_118	[p7l707t3144r968b3233],
9	reactivity	NN	O	reactivity	dep	2	SENT_118	[p7l1011t3146r1336b3233],
10	(	CD	NUMBER	(	num	11	SENT_118	[p7l1381t3141r1766b3233],
11	ADP	NN	O	adp	dep	9	SENT_118	[p7l1381t3141r1766b3233],
12	.	.	O	.	_	0	SENT_118	[p7l1381t3141r1766b3233],

1	—	NN	O	—	_	0	SENT_119	[p7l1381t3141r1766b3233],
2	.	.	O	.	_	0	SENT_119	[p7l1381t3141r1766b3233],

1	Ag	NN	O	ag	nn	2	SENT_120	[p7l1381t3141r1766b3233],
2	)	NN	O	)	nsubj	6	SENT_120	[p7l1381t3141r1766b3233],
3	were	VBD	O	be	cop	6	SENT_120	[p7l1812t3169r1978b3210],
4	not	RB	O	not	neg	6	SENT_120	[p7l2026t3161r2143b3210],
5	statistically	RB	O	statistically	advmod	6	SENT_120	[p7l13t3249r404b3339],
6	different	JJ	O	different	_	0	SENT_120	[p7l429t3249r726b3316],
7	in	IN	O	in	_	0	SENT_120	[p7l752t3252r820b3315],
8	these	DT	O	these	det	9	SENT_120	[p7l848t3249r1028b3316],
9	subgroups	NNS	O	subgroup	prep_in	6	SENT_120	[p7l1058t3249r1413b3339],
10	of	IN	O	of	_	0	SENT_120	[p7l1444t3249r1524b3316],
11	patients	NNS	O	patient	prep_of	9	SENT_120	[p7l1538t3252r1835b3339],
12	.	.	O	.	_	0	SENT_120	[p7l1538t3252r1835b3339],

1	Neither	DT	O	neither	det	3	SENT_121	[p7l1867t3249r2143b3316],
2	PR1	NN	O	pr1	nn	3	SENT_121	[p7l11t3356r154b3421],
3	VASP	NN	ORGANIZATION	vasp	_	0	SENT_121	[p7l185t3354r413b3422],
4	nor	CC	O	nor	_	0	SENT_121	[p7l441t3381r561b3422],
5	clinical	JJ	O	clinical	amod	7	SENT_121	[p7l588t3355r836b3422],
6	bleeding	NN	O	bleeding	nn	7	SENT_121	[p7l861t3355r1164b3445],
7	events	NNS	O	event	dobj	8	SENT_121	[p7l1192t3372r1407b3422],
8	differed	VBN	O	differ	conj_nor	3	SENT_121	[p7l1438t3355r1704b3422],
9	by	IN	O	by	_	0	SENT_121	[p7l1729t3356r1815b3445],
10	smoking	NN	O	smoking	prep_by	8	SENT_121	[p7l1840t3356r2143b3445],

1	Table	NNP	O	Table	_	0	SENT_122	[p8l63t108r211b152],
2	1	CD	NUMBER	1	dep	1	SENT_122	[p8l235t108r286b151],
3	.	.	O	.	_	0	SENT_122	[p8l235t108r286b151],

1	Patients	NNS	O	patient	dep	3	SENT_123	[p8l314t107r543b152],
2	characteristics	NNS	O	characteristic	dep	1	SENT_123	[p8l567t107r990b152],
3	(	VBP	O	(	_	0	SENT_123	[p8l1015t108r1074b162],
4	N	NN	O	n	dep	5	SENT_123	[p8l1015t108r1074b162],
5	=	JJ	O	=	acomp	3	SENT_123	[p8l1104t122r1143b142],
6	213	CD	NUMBER	213	num	7	SENT_123	[p8l1173t107r1301b162],
7	)	NN	O	)	nsubj	3	SENT_123	[p8l1173t107r1301b162],

1	Age	NNP	O	Age	advmod	3	SENT_124	[p8l64t236r169b288],
2	,	,	O	,	_	0	SENT_124	[p8l64t236r169b288],
3	yrs	VBZ	DURATION	yr	_	0	SENT_124	[p8l191t247r257b288],
4	58	CD	NUMBER	58	dobj	3	SENT_124	[p8l1895t237r1950b276],
5	:	:	O	:	_	0	SENT_124	[p8l1970t240r2005b274],
6	10	CD	NUMBER	10	num	7	SENT_124	[p8l2030t237r2082b276],
7	Women	NNS	O	woman	dep	4	SENT_124	[p8l63t338r248b379],
8	23	CD	NUMBER	23	number	9	SENT_124	[p8l1923t339r1977b379],
9	(	CD	NUMBER	(	dep	7	SENT_124	[p8l1996t337r2081b385],
10	11	CD	NUMBER	11	number	11	SENT_124	[p8l1996t337r2081b385],
11	)	CD	NUMBER	)	num	13	SENT_124	[p8l1996t337r2081b385],
12	Clinical	JJ	O	clinical	amod	13	SENT_124	[p8l64t438r232b481],
13	presentation	NN	O	presentation	nsubj	3	SENT_124	[p8l259t441r560b492],

1	NSTE	NNP	ORGANIZATION	NSTE	nn	2	SENT_125	[p8l124t542r242b583],
2	ACS	NN	O	ac	dep	9	SENT_125	[p8l264t542r358b583],
3	117	CD	NUMBER	117	num	4	SENT_125	[p8l1898t544r1978b582],
4	(	NN	O	(	dep	2	SENT_125	[p8l1996t542r2081b590],
5	55	CD	NUMBER	55	number	6	SENT_125	[p8l1996t542r2081b590],
6	)	CD	NUMBER	)	dep	4	SENT_125	[p8l1996t542r2081b590],
7	STEMI	NN	ORGANIZATION	stemus	dep	9	SENT_125	[p8l123t644r262b685],
8	96	CD	NUMBER	96	num	7	SENT_125	[p8l1923t646r1979b685],
9	(	CD	NUMBER	(	dep	24	SENT_125	[p8l1996t644r2081b691],
10	45	CD	NUMBER	45	num	12	SENT_125	[p8l1996t644r2081b691],
11	)	NN	O	)	nn	12	SENT_125	[p8l1996t644r2081b691],
12	Weight	NNP	O	Weight	dep	9	SENT_125	[p8l63t745r247b799],
13	,	,	O	,	_	0	SENT_125	[p8l63t745r247b799],
14	kg	NN	O	kg	appos	12	SENT_125	[p8l272t745r324b799],
15	82	CD	NUMBER	82	num	14	SENT_125	[p8l1895t748r1950b787],
16	:	:	O	:	_	0	SENT_125	[p8l1971t751r2006b785],
17	15	CD	NUMBER	15	num	20	SENT_125	[p8l2030t748r2080b787],
18	Body	NN	O	body	nn	20	SENT_125	[p8l67t847r185b901],
19	mass	NN	O	mass	nn	20	SENT_125	[p8l208t860r324b890],
20	index	NN	O	index	dep	12	SENT_125	[p8l349t847r489b896],
21	,	,	O	,	_	0	SENT_125	[p8l349t847r489b896],
22	kg/m2	NN	O	kg/m2	appos	20	SENT_125	[p8l514t837r659b901],
23	32	CD	NUMBER	32	num	22	SENT_125	[p8l1895t850r1949b890],
24	i	FW	O	i	dep	27	SENT_125	[p8l1970t853r2005b888],
25	7	CD	NUMBER	7	num	26	SENT_125	[p8l2027t851r2052b889],
26	Hypertension	NN	O	hypertension	dep	24	SENT_125	[p8l67t952r385b1004],
27	83	CD	NUMBER	83	dep	49	SENT_125	[p8l1923t952r1977b992],
28	(	CD	NUMBER	(	num	29	SENT_125	[p8l1996t950r2081b998],
29	39	CD	NUMBER	39	dep	27	SENT_125	[p8l1996t950r2081b998],
30	)	CD	NUMBER	)	num	47	SENT_125	[p8l1996t950r2081b998],
31	Diabetes	NNP	O	Diabetes	nn	47	SENT_125	[p8l66t1052r273b1094],
32	64	CD	NUMBER	64	num	47	SENT_125	[p8l1923t1055r1979b1094],
33	(	CD	NUMBER	(	num	47	SENT_125	[p8l1996t1053r2081b1101],
34	30	CD	NUMBER	30	num	47	SENT_125	[p8l1996t1053r2081b1101],
35	)	CD	NUMBER	)	num	47	SENT_125	[p8l1996t1053r2081b1101],
36	Smoker	NN	O	smoker	nn	47	SENT_125	[p8l65t1154r245b1196],
37	106	CD	NUMBER	106	num	47	SENT_125	[p8l1898t1157r1979b1196],
38	(	NN	O	(	nn	47	SENT_125	[p8l1996t1155r2081b1203],
39	50	CD	NUMBER	50	num	47	SENT_125	[p8l1996t1155r2081b1203],
40	)	CD	NUMBER	)	num	47	SENT_125	[p8l1996t1155r2081b1203],
41	Dyslipidemia	NN	O	dyslipidemia	nn	47	SENT_125	[p8l67t1256r372b1311],
42	104	CD	NUMBER	104	num	47	SENT_125	[p8l1898t1259r1980b1298],
43	(	NN	O	(	nn	47	SENT_125	[p8l1996t1257r2081b1305],
44	49	CD	NUMBER	49	num	47	SENT_125	[p8l1996t1257r2081b1305],
45	)	CD	NUMBER	)	num	47	SENT_125	[p8l1996t1257r2081b1305],
46	Familial	JJ	MISC	familial	amod	47	SENT_125	[p8l66t1358r245b1401],
47	history	NN	O	history	rcmod	29	SENT_125	[p8l272t1358r433b1412],
48	36	CD	NUMBER	36	num	49	SENT_125	[p8l1924t1359r2081b1407],
49	(	NN	O	(	dep	63	SENT_125	[p8l1924t1359r2081b1407],
50	17	CD	NUMBER	17	number	51	SENT_125	[p8l1924t1359r2081b1407],
51	)	CD	NUMBER	)	num	53	SENT_125	[p8l1924t1359r2081b1407],
52	Previous	JJ	O	previous	amod	53	SENT_125	[p8l67t1462r267b1503],
53	CAD	NN	O	cad	dep	49	SENT_125	[p8l290t1462r393b1503],
54	63	CD	NUMBER	63	number	55	SENT_125	[p8l1923t1463r1977b1503],
55	(	CD	NUMBER	(	num	57	SENT_125	[p8l1996t1461r2081b1509],
56	30	CD	NUMBER	30	number	57	SENT_125	[p8l1996t1461r2081b1509],
57	)	CD	NUMBER	)	npadvmod	58	SENT_125	[p8l1996t1461r2081b1509],
58	Prior	JJ	O	prior	amod	53	SENT_125	[p8l66t1564r176b1605],
59	antiplatelet	JJ	O	antiplatelet	amod	53	SENT_125	[p8l197t1562r471b1616],
60	68	CD	NUMBER	68	number	61	SENT_125	[p8l1923t1565r1979b1605],
61	(	CD	NUMBER	(	dep	59	SENT_125	[p8l1996t1563r2081b1612],
62	32	CD	NUMBER	32	num	63	SENT_125	[p8l1996t1563r2081b1612],
63	)	NN	O	)	_	0	SENT_125	[p8l1996t1563r2081b1612],

1	therapy	NN	O	therapy	nn	2	SENT_126	[p8l121t1642r307b1697],
2	Beta	NN	O	beta	dep	11	SENT_126	[p8l124t1745r445b1788],
3	—	CD	NUMBER	—	num	6	SENT_126	[p8l124t1745r445b1788],
4	b	NN	O	b	nn	6	SENT_126	[p8l124t1745r445b1788],
5	|	NN	O	|	nn	6	SENT_126	[p8l124t1745r445b1788],
6	ockers	NNS	O	ocker	dep	2	SENT_126	[p8l124t1745r445b1788],
7	164	CD	NUMBER	164	number	8	SENT_126	[p8l1898t1748r1980b1788],
8	(	CD	NUMBER	(	dep	6	SENT_126	[p8l1996t1746r2081b1794],
9	77	CD	NUMBER	77	dep	11	SENT_126	[p8l1996t1746r2081b1794],
10	)	CD	NUMBER	)	num	11	SENT_126	[p8l1996t1746r2081b1794],
11	PPI	NNP	O	PPI	dep	18	SENT_126	[p8l124t1849r192b1889],
12	209	CD	NUMBER	209	num	11	SENT_126	[p8l1894t1850r1979b1890],
13	(	CD	NUMBER	(	number	14	SENT_126	[p8l1996t1848r2081b1896],
14	98	CD	NUMBER	98	dep	11	SENT_126	[p8l1996t1848r2081b1896],
15	)	CD	NUMBER	)	num	16	SENT_126	[p8l1996t1848r2081b1896],
16	Statins	NNS	O	statin	dep	14	SENT_126	[p8l122t1951r281b1992],
17	207	CD	NUMBER	207	num	18	SENT_126	[p8l1894t1952r1978b1992],
18	(	CD	NUMBER	(	dep	24	SENT_126	[p8l1996t1950r2081b1998],
19	97	CD	NUMBER	97	number	20	SENT_126	[p8l1996t1950r2081b1998],
20	)	CD	NUMBER	)	dep	18	SENT_126	[p8l1996t1950r2081b1998],
21	LV	NN	O	lv	nn	23	SENT_126	[p8l67t2054r122b2093],
22	ejection	NN	O	ejection	nn	23	SENT_126	[p8l143t2054r331b2106],
23	fraction	NN	O	fraction	dep	20	SENT_126	[p8l355t2051r537b2094],
24	55	CD	NUMBER	55	dep	31	SENT_126	[p8l1895t2055r1948b2094],
25	i	FW	O	i	dep	24	SENT_126	[p8l1970t2057r2005b2092],
26	7	CD	NUMBER	7	num	27	SENT_126	[p8l2027t2055r2052b2093],
27	Creatinine	NN	O	creatinine	rcmod	25	SENT_126	[p8l64t2155r321b2203],
28	,	,	O	,	_	0	SENT_126	[p8l64t2155r321b2203],
29	,	,	O	,	_	0	SENT_126	[p8l345t2154r503b2208],
30	u.	NNP	O	u.	dep	27	SENT_126	[p8l345t2154r503b2208],
31	mo	NN	DURATION	mo	dep	32	SENT_126	[p8l345t2154r503b2208],
32	|	CD	NUMBER	|	_	0	SENT_126	[p8l345t2154r503b2208],
33	/	:	O	/	punct	32	SENT_126	[p8l345t2154r503b2208],
34	|	CD	NUMBER	|	dep	32	SENT_126	[p8l345t2154r503b2208],
35	92	CD	NUMBER	92	dep	34	SENT_126	[p8l1895t2157r1949b2196],
36	:	:	O	:	_	0	SENT_126	[p8l1971t2159r2005b2194],
37	54	CD	NUMBER	54	dep	35	SENT_126	[p8l2026t2157r2083b2196],

1	Values	NNS	O	value	nsubj	8	SENT_127	[p8l62t2285r200b2323],
2	are	VBP	O	be	cop	3	SENT_127	[p8l214t2296r278b2323],
3	n	NN	O	n	_	0	SENT_127	[p8l293t2296r315b2322],
4	(	CD	PERCENT	(	num	5	SENT_127	[p8l332t2286r395b2328],
5	%	NN	PERCENT	%	dep	3	SENT_127	[p8l332t2286r395b2328],
6	)	CD	NUMBER	)	dep	5	SENT_127	[p8l332t2286r395b2328],
7	or	CC	O	or	_	0	SENT_127	[p8l411t2296r454b2323],
8	mean	VB	O	mean	conj_or	3	SENT_127	[p8l468t2296r583b2323],
9	:	:	O	:	_	0	SENT_127	[p8l603t2290r633b2321],
10	SD	NN	O	sd	dobj	8	SENT_127	[p8l653t2286r719b2323],
11	.	.	O	.	_	0	SENT_127	[p8l653t2286r719b2323],

1	ACS	NN	O	ac	nn	5	SENT_128	[p8l115t2366r200b2403],
2	=	JJ	O	=	amod	5	SENT_128	[p8l220t2379r251b2391],
3	acute	JJ	O	acute	amod	5	SENT_128	[p8l271t2371r390b2403],
4	coronary	JJ	O	coronary	amod	5	SENT_128	[p8l407t2376r601b2413],
5	syndrome	NN	O	syndrome	_	0	SENT_128	[p8l616t2365r846b2413],
6	;	:	O	;	_	0	SENT_128	[p8l616t2365r846b2413],
7	CAD	NN	O	cad	nn	11	SENT_128	[p8l862t2366r955b2403],
8	=	JJ	O	=	amod	11	SENT_128	[p8l976t2379r1007b2391],
9	coronary	JJ	O	coronary	amod	11	SENT_128	[p8l1027t2376r1222b2413],
10	artery	NN	O	artery	nn	11	SENT_128	[p8l1237t2371r1364b2413],
11	disease	NN	O	disease	dep	5	SENT_128	[p8l1379t2365r1551b2408],
12	;	:	O	;	_	0	SENT_128	[p8l1379t2365r1551b2408],
13	LV	NN	O	lv	nsubj	15	SENT_128	[p8l1568t2367r1619b2402],
14	=	JJ	O	=	amod	13	SENT_128	[p8l1638t2379r1668b2391],
15	left	VBD	O	leave	dep	11	SENT_128	[p8l1690t2364r1759b2403],
16	ventricular	JJ	O	ventricular	acomp	15	SENT_128	[p8l1773t2365r2021b2408],
17	;	:	O	;	_	0	SENT_128	[p8l1773t2365r2021b2408],
18	NSTE	NN	O	nste	dep	5	SENT_128	[p8l66t2446r173b2483],
19	=	JJ	O	=	amod	20	SENT_128	[p8l202t2459r233b2471],
20	non	JJ	O	non	amod	18	SENT_128	[p8l264t2446r638b2493],
21	.	.	O	.	_	0	SENT_128	[p8l264t2446r638b2493],

1	—	NN	O	—	_	0	SENT_129	[p8l264t2446r638b2493],
2	.	.	O	.	_	0	SENT_129	[p8l264t2446r638b2493],

1	ST-segment	JJ	O	st-segment	amod	2	SENT_130	[p8l264t2446r638b2493],
2	elevation	NN	O	elevation	_	0	SENT_130	[p8l663t2445r877b2488],
3	;	:	O	;	_	0	SENT_130	[p8l663t2445r877b2488],
4	PPI	NNP	O	PPI	dep	2	SENT_130	[p8l904t2447r965b2482],
5	=	JJ	O	=	amod	8	SENT_130	[p8l997t2459r1027b2471],
6	proton	NN	O	proton	nn	8	SENT_130	[p8l1058t2451r1204b2492],
7	pump	NN	O	pump	nn	8	SENT_130	[p8l1232t2456r1360b2492],
8	inhibitor	NN	O	inhibitor	dep	4	SENT_130	[p8l1386t2445r1585b2488],
9	;	:	O	;	_	0	SENT_130	[p8l1386t2445r1585b2488],
10	STEMI	NN	O	stemus	nn	12	SENT_130	[p8l1611t2446r1738b2483],
11	=	JJ	O	=	amod	12	SENT_130	[p8l1769t2459r1800b2471],
12	ST-segment	NN	O	st-segment	dep	2	SENT_130	[p8l1830t2446r2090b2493],
13	elevation	NN	O	elevation	nn	15	SENT_130	[p8l64t2525r264b2563],
14	myocardial	JJ	O	myocardial	amod	15	SENT_130	[p8l284t2525r523b2573],
15	infarction	NN	O	infarction	dep	12	SENT_130	[p8l542t2525r763b2563],
16	.	.	O	.	_	0	SENT_130	[p8l542t2525r763b2563],

1	JACC	NN	O	jacc	_	0	SENT_131	[p8l9t2773r159b2804],
2	:	:	O	:	_	0	SENT_131	[p8l9t2773r159b2804],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_131	[p8l194t2773r693b2804],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_131	[p8l729t2773r1188b2809],
5	,	,	O	,	_	0	SENT_131	[p8l729t2773r1188b2809],
6	VOL	NNP	O	VOL	appos	4	SENT_131	[p8l1223t2773r1345b2804],
7	.	.	O	.	_	0	SENT_131	[p8l1223t2773r1345b2804],

1	5	CD	NUMBER	5	_	0	SENT_132	[p8l1381t2775r1423b2809],
2	,	,	O	,	_	0	SENT_132	[p8l1381t2775r1423b2809],
3	NO.	NNP	DATE	NO.	appos	1	SENT_132	[p8l1460t2773r1550b2804],
4	12	CD	DATE	12	num	3	SENT_132	[p8l1588t2774r1663b2809],
5	,	,	DATE	,	_	0	SENT_132	[p8l1588t2774r1663b2809],
6	2012	CD	DATE	2012	num	3	SENT_132	[p8l1699t2774r1823b2804],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_132	[p8l12t2837r296b2869],
8	2012:1280	CD	NUMBER	2012:1280	num	7	SENT_132	[p8l328t2838r683b2869],
9	-7	CD	NUMBER	-7	dep	7	SENT_132	[p8l328t2838r683b2869],

1	Table	NNP	O	Table	_	0	SENT_133	[p9l63t147r211b191],
2	2	CD	NUMBER	2	dep	1	SENT_133	[p9l235t147r285b191],
3	.	.	O	.	_	0	SENT_133	[p9l235t147r285b191],

1	Genetic	JJ	O	genetic	amod	2	SENT_134	[p9l310t147r515b191],
2	Distribution	NN	O	distribution	dep	15	SENT_134	[p9l538t147r842b191],
3	of	IN	O	of	_	0	SENT_134	[p9l865t147r916b191],
4	the	DT	O	the	det	9	SENT_134	[p9l934t147r1020b191],
5	CYP	NN	O	cyp	nn	9	SENT_134	[p9l1046t147r1160b191],
6	2C19	NN	O	2c19	nn	9	SENT_134	[p9l1176t147r1399b191],
7	*	NN	O	*	nn	9	SENT_134	[p9l1176t147r1399b191],
8	2	CD	NUMBER	2	num	9	SENT_134	[p9l1176t147r1399b191],
9	Loss-of-Function	NN	O	loss-of-function	prep_of	2	SENT_134	[p9l1417t147r1844b191],
10	and	CC	O	and	_	0	SENT_134	[p9l64t227r160b271],
11	CYP2C19	NN	O	cyp2c19	conj_and	2	SENT_134	[p9l189t227r1032b271],
12	*	CD	NUMBER	*	num	14	SENT_134	[p9l189t227r1032b271],
13	17Gain-of-Function	NN	O	17gain-of-function	nn	14	SENT_134	[p9l189t227r1032b271],
14	Polymorphisms	NNS	O	polymorphism	dep	11	SENT_134	[p9l1059t227r1474b282],
15	(	VBP	O	(	_	0	SENT_134	[p9l1499t227r1551b281],
16	n	NN	O	n	nsubj	17	SENT_134	[p9l1499t227r1551b281],
17	=	JJ	O	=	xcomp	15	SENT_134	[p9l1581t241r1620b261],
18	213	CD	NUMBER	213	num	19	SENT_134	[p9l1649t227r1778b281],
19	)	NN	O	)	nsubj	15	SENT_134	[p9l1649t227r1778b281],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_135	[p9l70t372r426b423],
2	Genetic	JJ	O	genetic	amod	3	SENT_135	[p9l1566t372r1763b413],
3	Distribution	NN	O	distribution	dep	1	SENT_135	[p9l1787t372r2082b413],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_136	[p9l65t524r322b564],
2	*	NN	O	*	_	0	SENT_136	[p9l65t524r322b564],
3	2	CD	NUMBER	2	num	4	SENT_136	[p9l65t524r322b564],
4	AA	NN	O	aa	dep	2	SENT_136	[p9l1721t524r1800b564],
5	:	:	O	:	_	0	SENT_136	[p9l1721t524r1800b564],
6	1	CD	PERCENT	1	num	7	SENT_136	[p9l1820t526r1833b564],
7	(	NN	PERCENT	(	dep	2	SENT_136	[p9l1859t523r1960b571],
8	1	CD	PERCENT	1	number	9	SENT_136	[p9l1859t523r1960b571],
9	%	NN	PERCENT	%	amod	7	SENT_136	[p9l1859t523r1960b571],
10	)	CD	NUMBER	)	num	11	SENT_136	[p9l1859t523r1960b571],
11	AG	NNP	O	AG	dep	7	SENT_136	[p9l1689t626r1771b667],
12	:	:	O	:	_	0	SENT_136	[p9l1689t626r1771b667],
13	49	CD	PERCENT	49	number	14	SENT_136	[p9l1785t627r1842b667],
14	(	CD	PERCENT	(	dep	2	SENT_136	[p9l1859t626r1990b673],
15	23	CD	PERCENT	23	num	16	SENT_136	[p9l1859t626r1990b673],
16	%	NN	PERCENT	%	dep	14	SENT_136	[p9l1859t626r1990b673],
17	)	CD	NUMBER	)	num	18	SENT_136	[p9l1859t626r1990b673],
18	GG	NNS	O	gg	dep	14	SENT_136	[p9l1658t728r1741b769],
19	:	:	O	:	_	0	SENT_136	[p9l1658t728r1741b769],
20	163	CD	PERCENT	163	number	21	SENT_136	[p9l1760t729r1840b769],
21	(	CD	PERCENT	(	dep	2	SENT_136	[p9l1859t727r1990b775],
22	76	CD	PERCENT	76	num	23	SENT_136	[p9l1859t727r1990b775],
23	%	NN	PERCENT	%	dep	21	SENT_136	[p9l1859t727r1990b775],
24	)	CD	NUMBER	)	num	25	SENT_136	[p9l1859t727r1990b775],
25	CYP2C19	NN	O	cyp2c19	dep	21	SENT_136	[p9l65t831r354b871],
26	*	CD	NUMBER	*	num	27	SENT_136	[p9l65t831r354b871],
27	77	CD	NUMBER	77	dep	25	SENT_136	[p9l65t831r354b871],
28	"	``	O	"	punct	27	SENT_136	[p9l1703t831r1771b871],
29	IT	PRP	O	it	dep	27	SENT_136	[p9l1703t831r1771b871],
30	:	:	O	:	_	0	SENT_136	[p9l1703t831r1771b871],
31	11	CD	PERCENT	11	number	32	SENT_136	[p9l1790t832r1833b870],
32	(	CD	PERCENT	(	dep	2	SENT_136	[p9l1859t830r1960b878],
33	5	CD	PERCENT	5	num	34	SENT_136	[p9l1859t830r1960b878],
34	%	NN	PERCENT	%	dep	32	SENT_136	[p9l1859t830r1960b878],
35	)	CD	NUMBER	)	num	36	SENT_136	[p9l1859t830r1960b878],
36	CT	NN	O	ct	dep	32	SENT_136	[p9l1700t933r1770b973],
37	:	:	O	:	_	0	SENT_136	[p9l1700t933r1770b973],
38	62	CD	PERCENT	62	number	39	SENT_136	[p9l1786t934r1841b973],
39	(	CD	PERCENT	(	dep	2	SENT_136	[p9l1859t932r1990b980],
40	29	CD	PERCENT	29	num	41	SENT_136	[p9l1859t932r1990b980],
41	%	NN	PERCENT	%	dep	39	SENT_136	[p9l1859t932r1990b980],
42	)	CD	NUMBER	)	dep	39	SENT_136	[p9l1859t932r1990b980],
43	"	``	O	"	punct	42	SENT_136	[p9l1673t1035r1741b1075],
44	IT	PRP	O	it	dep	42	SENT_136	[p9l1673t1035r1741b1075],
45	:	:	O	:	_	0	SENT_136	[p9l1673t1035r1741b1075],
46	139	CD	PERCENT	139	number	47	SENT_136	[p9l1760t1036r1842b1075],
47	(	CD	PERCENT	(	dep	2	SENT_136	[p9l1859t1034r1990b1082],
48	65	CD	PERCENT	65	num	49	SENT_136	[p9l1859t1034r1990b1082],
49	%	NN	PERCENT	%	dep	47	SENT_136	[p9l1859t1034r1990b1082],
50	)	CD	NUMBER	)	dep	2	SENT_136	[p9l1859t1034r1990b1082],

1	Values	NNS	O	value	nsubj	3	SENT_137	[p9l62t1164r200b1202],
2	are	VBP	O	be	cop	3	SENT_137	[p9l214t1176r278b1202],
3	n	NN	O	n	_	0	SENT_137	[p9l294t1176r315b1202],
4	(	CD	PERCENT	(	num	5	SENT_137	[p9l332t1165r407b1208],
5	%	NN	PERCENT	%	dep	3	SENT_137	[p9l332t1165r407b1208],
6	)	CD	NUMBER	)	dep	5	SENT_137	[p9l332t1165r407b1208],
7	.	.	O	.	_	0	SENT_137	[p9l332t1165r407b1208],

1	CYP	NN	O	cyp	_	0	SENT_138	[p9l115t1246r196b1282],
2	=	JJ	O	=	amod	4	SENT_138	[p9l215t1258r245b1271],
3	cytochrome	NN	O	cytochrome	nn	4	SENT_138	[p9l264t1244r517b1293],
4	P450	NN	O	p450	dep	1	SENT_138	[p9l533t1246r644b1282],
5	.	.	O	.	_	0	SENT_138	[p9l533t1246r644b1282],

1	status	NN	O	status	_	0	SENT_139	[p9l13t1494r230b1558],
2	,	,	O	,	_	0	SENT_139	[p9l13t1494r230b1558],
3	unlike	IN	O	unlike	dep	1	SENT_139	[p9l266t1477r484b1543],
4	published	VBN	O	publish	amod	5	SENT_139	[p9l518t1477r862b1566],
5	reports	NNS	O	report	pobj	3	SENT_139	[p9l895t1494r1139b1566],
6	regarding	VBG	O	regard	_	0	SENT_139	[p9l1175t1477r1513b1566],
7	clopidogrel	NN	O	clopidogrel	prep_regarding	5	SENT_139	[p9l1547t1477r1958b1566],
8	.	.	O	.	_	0	SENT_139	[p9l1547t1477r1958b1566],

1	The	DT	O	the	det	3	SENT_140	[p9l1994t1475r2140b1543],
2	genotype	NN	O	genotype	nn	3	SENT_140	[p9l10t1601r330b1673],
3	frequencies	NNS	O	frequency	nsubj	10	SENT_140	[p9l373t1584r769b1673],
4	for	IN	O	for	_	0	SENT_140	[p9l813t1584r914b1650],
5	each	DT	O	each	det	6	SENT_140	[p9l955t1584r1111b1650],
6	allele	NN	O	allele	prep_for	3	SENT_140	[p9l1155t1584r1331b1650],
7	considered	VBN	O	consider	partmod	6	SENT_140	[p9l1375t1584r1754b1650],
8	separately	RB	O	separately	advmod	7	SENT_140	[p9l1797t1584r2145b1673],
9	were	VBD	O	be	cop	10	SENT_140	[p9l8t1716r174b1756],
10	consistent	JJ	O	consistent	_	0	SENT_140	[p9l234t1693r589b1756],
11	with	IN	O	with	_	0	SENT_140	[p9l642t1690r803b1756],
12	Hardy-Weinberg	JJ	PERSON	hardy-weinberg	amod	13	SENT_140	[p9l862t1690r1483b1779],
13	predictions	NNS	O	prediction	prep_with	10	SENT_140	[p9l1538t1690r1952b1779],
14	,	,	O	,	_	0	SENT_140	[p9l1538t1690r1952b1779],
15	and	CC	O	and	_	0	SENT_140	[p9l2015t1690r2142b1756],
16	genetic	JJ	O	genetic	amod	17	SENT_140	[p9l10t1799r263b1885],
17	distributions	NNS	O	distribution	nsubjpass	19	SENT_140	[p9l296t1796r740b1862],
18	are	VBP	O	be	auxpass	19	SENT_140	[p9l776t1822r876b1862],
19	reported	VBN	O	report	conj_and	10	SENT_140	[p9l910t1796r1208b1885],
20	in	IN	O	in	_	0	SENT_140	[p9l1240t1799r1308b1862],
21	Table	NNP	O	Table	prep_in	19	SENT_140	[p9l1338t1795r1542b1862],
22	2	CD	NUMBER	2	num	21	SENT_140	[p9l1575t1800r1636b1863],
23	.	.	O	.	_	0	SENT_140	[p9l1575t1800r1636b1863],

1	Effect	NN	O	effect	_	0	SENT_141	[p9l14t1907r205b1966],
2	of	IN	O	of	_	0	SENT_141	[p9l236t1907r306b1966],
3	genotypes	NNS	O	genotype	prep_of	1	SENT_141	[p9l333t1917r695b1983],
4	on	IN	O	on	_	0	SENT_141	[p9l727t1925r811b1966],
5	prasugrel	NN	O	prasugrel	nn	6	SENT_141	[p9l847t1908r1168b1982],
6	response	NN	O	response	prep_on	1	SENT_141	[p9l1205t1925r1513b1981],
7	(	CD	NUMBER	(	num	10	SENT_141	[p9l1547t1910r1672b1975],
8	PRI	NNP	ORGANIZATION	PRI	nn	10	SENT_141	[p9l1547t1910r1672b1975],
9	VASP	NN	ORGANIZATION	vasp	nn	10	SENT_141	[p9l1705t1910r1930b1975],
10	)	NN	O	)	dep	6	SENT_141	[p9l1705t1910r1930b1975],
11	.	.	O	.	_	0	SENT_141	[p9l1705t1910r1930b1975],

1	At	IN	O	at	_	0	SENT_142	[p9l1977t1900r2072b1967],
2	1	CD	DURATION	1	num	3	SENT_142	[p9l2104t1905r2136b1966],
3	month	NN	NUMBER	month	prep_at	18	SENT_142	[p9l12t2007r266b2088],
4	,	,	O	,	_	0	SENT_142	[p9l12t2007r266b2088],
5	patient	NN	O	patient	appos	3	SENT_142	[p9l318t2010r567b2096],
6	who	WP	O	who	nsubj	8	SENT_142	[p9l612t2007r764b2073],
7	were	VBD	O	be	cop	8	SENT_142	[p9l812t2033r978b2074],
8	carriers	NNS	O	carrier	rcmod	5	SENT_142	[p9l1030t2010r1283b2073],
9	of	IN	O	of	_	0	SENT_142	[p9l1335t2007r1415b2073],
10	loss	NN	O	loss	nn	11	SENT_142	[p9l1451t2007r2023b2073],
11	—	NN	O	—	prep_of	8	SENT_142	[p9l1451t2007r2023b2073],
12	of	IN	O	of	_	0	SENT_142	[p9l1451t2007r2023b2073],
13	—	CD	NUMBER	—	num	15	SENT_142	[p9l1451t2007r2023b2073],
14	function	NN	O	function	nn	15	SENT_142	[p9l1451t2007r2023b2073],
15	*	NN	O	*	prep_of	11	SENT_142	[p9l2079t2010r2142b2074],
16	2	CD	NUMBER	2	num	17	SENT_142	[p9l2079t2010r2142b2074],
17	allele	NN	O	allele	nsubj	18	SENT_142	[p9l12t2113r189b2179],
18	had	VBD	O	have	_	0	SENT_142	[p9l224t2113r354b2179],
19	signiﬁcantly	RB	O	signiﬁcantly	advmod	20	SENT_142	[p9l390t2113r818b2202],
20	higher	JJR	O	higher	amod	22	SENT_142	[p9l849t2113r1078b2202],
21	PRI	NNP	O	PRI	nn	22	SENT_142	[p9l1112t2114r1255b2179],
22	VASP	NN	O	vasp	dobj	18	SENT_142	[p9l1292t2112r1520b2180],
23	than	IN	O	than	_	0	SENT_142	[p9l1554t2113r1712b2179],
24	noncarriers	JJ	O	noncarriers	amod	25	SENT_142	[p9l1748t2116r2139b2179],
25	(	NN	O	(	prep_than	22	SENT_142	[p9l14t2217r121b2299],
26	33	CD	NUMBER	33	dep	30	SENT_142	[p9l14t2217r121b2299],
27	i	FW	O	i	dep	26	SENT_142	[p9l158t2228r211b2281],
28	15	CD	PERCENT	15	num	29	SENT_142	[p9l248t2219r395b2286],
29	%	NN	PERCENT	%	dep	30	SENT_142	[p9l248t2219r395b2286],
30	VS.	NNP	O	VS.	dep	40	SENT_142	[p9l416t2245r504b2285],
31	27	CD	NUMBER	27	num	30	SENT_142	[p9l531t2221r618b2286],
32	i	FW	O	i	dep	30	SENT_142	[p9l650t2228r703b2281],
33	14	CD	PERCENT	14	num	34	SENT_142	[p9l740t2222r907b2300],
34	%	NN	PERCENT	%	dep	32	SENT_142	[p9l740t2222r907b2300],
35	,	,	O	,	_	0	SENT_142	[p9l740t2222r907b2300],
36	p	NN	O	p	appos	34	SENT_142	[p9l933t2245r975b2308],
37	=	JJ	O	=	amod	36	SENT_142	[p9l1008t2245r1061b2265],
38	0.03	CD	NUMBER	0.03	tmod	37	SENT_142	[p9l1095t2222r1266b2300],
39	,	,	O	,	_	0	SENT_142	[p9l1095t2222r1266b2300],
40	Fig	NN	O	fig	dep	22	SENT_142	[p9l1293t2220r1427b2308],
41	.	.	O	.	_	0	SENT_142	[p9l1293t2220r1427b2308],

1	1	CD	NUMBER	1	_	0	SENT_143	[p9l1460t2217r1522b2299],
2	)	NN	O	)	dep	1	SENT_143	[p9l1460t2217r1522b2299],
3	and	CC	O	and	_	0	SENT_143	[p9l1551t2219r1678b2285],
4	a	DT	O	a	det	6	SENT_143	[p9l1703t2245r1737b2285],
5	higher	JJR	O	higher	amod	6	SENT_143	[p9l1759t2219r1988b2308],
6	rate	NN	O	rate	dep	1	SENT_143	[p9l2010t2236r2140b2285],
7	of	IN	O	of	_	0	SENT_143	[p9l12t2325r91b2391],
8	HTPR	NN	O	htpr	prep_of	6	SENT_143	[p9l121t2323r374b2390],
9	(	CD	PERCENT	(	num	12	SENT_143	[p9l415t2323r593b2406],
10	16	CD	PERCENT	16	number	11	SENT_143	[p9l415t2323r593b2406],
11	%	NN	PERCENT	%	amod	12	SENT_143	[p9l415t2323r593b2406],
12	VS.	NN	O	v.	dep	1	SENT_143	[p9l631t2351r719b2392],
13	4	CD	PERCENT	4	number	14	SENT_143	[p9l764t2328r892b2406],
14	%	NN	PERCENT	%	amod	12	SENT_143	[p9l764t2328r892b2406],
15	,	,	O	,	_	0	SENT_143	[p9l764t2328r892b2406],
16	p	NN	O	p	appos	1	SENT_143	[p9l935t2351r977b2414],
17	=	JJ	O	=	amod	16	SENT_143	[p9l1027t2351r1080b2371],
18	0.01	CD	NUMBER	0.01	tmod	17	SENT_143	[p9l1131t2328r1303b2406],
19	,	,	O	,	_	0	SENT_143	[p9l1131t2328r1303b2406],
20	Fig	NN	O	fig	appos	1	SENT_143	[p9l1347t2326r1481b2414],
21	.	.	O	.	_	0	SENT_143	[p9l1347t2326r1481b2414],

1	2A	NN	O	2a	_	0	SENT_144	[p9l1525t2323r1681b2406],
2	)	NN	O	)	dep	1	SENT_144	[p9l1525t2323r1681b2406],
3	.	.	O	.	_	0	SENT_144	[p9l1525t2323r1681b2406],

1	Conversely	RB	O	conversely	advmod	17	SENT_145	[p9l1728t2325r2138b2414],
2	,	,	O	,	_	0	SENT_145	[p9l1728t2325r2138b2414],
3	patients	NNS	O	patient	nsubj	17	SENT_145	[p9l10t2434r287b2520],
4	who	WP	O	who	nsubj	6	SENT_145	[p9l310t2431r462b2497],
5	were	VBD	O	be	cop	6	SENT_145	[p9l486t2457r652b2497],
6	carriers	NNS	O	carrier	rcmod	3	SENT_145	[p9l679t2434r932b2497],
7	of	IN	O	of	_	0	SENT_145	[p9l959t2431r1040b2497],
8	*	NN	O	*	nn	12	SENT_145	[p9l1058t2434r1117b2496],
9	1	CD	NUMBER	1	number	10	SENT_145	[p9l1058t2434r1117b2496],
10	7	CD	NUMBER	7	amod	12	SENT_145	[p9l1132t2436r1170b2497],
11	gain	NN	O	gain	nn	12	SENT_145	[p9l1190t2431r1783b2520],
12	—	NN	O	—	prep_of	6	SENT_145	[p9l1190t2431r1783b2520],
13	of	IN	O	of	_	0	SENT_145	[p9l1190t2431r1783b2520],
14	—	CD	NUMBER	—	num	16	SENT_145	[p9l1190t2431r1783b2520],
15	function	NN	O	function	nn	16	SENT_145	[p9l1190t2431r1783b2520],
16	allele	NN	O	allele	prep_of	6	SENT_145	[p9l1810t2431r1986b2497],
17	had	VBD	O	have	_	0	SENT_145	[p9l2012t2431r2142b2497],
18	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_145	[p9l12t2537r441b2626],
19	lower	JJR	O	lower	amod	21	SENT_145	[p9l467t2537r663b2604],
20	PR1	NN	O	pr1	nn	21	SENT_145	[p9l692t2538r836b2603],
21	VASP	NN	O	vasp	dobj	17	SENT_145	[p9l869t2536r1096b2604],
22	than	IN	O	than	_	0	SENT_145	[p9l1128t2537r1285b2603],
23	noncarriers	JJ	O	noncarriers	amod	24	SENT_145	[p9l1318t2540r1709b2603],
24	(	NN	O	(	prep_than	21	SENT_145	[p9l1744t2535r1853b2618],
25	25	CD	NUMBER	25	dep	29	SENT_145	[p9l1744t2535r1853b2618],
26	i	FW	O	i	dep	25	SENT_145	[p9l1896t2547r1949b2600],
27	13	CD	PERCENT	13	num	28	SENT_145	[p9l1993t2540r2141b2604],
28	%	NN	PERCENT	%	dep	29	SENT_145	[p9l1993t2540r2141b2604],
29	VS.	NNP	O	VS.	dep	39	SENT_145	[p9l8t2669r96b2709],
30	31	CD	NUMBER	31	num	29	SENT_145	[p9l135t2646r215b2710],
31	i	FW	O	i	dep	29	SENT_145	[p9l263t2653r316b2705],
32	15	CD	PERCENT	15	num	33	SENT_145	[p9l363t2643r531b2724],
33	%	NN	PERCENT	%	dep	31	SENT_145	[p9l363t2643r531b2724],
34	,	,	O	,	_	0	SENT_145	[p9l363t2643r531b2724],
35	p	NN	O	p	appos	33	SENT_145	[p9l567t2669r609b2732],
36	=	JJ	O	=	amod	35	SENT_145	[p9l653t2669r707b2689],
37	0.03	CD	NUMBER	0.03	tmod	36	SENT_145	[p9l750t2646r922b2724],
38	,	,	O	,	_	0	SENT_145	[p9l750t2646r922b2724],
39	Fig	NN	O	fig	dep	21	SENT_145	[p9l960t2644r1094b2732],
40	.	.	O	.	_	0	SENT_145	[p9l960t2644r1094b2732],

1	1	CD	NUMBER	1	_	0	SENT_146	[p9l1137t2641r1200b2723],
2	)	NN	O	)	dep	1	SENT_146	[p9l1137t2641r1200b2723],
3	and	CC	O	and	_	0	SENT_146	[p9l1239t2643r1366b2709],
4	lower	JJR	O	lower	amod	5	SENT_146	[p9l1399t2643r1594b2709],
5	risk	NN	O	risk	dep	1	SENT_146	[p9l1627t2643r1758b2709],
6	of	IN	O	of	_	0	SENT_146	[p9l1788t2643r1868b2709],
7	HTPR	NN	O	htpr	nn	8	SENT_146	[p9l1891t2641r2144b2709],
8	(	NN	O	(	prep_of	5	SENT_146	[p9l14t2747r148b2829],
9	1	CD	PERCENT	1	number	10	SENT_146	[p9l14t2747r148b2829],
10	%	NN	PERCENT	%	amod	11	SENT_146	[p9l14t2747r148b2829],
11	VS.	NNP	O	VS.	dep	1	SENT_146	[p9l198t2775r286b2816],
12	10	CD	PERCENT	10	number	13	SENT_146	[p9l347t2752r515b2830],
13	%	NN	PERCENT	%	amod	11	SENT_146	[p9l347t2752r515b2830],
14	,	,	O	,	_	0	SENT_146	[p9l347t2752r515b2830],
15	p	NN	O	p	appos	1	SENT_146	[p9l570t2775r611b2838],
16	=	JJ	O	=	amod	15	SENT_146	[p9l674t2775r727b2795],
17	0.02	CD	NUMBER	0.02	tmod	16	SENT_146	[p9l790t2752r962b2830],
18	,	,	O	,	_	0	SENT_146	[p9l790t2752r962b2830],
19	Fig	NN	O	fig	appos	1	SENT_146	[p9l1018t2750r1152b2838],
20	.	.	O	.	_	0	SENT_146	[p9l1018t2750r1152b2838],

1	2B	NN	O	2b	_	0	SENT_147	[p9l1208t2747r1357b2829],
2	)	NN	O	)	dep	1	SENT_147	[p9l1208t2747r1357b2829],
3	.	.	O	.	_	0	SENT_147	[p9l1208t2747r1357b2829],

1	We	PRP	O	we	nsubj	2	SENT_148	[p9l1410t2750r1541b2816],
2	deﬁned	VBD	O	deﬁned	_	0	SENT_148	[p9l1595t2749r1856b2815],
3	hyperresponse	NN	O	hyperresponse	dobj	2	SENT_148	[p9l1908t2749r2138b2838, p9l11t2881r313b2944],
4	as	IN	O	as	_	0	SENT_148	[p9l358t2881r421b2921],
5	PRI	NNP	O	PRI	nn	6	SENT_148	[p9l466t2856r609b2920],
6	VASP	NN	ORGANIZATION	vasp	prep_as	2	SENT_148	[p9l654t2854r882b2922],
7	below	IN	O	below	_	0	SENT_148	[p9l922t2855r1135b2921],
8	the	DT	O	the	det	10	SENT_148	[p9l1174t2855r1284b2921],
9	75th	JJ	ORDINAL	75th	amod	10	SENT_148	[p9l1329t2855r1489b2921],
10	percentile	NN	O	percentile	prep_below	2	SENT_148	[p9l1531t2855r1876b2944],
11	of	IN	O	of	_	0	SENT_148	[p9l1920t2855r2000b2921],
12	the	DT	O	the	det	13	SENT_148	[p9l2030t2855r2140b2921],
13	population	NN	O	population	prep_of	10	SENT_148	[p9l10t2962r392b3051],
14	by	IN	O	by	_	0	SENT_148	[p9l417t2962r503b3051],
15	quartile	JJ	O	quartile	amod	16	SENT_148	[p9l526t2962r792b3052],
16	repartition	NN	O	repartition	prep_by	13	SENT_148	[p9l818t2965r1212b3051],
17	,	,	O	,	_	0	SENT_148	[p9l818t2965r1212b3051],
18	identifying	VBG	O	identify	partmod	2	SENT_148	[p9l1242t2962r1628b3051],
19	a	DT	O	a	det	20	SENT_148	[p9l1654t2988r1688b3028],
20	threshold	NN	O	threshold	dobj	18	SENT_148	[p9l1712t2962r2048b3028],
21	of	IN	O	of	_	0	SENT_148	[p9l2074t2962r2153b3028],
22	PR1	NN	O	pr1	nn	23	SENT_148	[p9l11t3069r155b3133],
23	VASP	NN	O	vasp	prep_of	20	SENT_148	[p9l188t3067r416b3135],
24	<	JJR	O	<	amod	23	SENT_148	[p9l453t3070r692b3135],
25	17	CD	PERCENT	17	num	26	SENT_148	[p9l453t3070r692b3135],
26	%	NN	PERCENT	%	dep	24	SENT_148	[p9l453t3070r692b3135],
27	.	.	O	.	_	0	SENT_148	[p9l453t3070r692b3135],

1	In	IN	O	in	_	0	SENT_149	[p9l728t3069r805b3134],
2	the	DT	O	the	det	4	SENT_149	[p9l837t3068r947b3134],
3	whole	JJ	O	whole	amod	4	SENT_149	[p9l975t3068r1189b3134],
4	cohort	NN	O	cohort	prep_in	15	SENT_149	[p9l1222t3068r1469b3149],
5	,	,	O	,	_	0	SENT_149	[p9l1222t3068r1469b3149],
6	55	CD	NUMBER	55	num	7	SENT_149	[p9l1504t3068r1586b3135],
7	patients	NNS	O	patient	nsubj	15	SENT_149	[p9l1620t3071r1896b3157],
8	(	IN	O	(	_	0	SENT_149	[p9l1933t3066r2137b3149],
9	26	CD	PERCENT	26	num	10	SENT_149	[p9l1933t3066r2137b3149],
10	%	NN	PERCENT	%	prep_(	7	SENT_149	[p9l1933t3066r2137b3149],
11	)	CD	NUMBER	)	dep	10	SENT_149	[p9l1933t3066r2137b3149],
12	were	VBD	O	be	cop	15	SENT_149	[p9l7t3201r174b3241],
13	hyper	JJ	O	hyper	amod	15	SENT_149	[p9l225t3175r859b3265],
14	—	NN	O	—	nn	15	SENT_149	[p9l225t3175r859b3265],
15	responders	NNS	O	responder	_	0	SENT_149	[p9l225t3175r859b3265],
16	.	.	O	.	_	0	SENT_149	[p9l225t3175r859b3265],

1	Incidence	NN	O	incidence	nsubj	8	SENT_150	[p9l913t3175r1256b3241],
2	of	IN	O	of	_	0	SENT_150	[p9l1307t3175r1387b3241],
3	hyper	JJ	O	hyper	amod	5	SENT_150	[p9l1424t3175r1963b3264],
4	—	NN	O	—	nn	5	SENT_150	[p9l1424t3175r1963b3264],
5	response	NN	O	response	prep_of	1	SENT_150	[p9l1424t3175r1963b3264],
6	was	VBD	O	be	cop	8	SENT_150	[p9l2011t3201r2140b3241],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_150	[p9l12t3281r441b3370],
8	higher	JJR	O	higher	_	0	SENT_150	[p9l472t3281r701b3370],
9	among	IN	O	among	_	0	SENT_150	[p9l735t3307r977b3370],
10	carriers	NNS	O	carrier	prep_among	8	SENT_150	[p9l1010t3284r1263b3347],
11	of	IN	O	of	_	0	SENT_150	[p9l1300t3281r1380b3347],
12	*	NN	O	*	nn	15	SENT_150	[p9l1407t3284r1519b3348],
13	17	CD	NUMBER	17	num	15	SENT_150	[p9l1407t3284r1519b3348],
14	gain	NN	O	gain	nn	15	SENT_150	[p9l1548t3281r2141b3370],
15	—	NN	O	—	prep_of	10	SENT_150	[p9l1548t3281r2141b3370],
16	of	IN	O	of	_	0	SENT_150	[p9l1548t3281r2141b3370],
17	—	CD	NUMBER	—	num	18	SENT_150	[p9l1548t3281r2141b3370],
18	function	NN	O	function	prep_of	15	SENT_150	[p9l1548t3281r2141b3370],

1	*	NN	O	*	nsubj	4	SENT_151	[p10l340t1854r388b1895],
2	2	CD	NUMBER	2	num	3	SENT_151	[p10l340t1854r388b1895],
3	Carriers	NNS	O	carrier	dep	1	SENT_151	[p10l404t1853r612b1895],
4	*	VBP	O	*	_	0	SENT_151	[p10l733t1853r785b1895],
5	2	CD	NUMBER	2	num	7	SENT_151	[p10l733t1853r785b1895],
6	non	JJ	O	non	amod	7	SENT_151	[p10l804t1863r897b1895],
7	Carriers	NNS	O	carrier	nsubj	8	SENT_151	[p10l919t1854r1125b1895],
8	*	VBP	O	*	ccomp	4	SENT_151	[p10l1230t1856r1272b1895],
9	1	CD	NUMBER	1	dobj	8	SENT_151	[p10l1230t1856r1272b1895],
10	?	.	O	?	_	0	SENT_151	[p10l1285t1854r1311b1895],

1	Carriers	NNS	O	carrier	nsubj	2	SENT_152	[p10l1329t1854r1535b1895],
2	*	VBP	O	*	_	0	SENT_152	[p10l1630t1854r1707b1895],
3	1	CD	NUMBER	1	dobj	2	SENT_152	[p10l1630t1854r1707b1895],
4	?	.	O	?	_	0	SENT_152	[p10l1630t1854r1707b1895],

1	Non	JJ	O	non	amod	2	SENT_153	[p10l1729t1854r1832b1895],
2	carriers	NNS	O	carrier	_	0	SENT_153	[p10l1848t1854r2047b1895],

1	Figure	NNP	O	Figure	_	0	SENT_154	[p10l66t2029r234b2084],
2	1	CD	NUMBER	1	dep	1	SENT_154	[p10l258t2030r308b2073],
3	.	.	O	.	_	0	SENT_154	[p10l258t2030r308b2073],

1	Prasugrel	NNP	O	Prasugrel	nn	2	SENT_155	[p10l336t2030r594b2084],
2	Response	NNP	O	Response	_	0	SENT_155	[p10l621t2030r887b2084],
3	According	VBG	O	accord	dep	2	SENT_155	[p10l909t2029r1190b2084],
4	to	TO	O	to	pcomp	3	SENT_155	[p10l1210t2031r1266b2074],
5	Genotypes	NNP	O	Genotypes	nn	7	SENT_155	[p10l1290t2029r1580b2084],
6	PRI	NNP	O	PRI	nn	7	SENT_155	[p10l66t2163r137b2206],
7	VASP	NN	ORGANIZATION	vasp	pobj	4	SENT_155	[p10l160t2163r290b2207],
8	according	VBG	O	accord	_	0	SENT_155	[p10l313t2161r556b2219],
9	to	TO	O	to	prepc_according_to	7	SENT_155	[p10l579t2169r630b2207],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_155	[p10l653t2163r921b2207],
11	*	NN	O	*	pobj	7	SENT_155	[p10l653t2163r921b2207],
12	2	CD	NUMBER	2	num	11	SENT_155	[p10l653t2163r921b2207],
13	and	CC	O	and	_	0	SENT_155	[p10l942t2161r1033b2207],
14	CYP2C19	NN	O	cyp2c19	dep	22	SENT_155	[p10l1058t2163r1358b2207],
15	*	CD	NUMBER	*	num	14	SENT_155	[p10l1058t2163r1358b2207],
16	17	CD	NUMBER	17	num	19	SENT_155	[p10l1058t2163r1358b2207],
17	status	NN	O	status	nn	19	SENT_155	[p10l1377t2169r1521b2207],
18	(	NN	O	(	nn	19	SENT_155	[p10l1545t2162r1589b2214],
19	n	NN	O	n	dep	14	SENT_155	[p10l1545t2162r1589b2214],
20	=	JJ	O	=	amod	22	SENT_155	[p10l1618t2179r1655b2194],
21	213	CD	NUMBER	213	num	22	SENT_155	[p10l1683t2162r1800b2214],
22	)	NN	O	)	conj_and	2	SENT_155	[p10l1683t2162r1800b2214],
23	.	.	O	.	_	0	SENT_155	[p10l1683t2162r1800b2214],

1	PRI	NNP	ORGANIZATION	PRI	_	0	SENT_156	[p10l1825t2163r1895b2206],
2	=	JJ	O	=	amod	5	SENT_156	[p10l1925t2178r1962b2194],
3	platelet	NN	O	platelet	nn	5	SENT_156	[p10l66t2246r251b2303],
4	reactivity	NN	O	reactivity	nn	5	SENT_156	[p10l274t2248r498b2304],
5	index	NN	O	index	dep	1	SENT_156	[p10l520t2246r666b2298],
6	;	:	O	;	_	0	SENT_156	[p10l520t2246r666b2298],
7	VASP	NN	ORGANIZATION	vasp	dep	1	SENT_156	[p10l686t2247r817b2291],
8	=	JJ	O	=	amod	10	SENT_156	[p10l844t2263r882b2278],
9	vasodilator-stimulated	JJ	O	vasodilator-stimulated	amod	10	SENT_156	[p10l908t2246r1463b2291],
10	phosphoprotein	NN	O	phosphoprotein	dep	7	SENT_156	[p10l1489t2246r1903b2303],
11	.	.	O	.	_	0	SENT_156	[p10l1489t2246r1903b2303],

1	Cuisset	NNP	O	Cuisset	_	0	SENT_157	[p10l1475t2527r1667b2571],
2	et	FW	O	et	nn	3	SENT_157	[p10l1693t2530r1745b2571],
3	al.	FW	O	al.	dep	1	SENT_157	[p10l1768t2528r1827b2571],
4	1283	CD	DATE	1283	dep	1	SENT_157	[p10l2009t2527r2150b2571],

1	Genetic	JJ	O	genetic	_	0	SENT_158	[p10l949t2609r1151b2653],
2	and	CC	O	and	_	0	SENT_158	[p10l1173t2610r1269b2653],
3	Prasugrel	NNP	O	Prasugrel	nn	5	SENT_158	[p10l1297t2610r1545b2664],
4	Response	NNP	O	Response	nn	5	SENT_158	[p10l1572t2610r1830b2663],
5	p	NN	O	p	conj_and	1	SENT_158	[p11l828t219r1029b284],
6	=	JJ	O	=	amod	1	SENT_158	[p11l828t219r1029b284],
7	0	CD	NUMBER	0	tmod	6	SENT_158	[p11l828t219r1029b284],
8	.	.	O	.	_	0	SENT_158	[p11l828t219r1029b284],

1	ﬂ1	NN	O	ﬂ1	_	0	SENT_159	[p11l828t219r1029b284],

1	ξ	NN	O	ξ	nsubj	11	SENT_160	[p11l213t212r271b292],
2	+	CC	O	+	_	0	SENT_160	[p11l213t212r271b292],
3	§	CD	NUMBER	§	num	4	SENT_160	[p11l213t287r258b383],
4	zo	NN	O	zo	conj_+	1	SENT_160	[p11l323t332r381b374],
5	u	CD	PERCENT	u	num	6	SENT_160	[p11l1828t377r1834b383],
6	%	NN	PERCENT	%	dep	4	SENT_160	[p11l213t386r258b461],
7	-	:	O	-	_	0	SENT_160	[p11l1512t374r1599b428],
8	*	NN	O	*	dep	1	SENT_160	[p11l1637t377r1689b422],
9	2	CD	NUMBER	2	num	10	SENT_160	[p11l1637t377r1689b422],
10	Carriers	NNS	O	carrier	dep	8	SENT_160	[p11l1709t377r1921b422, p11l213t463r258b541],
11	§	VBP	O	§	_	0	SENT_160	[p11l1709t377r1921b422, p11l213t463r258b541],
12	15	CD	NUMBER	15	num	15	SENT_160	[p11l326t509r381b551],
13	Z	NN	O	z	nn	15	SENT_160	[p11l1512t457r1599b509],
14	2N	NN	O	2n	nn	15	SENT_160	[p11l1660t457r1808b502],
15	|	NN	O	|	dobj	11	SENT_160	[p11l1660t457r1808b502],
16	on	IN	O	on	_	0	SENT_160	[p11l1660t457r1808b502],
17	Carriers	NNS	O	carrier	prep_on	11	SENT_160	[p11l1831t457r2040b502],
18	E	NNP	O	E	nn	19	SENT_160	[p11l213t560r258b611],
19	J.	NNP	O	J.	dep	17	SENT_160	[p11l213t614r271b672],
20	-	:	O	-	_	0	SENT_160	[p11l213t614r271b672],
21	.	.	O	.	_	0	SENT_160	[p11l213t614r271b672],

1	D	NN	O	d	_	0	SENT_161	[p11l213t695r258b730],
2	:	:	O	:	_	0	SENT_161	[p11l213t695r258b730],
3	10	CD	NUMBER	10	num	5	SENT_161	[p11l326t685r381b727],
4	Q.	NNP	O	Q.	nn	5	SENT_161	[p11l213t733r258b769],
5	Hi	NNP	O	Hi	dep	1	SENT_161	[p11l213t775r258b807],
6	I	PRP	O	I	nsubj	7	SENT_161	[p11l213t813r258b846],
7	‘	VBP	O	‘	rcmod	5	SENT_161	[p11l213t865r258b920],
8	:5	CD	NUMBER	:5	number	9	SENT_161	[p11l213t865r258b920],
9	5	CD	NUMBER	5	num	10	SENT_161	[p11l352t862r381b904],
10	ms	NNS	O	m	dobj	7	SENT_161	[p11l223t939r258b969],
11	at	IN	O	at	_	0	SENT_161	[p11l223t974r258b1004],
12	3	CD	NUMBER	3	prep_at	10	SENT_161	[p11l223t1007r258b1036],
13	:	:	O	:	_	0	SENT_161	[p11l223t1007r258b1036],
14	.	.	O	.	_	0	SENT_161	[p11l358t1039r360b1041],

1	F	NN	O	f	nn	4	SENT_162	[p11l217t1039r258b1084],
2	”	CD	NUMBER	”	num	4	SENT_162	[p11l217t1039r258b1084],
3	o	NN	O	o	nn	4	SENT_162	[p11l352t1039r381b1081],
4	E	NN	O	e	dep	8	SENT_162	[p11l213t1074r258b1152],
5	*	CD	NUMBER	*	number	6	SENT_162	[p11l538t1091r584b1133],
6	2	CD	NUMBER	2	num	7	SENT_162	[p11l538t1091r584b1133],
7	Carriers	NNS	O	carrier	dep	4	SENT_162	[p11l603t1091r806b1133],
8	*	VBP	O	*	_	0	SENT_162	[p11l1002t1091r1055b1133],
9	2	CD	NUMBER	2	num	11	SENT_162	[p11l1002t1091r1055b1133],
10	NDII1	NN	O	ndii1	nn	11	SENT_162	[p11l1074t1091r1174b1133],
11	Carriers	NNS	O	carrier	dobj	8	SENT_162	[p11l1190t1091r1393b1133],
12	E	NN	O	e	nsubj	8	SENT_162	[p11l213t1158r258b1197],

1	B	NN	O	b	_	0	SENT_163	[p11l84t1338r159b1431],

1	Vé	NN	O	vé	_	0	SENT_164	[p11l329t1421r357b1463],
2	U	NNP	O	U	nn	3	SENT_164	[p11l358t1421r384b1463],
3	’	NNP	O	’	dep	1	SENT_164	[p11l358t1421r384b1463],
4	!	.	O	!	_	0	SENT_164	[p11l358t1421r384b1463],

1	.1	CD	NUMBER	.1	num	2	SENT_165	[p11l329t1763r349b1805],
2	G	NN	O	g	_	0	SENT_165	[p11l355t1763r384b1805],

1	-	:	O	-	_	0	SENT_166	[p11l1515t1782r1603b1837],
2	*	NN	O	*	_	0	SENT_166	[p11l1641t1785r1725b1830],
3	1	CD	NUMBER	1	dep	2	SENT_166	[p11l1641t1785r1725b1830],
4	?	.	O	?	_	0	SENT_166	[p11l1641t1785r1725b1830],

1	Carriers	NNS	O	carrier	_	0	SENT_167	[p11l1747t1785r1957b1830],
2	Z	NN	O	z	nn	3	SENT_167	[p11l1515t1866r1603b1917],
3	*	NN	O	*	dep	1	SENT_167	[p11l1641t1866r1725b1911],
4	1	CD	NUMBER	1	dep	3	SENT_167	[p11l1641t1866r1725b1911],
5	?	.	O	?	_	0	SENT_167	[p11l1641t1866r1725b1911],

1	Non	NNP	O	Non	nn	2	SENT_168	[p11l1747t1866r1844b1911],
2	Carriers	NNP	O	Carriers	_	0	SENT_168	[p11l1866t1866r2076b1911],

1	Incidence	NN	O	incidence	_	0	SENT_169	[p11l217t2190r262b2447],
2	of	IN	O	of	_	0	SENT_169	[p11l217t2117r262b2172],
3	HITPR	NN	O	hitpr	nn	6	SENT_169	[p11l217t1946r262b2098],
4	(	CD	NUMBER	(	num	6	SENT_169	[p11l217t1808r274b1924],
5	PRI	NNP	O	PRI	nn	6	SENT_169	[p11l217t1808r274b1924],
6	VASF	NN	O	vasf	prep_of	1	SENT_169	[p11l217t1495r265b1792],
7	'	''	O	'	_	0	SENT_169	[p11l217t1495r265b1792],
8	>	JJR	O	>	dep	1	SENT_169	[p11l217t1495r265b1792],
9	5D	CD	PERCENT	5d	num	10	SENT_169	[p11l217t1495r265b1792],
10	%	NN	PERCENT	%	dep	8	SENT_169	[p11l217t1495r265b1792],
11	]	CD	NUMBER	]	dep	8	SENT_169	[p11l217t1463r274b1476],

1	in	IN	O	in	_	0	SENT_170	[p11l355t2107r384b2149],

1	Iﬁ	NN	O	iﬁ	_	0	SENT_171	[p11l355t2444r384b2486],

1	*	NN	O	*	nsubj	4	SENT_172	[p11l525t2499r603b2541],
2	17	CD	NUMBER	17	num	3	SENT_172	[p11l525t2499r603b2541],
3	Carriers	NNS	O	carrier	dep	1	SENT_172	[p11l619t2499r822b2541],
4	*	VBP	O	*	_	0	SENT_172	[p11l996t2499r1074b2541],
5	1	CD	NUMBER	1	dobj	4	SENT_172	[p11l996t2499r1074b2541],
6	?	.	O	?	_	0	SENT_172	[p11l996t2499r1074b2541],

1	’	NN	O	’	_	0	SENT_173	[p11l996t2499r1074b2541],
2	Man	NN	O	man	nn	3	SENT_173	[p11l1093t2499r1194b2541],
3	Carriers	NNS	O	carrier	dep	1	SENT_173	[p11l1212t2499r1412b2541],

1	Figure	NN	O	figure	_	0	SENT_174	[p11l63t2679r232b2734],
2	2	CD	NUMBER	2	dep	1	SENT_174	[p11l257t2679r307b2723],
3	.	.	O	.	_	0	SENT_174	[p11l257t2679r307b2723],

1	Incidence	NN	O	incidence	_	0	SENT_175	[p11l335t2679r602b2724],
2	of	IN	O	of	_	0	SENT_175	[p11l625t2679r678b2724],
3	HTPR	NNP	O	HTPR	prep_of	1	SENT_175	[p11l701t2679r851b2723],
4	According	VBG	O	accord	_	0	SENT_175	[p11l874t2679r1157b2734],
5	to	TO	O	to	prepc_according_to	1	SENT_175	[p11l1176t2680r1233b2724],
6	CYP2C19	NN	O	cyp2c19	nn	7	SENT_175	[p11l1260t2679r1606b2724],
7	*	NN	O	*	pobj	1	SENT_175	[p11l1260t2679r1606b2724],
8	2	CD	NUMBER	2	dep	7	SENT_175	[p11l1260t2679r1606b2724],
9	and	CC	O	and	_	0	SENT_175	[p11l1624t2679r1722b2724],
10	CYP2C19	NNP	O	CYP2C19	nn	11	SENT_175	[p11l65t2760r334b2804],
11	Status	NNP	O	Status	pobj	1	SENT_175	[p11l352t2759r534b2804],

1	High	JJ	O	high	nsubj	10	SENT_176	[p11l64t2893r181b2951],
2	on	IN	O	on	_	0	SENT_176	[p11l208t2899r556b2938],
3	—	NN	O	—	nn	5	SENT_176	[p11l208t2899r556b2938],
4	treatment	NN	O	treatment	nn	5	SENT_176	[p11l208t2899r556b2938],
5	platelet	NN	O	platelet	prep_on	1	SENT_176	[p11l581t2893r776b2950],
6	reactivity	NN	O	reactivity	nn	9	SENT_176	[p11l802t2895r1038b2951],
7	(	CD	NUMBER	(	num	9	SENT_176	[p11l1063t2894r1230b2946],
8	HTPR	NN	O	htpr	nn	9	SENT_176	[p11l1063t2894r1230b2946],
9	)	NN	O	)	dep	5	SENT_176	[p11l1063t2894r1230b2946],
10	deﬁned	VBN	O	deﬁned	_	0	SENT_176	[p11l1256t2892r1451b2938],
11	as	IN	O	as	_	0	SENT_176	[p11l1478t2906r1529b2938],
12	PRI	NNP	ORGANIZATION	PRI	nn	13	SENT_176	[p11l1556t2895r1629b2938],
13	VASP	NN	ORGANIZATION	vasp	prep_as	10	SENT_176	[p11l1655t2894r1790b2938],
14	>	JJR	O	>	dobj	10	SENT_176	[p11l1818t2899r1860b2935],
15	50	CD	PERCENT	50	number	16	SENT_176	[p11l1889t2896r1999b2938],
16	%	NN	PERCENT	%	amod	14	SENT_176	[p11l1889t2896r1999b2938],
17	according	VBG	O	accord	_	0	SENT_176	[p11l62t2978r316b3036],
18	to	TO	O	to	prepc_according_to	10	SENT_176	[p11l342t2985r395b3023],
19	(	CD	NUMBER	(	pobj	10	SENT_176	[p11l421t2979r495b3030],
20	A	DT	O	a	det	23	SENT_176	[p11l421t2979r495b3030],
21	)	NN	O	)	nn	23	SENT_176	[p11l421t2979r495b3030],
22	CYP2C19	NN	O	cyp2c19	nn	23	SENT_176	[p11l521t2980r800b3023],
23	*	NN	O	*	dep	32	SENT_176	[p11l521t2980r800b3023],
24	2	CD	NUMBER	2	num	25	SENT_176	[p11l521t2980r800b3023],
25	status	NN	O	status	dep	23	SENT_176	[p11l825t2985r976b3023],
26	and	CC	O	and	_	0	SENT_176	[p11l1001t2978r1095b3023],
27	(	NN	O	(	nn	28	SENT_176	[p11l1123t2979r1194b3030],
28	B	NN	O	b	conj_and	25	SENT_176	[p11l1123t2979r1194b3030],
29	)	CD	NUMBER	)	num	30	SENT_176	[p11l1123t2979r1194b3030],
30	CYP2C19	NN	O	cyp2c19	dep	32	SENT_176	[p11l1221t2980r1534b3023],
31	*	CD	NUMBER	*	num	32	SENT_176	[p11l1221t2980r1534b3023],
32	17	CD	NUMBER	17	dep	19	SENT_176	[p11l1221t2980r1534b3023],
33	status	NN	O	status	nn	35	SENT_176	[p11l1555t2985r1706b3023],
34	(	NN	O	(	nn	35	SENT_176	[p11l1733t2979r1777b3031],
35	n	NN	O	n	dep	32	SENT_176	[p11l1733t2979r1777b3031],
36	=	JJ	O	=	amod	38	SENT_176	[p11l1809t2995r1847b3009],
37	213	CD	NUMBER	213	tmod	36	SENT_176	[p11l1878t2979r2001b3031],
38	)	NN	O	)	dep	35	SENT_176	[p11l1878t2979r2001b3031],
39	.	.	O	.	_	0	SENT_176	[p11l1878t2979r2001b3031],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_177	[p11l61t3063r423b3109],
2	as	IN	O	as	prep	1	SENT_177	[p11l448t3076r499b3109],
3	in	IN	O	in	pcomp	2	SENT_177	[p11l526t3065r568b3108],
4	Figure	NNP	O	Figure	pobj	3	SENT_177	[p11l597t3065r757b3121],
5	1	CD	NUMBER	1	num	4	SENT_177	[p11l786t3067r823b3108],
6	.	.	O	.	_	0	SENT_177	[p11l786t3067r823b3108],

1	allele	NN	O	allele	_	0	SENT_178	[p11l9t3305r187b3372],
2	than	IN	O	than	dep	1	SENT_178	[p11l222t3306r382b3372],
3	in	IN	O	in	pcomp	2	SENT_178	[p11l416t3309r484b3371],
4	noncarriers	NNS	O	noncarrier	pobj	3	SENT_178	[p11l520t3308r934b3372],
5	:	:	O	:	_	0	SENT_178	[p11l520t3308r934b3372],
6	34	CD	PERCENT	34	num	7	SENT_178	[p11l974t3309r1126b3372],
7	%	NN	PERCENT	%	dep	21	SENT_178	[p11l974t3309r1126b3372],
8	(	CD	NUMBER	(	num	9	SENT_178	[p11l1164t3303r1235b3386],
9	n	NN	O	n	dep	7	SENT_178	[p11l1164t3303r1235b3386],
10	=	JJ	O	=	amod	9	SENT_178	[p11l1279t3331r1332b3352],
11	25	CD	NUMBER	25	tmod	10	SENT_178	[p11l1374t3305r1459b3373],
12	of	IN	O	of	_	0	SENT_178	[p11l1498t3305r1578b3372],
13	73	CD	NUMBER	73	number	14	SENT_178	[p11l1602t3303r1712b3386],
14	)	CD	NUMBER	)	num	15	SENT_178	[p11l1602t3303r1712b3386],
15	Versus	NNP	O	Versus	prep_of	9	SENT_178	[p11l1747t3331r1962b3372],
16	21	CD	PERCENT	21	number	17	SENT_178	[p11l1997t3309r2152b3373],
17	%	NN	PERCENT	%	amod	15	SENT_178	[p11l1997t3309r2152b3373],
18	(	CD	NUMBER	(	num	19	SENT_178	[p11l11t3410r81b3493],
19	n	NN	O	n	dep	21	SENT_178	[p11l11t3410r81b3493],
20	=	JJ	O	=	amod	21	SENT_178	[p11l123t3438r177b3459],
21	30	CD	NUMBER	30	dep	30	SENT_178	[p11l220t3416r304b3479],
22	of	IN	O	of	_	0	SENT_178	[p11l339t3412r419b3479],
23	140	CD	NUMBER	140	num	24	SENT_178	[p11l445t3410r620b3493],
24	)	NN	O	)	prep_of	21	SENT_178	[p11l445t3410r620b3493],
25	,	,	O	,	_	0	SENT_178	[p11l445t3410r620b3493],
26	p	NN	O	p	appos	24	SENT_178	[p11l655t3439r698b3502],
27	=	JJ	O	=	amod	26	SENT_178	[p11l741t3438r794b3459],
28	0.02	CD	NUMBER	0.02	tmod	27	SENT_178	[p11l837t3416r988b3480],
29	(	CD	NUMBER	(	num	30	SENT_178	[p11l1027t3410r1188b3502],
30	Fig	NN	O	fig	dep	1	SENT_178	[p11l1027t3410r1188b3502],
31	.	.	O	.	_	0	SENT_178	[p11l1027t3410r1188b3502],

1	3	CD	NUMBER	3	_	0	SENT_179	[p11l1227t3410r1316b3493],
2	)	NN	O	)	dep	1	SENT_179	[p11l1227t3410r1316b3493],
3	.	.	O	.	_	0	SENT_179	[p11l1227t3410r1316b3493],

1	Effect	NN	O	effect	_	0	SENT_180	[p11l11t3525r195b3585],
2	of	IN	O	of	_	0	SENT_180	[p11l215t3525r284b3585],
3	genotypes	NNS	O	genotype	prep_of	1	SENT_180	[p11l299t3534r652b3601],
4	on	IN	O	on	_	0	SENT_180	[p11l672t3543r754b3585],
5	platelet	NN	O	platelet	nn	6	SENT_180	[p11l780t3526r1031b3600],
6	reactivity	NN	O	reactivity	prep_on	3	SENT_180	[p11l1053t3528r1360b3601],
7	(	CD	NUMBER	(	num	8	SENT_180	[p11l1380t3527r1526b3594],
8	LTA	NN	ORGANIZATION	lta	dep	1	SENT_180	[p11l1380t3527r1526b3594],
9	with	IN	O	with	_	0	SENT_180	[p11l1544t3526r1689b3585],
10	ADP-Ag	JJ	O	adp-ag	amod	11	SENT_180	[p11l1711t3527r2013b3601],
11	)	NN	O	)	prep_with	8	SENT_180	[p11l1711t3527r2013b3601],
12	.	.	O	.	_	0	SENT_180	[p11l1711t3527r2013b3601],

1	At	IN	O	at	_	0	SENT_181	[p11l2058t3517r2153b3585],

1	1	CD	DURATION	1	num	2	SENT_182	[p12l12t23r44b85],
2	month	NN	DURATION	month	tmod	15	SENT_182	[p12l85t20r341b100],
3	,	,	O	,	_	0	SENT_182	[p12l85t20r341b100],
4	patients	NNS	O	patient	nsubj	15	SENT_182	[p12l378t22r657b109],
5	who	WP	O	who	nsubj	7	SENT_182	[p12l690t19r843b86],
6	were	VBD	O	be	cop	7	SENT_182	[p12l875t45r1043b86],
7	carriers	NNS	O	carrier	rcmod	4	SENT_182	[p12l1080t22r1334b86],
8	of	IN	O	of	_	0	SENT_182	[p12l1371t19r1452b86],
9	loss-of-function	JJ	O	loss-of-function	amod	12	SENT_182	[p12l1473t19r2048b86],
10	*	NN	O	*	nn	12	SENT_182	[p12l2089t23r2153b86],
11	2	CD	NUMBER	2	num	12	SENT_182	[p12l2089t23r2153b86],
12	allele	NN	O	allele	prep_of	7	SENT_182	[p12l10t125r187b192],
13	did	VBD	O	do	aux	15	SENT_182	[p12l215t125r328b192],
14	not	RB	O	not	neg	15	SENT_182	[p12l355t142r472b192],
15	have	VB	O	have	_	0	SENT_182	[p12l497t126r656b192],
16	signiﬁcantly	RB	O	signiﬁcantly	advmod	17	SENT_182	[p12l684t125r1116b215],
17	higher	JJR	O	higher	amod	18	SENT_182	[p12l1138t125r1368b215],
18	ADP	NN	O	adp	dobj	15	SENT_182	[p12l1391t124r1731b215],
19	.	.	O	.	_	0	SENT_182	[p12l1391t124r1731b215],

1	—	NN	O	—	_	0	SENT_183	[p12l1391t124r1731b215],
2	.	.	O	.	_	0	SENT_183	[p12l1391t124r1731b215],

1	Ag	NN	O	ag	nn	2	SENT_184	[p12l1391t124r1731b215],
2	Values	NNS	O	value	nsubj	37	SENT_184	[p12l1751t125r1965b192],
3	than	IN	O	than	_	0	SENT_184	[p12l1992t125r2152b192],
4	noncarriers	JJ	O	noncarriers	amod	5	SENT_184	[p12l9t235r403b298],
5	(	NN	O	(	prep_than	2	SENT_184	[p12l457t229r566b312],
6	48	CD	NUMBER	48	num	5	SENT_184	[p12l457t229r566b312],
7	i	FW	O	i	dep	5	SENT_184	[p12l626t241r679b294],
8	15	CD	PERCENT	15	number	9	SENT_184	[p12l742t232r891b298],
9	%	NN	PERCENT	%	amod	7	SENT_184	[p12l742t232r891b298],
10	VS.	NNP	O	VS.	dep	5	SENT_184	[p12l936t258r1025b298],
11	46	CD	NUMBER	46	num	10	SENT_184	[p12l1077t235r1162b298],
12	i	FW	O	i	dep	10	SENT_184	[p12l1221t241r1275b294],
13	14	CD	PERCENT	14	number	14	SENT_184	[p12l1337t235r1506b312],
14	%	NN	PERCENT	%	amod	12	SENT_184	[p12l1337t235r1506b312],
15	,	,	O	,	_	0	SENT_184	[p12l1337t235r1506b312],
16	p	NN	O	p	prep_than	2	SENT_184	[p12l1556t258r1598b321],
17	=	JJ	O	=	amod	19	SENT_184	[p12l1657t257r1711b277],
18	0.78	CD	NUMBER	0.78	tmod	17	SENT_184	[p12l1769t230r1971b312],
19	)	NN	O	)	dep	16	SENT_184	[p12l1769t230r1971b312],
20	,	,	O	,	_	0	SENT_184	[p12l1769t230r1971b312],
21	and	CC	O	and	_	0	SENT_184	[p12l2024t231r2153b298],
22	patients	NNS	O	patient	prep_than	2	SENT_184	[p12l7t340r285b427],
23	who	WP	O	who	nsubj	25	SENT_184	[p12l312t337r464b404],
24	were	VBD	O	be	cop	25	SENT_184	[p12l490t363r657b404],
25	carriers	NNS	O	carrier	rcmod	22	SENT_184	[p12l686t340r941b404],
26	of	IN	O	of	_	0	SENT_184	[p12l971t337r1052b404],
27	*	NN	O	*	nn	30	SENT_184	[p12l1072t341r1185b404],
28	17	CD	NUMBER	17	num	30	SENT_184	[p12l1072t341r1185b404],
29	gain	NN	O	gain	nn	30	SENT_184	[p12l1206t337r1803b427],
30	—	NN	O	—	prep_of	25	SENT_184	[p12l1206t337r1803b427],
31	of	IN	O	of	_	0	SENT_184	[p12l1206t337r1803b427],
32	—	CD	NUMBER	—	num	34	SENT_184	[p12l1206t337r1803b427],
33	function	NN	O	function	nn	34	SENT_184	[p12l1206t337r1803b427],
34	allele	NN	O	allele	prep_of	25	SENT_184	[p12l1833t337r2010b404],
35	did	VBD	O	do	aux	37	SENT_184	[p12l2039t337r2153b404],
36	not	RB	O	not	neg	37	SENT_184	[p12l9t461r127b510],
37	have	VB	O	have	_	0	SENT_184	[p12l162t444r321b510],
38	signiﬁcantly	RB	O	signiﬁcantly	advmod	39	SENT_184	[p12l360t443r792b533],
39	lower	JJR	O	lower	amod	40	SENT_184	[p12l824t443r1021b510],
40	ADP	NN	O	adp	dobj	37	SENT_184	[p12l1054t442r1394b533],
41	.	.	O	.	_	0	SENT_184	[p12l1054t442r1394b533],

1	—	NN	O	—	_	0	SENT_185	[p12l1054t442r1394b533],
2	.	.	O	.	_	0	SENT_185	[p12l1054t442r1394b533],

1	Ag	NN	O	ag	nn	2	SENT_186	[p12l1054t442r1394b533],
2	Values	NNS	O	value	dep	7	SENT_186	[p12l1426t444r1639b510],
3	than	IN	O	than	_	0	SENT_186	[p12l1677t443r1837b510],
4	noncarriers	JJ	O	noncarriers	amod	5	SENT_186	[p12l1875t469r2149b510, p12l8t552r158b616],
5	(	NN	O	(	prep_than	2	SENT_186	[p12l196t547r305b630],
6	45	CD	NUMBER	45	dep	7	SENT_186	[p12l196t547r305b630],
7	i	FW	O	i	dep	10	SENT_186	[p12l350t559r403b612],
8	13	CD	PERCENT	13	num	9	SENT_186	[p12l450t553r599b616],
9	%	NN	PERCENT	%	dep	7	SENT_186	[p12l450t553r599b616],
10	VS.	NNP	O	VS.	dep	11	SENT_186	[p12l629t576r718b616],
11	48	CD	NUMBER	48	_	0	SENT_186	[p12l755t553r838b616],
12	:	:	O	:	_	0	SENT_186	[p12l883t559r936b612],
13	14	CD	PERCENT	14	number	14	SENT_186	[p12l983t553r1152b630],
14	%	NN	PERCENT	%	dep	16	SENT_186	[p12l983t553r1152b630],
15	,	,	O	,	_	0	SENT_186	[p12l983t553r1152b630],
16	p	NN	O	p	dep	11	SENT_186	[p12l1187t576r1229b639],
17	=	JJ	O	=	amod	16	SENT_186	[p12l1272t575r1326b596],
18	0.36	CD	NUMBER	0.36	num	19	SENT_186	[p12l1368t547r1569b630],
19	)	NN	O	)	dep	17	SENT_186	[p12l1368t547r1569b630],
20	.	.	O	.	_	0	SENT_186	[p12l1368t547r1569b630],

1	Classiﬁcation	NN	O	classiﬁcation	_	0	SENT_187	[p12l9t662r460b721],
2	of	IN	O	of	_	0	SENT_187	[p12l491t662r561b721],
3	patients	NNS	O	patient	prep_of	1	SENT_187	[p12l587t664r866b736],
4	according	VBG	O	accord	_	0	SENT_187	[p12l894t662r1234b737],
5	to	TO	O	to	prepc_according_to	3	SENT_187	[p12l1263t670r1333b721],
6	genotypes	NNS	O	genotype	pobj	3	SENT_187	[p12l1361t670r1745b737],
7	:	:	O	:	_	0	SENT_187	[p12l1361t670r1745b737],
8	interaction	NN	O	interaction	dep	1	SENT_187	[p12l1775t664r2148b721],
9	of	IN	O	of	_	0	SENT_187	[p12l9t768r79b827],
10	*	NN	O	*	prep_of	8	SENT_187	[p12l131t771r203b827],
11	2	CD	NUMBER	2	num	10	SENT_187	[p12l131t771r203b827],
12	and	CC	O	and	_	0	SENT_187	[p12l261t768r388b827],
13	*	CD	NUMBER	*	number	14	SENT_187	[p12l446t771r562b827],
14	17	CD	NUMBER	17	num	15	SENT_187	[p12l446t771r562b827],
15	alleles	NNS	O	allele	dep	1	SENT_187	[p12l620t768r854b827],
16	.	.	O	.	_	0	SENT_187	[p12l620t768r854b827],

1	Given	VBN	O	give	dep	121	SENT_188	[p12l905t761r1121b828],
2	the	DT	O	the	dep	121	SENT_188	[p12l1176t761r1287b828],
3	signiﬁcant	JJ	O	signiﬁcant	dep	121	SENT_188	[p12l1344t761r1712b851],
4	association	NN	O	association	dep	121	SENT_188	[p12l1767t764r2152b828],
5	between	IN	O	between	dep	121	SENT_188	[p12l6t868r301b934],
6	PRI	NNP	ORGANIZATION	PRI	dep	121	SENT_188	[p12l352t868r496b933],
7	VASP	NN	ORGANIZATION	vasp	dep	121	SENT_188	[p12l549t866r778b934],
8	and	CC	O	and	dep	121	SENT_188	[p12l830t868r958b934],
9	genetic	JJ	O	genetic	dep	121	SENT_188	[p12l1006t870r1261b957],
10	Variants	NNS	O	variant	dep	121	SENT_188	[p12l1307t870r1605b948],
11	,	,	O	,	_	0	SENT_188	[p12l1307t870r1605b948],
12	patients	NNS	O	patient	dep	121	SENT_188	[p12l1657t870r1935b957],
13	were	VBD	O	be	dep	121	SENT_188	[p12l1984t893r2151b934],
14	classiﬁed	VBN	O	classiﬁed	dep	121	SENT_188	[p12l9t974r324b1041],
15	according	VBG	O	accord	dep	121	SENT_188	[p12l356t974r701b1064],
16	to	TO	O	to	dep	121	SENT_188	[p12l730t992r798b1041],
17	their	PRP$	O	they	dep	121	SENT_188	[p12l830t974r998b1041],
18	genotypes	NNS	O	genotype	dep	121	SENT_188	[p12l1027t991r1379b1064],
19	as	IN	O	as	dep	121	SENT_188	[p12l1413t1001r1477b1041],
20	poor	JJ	O	poor	dep	121	SENT_188	[p12l1509t1000r1673b1064],
21	metabolizers	NNS	O	metabolizer	dep	121	SENT_188	[p12l1703t974r2150b1041],
22	(	VBP	O	(	dep	121	SENT_188	[p12l11t1078r106b1161],
23	*	NN	O	*	dep	121	SENT_188	[p12l11t1078r106b1161],
24	2	CD	NUMBER	2	dep	121	SENT_188	[p12l11t1078r106b1161],
25	loss	NN	O	loss	dep	121	SENT_188	[p12l128t1080r704b1147],
26	—	NN	O	—	dep	121	SENT_188	[p12l128t1080r704b1147],
27	of	IN	O	of	dep	121	SENT_188	[p12l128t1080r704b1147],
28	—	CD	NUMBER	—	dep	121	SENT_188	[p12l128t1080r704b1147],
29	function	NN	O	function	dep	121	SENT_188	[p12l128t1080r704b1147],
30	allele	NN	O	allele	dep	121	SENT_188	[p12l730t1081r907b1147],
31	carriers	NNS	O	carrier	dep	121	SENT_188	[p12l933t1080r1289b1147],
32	/	:	O	/	dep	121	SENT_188	[p12l933t1080r1289b1147],
33	*	CD	NUMBER	*	dep	121	SENT_188	[p12l933t1080r1289b1147],
34	1	CD	NUMBER	1	dep	121	SENT_188	[p12l933t1080r1289b1147],
35	7	CD	NUMBER	7	dep	121	SENT_188	[p12l1304t1086r1342b1147],
36	gain	NN	O	gain	dep	121	SENT_188	[p12l1360t1080r1957b1170],
37	—	NN	O	—	dep	121	SENT_188	[p12l1360t1080r1957b1170],
38	of	IN	O	of	dep	121	SENT_188	[p12l1360t1080r1957b1170],
39	—	CD	NUMBER	—	dep	121	SENT_188	[p12l1360t1080r1957b1170],
40	function	NN	O	function	dep	121	SENT_188	[p12l1360t1080r1957b1170],
41	allele	NN	O	allele	dep	121	SENT_188	[p12l1982t1080r2151b1147],
42	noncarriers	NNS	O	noncarrier	dep	121	SENT_188	[p12l9t1184r411b1267],
43	)	VBP	O	)	dep	121	SENT_188	[p12l9t1184r411b1267],
44	(	CD	NUMBER	(	dep	121	SENT_188	[p12l466t1184r535b1267],
45	n	NN	O	n	dep	121	SENT_188	[p12l466t1184r535b1267],
46	=	JJ	O	=	dep	121	SENT_188	[p12l593t1212r646b1233],
47	42	CD	NUMBER	42	dep	121	SENT_188	[p12l704t1184r834b1268],
48	)	NN	O	)	dep	121	SENT_188	[p12l704t1184r834b1268],
49	,	,	O	,	_	0	SENT_188	[p12l704t1184r834b1268],
50	intermediate	JJ	O	intermediate	dep	121	SENT_188	[p12l886t1187r1317b1253],
51	metabolizers	NNS	O	metabolizer	dep	121	SENT_188	[p12l1367t1187r1795b1253],
52	(	VBP	O	(	dep	121	SENT_188	[p12l1848t1184r1940b1267],
53	*	NN	O	*	dep	121	SENT_188	[p12l1848t1184r1940b1267],
54	2	CD	NUMBER	2	dep	121	SENT_188	[p12l1848t1184r1940b1267],
55	lossof-function	JJ	O	lossof-function	dep	121	SENT_188	[p12l1987t1187r2149b1253, p12l9t1293r415b1360],
56	allele	NN	O	allele	dep	121	SENT_188	[p12l440t1293r618b1360],
57	carriers	NNS	O	carrier	dep	121	SENT_188	[p12l643t1293r999b1360],
58	/	:	O	/	dep	121	SENT_188	[p12l643t1293r999b1360],
59	*	CD	NUMBER	*	dep	121	SENT_188	[p12l643t1293r999b1360],
60	]	NN	O	]	dep	121	SENT_188	[p12l643t1293r999b1360],
61	7	CD	NUMBER	7	dep	121	SENT_188	[p12l1015t1299r1052b1360],
62	gain	NN	O	gain	dep	121	SENT_188	[p12l1070t1293r1667b1383],
63	—	NN	O	—	dep	121	SENT_188	[p12l1070t1293r1667b1383],
64	of	IN	O	of	dep	121	SENT_188	[p12l1070t1293r1667b1383],
65	—	CD	NUMBER	—	dep	121	SENT_188	[p12l1070t1293r1667b1383],
66	function	NN	O	function	dep	121	SENT_188	[p12l1070t1293r1667b1383],
67	allele	NN	O	allele	dep	121	SENT_188	[p12l1693t1294r1870b1360],
68	carriers	NNS	O	carrier	dep	121	SENT_188	[p12l1896t1296r2150b1360],
69	or	CC	O	or	dep	121	SENT_188	[p12l9t1425r83b1466],
70	*	NN	O	*	dep	121	SENT_188	[p12l153t1403r218b1466],
71	2	CD	NUMBER	2	dep	121	SENT_188	[p12l153t1403r218b1466],
72	loss-of	JJ	O	loss-of	dep	121	SENT_188	[p12l283t1399r886b1466],
73	—	NN	O	—	dep	121	SENT_188	[p12l283t1399r886b1466],
74	function	NN	O	function	dep	121	SENT_188	[p12l283t1399r886b1466],
75	allele	NN	O	allele	dep	121	SENT_188	[p12l954t1399r1141b1466],
76	noncarriers	NNS	O	noncarrier	dep	121	SENT_188	[p12l1208t1399r1783b1466],
77	/	:	O	/	dep	121	SENT_188	[p12l1208t1399r1783b1466],
78	*	CD	NUMBER	*	dep	121	SENT_188	[p12l1208t1399r1783b1466],
79	17	CD	NUMBER	17	dep	121	SENT_188	[p12l1208t1399r1783b1466],
80	gain	NN	O	gain	dep	121	SENT_188	[p12l1843t1399r2149b1489],
81	—	NN	O	—	dep	121	SENT_188	[p12l1843t1399r2149b1489],
82	of	IN	O	of	dep	121	SENT_188	[p12l1843t1399r2149b1489],
83	—	CD	NUMBER	—	dep	121	SENT_188	[p12l1843t1399r2149b1489],
84	function	NN	O	function	dep	121	SENT_188	[p12l8t1505r306b1572],
85	allele	NN	O	allele	dep	121	SENT_188	[p12l332t1506r509b1572],
86	noncarriers	NNS	O	noncarrier	dep	121	SENT_188	[p12l535t1503r956b1586],
87	)	VBP	O	)	dep	121	SENT_188	[p12l535t1503r956b1586],
88	(	CD	NUMBER	(	dep	121	SENT_188	[p12l987t1504r1058b1586],
89	n	NN	O	n	dep	121	SENT_188	[p12l987t1504r1058b1586],
90	=	JJ	O	=	dep	121	SENT_188	[p12l1090t1531r1144b1552],
91	107	CD	NUMBER	107	dep	121	SENT_188	[p12l1181t1504r1357b1587],
92	)	NN	O	)	dep	121	SENT_188	[p12l1181t1504r1357b1587],
93	,	,	O	,	_	0	SENT_188	[p12l1181t1504r1357b1587],
94	and	CC	O	and	dep	121	SENT_188	[p12l1385t1505r1514b1572],
95	ultrametabolizers	NNS	O	ultrametabolizer	dep	121	SENT_188	[p12l1536t1505r2150b1572],
96	(	VBP	O	(	dep	121	SENT_188	[p12l11t1610r106b1693],
97	*	NN	O	*	dep	121	SENT_188	[p12l11t1610r106b1693],
98	2	CD	NUMBER	2	dep	121	SENT_188	[p12l11t1610r106b1693],
99	loss	NN	O	loss	dep	121	SENT_188	[p12l142t1612r718b1679],
100	—	NN	O	—	dep	121	SENT_188	[p12l142t1612r718b1679],
101	of	IN	O	of	dep	121	SENT_188	[p12l142t1612r718b1679],
102	—	CD	NUMBER	—	dep	121	SENT_188	[p12l142t1612r718b1679],
103	function	NN	O	function	dep	121	SENT_188	[p12l142t1612r718b1679],
104	allele	NN	O	allele	dep	121	SENT_188	[p12l757t1612r934b1679],
105	noncarriers	NNS	O	noncarrier	dep	121	SENT_188	[p12l974t1612r1522b1679],
106	/	:	O	/	dep	121	SENT_188	[p12l974t1612r1522b1679],
107	*	CD	NUMBER	*	dep	121	SENT_188	[p12l974t1612r1522b1679],
108	17	CD	NUMBER	17	dep	121	SENT_188	[p12l974t1612r1522b1679],
109	gain	NN	O	gain	dep	121	SENT_188	[p12l1555t1612r2152b1702],
110	—	NN	O	—	dep	121	SENT_188	[p12l1555t1612r2152b1702],
111	of	IN	O	of	dep	121	SENT_188	[p12l1555t1612r2152b1702],
112	—	CD	NUMBER	—	dep	121	SENT_188	[p12l1555t1612r2152b1702],
113	function	NN	O	function	dep	121	SENT_188	[p12l1555t1612r2152b1702],
114	allele	NN	O	allele	dep	121	SENT_188	[p12l9t1719r187b1785],
115	carriers	NNS	O	carrier	dep	121	SENT_188	[p12l222t1716r503b1799],
116	)	VBP	O	)	dep	121	SENT_188	[p12l222t1716r503b1799],
117	(	CD	NUMBER	(	dep	121	SENT_188	[p12l544t1716r614b1799],
118	n	NN	O	n	dep	121	SENT_188	[p12l544t1716r614b1799],
119	=	JJ	O	=	dep	121	SENT_188	[p12l655t1744r709b1765],
120	64	CD	NUMBER	64	dep	121	SENT_188	[p12l753t1716r885b1799],
121	)	NN	O	)	_	0	SENT_188	[p12l753t1716r885b1799],
122	.	.	O	.	_	0	SENT_188	[p12l753t1716r885b1799],

1	This	DT	O	this	det	2	SENT_189	[p12l95t1824r259b1892],
2	classiﬁcation	NN	O	classiﬁcation	nsubjpass	4	SENT_189	[p12l311t1825r761b1892],
3	was	VBD	O	be	auxpass	4	SENT_189	[p12l807t1852r937b1892],
4	associated	VBN	O	associate	_	0	SENT_189	[p12l990t1825r1344b1892],
5	with	IN	O	with	_	0	SENT_189	[p12l1390t1826r1552b1892],
6	the	DT	O	the	det	8	SENT_189	[p12l1601t1825r1712b1892],
7	mean	NN	O	mean	nn	8	SENT_189	[p12l1764t1852r1955b1892],
8	PR1	NN	O	pr1	prep_with	4	SENT_189	[p12l2006t1826r2150b1891],

1	VASP	NN	ORGANIZATION	vasp	nn	2	SENT_190	[p12l8t1931r237b1999],
2	Values	NNS	O	value	nsubj	4	SENT_190	[p12l260t1933r473b1999],
3	and	CC	O	and	dep	4	SENT_190	[p12l503t1933r631b1999],
4	with	IN	O	with	_	0	SENT_190	[p12l652t1933r815b1999],
5	the	DT	O	the	det	6	SENT_190	[p12l840t1932r951b1999],
6	incidence	NN	O	incidence	pobj	4	SENT_190	[p12l978t1932r1313b1999],
7	of	IN	O	of	_	0	SENT_190	[p12l1341t1932r1421b1999],
8	HTPR	NN	O	htpr	prep_of	6	SENT_190	[p12l1436t1931r1690b1998],
9	on	IN	O	on	_	0	SENT_190	[p12l1714t1959r1802b1999],
10	prasugrel	NN	O	prasugrel	prep_on	4	SENT_190	[p12l1827t1933r2153b2022],
11	10	CD	NUMBER	10	num	14	SENT_190	[p12l12t2042r93b2105],
12	mg	NN	O	mg	nn	14	SENT_190	[p12l125t2065r238b2128],
13	(	NN	O	(	nn	14	SENT_190	[p12l270t2036r464b2128],
14	Figs	NNS	O	fig	dep	10	SENT_190	[p12l270t2036r464b2128],
15	.	.	O	.	_	0	SENT_190	[p12l270t2036r464b2128],

1	4A	NN	O	4a	_	0	SENT_191	[p12l499t2037r608b2104],
2	and	CC	O	and	_	0	SENT_191	[p12l639t2039r767b2105],
3	4B	NN	O	4b	conj_and	1	SENT_191	[p12l796t2037r944b2119],
4	)	NN	O	)	dep	1	SENT_191	[p12l796t2037r944b2119],
5	.	.	O	.	_	0	SENT_191	[p12l796t2037r944b2119],

1	Indeed	RB	O	indeed	advmod	11	SENT_192	[p12l979t2038r1246b2120],
2	,	,	O	,	_	0	SENT_192	[p12l979t2038r1246b2120],
3	the	DT	O	the	det	4	SENT_192	[p12l1280t2038r1390b2105],
4	rate	NN	O	rate	nsubj	11	SENT_192	[p12l1422t2056r1553b2105],
5	of	IN	O	of	_	0	SENT_192	[p12l1585t2038r1665b2105],
6	patients	NNS	O	patient	prep_of	4	SENT_192	[p12l1683t2041r1961b2128],
7	with	IN	O	with	_	0	SENT_192	[p12l1990t2039r2152b2105],
8	HTPR	NN	O	htpr	prep_with	6	SENT_192	[p12l9t2143r263b2210],
9	was	VBD	O	be	cop	11	SENT_192	[p12l286t2171r416b2211],
10	19	CD	PERCENT	19	num	11	SENT_192	[p12l453t2148r601b2211],
11	%	NN	PERCENT	%	dep	15	SENT_192	[p12l453t2148r601b2211],
12	in	IN	O	in	_	0	SENT_192	[p12l632t2148r700b2210],
13	poor	JJ	O	poor	amod	14	SENT_192	[p12l728t2170r894b2234],
14	metabolizers	NNS	O	metabolizer	prep_in	11	SENT_192	[p12l923t2145r1369b2211],
15	(	VBP	O	(	_	0	SENT_192	[p12l1404t2142r1475b2225],
16	n	NN	O	n	dobj	15	SENT_192	[p12l1404t2142r1475b2225],
17	=	JJ	O	=	amod	16	SENT_192	[p12l1514t2170r1567b2191],
18	8	CD	NUMBER	8	tmod	17	SENT_192	[p12l1609t2148r1644b2211],
19	of	IN	O	of	_	0	SENT_192	[p12l1678t2144r1759b2211],
20	42	CD	NUMBER	42	num	21	SENT_192	[p12l1776t2143r1912b2225],
21	)	CD	NUMBER	)	prep_of	16	SENT_192	[p12l1776t2143r1912b2225],
22	,	,	O	,	_	0	SENT_192	[p12l1776t2143r1912b2225],
23	6	CD	PERCENT	6	number	24	SENT_192	[p12l1947t2148r2053b2211],
24	%	NN	PERCENT	%	amod	16	SENT_192	[p12l1947t2148r2053b2211],
25	in	IN	O	in	_	0	SENT_192	[p12l2083t2147r2151b2210],
26	1284	CD	DATE	1284	prep_in	15	SENT_192	[p12l9t2248r151b2292],
27	Cuisset	NNP	O	Cuisset	nsubj	15	SENT_192	[p12l330t2248r522b2292],
28	et	FW	O	et	nn	29	SENT_192	[p12l543t2251r595b2292],
29	al.	FW	O	al.	dep	27	SENT_192	[p12l613t2249r672b2292],
30	.	.	O	.	_	0	SENT_192	[p12l613t2249r672b2292],

1	Genetic	JJ	O	genetic	_	0	SENT_193	[p12l330t2330r531b2374],
2	and	CC	O	and	_	0	SENT_193	[p12l552t2331r648b2374],
3	Prasugrel	NNP	O	Prasugrel	nn	5	SENT_193	[p12l674t2331r922b2385],
4	Response	NNP	O	Response	nn	5	SENT_193	[p12l948t2331r1205b2384],
5	p	NN	O	p	conj_and	1	SENT_193	[p13l744t304r964b375],
6	=	JJ	O	=	amod	8	SENT_193	[p13l744t304r964b375],
7	1D	NN	O	1d	nn	8	SENT_193	[p13l744t304r964b375],
8	.0	NN	NUMBER	.0	dep	1	SENT_193	[p13l744t304r964b375],
9	=	JJ	O	=	amod	8	SENT_193	[p13l744t304r964b375],
10	2	CD	NUMBER	2	tmod	9	SENT_193	[p13l744t304r964b375],

1	ha	NN	O	ha	_	0	SENT_194	[p13l194t426r223b468],
2	ﬂ	SYM	O	ﬂ	dep	1	SENT_194	[p13l223t426r252b468],

1	@	IN	O	@	_	0	SENT_195	[p13l1483t808r1580b863],
2	I	PRP	O	I	pobj	1	SENT_195	[p13l1483t808r1580b863],
3	+	CC	O	+	_	0	SENT_195	[p13l1483t808r1580b863],
4	*	CD	NUMBER	*	num	5	SENT_195	[p13l1618t808r1708b856],
5	1	CD	NUMBER	1	conj_+	2	SENT_195	[p13l1618t808r1708b856],
6	?	.	O	?	_	0	SENT_195	[p13l1618t808r1708b856],

1	Carriers	NNS	O	carrier	nsubj	2	SENT_196	[p13l1731t808r1950b857],
2	м	VBP	O	м	_	0	SENT_196	[p13l1483t895r1580b950],
3	I	PRP	O	I	dobj	2	SENT_196	[p13l1483t895r1580b950],
4	+	CC	O	+	_	0	SENT_196	[p13l1483t895r1580b950],
5	*	CD	NUMBER	*	num	6	SENT_196	[p13l1618t895r1708b941],
6	1	CD	NUMBER	1	dobj	2	SENT_196	[p13l1618t895r1708b941],
7	?	.	O	?	_	0	SENT_196	[p13l1618t895r1708b941],

1	NU	NNP	O	NU	nn	3	SENT_197	[p13l1731t895r2076b941],
2	’	CD	NUMBER	’	num	3	SENT_197	[p13l1731t895r2076b941],
3	l’i1Cai	NN	O	l’i1cai	_	0	SENT_197	[p13l1731t895r2076b941],
4	‘	CD	NUMBER	‘	num	5	SENT_197	[p13l1731t895r2076b941],
5	Fi	NN	O	fus	dep	3	SENT_197	[p13l1731t895r2076b941],
6	»	CD	NUMBER	»	num	7	SENT_197	[p13l1731t895r2076b941],
7	EfS	NNS	O	ef	dep	3	SENT_197	[p13l1731t895r2076b941],

1	lni	NNS	O	lnus	_	0	SENT_198	[p13l81t1367r126b1645],
2	:	:	O	:	_	0	SENT_198	[p13l81t1367r126b1645],
3	:	:	O	:	_	0	SENT_198	[p13l81t1367r126b1645],
4	Id	NN	O	id	dep	12	SENT_198	[p13l81t1367r126b1645],
5	;	:	O	;	_	0	SENT_198	[p13l81t1367r126b1645],
6	en	IN	O	en	dep	4	SENT_198	[p13l81t1367r126b1645],
7	»	CD	NUMBER	»	num	8	SENT_198	[p13l81t1367r126b1645],
8	ea	NN	O	ea	pobj	6	SENT_198	[p13l81t1367r126b1645],
9	of	IN	O	of	_	0	SENT_198	[p13l81t1285r126b1342],
10	‘	CD	NUMBER	‘	prep_of	8	SENT_198	[p13l81t1076r139b1266],
11	Hyper	NNP	O	Hyper	nn	12	SENT_198	[p13l81t1076r139b1266],
12	Response	NNP	O	Response	dep	1	SENT_198	[p13l81t753r139b1056],
13	‘	CD	NUMBER	‘	number	14	SENT_198	[p13l81t753r139b1056],
14	[	CD	NUMBER	[	num	15	SENT_198	[p13l81t612r139b728],
15	PR1	NN	O	pr1	dep	12	SENT_198	[p13l81t612r139b728],
16	‘	CD	NUMBER	‘	num	17	SENT_198	[p13l81t420r126b586],
17	U'AS	NN	O	u'a	dep	15	SENT_198	[p13l81t420r126b586],
18	.	.	O	.	_	0	SENT_198	[p13l81t420r126b586],

1	F	NN	O	f	_	0	SENT_199	[p13l81t420r126b586],
2	‘	CD	NUMBER	‘	number	3	SENT_199	[p13l81t420r126b586],
3	4	CD	NUMBER	4	dep	1	SENT_199	[p13l87t368r120b401],
4	:	:	O	:	_	0	SENT_199	[p13l87t368r120b401],
5	117	CD	PERCENT	117	num	6	SENT_199	[p13l81t201r139b342],
6	%	NN	PERCENT	%	dep	3	SENT_199	[p13l81t201r139b342],
7	]	CD	NUMBER	]	dep	6	SENT_199	[p13l81t201r139b342],

1	E	NN	O	e	_	0	SENT_200	[p13l223t1509r252b1551],

1	*	NN	O	*	_	0	SENT_201	[p13l422t1564r500b1609],
2	1	CD	NUMBER	1	dep	1	SENT_201	[p13l422t1564r500b1609],
3	?	.	O	?	_	0	SENT_201	[p13l422t1564r500b1609],

1	carriers	NNS	O	carrier	nsubj	2	SENT_202	[p13l519t1564r732b1609],
2	*	VBP	O	*	_	0	SENT_202	[p13l915t1564r996b1609],
3	1	CD	NUMBER	1	dobj	2	SENT_202	[p13l915t1564r996b1609],
4	?	.	O	?	_	0	SENT_202	[p13l915t1564r996b1609],

1	Non	NNP	O	Non	_	0	SENT_203	[p13l1015t1564r1119b1609],
2	:	:	O	:	_	0	SENT_203	[p13l1015t1564r1119b1609],
3	Carriers	NNS	O	carrier	dep	1	SENT_203	[p13l1129t1536r1351b1609],

1	Figure	NNP	O	Figure	_	0	SENT_204	[p13l63t1782r232b1838],
2	3	CD	NUMBER	3	dep	1	SENT_204	[p13l255t1782r306b1827],
3	.	.	O	.	_	0	SENT_204	[p13l255t1782r306b1827],

1	Incidence	NN	O	incidence	_	0	SENT_205	[p13l333t1782r590b1827],
2	of	IN	O	of	_	0	SENT_205	[p13l612t1782r664b1827],
3	Hyper-Response	NNP	O	Hyper-Response	prep_of	1	SENT_205	[p13l684t1783r1112b1838],
4	According	VBG	O	accord	prep	3	SENT_205	[p13l1132t1782r1405b1838],
5	to	TO	O	to	pcomp	4	SENT_205	[p13l1423t1784r1478b1827],
6	CYP2C19	NN	O	cyp2c19	pobj	5	SENT_205	[p13l1503t1782r1765b1827],
7	*	CD	NUMBER	*	num	6	SENT_205	[p13l1773t1783r1877b1826],
8	17	CD	NUMBER	17	num	10	SENT_205	[p13l1773t1783r1877b1826],
9	Status	NNP	O	Status	nn	10	SENT_205	[p13l1890t1782r2066b1827],
10	Incidence	NN	O	incidence	dep	1	SENT_205	[p13l64t1916r311b1961],
11	of	IN	O	of	_	0	SENT_205	[p13l336t1915r389b1961],
12	hyper-response	JJ	O	hyper-response	prep_of	10	SENT_205	[p13l412t1916r814b1974],
13	deﬁned	VBN	O	deﬁned	partmod	12	SENT_205	[p13l839t1915r1034b1961],
14	as	IN	O	as	_	0	SENT_205	[p13l1060t1929r1111b1961],
15	PRI	NNP	O	PRI	nn	16	SENT_205	[p13l1138t1917r1212b1961],
16	VASP	NN	O	vasp	prep_as	13	SENT_205	[p13l1237t1917r1372b1961],
17	<	JJR	O	<	amod	16	SENT_205	[p13l1400t1918r1560b1961],
18	17	CD	PERCENT	17	num	19	SENT_205	[p13l1400t1918r1560b1961],
19	%	NN	PERCENT	%	dep	17	SENT_205	[p13l1400t1918r1560b1961],
20	according	VBG	O	accord	_	0	SENT_205	[p13l1584t1916r1839b1974],
21	to	TO	O	to	prepc_according_to	13	SENT_205	[p13l1864t1922r1917b1961],
22	CYP2C19	NN	O	cyp2c19	pobj	13	SENT_205	[p13l62t2002r375b2046],
23	*	CD	NUMBER	*	number	24	SENT_205	[p13l62t2002r375b2046],
24	17	CD	NUMBER	17	num	25	SENT_205	[p13l62t2002r375b2046],
25	status	NN	O	status	dep	22	SENT_205	[p13l396t2007r547b2046],
26	(	CD	NUMBER	(	num	28	SENT_205	[p13l575t2002r666b2053],
27	PRI	NNP	O	PRI	nn	28	SENT_205	[p13l575t2002r666b2053],
28	VASP	NN	O	vasp	dep	22	SENT_205	[p13l691t2002r826b2046],
29	<	JJR	O	<	amod	31	SENT_205	[p13l855t2001r1017b2046],
30	75th	JJ	ORDINAL	75th	amod	31	SENT_205	[p13l855t2001r1017b2046],
31	percentile	NN	O	percentile	dep	28	SENT_205	[p13l1046t2001r1316b2058],
32	,	,	O	,	_	0	SENT_205	[p13l1046t2001r1316b2058],
33	quartile	JJ	O	quartile	amod	35	SENT_205	[p13l1341t2001r1539b2058],
34	repartition	NN	O	repartition	nn	35	SENT_205	[p13l1566t2002r1869b2058],
35	)	NN	O	)	appos	22	SENT_205	[p13l1566t2002r1869b2058],
36	.	.	O	.	_	0	SENT_205	[p13l1566t2002r1869b2058],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_206	[p13l1893t2001r2071b2046, p13l60t2088r262b2131],
2	as	IN	O	as	prep	1	SENT_206	[p13l287t2099r338b2131],
3	in	IN	O	in	pcomp	2	SENT_206	[p13l364t2088r406b2131],
4	Figure	NNP	O	Figure	pobj	3	SENT_206	[p13l435t2088r595b2144],
5	1	CD	NUMBER	1	num	4	SENT_206	[p13l625t2090r661b2131],
6	.	.	O	.	_	0	SENT_206	[p13l625t2090r661b2131],

1	intermediate	JJ	O	intermediate	amod	2	SENT_207	[p13l8t2327r458b2394],
2	metabolizers	NNS	O	metabolizer	nsubj	3	SENT_207	[p13l515t2327r962b2394],
3	(	VBP	O	(	_	0	SENT_207	[p13l1022t2325r1093b2408],
4	n	NN	O	n	dobj	3	SENT_207	[p13l1022t2325r1093b2408],
5	=	JJ	O	=	amod	4	SENT_207	[p13l1157t2353r1211b2374],
6	6	CD	NUMBER	6	tmod	5	SENT_207	[p13l1277t2331r1314b2394],
7	of	IN	O	of	_	0	SENT_207	[p13l1373t2327r1453b2394],
8	107	CD	NUMBER	107	num	9	SENT_207	[p13l1501t2325r1676b2408],
9	)	NN	O	)	prep_of	4	SENT_207	[p13l1501t2325r1676b2408],
10	,	,	O	,	_	0	SENT_207	[p13l1501t2325r1676b2408],
11	and	CC	O	and	_	0	SENT_207	[p13l1736t2327r1864b2394],
12	1	CD	PERCENT	1	num	13	SENT_207	[p13l1924t2330r2028b2394],
13	%	NN	PERCENT	%	dep	19	SENT_207	[p13l1924t2330r2028b2394],
14	in	IN	O	in	_	0	SENT_207	[p13l2083t2330r2152b2393],
15	ultrametabolizers	NNS	O	ultrametabolizer	prep_in	13	SENT_207	[p13l7t2434r621b2500],
16	(	CD	NUMBER	(	num	17	SENT_207	[p13l657t2432r727b2514],
17	n	NN	O	n	dep	19	SENT_207	[p13l657t2432r727b2514],
18	=	JJ	O	=	amod	19	SENT_207	[p13l767t2460r820b2480],
19	1	CD	NUMBER	1	dep	24	SENT_207	[p13l865t2438r896b2499],
20	of	IN	O	of	_	0	SENT_207	[p13l933t2434r1014b2500],
21	64	CD	NUMBER	64	num	22	SENT_207	[p13l1034t2432r1144b2514],
22	)	CD	NUMBER	)	prep_of	19	SENT_207	[p13l1034t2432r1144b2514],
23	(	CD	NUMBER	(	num	24	SENT_207	[p13l1182t2432r1344b2523],
24	Fig	NN	O	fig	conj_and	3	SENT_207	[p13l1182t2432r1344b2523],
25	.	.	O	.	_	0	SENT_207	[p13l1182t2432r1344b2523],

1	4B	NN	O	4b	_	0	SENT_208	[p13l1379t2432r1506b2514],
2	)	CD	NUMBER	)	num	4	SENT_208	[p13l1379t2432r1506b2514],
3	(	NN	O	(	nn	4	SENT_208	[p13l1543t2432r1611b2524],
4	p	NN	O	p	dep	1	SENT_208	[p13l1543t2432r1611b2524],
5	=	JJ	O	=	amod	7	SENT_208	[p13l1651t2460r1705b2480],
6	0.002	CD	NUMBER	0.002	tmod	5	SENT_208	[p13l1746t2432r1991b2515],
7	)	NN	O	)	dep	4	SENT_208	[p13l1746t2432r1991b2515],
8	.	.	O	.	_	0	SENT_208	[p13l1746t2432r1991b2515],

1	For	IN	O	for	_	0	SENT_209	[p13l2027t2435r2153b2500],
2	the	DT	O	the	det	3	SENT_209	[p13l8t2540r119b2606],
3	rate	NN	O	rate	prep_for	8	SENT_209	[p13l169t2557r300b2606],
4	of	IN	O	of	_	0	SENT_209	[p13l351t2540r431b2606],
5	hyper-response	NN	O	hyper-response	prep_of	3	SENT_209	[p13l468t2540r1031b2630],
6	,	,	O	,	_	0	SENT_209	[p13l468t2540r1031b2630],
7	we	PRP	O	we	nsubj	8	SENT_209	[p13l1079t2566r1178b2606],
8	observed	VBD	O	observe	_	0	SENT_209	[p13l1230t2540r1540b2606],
9	a	DT	O	a	det	10	SENT_209	[p13l1589t2566r1624b2606],
10	trend	NN	O	trend	dobj	8	SENT_209	[p13l1672t2540r1861b2606],
11	with	IN	O	with	_	0	SENT_209	[p13l1906t2540r2068b2607],
12	a	DT	O	a	det	15	SENT_209	[p13l2119t2566r2153b2606],
13	numerically	RB	O	numerically	advmod	14	SENT_209	[p13l9t2647r426b2736],
14	higher	JJR	O	higher	amod	15	SENT_209	[p13l460t2647r691b2736],
15	rate	NN	O	rate	prep_with	8	SENT_209	[p13l727t2664r858b2713],
16	of	IN	O	of	_	0	SENT_209	[p13l898t2647r978b2713],
17	hyper-response	NN	O	hyper-response	prep_of	15	SENT_209	[p13l1004t2647r1546b2737],
18	of	IN	O	of	_	0	SENT_209	[p13l1586t2647r1667b2713],
19	14	CD	PERCENT	14	num	20	SENT_209	[p13l1697t2650r1845b2713],
20	%	NN	PERCENT	%	prep_of	17	SENT_209	[p13l1697t2650r1845b2713],
21	in	IN	O	in	_	0	SENT_209	[p13l1883t2650r1952b2712],
22	poor	JJ	O	poor	prep_in	8	SENT_209	[p13l1989t2673r2153b2737],

1	A	DT	O	a	det	2	SENT_210	[p14l81t170r165b260],
2	p	NN	O	p	_	0	SENT_210	[p14l860t170r1071b225],
3	=	JJ	O	=	dep	2	SENT_210	[p14l860t170r1071b225],
4	U.	NNP	O	U.	nn	5	SENT_210	[p14l860t170r1071b225],
5	|	NNP	O	|	dep	2	SENT_210	[p14l860t170r1071b225],
6	.	.	O	.	_	0	SENT_210	[p14l860t170r1071b225],
7	'	''	O	'	_	0	SENT_210	[p14l860t170r1071b225],

1	J05	NN	O	j05	_	0	SENT_211	[p14l860t170r1071b225],

1	FRI	NNP	DATE	FRI	nn	2	SENT_212	[p14l97t840r136b917],
2	VASP	NN	ORGANIZATION	vasp	_	0	SENT_212	[p14l97t688r136b821],
3	(	CD	NUMBER	(	number	4	SENT_212	[p14l97t621r146b673],
4	‘	CD	NUMBER	‘	dep	2	SENT_212	[p14l97t621r146b673],
5	"	``	O	"	punct	7	SENT_212	[p14l97t621r146b673],
6	35	CD	NUMBER	35	num	7	SENT_212	[p14l97t621r146b673],
7	}	NN	O	}	dep	4	SENT_212	[p14l97t592r146b605],

1	iP	NN	O	ip	nn	3	SENT_213	[p14l297t1255r690b1293],
2	«	CD	NUMBER	«	num	3	SENT_213	[p14l297t1255r690b1293],
3	oo	NN	O	oo	_	0	SENT_213	[p14l297t1255r690b1293],
4	:	:	O	:	_	0	SENT_213	[p14l297t1255r690b1293],
5	riMetaibelEe_r-3	NN	O	rimetaibelee_r-3	dep	3	SENT_213	[p14l297t1255r690b1293],
6	Interrnedi	NNP	O	Interrnedi	dep	5	SENT_213	[p14l719t1234r1284b1293],
7	?	.	O	?	_	0	SENT_213	[p14l719t1234r1284b1293],

1	ateNMfetaboliizers	NNS	O	atenmfetaboliizer	_	0	SENT_214	[p14l719t1234r1284b1293],
2	LI‘iItra	NNP	O	LI‘iItra	nn	4	SENT_214	[p14l1319t1255r1419b1293],
3	Metabolizers	NNPS	O	Metabolizers	nn	4	SENT_214	[p14l1435t1234r1709b1293],
4	p	NN	O	p	dep	1	SENT_214	[p14l783t1344r1005b1403],
5	=	JJ	O	=	amod	6	SENT_214	[p14l783t1344r1005b1403],
6	D.	NNP	O	D.	dep	4	SENT_214	[p14l783t1344r1005b1403],
7	0	CD	NUMBER	0	num	9	SENT_214	[p14l783t1344r1005b1403],
8	~	NN	O	~	nn	9	SENT_214	[p14l783t1344r1005b1403],
9	ﬂ21	NN	O	ﬂ21	dep	1	SENT_214	[p14l783t1344r1005b1403],

1	-	:	O	-	_	0	SENT_215	[p14l1390t1612r1467b1657],
2	Peer	NNP	O	Peer	nn	3	SENT_215	[p14l1499t1612r1606b1653],
3	Mietabelizers	NNP	PERCENT	Mietabelizers	dep	9	SENT_215	[p14l1625t1612r1908b1653],
4	%	NN	PERCENT	%	prep	3	SENT_215	[p14l1389t1683r1467b1728],
5	lntemmediate	JJ	O	lntemmediate	amod	6	SENT_215	[p14l1499t1686r1780b1725],
6	Metaibolizers	NNS	O	metaibolizer	dep	4	SENT_215	[p14l1798t1686r2085b1725],
7	2	CD	NUMBER	2	num	9	SENT_215	[p14l1390t1756r1467b1802],
8	Ultra	NNP	O	Ultra	nn	9	SENT_215	[p14l1502t1757r1599b1796],
9	Metabolizers	NNPS	O	Metabolizers	_	0	SENT_215	[p14l1619t1756r1902b1796],

1	Incidence	NN	O	incidence	_	0	SENT_216	[p14l78t1902r114b2111],
2	of	IN	O	of	_	0	SENT_216	[p14l78t1840r114b1883],
3	HTPR	NN	O	htpr	prep_of	1	SENT_216	[p14l78t1699r114b1824],

1	[	RB	O	[	dep	2	SENT_217	[p14l136t1992r181b2085],
2	FRI	NNP	DATE	FRI	dep	3	SENT_217	[p14l136t1992r181b2085],
3	VASP	NN	O	vasp	_	0	SENT_217	[p14l136t1725r181b1979],
4	:	:	O	:	_	0	SENT_217	[p14l136t1725r181b1979],
5	-50	CD	PERCENT	-50	num	6	SENT_217	[p14l136t1725r181b1979],
6	%	NN	PERCENT	%	dep	3	SENT_217	[p14l136t1725r181b1979],
7	)	CD	NUMBER	)	dep	6	SENT_217	[p14l136t1725r181b1979],

1	Figure	NNP	O	Figure	_	0	SENT_218	[p14l63t2378r232b2433],
2	4	CD	NUMBER	4	dep	1	SENT_218	[p14l255t2378r307b2422],
3	.	.	O	.	_	0	SENT_218	[p14l255t2378r307b2422],

1	Prasugrel	NNP	O	Prasugrel	nn	2	SENT_219	[p14l335t2378r594b2433],
2	Response	NNP	O	Response	_	0	SENT_219	[p14l622t2378r890b2433],
3	According	VBG	O	accord	_	0	SENT_219	[p14l912t2378r1195b2433],
4	to	TO	O	to	prepc_according_to	2	SENT_219	[p14l1215t2379r1271b2423],
5	Genotype	NNP	O	Genotype	nn	6	SENT_219	[p14l1295t2378r1556b2433],
6	Group	NNP	O	Group	pobj	2	SENT_219	[p14l1580t2378r1741b2433],

1	Values	NNS	O	value	_	0	SENT_220	[p14l59t2511r228b2557],
2	of	IN	O	of	_	0	SENT_220	[p14l253t2510r306b2557],
3	PRI	NNP	ORGANIZATION	PRI	nn	4	SENT_220	[p14l329t2513r402b2556],
4	VASP	NN	ORGANIZATION	vasp	prep_of	1	SENT_220	[p14l427t2513r563b2557],
5	on	IN	O	on	_	0	SENT_220	[p14l588t2524r651b2557],
6	prasugrel	NN	O	prasugrel	nn	10	SENT_220	[p14l680t2511r919b2570],
7	10	CD	NUMBER	10	num	10	SENT_220	[p14l950t2514r1006b2557],
8	mg	NN	O	mg	nn	10	SENT_220	[p14l1033t2524r1112b2569],
9	(	NN	O	(	nn	10	SENT_220	[p14l1140t2512r1214b2563],
10	A	NN	O	a	prep_on	4	SENT_220	[p14l1140t2512r1214b2563],
11	)	NN	O	)	dep	20	SENT_220	[p14l1140t2512r1214b2563],
12	and	CC	O	and	_	0	SENT_220	[p14l1240t2511r1334b2557],
13	incidence	NN	O	incidence	dep	20	SENT_220	[p14l1363t2511r1610b2557],
14	of	IN	O	of	_	0	SENT_220	[p14l1635t2510r1688b2557],
15	prasugrel	NN	O	prasugrel	nn	17	SENT_220	[p14l1711t2511r1949b2569],
16	low	JJ	O	low	amod	17	SENT_220	[p14l1979t2511r2069b2557],
17	response	NN	O	response	prep_of	11	SENT_220	[p14l64t2610r295b2654],
18	(	CD	NUMBER	(	num	19	SENT_220	[p14l322t2597r473b2649],
19	HTPR	NN	O	htpr	nsubj	20	SENT_220	[p14l322t2597r473b2649],
20	deﬁned	VBN	O	deﬁned	rcmod	1	SENT_220	[p14l498t2595r692b2642],
21	as	IN	O	as	mark	29	SENT_220	[p14l719t2610r770b2642],
22	PRI	NNP	ORGANIZATION	PRI	nn	23	SENT_220	[p14l798t2598r871b2642],
23	VASP	NN	O	vasp	dep	24	SENT_220	[p14l896t2598r1031b2642],
24	>	JJR	O	>	nsubj	29	SENT_220	[p14l1059t2603r1102b2639],
25	50	CD	PERCENT	50	number	26	SENT_220	[p14l1130t2597r1255b2649],
26	%	NN	PERCENT	%	amod	24	SENT_220	[p14l1130t2597r1255b2649],
27	)	CD	NUMBER	)	num	29	SENT_220	[p14l1130t2597r1255b2649],
28	(	NN	O	(	nn	29	SENT_220	[p14l1283t2597r1354b2649],
29	B	NN	O	b	advcl	20	SENT_220	[p14l1283t2597r1354b2649],
30	)	CD	NUMBER	)	nsubj	38	SENT_220	[p14l1283t2597r1354b2649],
31	according	VBG	O	accord	_	0	SENT_220	[p14l1380t2596r1635b2654],
32	to	TO	O	to	prepc_according_to	30	SENT_220	[p14l1660t2603r1713b2642],
33	genotype	NN	O	genotype	nn	34	SENT_220	[p14l1737t2604r1986b2655],
34	groups	NNS	O	group	pobj	30	SENT_220	[p14l62t2695r242b2739],
35	between	IN	O	between	_	0	SENT_220	[p14l269t2681r492b2727],
36	poor	JJ	O	poor	amod	37	SENT_220	[p14l521t2695r642b2739],
37	metabolizers	NNS	O	metabolizer	prep_between	34	SENT_220	[p14l667t2681r998b2727],
38	(	VBP	O	(	rcmod	29	SENT_220	[p14l1025t2682r1095b2734],
39	*	NN	O	*	dobj	38	SENT_220	[p14l1025t2682r1095b2734],
40	2	CD	NUMBER	2	num	41	SENT_220	[p14l1025t2682r1095b2734],
41	carriers	NNS	O	carrier	dep	39	SENT_220	[p14l1119t2683r1418b2729],
42	/	:	O	/	punct	45	SENT_220	[p14l1119t2683r1418b2729],
43	*	CD	NUMBER	*	num	45	SENT_220	[p14l1119t2683r1418b2729],
44	17	CD	NUMBER	17	num	45	SENT_220	[p14l1119t2683r1418b2729],
45	noncarriers	NNS	O	noncarrier	dep	39	SENT_220	[p14l1441t2682r1745b2734],
46	)	CD	NUMBER	)	number	47	SENT_220	[p14l1441t2682r1745b2734],
47	(	CD	NUMBER	(	num	48	SENT_220	[p14l1774t2682r1819b2734],
48	n	NN	O	n	nsubj	55	SENT_220	[p14l1774t2682r1819b2734],
49	=	JJ	O	=	amod	48	SENT_220	[p14l1851t2698r1888b2713],
50	42	CD	NUMBER	42	num	51	SENT_220	[p14l1917t2682r2009b2734],
51	)	NN	O	)	tmod	49	SENT_220	[p14l1917t2682r2009b2734],
52	,	,	O	,	_	0	SENT_220	[p14l1917t2682r2009b2734],
53	intermediate	JJ	O	intermediate	amod	54	SENT_220	[p14l63t2766r396b2812],
54	metabolizers	NNS	O	metabolizer	appos	51	SENT_220	[p14l422t2766r753b2812],
55	(	VBP	O	(	rcmod	45	SENT_220	[p14l780t2767r850b2819],
56	*	NN	O	*	dobj	55	SENT_220	[p14l780t2767r850b2819],
57	2	CD	NUMBER	2	num	58	SENT_220	[p14l780t2767r850b2819],
58	carriers	NNS	O	carrier	dep	56	SENT_220	[p14l874t2768r1174b2814],
59	/	:	O	/	punct	45	SENT_220	[p14l874t2768r1174b2814],
60	*	CD	NUMBER	*	number	61	SENT_220	[p14l874t2768r1174b2814],
61	77	CD	NUMBER	77	num	62	SENT_220	[p14l874t2768r1174b2814],
62	carriers	NNS	O	carrier	dep	39	SENT_220	[p14l1194t2769r1380b2812],
63	and	CC	O	and	_	0	SENT_220	[p14l1406t2766r1500b2812],
64	*	NN	O	*	dep	39	SENT_220	[p14l1529t2768r1580b2811],
65	2	CD	NUMBER	2	num	66	SENT_220	[p14l1529t2768r1580b2811],
66	noncarriers	NNS	O	noncarrier	dep	64	SENT_220	[p14l1606t2768r2008b2814],
67	/	:	O	/	punct	76	SENT_220	[p14l1606t2768r2008b2814],
68	*	CD	NUMBER	*	number	69	SENT_220	[p14l1606t2768r2008b2814],
69	77	CD	NUMBER	77	num	70	SENT_220	[p14l1606t2768r2008b2814],
70	noncarriers	NNS	O	noncarrier	dep	76	SENT_220	[p14l64t2852r368b2904],
71	)	CD	NUMBER	)	number	72	SENT_220	[p14l64t2852r368b2904],
72	(	CD	NUMBER	(	num	73	SENT_220	[p14l397t2852r441b2904],
73	n	NN	O	n	npadvmod	74	SENT_220	[p14l397t2852r441b2904],
74	=	JJ	O	=	amod	70	SENT_220	[p14l473t2869r511b2883],
75	107	CD	NUMBER	107	num	76	SENT_220	[p14l546t2852r664b2904],
76	)	NN	O	)	parataxis	29	SENT_220	[p14l546t2852r664b2904],
77	,	,	O	,	_	0	SENT_220	[p14l546t2852r664b2904],
78	and	CC	O	and	_	0	SENT_220	[p14l689t2851r783b2897],
79	ultrametabolizers	NNS	O	ultrametabolizer	nsubj	80	SENT_220	[p14l812t2851r1264b2897],
80	(	VBP	O	(	rcmod	1	SENT_220	[p14l1291t2852r1361b2904],
81	*	NN	O	*	dobj	80	SENT_220	[p14l1291t2852r1361b2904],
82	2	CD	NUMBER	2	num	83	SENT_220	[p14l1291t2852r1361b2904],
83	noncarriers	NNS	O	noncarrier	dep	81	SENT_220	[p14l1386t2853r1788b2899],
84	/	:	O	/	punct	1	SENT_220	[p14l1386t2853r1788b2899],
85	*	CD	NUMBER	*	number	86	SENT_220	[p14l1386t2853r1788b2899],
86	77	CD	NUMBER	77	num	87	SENT_220	[p14l1386t2853r1788b2899],
87	carriers	NNS	O	carrier	nsubj	88	SENT_220	[p14l1809t2852r2011b2904],
88	)	VBP	O	)	dep	1	SENT_220	[p14l1809t2852r2011b2904],
89	(	CD	NUMBER	(	num	90	SENT_220	[p14l64t2937r108b2989],
90	n	NN	O	n	nsubj	93	SENT_220	[p14l64t2937r108b2989],
91	=	JJ	O	=	amod	93	SENT_220	[p14l140t2953r178b2968],
92	64	CD	NUMBER	64	num	93	SENT_220	[p14l208t2937r299b2989],
93	)	NN	O	)	xcomp	88	SENT_220	[p14l208t2937r299b2989],
94	.	.	O	.	_	0	SENT_220	[p14l208t2937r299b2989],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_221	[p14l324t2936r686b2982],
2	as	IN	O	as	prep	1	SENT_221	[p14l710t2949r761b2982],
3	in	IN	O	in	pcomp	2	SENT_221	[p14l788t2939r830b2981],
4	Figures	NNS	O	figure	pobj	3	SENT_221	[p14l859t2939r1043b2994],
5	1	CD	NUMBER	1	num	4	SENT_221	[p14l1073t2940r1087b2981],
6	and	CC	O	and	_	0	SENT_221	[p14l1121t2936r1216b2982],
7	2	CD	NUMBER	2	conj_and	4	SENT_221	[p14l1243t2940r1284b2982],
8	.	.	O	.	_	0	SENT_221	[p14l1243t2940r1284b2982],

1	JACC	NN	O	jacc	_	0	SENT_222	[p14l315t3218r465b3249],
2	:	:	O	:	_	0	SENT_222	[p14l315t3218r465b3249],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_222	[p14l502t3218r1001b3249],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_222	[p14l1038t3218r1497b3254],
5	,	,	O	,	_	0	SENT_222	[p14l1038t3218r1497b3254],
6	VOL	NNP	O	VOL	appos	4	SENT_222	[p14l1533t3218r1655b3249],
7	.	.	O	.	_	0	SENT_222	[p14l1533t3218r1655b3249],

1	5	CD	NUMBER	5	_	0	SENT_223	[p14l1692t3220r1735b3254],
2	,	,	O	,	_	0	SENT_223	[p14l1692t3220r1735b3254],
3	NO.	NNP	DATE	NO.	appos	1	SENT_223	[p14l1773t3218r1863b3249],
4	12	CD	DATE	12	num	3	SENT_223	[p14l1902t3219r1978b3254],
5	,	,	DATE	,	_	0	SENT_223	[p14l1902t3219r1978b3254],
6	2012	CD	DATE	2012	num	3	SENT_223	[p14l2015t3219r2140b3249],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_223	[p14l1463t3282r1748b3314],
8	2012:1280	CD	NUMBER	2012:1280	num	7	SENT_223	[p14l1784t3283r2140b3314],
9	—	CD	NUMBER	—	number	10	SENT_223	[p14l1784t3283r2140b3314],
10	7	CD	NUMBER	7	dep	7	SENT_223	[p14l1784t3283r2140b3314],

1	pE0	NN	O	pe0	_	0	SENT_224	[p15l1037t202r1367b308],
2	.03	CD	NUMBER	.03	num	1	SENT_224	[p15l1037t202r1367b308],

1	Q.	NNP	O	Q.	_	0	SENT_225	[p15l265t830r307b897],

1	PR	NN	O	pr	_	0	SENT_226	[p15l83t1504r156b1648],
2	!	.	O	!	_	0	SENT_226	[p15l83t1504r156b1648],

1	VASP	NN	ORGANIZATION	vasp	_	0	SENT_227	[p15l83t1223r156b1473],
2	)	SYM	O	)	dep	1	SENT_227	[p15l83t1040r175b1191],

1	Blecliing	VBG	O	bleclie	_	0	SENT_228	[p15l441t2362r800b2446],
2	Events	NNS	O	event	nsubj	5	SENT_228	[p15l834t2362r1111b2426],
3	No	DT	O	no	det	5	SENT_228	[p15l1232t2362r1338b2426],
4	Bleecling	NN	O	bleecling	nn	5	SENT_228	[p15l1373t2362r1728b2446],
5	Events	NNS	O	event	xcomp	1	SENT_228	[p15l1761t2362r2039b2426],

1	Figure	NNP	O	Figure	_	0	SENT_229	[p15l65t2582r233b2637],
2	5	CD	NUMBER	5	dep	1	SENT_229	[p15l258t2583r307b2627],
3	.	.	O	.	_	0	SENT_229	[p15l258t2583r307b2627],

1	Prasugrel	NNP	O	Prasugrel	nn	2	SENT_230	[p15l335t2583r593b2637],
2	Response	NNP	O	Response	_	0	SENT_230	[p15l620t2583r886b2637],
3	and	CC	O	and	_	0	SENT_230	[p15l910t2583r1007b2627],
4	Bleeding	NNP	O	Bleeding	conj_and	2	SENT_230	[p15l1033t2582r1273b2637],

1	Prasugrel	NN	O	prasugrel	nn	2	SENT_231	[p15l66t2715r300b2772],
2	response	NN	O	response	_	0	SENT_231	[p15l329t2728r560b2772],
3	among	IN	O	among	_	0	SENT_231	[p15l584t2728r764b2773],
4	patients	NNS	O	patient	prep_among	2	SENT_231	[p15l792t2717r998b2772],
5	with	IN	O	with	prep	4	SENT_231	[p15l1021t2715r1132b2760],
6	or	CC	O	or	_	0	SENT_231	[p15l1159t2728r1210b2760],
7	without	IN	O	without	prep	4	SENT_231	[p15l1233t2715r1435b2760],
8	bleeding	VBG	O	bleed	amod	9	SENT_231	[p15l1461t2715r1685b2772],
9	complications	NNS	O	complication	pobj	7	SENT_231	[p15l1711t2715r2085b2772],
10	.	.	O	.	_	0	SENT_231	[p15l1711t2715r2085b2772],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_232	[p15l63t2799r422b2844],
2	as	IN	O	as	prep	1	SENT_232	[p15l447t2812r498b2844],
3	in	IN	O	in	pcomp	2	SENT_232	[p15l524t2801r566b2844],
4	Figure	NNP	O	Figure	pobj	3	SENT_232	[p15l595t2801r754b2857],
5	1	CD	NUMBER	1	num	4	SENT_232	[p15l783t2803r820b2844],
6	.	.	O	.	_	0	SENT_232	[p15l783t2803r820b2844],

1	metabolizers	NNS	O	metabolizer	dep	15	SENT_233	[p15l11t3076r455b3142],
2	(	CD	NUMBER	(	num	3	SENT_233	[p15l496t3074r566b3156],
3	n	NN	O	n	dep	1	SENT_233	[p15l496t3074r566b3156],
4	=	JJ	O	=	amod	3	SENT_233	[p15l611t3102r664b3122],
5	6	CD	NUMBER	6	tmod	4	SENT_233	[p15l711t3080r749b3142],
6	of	IN	O	of	_	0	SENT_233	[p15l788t3076r868b3142],
7	42	CD	NUMBER	42	num	8	SENT_233	[p15l892t3074r1027b3157],
8	)	CD	NUMBER	)	prep_of	3	SENT_233	[p15l892t3074r1027b3157],
9	,	,	O	,	_	0	SENT_233	[p15l892t3074r1027b3157],
10	24	CD	PERCENT	24	num	11	SENT_233	[p15l1064t3080r1218b3143],
11	%	NN	PERCENT	%	nsubj	15	SENT_233	[p15l1064t3080r1218b3143],
12	in	IN	O	in	_	0	SENT_233	[p15l1255t3079r1322b3141],
13	intermediate	JJ	O	intermediate	amod	14	SENT_233	[p15l1359t3076r1806b3142],
14	metabolizers	NNS	O	metabolizer	prep_in	11	SENT_233	[p15l1844t3076r2137b3142, p15l9t3186r190b3252],
15	(	VBP	O	(	_	0	SENT_233	[p15l218t3184r288b3266],
16	n	NN	O	n	dobj	15	SENT_233	[p15l218t3184r288b3266],
17	=	JJ	O	=	amod	16	SENT_233	[p15l320t3212r373b3232],
18	26	CD	NUMBER	26	tmod	17	SENT_233	[p15l404t3190r489b3253],
19	of	IN	O	of	_	0	SENT_233	[p15l516t3186r595b3252],
20	107	CD	NUMBER	107	num	21	SENT_233	[p15l611t3184r785b3266],
21	)	NN	O	)	prep_of	16	SENT_233	[p15l611t3184r785b3266],
22	,	,	O	,	_	0	SENT_233	[p15l611t3184r785b3266],
23	and	CC	O	and	_	0	SENT_233	[p15l813t3186r941b3252],
24	36	CD	PERCENT	36	num	25	SENT_233	[p15l964t3190r1115b3252],
25	%	NN	PERCENT	%	dep	31	SENT_233	[p15l964t3190r1115b3252],
26	in	IN	O	in	_	0	SENT_233	[p15l1139t3189r1206b3251],
27	ultrametabolizers	NNS	O	ultrametabolizer	prep_in	25	SENT_233	[p15l1229t3186r1839b3252],
28	(	CD	NUMBER	(	num	29	SENT_233	[p15l1867t3184r1937b3266],
29	n	NN	O	n	dep	31	SENT_233	[p15l1867t3184r1937b3266],
30	=	JJ	O	=	amod	31	SENT_233	[p15l1969t3212r2022b3232],
31	23	CD	NUMBER	23	dep	39	SENT_233	[p15l2053t3190r2136b3253],
32	of	IN	O	of	_	0	SENT_233	[p15l11t3296r90b3362],
33	64	CD	NUMBER	64	number	34	SENT_233	[p15l113t3294r223b3377],
34	)	CD	NUMBER	)	num	36	SENT_233	[p15l113t3294r223b3377],
35	(	NN	O	(	nn	36	SENT_233	[p15l262t3294r329b3386],
36	p	NN	O	p	prep_of	31	SENT_233	[p15l262t3294r329b3386],
37	=	JJ	O	=	amod	36	SENT_233	[p15l372t3322r425b3342],
38	0.10	CD	NUMBER	0.10	tmod	37	SENT_233	[p15l468t3294r667b3377],
39	)	NN	O	)	conj_and	15	SENT_233	[p15l468t3294r667b3377],
40	.	.	O	.	_	0	SENT_233	[p15l468t3294r667b3377],

1	Clinical	JJ	O	clinical	amod	2	SENT_234	[p15l11t3413r255b3472],
2	outcomes	NNS	O	outcome	_	0	SENT_234	[p15l294t3422r649b3472],
3	.	.	O	.	_	0	SENT_234	[p15l294t3422r649b3472],

1	In	IN	O	in	_	0	SENT_235	[p15l698t3407r775b3471],
2	the	DT	O	the	det	4	SENT_235	[p15l810t3406r920b3472],
3	overall	JJ	O	overall	amod	4	SENT_235	[p15l957t3406r1188b3472],
4	population	NN	O	population	prep_in	21	SENT_235	[p15l1221t3406r1623b3496],
5	,	,	O	,	_	0	SENT_235	[p15l1221t3406r1623b3496],
6	the	DT	O	the	det	7	SENT_235	[p15l1661t3406r1771b3472],
7	incidence	NN	O	incidence	nsubj	21	SENT_235	[p15l1807t3406r2140b3472],
8	of	IN	O	of	_	0	SENT_235	[p15l11t3516r90b3582],
9	bleeding	VBG	O	bleed	amod	10	SENT_235	[p15l113t3516r418b3605],
10	complications	NNS	O	complication	prep_of	7	SENT_235	[p15l454t3516r942b3605],
11	at	IN	O	at	_	0	SENT_235	[p15l982t3533r1045b3582],
12	1	CD	DURATION	1	num	13	SENT_235	[p15l1085t3520r1116b3581],
13	month	NN	NUMBER	month	prep_at	10	SENT_235	[p15l1160t3516r1395b3582],
14	was	VBD	O	be	cop	21	SENT_235	[p15l1428t3542r1557b3582],
15	15	CD	PERCENT	15	num	16	SENT_235	[p15l1600t3516r1748b3582],
16	%	NN	PERCENT	%	nn	21	SENT_235	[p15l1600t3516r1748b3582],
17	(	CD	NUMBER	(	num	18	SENT_235	[p15l1788t3514r1858b3596],
18	n	NN	O	n	dep	16	SENT_235	[p15l1788t3514r1858b3596],
19	=	JJ	O	=	amod	21	SENT_235	[p15l1903t3542r1957b3562],
20	32	CD	NUMBER	32	tmod	19	SENT_235	[p15l2004t3514r2137b3597],
21	)	NN	O	)	_	0	SENT_235	[p15l2004t3514r2137b3597],
22	,	,	O	,	_	0	SENT_235	[p15l2004t3514r2137b3597],
23	including	VBG	O	include	_	0	SENT_235	[p15l10t3626r344b3715],
24	16	CD	NUMBER	16	num	25	SENT_235	[p15l401t3629r480b3693],
25	BARC	NN	ORGANIZATION	barc	prep_including	21	SENT_235	[p15l536t3624r784b3693],
26	1	CD	NUMBER	1	dep	25	SENT_235	[p15l844t3630r900b3707],
27	,	,	O	,	_	0	SENT_235	[p15l844t3630r900b3707],
28	13	CD	NUMBER	13	num	29	SENT_235	[p15l962t3629r1039b3693],
29	BARC	NN	ORGANIZATION	barc	conj_and	25	SENT_235	[p15l1097t3624r1344b3693],
30	2	CD	NUMBER	2	dep	29	SENT_235	[p15l1399t3629r1461b3707],
31	,	,	O	,	_	0	SENT_235	[p15l1399t3629r1461b3707],
32	and	CC	NUMBER	and	_	0	SENT_235	[p15l1519t3626r1647b3692],
33	3	CD	NUMBER	3	num	34	SENT_235	[p15l1701t3629r1737b3693],
34	BARC	NN	ORGANIZATION	barc	conj_and	25	SENT_235	[p15l1796t3625r2043b3693],
35	3	CD	NUMBER	3	dep	34	SENT_235	[p15l2100t3629r2136b3693],

1	bleeding	VBG	O	bleed	_	0	SENT_236	[p16l8t17r312b106],
2	events	NNS	O	event	dobj	1	SENT_236	[p16l350t34r585b83],
3	.	.	O	.	_	0	SENT_236	[p16l350t34r585b83],

1	Patients	NNS	O	patient	nsubj	10	SENT_237	[p16l629t18r913b83],
2	who	WP	O	who	nsubj	3	SENT_237	[p16l950t17r1102b83],
3	had	VBD	O	have	rcmod	1	SENT_237	[p16l1142t17r1272b83],
4	bleeding	JJ	O	bleeding	amod	5	SENT_237	[p16l1308t17r1612b106],
5	complications	NNS	O	complication	dobj	3	SENT_237	[p16l1650t17r2138b107],
6	according	VBG	O	accord	_	0	SENT_237	[p16l11t127r354b216],
7	to	TO	O	to	prepc_according_to	3	SENT_237	[p16l381t144r449b193],
8	BARC	NN	ORGANIZATION	barc	nn	9	SENT_237	[p16l479t126r726b194],
9	deﬁnitions	NNS	O	deﬁnitions	pobj	3	SENT_237	[p16l758t127r1131b193],
10	had	VBD	O	have	_	0	SENT_237	[p16l1161t127r1291b193],
11	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_237	[p16l1320t127r1749b216],
12	lower	JJR	O	lower	amod	14	SENT_237	[p16l1772t127r1968b194],
13	PR1	NN	O	pr1	nn	14	SENT_237	[p16l1995t128r2138b193],
14	VASP	NN	O	vasp	dobj	10	SENT_237	[p16l10t236r238b304],
15	than	IN	O	than	_	0	SENT_237	[p16l291t237r449b303],
16	patients	NNS	O	patient	prep_than	10	SENT_237	[p16l501t240r777b327],
17	without	IN	O	without	_	0	SENT_237	[p16l828t237r1109b304],
18	complications	NNS	O	complication	prep_without	10	SENT_237	[p16l1161t237r1669b326],
19	:	:	O	:	_	0	SENT_237	[p16l1161t237r1669b326],
20	24	CD	NUMBER	24	dep	18	SENT_237	[p16l1724t240r1812b304],
21	i	FW	O	i	dep	20	SENT_237	[p16l1873t246r1926b299],
22	14	CD	PERCENT	14	num	23	SENT_237	[p16l1992t240r2140b303],
23	%	NN	PERCENT	%	dep	21	SENT_237	[p16l1992t240r2140b303],
24	versus	CC	O	versus	prep	23	SENT_237	[p16l7t373r220b413],
25	30.1	CD	NUMBER	30.1	dep	24	SENT_237	[p16l274t350r420b414],
26	i	FW	O	i	dep	32	SENT_237	[p16l485t356r538b409],
27	14	CD	PERCENT	14	num	28	SENT_237	[p16l603t350r751b413],
28	%	NN	PERCENT	%	dep	26	SENT_237	[p16l603t350r751b413],
29	(	CD	NUMBER	(	num	30	SENT_237	[p16l806t345r873b436],
30	p	NN	O	p	dep	32	SENT_237	[p16l806t345r873b436],
31	=	JJ	O	=	amod	32	SENT_237	[p16l934t373r987b393],
32	0.03	CD	NUMBER	0.03	dep	23	SENT_237	[p16l1048t345r1226b428],
33	)	CD	NUMBER	)	number	34	SENT_237	[p16l1048t345r1226b428],
34	(	CD	NUMBER	(	dep	32	SENT_237	[p16l1284t345r1445b436],
35	Fig	NN	O	fig	dep	34	SENT_237	[p16l1284t345r1445b436],
36	.	.	O	.	_	0	SENT_237	[p16l1284t345r1445b436],

1	5	CD	NUMBER	5	_	0	SENT_238	[p16l1501t345r1590b427],
2	)	NN	O	)	dep	1	SENT_238	[p16l1501t345r1590b427],
3	.	.	O	.	_	0	SENT_238	[p16l1501t345r1590b427],

1	Patients	NNS	O	patient	nsubj	6	SENT_239	[p16l1646t348r1929b413],
2	with	IN	O	with	_	0	SENT_239	[p16l1979t347r2140b414],
3	hyper	JJ	O	hyper	amod	5	SENT_239	[p16l10t458r549b548],
4	—	NN	O	—	nn	5	SENT_239	[p16l10t458r549b548],
5	response	NN	O	response	prep_with	1	SENT_239	[p16l10t458r549b548],
6	had	VBD	O	have	_	0	SENT_239	[p16l588t458r718b524],
7	a	DT	O	a	det	10	SENT_239	[p16l758t484r792b524],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	9	SENT_239	[p16l832t458r1261b547],
9	higher	JJR	O	higher	amod	10	SENT_239	[p16l1296t458r1525b547],
10	rate	NN	O	rate	dobj	6	SENT_239	[p16l1562t475r1693b524],
11	of	IN	O	of	_	0	SENT_239	[p16l1733t458r1813b524],
12	bleeding	VBG	O	bleed	amod	13	SENT_239	[p16l1838t458r2142b547],
13	complications	NNS	O	complication	prep_of	10	SENT_239	[p16l11t604r508b694],
14	compared	VBN	O	compare	_	0	SENT_239	[p16l574t604r927b694],
15	with	IN	O	with	prepc_compared_with	13	SENT_239	[p16l986t604r1150b670],
16	patients	NNS	O	patient	pobj	13	SENT_239	[p16l1212t607r1494b693],
17	without	IN	O	without	_	0	SENT_239	[p16l1556t604r1841b671],
18	hyperresponse	NN	O	hyperresponse	prep_without	16	SENT_239	[p16l1902t604r2136b694, p16l10t740r331b803],
19	:	:	O	:	_	0	SENT_239	[p16l1902t604r2136b694, p16l10t740r331b803],
20	24	CD	PERCENT	24	num	21	SENT_239	[p16l364t717r518b781],
21	%	NN	PERCENT	%	dep	10	SENT_239	[p16l364t717r518b781],
22	(	CD	NUMBER	(	num	23	SENT_239	[p16l552t712r622b794],
23	n	NN	O	n	dep	21	SENT_239	[p16l552t712r622b794],
24	=	JJ	O	=	amod	25	SENT_239	[p16l661t740r714b760],
25	13	CD	NUMBER	13	dep	23	SENT_239	[p16l758t717r835b781],
26	of	IN	O	of	_	0	SENT_239	[p16l871t714r950b780],
27	55	CD	NUMBER	55	number	28	SENT_239	[p16l969t712r1080b794],
28	)	CD	NUMBER	)	prep_of	25	SENT_239	[p16l969t712r1080b794],
29	versus	CC	O	versus	prep	28	SENT_239	[p16l1111t740r1324b780],
30	12	CD	PERCENT	12	num	31	SENT_239	[p16l1360t717r1508b781],
31	%	NN	PERCENT	%	dep	29	SENT_239	[p16l1360t717r1508b781],
32	(	CD	NUMBER	(	num	33	SENT_239	[p16l1542t712r1612b795],
33	n	NN	O	n	dep	43	SENT_239	[p16l1542t712r1612b795],
34	=	JJ	O	=	amod	33	SENT_239	[p16l1651t740r1704b760],
35	19	CD	NUMBER	19	tmod	34	SENT_239	[p16l1748t717r1827b780],
36	of	IN	O	of	_	0	SENT_239	[p16l1860t714r1940b780],
37	158	CD	NUMBER	158	num	38	SENT_239	[p16l1963t712r2137b795],
38	)	NN	O	)	prep_of	33	SENT_239	[p16l1963t712r2137b795],
39	,	,	O	,	_	0	SENT_239	[p16l1963t712r2137b795],
40	odds	NNS	O	odds	appos	38	SENT_239	[p16l11t824r173b890],
41	ratio	NN	O	ratio	dep	43	SENT_239	[p16l198t827r358b890],
42	(	CD	NUMBER	(	num	41	SENT_239	[p16l386t822r569b904],
43	OR	NN	O	or	dep	51	SENT_239	[p16l386t822r569b904],
44	)	CD	PERCENT	)	number	45	SENT_239	[p16l386t822r569b904],
45	[	CD	PERCENT	[	dep	43	SENT_239	[p16l602t822r780b904],
46	95	CD	PERCENT	95	num	49	SENT_239	[p16l602t822r780b904],
47	%	NN	PERCENT	%	nn	49	SENT_239	[p16l602t822r780b904],
48	conﬁdence	NN	O	conﬁdence	nn	49	SENT_239	[p16l805t824r1182b890],
49	interval	NN	O	interval	dep	45	SENT_239	[p16l1206t824r1471b890],
50	(	CD	NUMBER	(	num	51	SENT_239	[p16l1496t822r1697b904],
51	CI	NN	O	ci	dep	52	SENT_239	[p16l1496t822r1697b904],
52	)	NN	O	)	dep	25	SENT_239	[p16l1496t822r1697b904],
53	]	CD	NUMBER	]	num	52	SENT_239	[p16l1496t822r1697b904],
54	:	:	O	:	_	0	SENT_239	[p16l1496t822r1697b904],
55	2.2	CD	NUMBER	2.2	num	56	SENT_239	[p16l1723t827r1831b891],
56	[	NN	O	[	dep	10	SENT_239	[p16l1862t822r1924b904],
57	1	CD	NUMBER	1	number	60	SENT_239	[p16l1862t822r1924b904],
58	to	TO	O	to	dep	60	SENT_239	[p16l1952t841r2020b890],
59	5	CD	NUMBER	5	number	60	SENT_239	[p16l2045t822r2137b904],
60	]	CD	NUMBER	]	dep	56	SENT_239	[p16l2045t822r2137b904],
61	;	:	O	;	_	0	SENT_239	[p16l2045t822r2137b904],
62	p	NN	O	p	dep	10	SENT_239	[p16l9t960r51b1023],
63	=	JJ	O	=	amod	62	SENT_239	[p16l84t960r137b980],
64	0.04	CD	NUMBER	0.04	number	65	SENT_239	[p16l169t932r347b1015],
65	)	CD	NUMBER	)	dep	63	SENT_239	[p16l169t932r347b1015],
66	(	CD	NUMBER	(	num	67	SENT_239	[p16l377t932r538b1023],
67	Fig	NN	O	fig	dep	10	SENT_239	[p16l377t932r538b1023],
68	.	.	O	.	_	0	SENT_239	[p16l377t932r538b1023],

1	6	CD	NUMBER	6	_	0	SENT_240	[p16l567t932r654b1014],
2	)	NN	O	)	dep	1	SENT_240	[p16l567t932r654b1014],
3	.	.	O	.	_	0	SENT_240	[p16l567t932r654b1014],

1	Values	NNS	O	value	nsubj	7	SENT_241	[p16l682t934r914b1001],
2	of	IN	O	of	_	0	SENT_241	[p16l940t934r1019b1000],
3	ADP-Ag	NN	O	adp-ag	prep_of	1	SENT_241	[p16l1028t932r1366b1023],
4	were	VBD	O	be	cop	7	SENT_241	[p16l1384t960r1550b1000],
5	not	RB	O	not	neg	7	SENT_241	[p16l1575t951r1692b1000],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_241	[p16l1715t934r2144b1023],
7	different	JJ	O	different	dep	16	SENT_241	[p16l11t1044r307b1110],
8	between	IN	O	between	_	0	SENT_241	[p16l337t1044r630b1111],
9	patients	NNS	O	patient	prep_between	7	SENT_241	[p16l663t1047r939b1134],
10	with	IN	O	with	_	0	SENT_241	[p16l970t1044r1132b1110],
11	and	CC	O	and	_	0	SENT_241	[p16l1166t1044r1294b1110],
12	without	IN	O	without	_	0	SENT_241	[p16l1323t1044r1603b1110],
13	BARC	NN	ORGANIZATION	barc	prep_without	7	SENT_241	[p16l1635t1043r1882b1111],
14	bleeding	NN	O	bleeding	nn	15	SENT_241	[p16l1916t1044r2137b1110, p16l10t1157r122b1243],
15	complications	NNS	O	complication	nsubj	16	SENT_241	[p16l173t1154r661b1244],
16	(	VBP	O	(	_	0	SENT_241	[p16l717t1152r892b1234],
17	data	NNS	O	datum	dobj	16	SENT_241	[p16l717t1152r892b1234],
18	not	RB	O	not	neg	19	SENT_241	[p16l943t1171r1060b1220],
19	shown	VBN	O	show	rcmod	17	SENT_241	[p16l1111t1152r1386b1234],
20	)	NN	O	)	dobj	19	SENT_241	[p16l1111t1152r1386b1234],
21	.	.	O	.	_	0	SENT_241	[p16l1111t1152r1386b1234],

1	For	IN	O	for	_	0	SENT_242	[p16l1442t1155r1568b1220],
2	the	DT	O	the	det	3	SENT_242	[p16l1617t1154r1728b1220],
3	impact	NN	O	impact	prep_for	24	SENT_242	[p16l1780t1157r2022b1244],
4	of	IN	O	of	_	0	SENT_242	[p16l2072t1154r2152b1220],
5	genetic	JJ	O	genetic	amod	6	SENT_242	[p16l9t1268r262b1354],
6	variants	NNS	O	variant	prep_of	3	SENT_242	[p16l303t1268r578b1331],
7	on	IN	O	on	_	0	SENT_242	[p16l626t1291r713b1331],
8	clinical	JJ	O	clinical	amod	9	SENT_242	[p16l760t1265r1009b1331],
9	outcomes	NNS	O	outcome	prep_on	6	SENT_242	[p16l1054t1282r1409b1346],
10	;	:	O	;	_	0	SENT_242	[p16l1054t1282r1409b1346],
11	patients	NNS	O	patient	nsubj	24	SENT_242	[p16l1456t1268r1733b1355],
12	who	WP	O	who	nsubj	14	SENT_242	[p16l1777t1265r1929b1331],
13	were	VBD	O	be	cop	14	SENT_242	[p16l1973t1291r2139b1331],
14	carriers	NNS	O	carrier	rcmod	11	SENT_242	[p16l11t1379r263b1442],
15	of	IN	O	of	_	0	SENT_242	[p16l314t1376r393b1442],
16	*	CD	NUMBER	*	num	19	SENT_242	[p16l434t1379r546b1442],
17	Z7	NN	O	z7	nn	19	SENT_242	[p16l434t1379r546b1442],
18	gain	NN	O	gain	nn	19	SENT_242	[p16l587t1376r1181b1465],
19	—	NN	O	—	prep_of	14	SENT_242	[p16l587t1376r1181b1465],
20	of	IN	O	of	_	0	SENT_242	[p16l587t1376r1181b1465],
21	—	CD	NUMBER	—	num	23	SENT_242	[p16l587t1376r1181b1465],
22	function	NN	O	function	nn	23	SENT_242	[p16l587t1376r1181b1465],
23	allele	NN	O	allele	prep_of	19	SENT_242	[p16l1230t1376r1407b1442],
24	had	VBD	O	have	_	0	SENT_242	[p16l1455t1376r1585b1442],
25	a	DT	O	a	det	28	SENT_242	[p16l1633t1402r1667b1442],
26	signiﬁcantly	RB	O	signiﬁcantly	advmod	27	SENT_242	[p16l1715t1376r2144b1465],
27	higher	JJR	O	higher	amod	28	SENT_242	[p16l10t1486r239b1575],
28	rate	NN	O	rate	dobj	24	SENT_242	[p16l270t1503r400b1552],
29	of	IN	O	of	_	0	SENT_242	[p16l434t1486r514b1552],
30	BARC	NN	ORGANIZATION	barc	nn	32	SENT_242	[p16l535t1485r782b1553],
31	bleeding	NN	O	bleeding	nn	32	SENT_242	[p16l814t1486r1119b1575],
32	complications	NNS	O	complication	prep_of	28	SENT_242	[p16l1150t1486r1639b1576],
33	than	IN	O	than	_	0	SENT_242	[p16l1673t1486r1831b1552],
34	noncar	JJ	O	noncar	amod	36	SENT_242	[p16l1865t1512r2137b1552],
35	—	NN	O	—	nn	36	SENT_242	[p16l1865t1512r2137b1552],
36	riers	NNS	O	rier	prep_than	32	SENT_242	[p16l10t1599r179b1662],
37	:	:	O	:	_	0	SENT_242	[p16l10t1599r179b1662],
38	23	CD	PERCENT	23	num	39	SENT_242	[p16l209t1599r362b1663],
39	%	NN	PERCENT	%	dep	32	SENT_242	[p16l209t1599r362b1663],
40	versus	CC	O	versus	dep	49	SENT_242	[p16l387t1622r600b1663],
41	11	CD	PERCENT	11	num	42	SENT_242	[p16l634t1599r801b1677],
42	%	NN	PERCENT	%	dep	40	SENT_242	[p16l634t1599r801b1677],
43	,	,	O	,	_	0	SENT_242	[p16l634t1599r801b1677],
44	(	CD	NUMBER	(	num	45	SENT_242	[p16l835t1594r996b1677],
45	OR	NN	O	or	appos	42	SENT_242	[p16l835t1594r996b1677],
46	[	CD	PERCENT	[	number	47	SENT_242	[p16l1026t1594r1204b1677],
47	95	CD	PERCENT	95	num	48	SENT_242	[p16l1026t1594r1204b1677],
48	%	NN	PERCENT	%	dep	45	SENT_242	[p16l1026t1594r1204b1677],
49	CI	NN	O	ci	rcmod	39	SENT_242	[p16l1234t1594r1378b1677],
50	]	CD	NUMBER	]	num	49	SENT_242	[p16l1234t1594r1378b1677],
51	:	:	O	:	_	0	SENT_242	[p16l1234t1594r1378b1677],
52	2.5	CD	NUMBER	2.5	dep	32	SENT_242	[p16l1407t1596r1514b1663],
53	[	CD	NUMBER	[	number	57	SENT_242	[p16l1551t1594r1683b1677],
54	1.2	CD	NUMBER	1.2	number	57	SENT_242	[p16l1551t1594r1683b1677],
55	to	TO	O	to	dep	57	SENT_242	[p16l1712t1613r1780b1662],
56	5.4	CD	NUMBER	5.4	number	57	SENT_242	[p16l1809t1594r1968b1677],
57	]	CD	NUMBER	]	dep	52	SENT_242	[p16l1809t1594r1968b1677],
58	;	:	O	;	_	0	SENT_242	[p16l1809t1594r1968b1677],
59	p	NN	O	p	dep	32	SENT_242	[p16l1998t1622r2040b1685],
60	=	JJ	O	=	amod	59	SENT_242	[p16l2078t1622r2131b1642],
61	0.02	CD	NUMBER	0.02	tmod	60	SENT_242	[p16l10t1704r188b1786],
62	)	CD	NUMBER	)	number	63	SENT_242	[p16l10t1704r188b1786],
63	(	CD	NUMBER	(	dep	32	SENT_242	[p16l234t1704r394b1795],
64	Fig	NN	O	fig	dep	63	SENT_242	[p16l234t1704r394b1795],
65	.	.	O	.	_	0	SENT_242	[p16l234t1704r394b1795],

1	7	CD	NUMBER	7	_	0	SENT_243	[p16l440t1704r527b1787],
2	)	NN	O	)	dep	1	SENT_243	[p16l440t1704r527b1787],
3	.	.	O	.	_	0	SENT_243	[p16l440t1704r527b1787],

1	In	IN	O	in	_	0	SENT_244	[p16l569t1707r647b1771],
2	the	DT	O	the	det	4	SENT_244	[p16l686t1706r796b1772],
3	different	JJ	O	different	amod	4	SENT_244	[p16l837t1706r1133b1772],
4	groups	NNS	O	group	prep_in	10	SENT_244	[p16l1169t1732r1405b1796],
5	according	VBG	O	accord	_	0	SENT_244	[p16l1447t1706r1790b1795],
6	to	TO	O	to	prepc_according_to	4	SENT_244	[p16l1827t1723r1895b1772],
7	genotypes	NNS	O	genotype	pobj	4	SENT_244	[p16l1934t1732r2137b1795, p16l10t1833r208b1905],
8	,	,	O	,	_	0	SENT_244	[p16l1934t1732r2137b1795, p16l10t1833r208b1905],
9	we	PRP	O	we	nsubj	10	SENT_244	[p16l243t1842r342b1882],
10	observed	VBD	O	observe	_	0	SENT_244	[p16l379t1816r687b1883],
11	a	DT	O	a	det	13	SENT_244	[p16l723t1842r758b1882],
12	nonsigniﬁcant	JJ	O	nonsigniﬁcant	amod	13	SENT_244	[p16l793t1816r1297b1905],
13	trend	NN	O	trend	dobj	10	SENT_244	[p16l1331t1816r1519b1882],
14	for	IN	O	for	_	0	SENT_244	[p16l1553t1816r1654b1882],
15	the	DT	O	the	det	16	SENT_244	[p16l1688t1816r1798b1882],
16	distribution	NN	O	distribution	prep_for	10	SENT_244	[p16l1835t1816r2137b1882, p16l10t1929r150b1992],
17	of	IN	O	of	_	0	SENT_244	[p16l208t1926r288b1992],
18	bleeding	VBG	O	bleed	prepc_of	16	SENT_244	[p16l330t1926r634b2015],
19	complications	NNS	O	complication	dobj	18	SENT_244	[p16l691t1926r1199b2015],
20	:	:	O	:	_	0	SENT_244	[p16l691t1926r1199b2015],
21	10	CD	PERCENT	10	num	22	SENT_244	[p16l1264t1929r1412b1993],
22	%	NN	PERCENT	%	dep	19	SENT_244	[p16l1264t1929r1412b1993],
23	(	CD	NUMBER	(	num	24	SENT_244	[p16l1472t1924r1542b2007],
24	n	NN	O	n	npadvmod	25	SENT_244	[p16l1472t1924r1542b2007],
25	=	JJ	O	=	amod	22	SENT_244	[p16l1608t1952r1661b1972],
26	4	CD	NUMBER	4	num	27	SENT_244	[p16l1726t1924r1794b2006],
27	)	NN	O	)	advmod	22	SENT_244	[p16l1726t1924r1794b2006],
28	in	IN	O	in	_	0	SENT_244	[p16l1854t1929r1922b1991],
29	poor	JJ	O	poor	amod	30	SENT_244	[p16l1978t1952r2142b2015],
30	metabolizers	NNS	O	metabolizer	prep_in	27	SENT_244	[p16l11t2036r476b2116],
31	,	,	O	,	_	0	SENT_244	[p16l11t2036r476b2116],
32	14	CD	PERCENT	14	num	33	SENT_244	[p16l521t2039r669b2102],
33	%	NN	PERCENT	%	appos	30	SENT_244	[p16l521t2039r669b2102],
34	(	CD	NUMBER	(	num	35	SENT_244	[p16l710t2034r780b2116],
35	n	NN	O	n	npadvmod	36	SENT_244	[p16l710t2034r780b2116],
36	=	JJ	O	=	amod	33	SENT_244	[p16l826t2062r880b2082],
37	15	CD	NUMBER	15	num	38	SENT_244	[p16l931t2034r1038b2116],
38	)	NN	O	)	dep	22	SENT_244	[p16l931t2034r1038b2116],
39	in	IN	O	in	_	0	SENT_244	[p16l1080t2039r1147b2101],
40	intermediate	JJ	O	intermediate	amod	41	SENT_244	[p16l1185t2036r1633b2102],
41	metabolizers	NNS	O	metabolizer	prep_in	38	SENT_244	[p16l1672t2036r2137b2116],
42	,	,	O	,	_	0	SENT_244	[p16l1672t2036r2137b2116],

1	JACC	NN	O	jacc	_	0	SENT_245	[p16l8t2276r158b2307],
2	:	:	O	:	_	0	SENT_245	[p16l8t2276r158b2307],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_245	[p16l193t2276r692b2307],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_245	[p16l728t2276r1187b2312],
5	,	,	O	,	_	0	SENT_245	[p16l728t2276r1187b2312],
6	VOL	NNP	O	VOL	appos	4	SENT_245	[p16l1221t2276r1344b2307],
7	.	.	O	.	_	0	SENT_245	[p16l1221t2276r1344b2307],

1	5	CD	NUMBER	5	_	0	SENT_246	[p16l1379t2277r1422b2312],
2	,	,	O	,	_	0	SENT_246	[p16l1379t2277r1422b2312],
3	NO.	NNP	DATE	NO.	appos	1	SENT_246	[p16l1459t2276r1549b2307],
4	12	CD	DATE	12	num	3	SENT_246	[p16l1587t2277r1662b2312],
5	,	,	DATE	,	_	0	SENT_246	[p16l1587t2277r1662b2312],
6	2012	CD	DATE	2012	num	3	SENT_246	[p16l1698t2277r1822b2307],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_246	[p16l11t2340r295b2372],
8	2012:1280	CD	NUMBER	2012:1280	num	7	SENT_246	[p16l327t2341r682b2372],
9	—	CD	NUMBER	—	number	10	SENT_246	[p16l327t2341r682b2372],
10	7	CD	NUMBER	7	dep	7	SENT_246	[p16l327t2341r682b2372],

1	p	NN	O	p	_	0	SENT_247	[p17l713t200r937b271],
2	=	JJ	O	=	amod	3	SENT_247	[p17l713t200r937b271],
3	o.M	NN	O	o.m	dep	1	SENT_247	[p17l713t200r937b271],

1	my	PRP$	O	my	_	0	SENT_248	[p17l166t693r227b738],

1	PԾw2	NN	O	pծw2	_	0	SENT_249	[p17l1470t712r1568b770],
2	+	CC	O	+	_	0	SENT_249	[p17l1470t712r1568b770],
3	Hyper	NNP	O	Hyper	nn	4	SENT_249	[p17l1607t715r1770b776],
4	Response	NNP	O	Response	conj_+	1	SENT_249	[p17l1793t715r2065b776],
5	b	NN	O	b	nn	6	SENT_249	[p17l1470t802r1568b856],
6	w2	NN	O	w2	dep	1	SENT_249	[p17l1470t802r1568b856],
7	+	CC	O	+	_	0	SENT_249	[p17l1470t802r1568b856],
8	Other	JJ	O	other	amod	9	SENT_249	[p17l1607t802r1754b850],
9	Patients	NNS	O	patient	conj_+	6	SENT_249	[p17l1779t802r1997b850],

1	§	NNP	O	§	amod	2	SENT_250	[p17l82t331r141b398],
2	Am	NNP	O	Am	_	0	SENT_250	[p17l92t418r130b453],
3	:	:	O	:	_	0	SENT_250	[p17l92t456r130b493],
4	:	:	O	:	_	0	SENT_250	[p17l92t456r130b493],
5	E	NN	O	e	dep	2	SENT_250	[p17l82t494r131b540],
6	;	:	O	;	_	0	SENT_250	[p17l82t494r131b540],
7	-5	CD	NUMBER	-5	dep	5	SENT_250	[p17l82t546r131b600],
8	.	.	O	.	_	0	SENT_250	[p17l82t546r131b600],

1	£	NN	MONEY	£	_	0	SENT_251	[p17l82t603r130b648],
2	1	CD	MONEY	1	num	1	SENT_251	[p17l82t603r130b648],

1	E	NN	O	e	_	0	SENT_252	[p17l92t709r128b754],
2	at	IN	O	at	_	0	SENT_252	[p17l92t760r130b796],
3	U	NNP	O	U	nn	4	SENT_252	[p17l82t799r128b843],
4	E5	NNP	O	E5	prep_at	1	SENT_252	[p17l92t866r141b905],
5	5	CD	NUMBER	5	num	4	SENT_252	[p17l82t906r130b951],
6	;	:	O	;	_	0	SENT_252	[p17l82t906r130b951],
7	.9	CD	NUMBER	.9	dep	1	SENT_252	[p17l82t957r131b990],
8	.	.	O	.	_	0	SENT_252	[p17l82t957r131b990],

1	H	NN	O	h	_	0	SENT_253	[p17l92t993r128b1025],
2	)	CD	NUMBER	)	num	1	SENT_253	[p17l92t993r128b1025],
3	Q	NNP	O	Q	dep	1	SENT_253	[p17l82t1026r130b1073],
4	:	:	O	:	_	0	SENT_253	[p17l82t1026r130b1073],
5	in	IN	O	in	dep	3	SENT_253	[p17l82t1079r128b1118],
6	"	``	O	"	punct	8	SENT_253	[p17l82t1137r130b1198],
7	51	CD	NUMBER	51	num	8	SENT_253	[p17l82t1137r130b1198],
8	m	NN	O	m	pobj	5	SENT_253	[p17l92t1220r130b1252],
9	‘	CD	NUMBER	‘	num	11	SENT_253	[p17l92t1220r130b1252],
10	U	NNP	O	U	nn	11	SENT_253	[p17l92t1255r128b1287],
11	E	NNP	O	E	dep	8	SENT_253	[p17l92t1293r130b1322],
12	:	:	O	:	_	0	SENT_253	[p17l92t1293r130b1322],
13	m	NN	O	m	nn	15	SENT_253	[p17l92t1325r130b1358],
14	‘	CD	NUMBER	‘	num	15	SENT_253	[p17l92t1325r130b1358],
15	E	NN	O	e	dep	1	SENT_253	[p17l82t1364r130b1409],
16	U	NNP	O	U	nn	17	SENT_253	[p17l92t1415r128b1447],
17	E	NNP	O	E	dep	15	SENT_253	[p17l82t1453r130b1499],

1	Hyper	JJ	O	hyper	amod	2	SENT_254	[p17l316t1489r476b1547],
2	Response	NN	O	response	_	0	SENT_254	[p17l492t1481r768b1547],
3	Other	JJ	O	other	amod	4	SENT_254	[p17l915t1489r1070b1534],
4	Patients	NNS	O	patient	dep	2	SENT_254	[p17l1088t1481r1306b1534],

1	Figure	NNP	O	Figure	_	0	SENT_255	[p17l65t1683r233b1738],
2	6	CD	NUMBER	6	dep	1	SENT_255	[p17l257t1683r307b1727],
3	.	.	O	.	_	0	SENT_255	[p17l257t1683r307b1727],

1	Hyper-Response	NN	O	hyper-response	nn	4	SENT_256	[p17l335t1683r776b1738],
2	and	CC	O	and	_	0	SENT_256	[p17l799t1683r896b1727],
3	Bleeding	NN	O	bleeding	conj_and	1	SENT_256	[p17l923t1683r1162b1738],
4	incidence	NN	O	incidence	_	0	SENT_256	[p17l65t1815r311b1861],
5	of	IN	O	of	_	0	SENT_256	[p17l335t1815r389b1861],
6	bleeding	VBG	O	bleed	prepc_of	4	SENT_256	[p17l411t1815r634b1873],
7	complications	NNS	O	complication	dobj	6	SENT_256	[p17l661t1815r1022b1873],
8	among	IN	O	among	_	0	SENT_256	[p17l1046t1829r1226b1873],
9	patients	NNS	O	patient	prep_among	6	SENT_256	[p17l1255t1817r1460b1873],
10	with	IN	O	with	_	0	SENT_256	[p17l1484t1815r1594b1861],
11	hyper	JJ	O	hyper	amod	16	SENT_256	[p17l1623t1815r2023b1874],
12	—	NN	O	—	nn	16	SENT_256	[p17l1623t1815r2023b1874],
13	response	NN	O	response	nn	16	SENT_256	[p17l1623t1815r2023b1874],
14	(	CD	NUMBER	(	num	16	SENT_256	[p17l65t1900r156b1952],
15	PRI	NNP	ORGANIZATION	PRI	nn	16	SENT_256	[p17l65t1900r156b1952],
16	VASP	NN	O	vasp	prep_with	9	SENT_256	[p17l181t1901r315b1945],
17	<	JJR	O	<	amod	16	SENT_256	[p17l343t1900r517b1952],
18	17	CD	PERCENT	17	num	19	SENT_256	[p17l343t1900r517b1952],
19	%	NN	PERCENT	%	dep	17	SENT_256	[p17l343t1900r517b1952],
20	)	CD	NUMBER	)	tmod	6	SENT_256	[p17l343t1900r517b1952],
21	and	CC	O	and	_	0	SENT_256	[p17l543t1899r637b1945],
22	others	NNS	O	other	tmod	6	SENT_256	[p17l664t1899r838b1945],
23	.	.	O	.	_	0	SENT_256	[p17l664t1899r838b1945],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_257	[p17l862t1899r1222b1945],
2	as	IN	O	as	prep	1	SENT_257	[p17l1247t1913r1298b1945],
3	in	IN	O	in	pcomp	2	SENT_257	[p17l1324t1902r1366b1944],
4	Figure	NNP	O	Figure	pobj	3	SENT_257	[p17l1395t1902r1554b1957],
5	1	CD	NUMBER	1	num	4	SENT_257	[p17l1583t1903r1619b1945],
6	.	.	O	.	_	0	SENT_257	[p17l1583t1903r1619b1945],

1	and	CC	O	and	cc	2	SENT_258	[p17l12t2177r139b2243],
2	20	CD	PERCENT	20	num	3	SENT_258	[p17l182t2180r336b2244],
3	%	NN	PERCENT	%	_	0	SENT_258	[p17l182t2180r336b2244],
4	(	CD	NUMBER	(	num	5	SENT_258	[p17l384t2175r455b2257],
5	n	NN	O	n	dep	3	SENT_258	[p17l384t2175r455b2257],
6	=	JJ	O	=	amod	8	SENT_258	[p17l508t2202r562b2223],
7	13	CD	NUMBER	13	tmod	6	SENT_258	[p17l620t2175r727b2257],
8	)	NN	O	)	dep	3	SENT_258	[p17l620t2175r727b2257],
9	in	IN	O	in	_	0	SENT_258	[p17l777t2180r844b2242],
10	the	DT	O	the	det	12	SENT_258	[p17l889t2177r1000b2243],
11	ultrametabolizers	NNS	O	ultrametabolizer	nn	12	SENT_258	[p17l1045t2177r1655b2243],
12	group	NN	O	group	prep_in	8	SENT_258	[p17l1701t2202r1906b2266],
13	(	CD	NUMBER	(	num	14	SENT_258	[p17l1956t2175r2023b2266],
14	p	NN	O	p	npadvmod	15	SENT_258	[p17l1956t2175r2023b2266],
15	=	JJ	O	=	amod	8	SENT_258	[p17l2078t2202r2131b2223],
16	0.20	CD	NUMBER	0.20	num	17	SENT_258	[p17l10t2282r210b2364],
17	)	NN	O	)	dep	8	SENT_258	[p17l10t2282r210b2364],
18	.	.	O	.	_	0	SENT_258	[p17l10t2282r210b2364],

1	During	IN	O	during	_	0	SENT_259	[p17l99t2391r359b2479],
2	the	DT	O	the	det	3	SENT_259	[p17l413t2390r523b2456],
3	1-month	JJ	DURATION	1-month	prep_during	9	SENT_259	[p17l585t2390r897b2456],
4	follow	VBP	O	follow	rcmod	3	SENT_259	[p17l953t2390r1318b2479],
5	—	RB	O	—	advmod	4	SENT_259	[p17l953t2390r1318b2479],
6	up	RB	O	up	advmod	4	SENT_259	[p17l953t2390r1318b2479],
7	,	,	O	,	_	0	SENT_259	[p17l953t2390r1318b2479],
8	We	PRP	O	we	nsubj	9	SENT_259	[p17l1374t2416r1472b2456],
9	observed	VBD	O	observe	_	0	SENT_259	[p17l1530t2390r1838b2456],
10	only	RB	O	only	quantmod	11	SENT_259	[p17l1894t2390r2047b2479],
11	2	CD	NUMBER	2	num	13	SENT_259	[p17l2097t2393r2139b2457],
12	ischemic	JJ	O	ischemic	amod	13	SENT_259	[p17l10t2496r317b2562],
13	events	NNS	O	event	dobj	9	SENT_259	[p17l355t2513r592b2577],
14	,	,	O	,	_	0	SENT_259	[p17l355t2513r592b2577],
15	including	VBG	O	include	_	0	SENT_259	[p17l632t2496r966b2585],
16	1	CD	NUMBER	1	num	17	SENT_259	[p17l1005t2499r1037b2561],
17	deﬁnite	NN	O	deﬁnite	prep_including	13	SENT_259	[p17l1081t2496r1346b2562],
18	and	CC	O	and	_	0	SENT_259	[p17l1385t2496r1513b2562],
19	1	CD	NUMBER	1	num	22	SENT_259	[p17l1553t2499r1585b2561],
20	probable	JJ	O	probable	amod	22	SENT_259	[p17l1626t2496r1932b2585],
21	stent	NN	O	stent	nn	22	SENT_259	[p17l1971t2513r2142b2562],
22	thrombosis	NN	O	thrombosis	prep_including	13	SENT_259	[p17l10t2603r423b2669],
23	.	.	O	.	_	0	SENT_259	[p17l10t2603r423b2669],

1	Genetic	JJ	O	genetic	amod	4	SENT_260	[p17l465t2603r745b2669],
2	and	CC	O	and	_	0	SENT_260	[p17l781t2603r908b2669],
3	platelet	NN	O	platelet	conj_and	1	SENT_260	[p17l942t2603r1203b2692],
4	parameters	NNS	O	parameter	nsubj	8	SENT_260	[p17l1236t2620r1621b2692],
5	were	VBD	O	be	cop	8	SENT_260	[p17l1655t2628r1821b2669],
6	not	RB	O	not	neg	8	SENT_260	[p17l1858t2620r1975b2669],
7	signiﬁcantly	RB	O	signiﬁcantly	advmod	8	SENT_260	[p17l2011t2606r2137b2692, p17l11t2709r342b2798],
8	different	JJ	O	different	dep	16	SENT_260	[p17l364t2709r661b2775],
9	among	IN	O	among	_	0	SENT_260	[p17l686t2735r927b2798],
10	patients	NNS	O	patient	prep_among	8	SENT_260	[p17l950t2712r1226b2798],
11	with	IN	O	with	_	0	SENT_260	[p17l1250t2709r1412b2775],
12	or	CC	O	or	_	0	SENT_260	[p17l1438t2734r1510b2775],
13	without	IN	O	without	_	0	SENT_260	[p17l1530t2709r1811b2775],
14	ischemic	JJ	O	ischemic	amod	15	SENT_260	[p17l1834t2709r2141b2775],
15	events	NNS	O	event	prep_without	8	SENT_260	[p17l11t2832r227b2881],
16	(	VBP	O	(	_	0	SENT_260	[p17l277t2813r451b2895],
17	data	NNS	O	datum	dobj	16	SENT_260	[p17l277t2813r451b2895],
18	not	RB	O	not	neg	19	SENT_260	[p17l497t2832r614b2881],
19	shown	VBN	O	show	partmod	17	SENT_260	[p17l659t2813r934b2895],
20	)	NN	O	)	nsubj	16	SENT_260	[p17l659t2813r934b2895],
21	.	.	O	.	_	0	SENT_260	[p17l659t2813r934b2895],

1	Using	VBG	O	use	partmod	22	SENT_261	[p17l982t2816r1194b2904],
2	the	DT	O	the	det	4	SENT_261	[p17l1238t2815r1348b2881],
3	TIMI	NNP	ORGANIZATION	TIMI	nn	4	SENT_261	[p17l1391t2813r1605b2880],
4	deﬁnition	NN	O	deﬁnition	dobj	1	SENT_261	[p17l1653t2815r1996b2881],
5	for	IN	O	for	_	0	SENT_261	[p17l2041t2815r2142b2881],
6	bleeding	VBG	O	bleed	amod	7	SENT_261	[p17l8t2921r312b3010],
7	complications	NNS	O	complication	prep_for	4	SENT_261	[p17l342t2921r851b3010],
8	,	,	O	,	_	0	SENT_261	[p17l342t2921r851b3010],
9	only	RB	O	only	quantmod	10	SENT_261	[p17l885t2921r1038b3010],
10	1	CD	NUMBER	1	nsubj	22	SENT_261	[p17l1068t2924r1100b2986],
11	TIMI	NN	ORGANIZATION	timus	nn	13	SENT_261	[p17l1132t2919r1346b2986],
12	major	JJ	O	major	amod	13	SENT_261	[p17l1378t2922r1582b3010],
13	bleeding	NN	O	bleeding	dep	10	SENT_261	[p17l1608t2921r1912b3010],
14	and	CC	O	and	_	0	SENT_261	[p17l1943t2921r2070b2987],
15	7	CD	NUMBER	7	num	16	SENT_261	[p17l2101t2922r2140b2987],
16	TIMI	NN	ORGANIZATION	timus	conj_and	10	SENT_261	[p17l7t3025r220b3092],
17	minor	JJ	O	minor	amod	18	SENT_261	[p17l251t3030r466b3093],
18	bleeding	NN	O	bleeding	nsubj	19	SENT_261	[p17l490t3027r794b3116],
19	occurred	VBD	O	occur	rcmod	16	SENT_261	[p17l821t3027r1125b3093],
20	during	IN	O	during	_	0	SENT_261	[p17l1153t3027r1386b3116],
21	the	DT	O	the	prep_during	19	SENT_261	[p17l1412t3027r1522b3093],
22	follow	VBP	O	follow	_	0	SENT_261	[p17l1550t3027r1916b3116],
23	—	RB	O	—	advmod	22	SENT_261	[p17l1550t3027r1916b3116],
24	up	RB	O	up	advmod	22	SENT_261	[p17l1550t3027r1916b3116],
25	,	,	O	,	_	0	SENT_261	[p17l1550t3027r1916b3116],
26	without	IN	O	without	_	0	SENT_261	[p17l1944t3027r2137b3093, p17l11t3151r126b3200],
27	statistical	JJ	O	statistical	amod	29	SENT_261	[p17l186t3134r513b3200],
28	signiﬁcant	JJ	O	signiﬁcant	amod	29	SENT_261	[p17l573t3134r938b3223],
29	association	NN	O	association	prep_without	22	SENT_261	[p17l998t3137r1380b3200],
30	With	IN	O	with	_	0	SENT_261	[p17l1436t3134r1598b3200],
31	genotypes	NNS	O	genotype	prep_with	29	SENT_261	[p17l1656t3151r2007b3223],
32	or	CC	O	or	_	0	SENT_261	[p17l2070t3159r2142b3200],
33	platelet	NN	O	platelet	nn	34	SENT_261	[p17l9t3275r270b3364],
34	testing	NN	O	testing	prep_with	29	SENT_261	[p17l301t3278r556b3364],
35	.	.	O	.	_	0	SENT_261	[p17l301t3278r556b3364],

1	Discussion	NN	O	discussion	_	0	SENT_262	[p17l12t3524r469b3587],

1	In	IN	O	in	_	0	SENT_263	[p18l9t40r87b105],
2	the	DT	O	the	det	4	SENT_263	[p18l134t39r244b106],
3	present	JJ	DATE	present	amod	4	SENT_263	[p18l290t56r549b129],
4	study	NN	O	study	prep_in	7	SENT_263	[p18l595t39r800b129],
5	,	,	O	,	_	0	SENT_263	[p18l595t39r800b129],
6	We	PRP	O	we	nsubj	7	SENT_263	[p18l846t66r944b106],
7	observed	VBD	O	observe	_	0	SENT_263	[p18l993t39r1301b106],
8	a	DT	O	a	det	10	SENT_263	[p18l1349t66r1383b106],
9	significant	JJ	O	significant	amod	10	SENT_263	[p18l1430t39r1795b129],
10	effect	NN	O	effect	dobj	7	SENT_263	[p18l1841t39r2026b106],
11	of	IN	O	of	_	0	SENT_263	[p18l2072t39r2152b106],
12	CYP2C19	NN	O	cyp2c19	nn	13	SENT_263	[p18l17t149r431b213],
13	*	NN	O	*	prep_of	10	SENT_263	[p18l17t149r431b213],
14	2	CD	NUMBER	2	num	13	SENT_263	[p18l17t149r431b213],
15	and	CC	O	and	_	0	SENT_263	[p18l491t145r618b212],
16	*	CD	NUMBER	*	num	18	SENT_263	[p18l683t149r795b212],
17	J7	NN	O	j7	nn	18	SENT_263	[p18l683t149r795b212],
18	alleles	NNS	O	allele	conj_and	10	SENT_263	[p18l852t145r1058b212],
19	on	IN	O	on	_	0	SENT_263	[p18l1120t172r1208b212],
20	prasugrel	NN	O	prasugrel	nn	21	SENT_263	[p18l1267t145r1590b235],
21	response	NN	O	response	prep_on	18	SENT_263	[p18l1648t171r1951b235],
22	and	CC	O	and	_	0	SENT_263	[p18l2013t145r2141b212],
23	bleeding	NN	O	bleeding	nn	24	SENT_263	[p18l8t251r312b341],
24	events	NNS	O	event	conj_and	21	SENT_263	[p18l349t269r565b318],
25	in	IN	O	in	_	0	SENT_263	[p18l605t254r673b317],
26	patients	NNS	O	patient	prep_in	7	SENT_263	[p18l710t254r986b341],
27	treated	VBN	O	treat	partmod	26	SENT_263	[p18l1026t251r1271b318],
28	with	IN	O	with	_	0	SENT_263	[p18l1305t251r1466b318],
29	10	CD	NUMBER	10	num	30	SENT_263	[p18l1509t255r1589b318],
30	mg	NN	O	mg	prep_with	27	SENT_263	[p18l1629t278r1741b341],
31	daily	RB	SET	daily	advmod	27	SENT_263	[p18l1778t251r1947b341],
32	after	IN	O	after	_	0	SENT_263	[p18l1983t251r2142b318],
33	PCI	NNP	O	PCI	prep_after	27	SENT_263	[p18l10t357r158b424],
34	for	IN	O	for	_	0	SENT_263	[p18l190t357r291b424],
35	ACS	NNP	O	ACS	prep_for	33	SENT_263	[p18l316t356r515b424],
36	.	.	O	.	_	0	SENT_263	[p18l316t356r515b424],

1	This	DT	O	this	det	2	SENT_264	[p18l546t356r710b424],
2	study	NN	O	study	nsubj	3	SENT_264	[p18l743t357r932b447],
3	provides	VBZ	O	provide	_	0	SENT_264	[p18l957t357r1252b447],
4	for	IN	O	for	_	0	SENT_264	[p18l1283t357r1384b424],
5	the	DT	O	the	det	7	SENT_264	[p18l1412t358r1522b424],
6	ﬁrst	JJ	O	ﬁrst	amod	7	SENT_264	[p18l1553t357r1690b424],
7	time	NN	O	time	prep_for	3	SENT_264	[p18l1719t360r1897b438],
8	,	,	O	,	_	0	SENT_264	[p18l1719t360r1897b438],
9	to	TO	O	to	_	0	SENT_264	[p18l1930t375r1997b424],
10	the	DT	O	the	det	11	SENT_264	[p18l2029t357r2139b424],
11	best	JJS	O	best	prep_to	3	SENT_264	[p18l8t464r151b530],
12	of	IN	O	of	_	0	SENT_264	[p18l212t463r292b530],
13	our	PRP$	O	we	poss	14	SENT_264	[p18l342t489r459b530],
14	knowledge	NN	O	knowledge	prep_of	11	SENT_264	[p18l519t463r919b553],
15	,	,	O	,	_	0	SENT_264	[p18l519t463r919b553],
16	data	NNS	O	datum	appos	14	SENT_264	[p18l985t463r1132b530],
17	about	IN	O	about	_	0	SENT_264	[p18l1194t463r1392b530],
18	CYPZC19	NN	O	cypzc19	prep_about	16	SENT_264	[p18l1453t463r1825b531],
19	genetic	JJ	O	genetic	amod	20	SENT_264	[p18l1887t466r2141b553],
20	polymorphisms	NNS	O	polymorphism	nsubj	21	SENT_264	[p18l9t570r572b660],
21	’	VBP	O	’	rcmod	18	SENT_264	[p18l9t570r572b660],
22	modulation	NN	O	modulation	dobj	21	SENT_264	[p18l604t570r1011b637],
23	of	IN	O	of	_	0	SENT_264	[p18l1042t570r1122b637],
24	platelet	NN	O	platelet	nn	25	SENT_264	[p18l1138t570r1399b660],
25	response	NN	O	response	prep_of	22	SENT_264	[p18l1427t596r1730b660],
26	and	CC	O	and	_	0	SENT_264	[p18l1762t570r1889b637],
27	bleeding	NN	O	bleeding	prep_of	22	SENT_264	[p18l1916t570r2137b637, p18l10t715r122b802],

1	risk	NN	O	risk	nsubj	5	SENT_265	[p18l153t712r284b779],
2	in	IN	O	in	_	0	SENT_265	[p18l313t715r381b778],
3	prasugrel	NN	O	prasugrel	nn	4	SENT_265	[p18l412t712r1018b802],
4	—	NN	O	—	prep_in	1	SENT_265	[p18l412t712r1018b802],
5	treated	VBN	O	treat	_	0	SENT_265	[p18l412t712r1018b802],
6	patients	NNS	O	patient	dobj	5	SENT_265	[p18l1050t715r1327b802],
7	after	IN	O	after	_	0	SENT_265	[p18l1363t712r1522b779],
8	ACS	NN	O	ac	prep_after	5	SENT_265	[p18l1550t711r1749b779],
9	.	.	O	.	_	0	SENT_265	[p18l1550t711r1749b779],

1	A	DT	O	a	det	3	SENT_266	[p18l96t817r163b884],
2	large	JJ	O	large	amod	3	SENT_266	[p18l185t818r354b908],
3	amount	NN	O	amount	nsubj	7	SENT_266	[p18l381t836r653b885],
4	of	IN	O	of	_	0	SENT_266	[p18l677t818r757b885],
5	data	NNS	O	datum	prep_of	3	SENT_266	[p18l770t818r918b885],
6	has	VBZ	O	have	aux	7	SENT_266	[p18l942t818r1054b885],
7	demonstrated	VBN	O	demonstrate	_	0	SENT_266	[p18l1082t818r1567b885],
8	the	DT	O	the	det	9	SENT_266	[p18l1591t819r1701b885],
9	inﬂuence	NN	O	inﬂuence	dobj	7	SENT_266	[p18l1726t818r2046b885],
10	of	IN	O	of	_	0	SENT_266	[p18l2073t818r2152b885],
11	CYP2C19	NN	O	cyp2c19	prep_of	9	SENT_266	[p18l17t928r431b992],
12	*	NN	O	*	nn	17	SENT_266	[p18l17t928r431b992],
13	2	CD	NUMBER	2	num	17	SENT_266	[p18l17t928r431b992],
14	loss-of	JJ	O	loss-of	amod	17	SENT_266	[p18l469t924r1041b991],
15	—	NN	O	—	nn	17	SENT_266	[p18l469t924r1041b991],
16	function	NN	O	function	nn	17	SENT_266	[p18l469t924r1041b991],
17	allele	NN	O	allele	npadvmod	7	SENT_266	[p18l1083t924r1259b991],
18	on	IN	O	on	_	0	SENT_266	[p18l1301t951r1388b991],
19	platelet	NN	O	platelet	nn	20	SENT_266	[p18l1428t924r1688b1014],
20	response	NN	O	response	prep_on	7	SENT_266	[p18l1727t950r2029b1014],
21	to	TO	O	to	_	0	SENT_266	[p18l2071t942r2138b991],
22	clopidogrel	NN	O	clopidogrel	prep_to	7	SENT_266	[p18l11t1031r405b1121],
23	in	IN	O	in	_	0	SENT_266	[p18l439t1034r506b1097],
24	unstable	JJ	O	unstable	amod	25	SENT_266	[p18l541t1031r833b1098],
25	patients	NNS	O	patient	prep_in	22	SENT_266	[p18l868t1034r1144b1121],
26	(	IN	O	(	_	0	SENT_266	[p18l1184t1029r1277b1112],
27	5	CD	NUMBER	5	num	28	SENT_266	[p18l1184t1029r1277b1112],
28	)	NN	O	)	prep_(	7	SENT_266	[p18l1184t1029r1277b1112],
29	and	CC	O	and	_	0	SENT_266	[p18l1318t1032r1445b1098],
30	an	DT	O	a	det	40	SENT_266	[p18l1481t1058r1561b1098],
31	impaired	JJ	O	impaired	dep	32	SENT_266	[p18l1596t1031r1911b1121],
32	prognosis	NN	O	prognosis	amod	40	SENT_266	[p18l1944t1057r2138b1121, p18l11t1140r183b1204],
33	in	IN	O	in	_	0	SENT_266	[p18l219t1140r286b1203],
34	clopidogrel	NN	O	clopidogrel	nn	35	SENT_266	[p18l321t1137r998b1227],
35	—	NN	O	—	prep_in	32	SENT_266	[p18l321t1137r998b1227],
36	treated	VBN	O	treat	partmod	35	SENT_266	[p18l321t1137r998b1227],
37	patients	NNS	O	patient	dobj	36	SENT_266	[p18l1029t1140r1306b1227],
38	(	CD	NUMBER	(	number	39	SENT_266	[p18l1344t1135r1526b1218],
39	6,7	CD	NUMBER	6,7	num	40	SENT_266	[p18l1344t1135r1526b1218],
40	)	NN	O	)	conj_and	28	SENT_266	[p18l1344t1135r1526b1218],
41	.	.	O	.	_	0	SENT_266	[p18l1344t1135r1526b1218],

1	By	IN	O	by	_	0	SENT_267	[p18l1565t1138r1662b1227],
2	contrast	NN	O	contrast	agent	12	SENT_267	[p18l1693t1154r1993b1218],
3	,	,	O	,	_	0	SENT_267	[p18l1693t1154r1993b1218],
4	the	DT	O	the	det	7	SENT_267	[p18l2029t1137r2139b1204],
5	gain-of	JJ	O	gain-of	amod	7	SENT_267	[p18l9t1243r602b1333],
6	—	NN	O	—	nn	7	SENT_267	[p18l9t1243r602b1333],
7	function	NN	O	function	nsubjpass	12	SENT_267	[p18l9t1243r602b1333],
8	*	CD	NUMBER	*	num	10	SENT_267	[p18l638t1247r750b1310],
9	17	CD	NUMBER	17	num	10	SENT_267	[p18l638t1247r750b1310],
10	allele	NN	O	allele	dep	7	SENT_267	[p18l776t1243r952b1310],
11	was	VBD	O	be	auxpass	12	SENT_267	[p18l980t1270r1109b1310],
12	described	VBN	O	describe	ccomp	40	SENT_267	[p18l1142t1243r1474b1310],
13	as	IN	O	as	mark	14	SENT_267	[p18l1505t1270r1568b1310],
14	associated	VBN	O	associate	advcl	12	SENT_267	[p18l1601t1243r1954b1310],
15	with	IN	O	with	_	0	SENT_267	[p18l1979t1243r2140b1310],
16	a	DT	O	a	det	18	SENT_267	[p18l11t1376r46b1416],
17	better	JJR	O	better	amod	18	SENT_267	[p18l95t1350r303b1416],
18	response	NN	O	response	prep_with	14	SENT_267	[p18l354t1375r656b1439],
19	to	TO	O	to	_	0	SENT_267	[p18l710t1367r778b1416],
20	clopidogrel	NN	O	clopidogrel	nn	21	SENT_267	[p18l833t1349r1227b1439],
21	(	NN	O	(	prep_to	18	SENT_267	[p18l1282t1347r1375b1430],
22	8	CD	NUMBER	8	num	23	SENT_267	[p18l1282t1347r1375b1430],
23	)	NN	O	)	dobj	14	SENT_267	[p18l1282t1347r1375b1430],
24	and	CC	O	and	_	0	SENT_267	[p18l1433t1349r1560b1416],
25	higher	JJR	O	higher	amod	26	SENT_267	[p18l1612t1349r1841b1439],
26	risk	NN	O	risk	conj_and	23	SENT_267	[p18l1892t1349r2023b1416],
27	of	IN	O	of	_	0	SENT_267	[p18l2072t1349r2152b1416],
28	bleeding	NN	O	bleeding	prep_of	26	SENT_267	[p18l8t1455r312b1545],
29	+	CC	O	+	_	0	SENT_267	[p18l356t1453r471b1536],
30	Recently	RB	DATE	recently	advmod	23	SENT_267	[p18l520t1455r846b1545],
31	,	,	O	,	_	0	SENT_267	[p18l520t1455r846b1545],
32	a	DT	O	a	det	36	SENT_267	[p18l892t1482r927b1522],
33	third	JJ	ORDINAL	third	amod	36	SENT_267	[p18l968t1455r1555b1545],
34	—	NN	O	—	nn	36	SENT_267	[p18l968t1455r1555b1545],
35	generation	NN	O	generation	nn	36	SENT_267	[p18l968t1455r1555b1545],
36	thienopyridine	NN	O	thienopyridine	conj_+	23	SENT_267	[p18l1598t1455r2137b1545],
37	,	,	O	,	_	0	SENT_267	[p18l1598t1455r2137b1545],
38	prasugrel	NN	O	prasugrel	appos	36	SENT_267	[p18l9t1562r351b1652],
39	,	,	O	,	_	0	SENT_267	[p18l9t1562r351b1652],
40	provides	VBZ	O	provide	_	0	SENT_267	[p18l398t1562r692b1652],
41	a	DT	O	a	dep	42	SENT_267	[p18l741t1589r775b1629],
42	faster	RBR	O	faster	advmod	40	SENT_267	[p18l819t1562r1029b1644],
43	,	,	O	,	_	0	SENT_267	[p18l819t1562r1029b1644],
44	more	RBR	O	more	advmod	45	SENT_267	[p18l1079t1588r1258b1629],
45	potent	JJ	O	potent	amod	49	SENT_267	[p18l1303t1580r1534b1652],
46	and	CC	O	and	_	0	SENT_267	[p18l1579t1562r1707b1629],
47	predictable	JJ	O	predictable	amod	49	SENT_267	[p18l1750t1562r2139b1652],
48	platelet	NN	O	platelet	nn	49	SENT_267	[p18l9t1668r270b1758],
49	inhibition	NN	O	inhibition	dep	40	SENT_267	[p18l298t1668r650b1735],
50	compared	VBN	O	compare	_	0	SENT_267	[p18l681t1668r1028b1758],
51	with	IN	O	with	prepc_compared_with	49	SENT_267	[p18l1054t1669r1215b1735],
52	clopidogrel	NN	O	clopidogrel	pobj	49	SENT_267	[p18l1246t1669r1641b1758],
53	(	CD	NUMBER	(	num	52	SENT_267	[p18l1673t1666r1943b1749],
54	10,11	CD	NUMBER	10,11	num	55	SENT_267	[p18l1673t1666r1943b1749],
55	)	NN	O	)	nsubj	40	SENT_267	[p18l1673t1666r1943b1749],
56	.	.	O	.	_	0	SENT_267	[p18l1673t1666r1943b1749],

1	This	DT	O	this	det	3	SENT_268	[p18l1975t1667r2138b1735],
2	higher	JJR	O	higher	amod	3	SENT_268	[p18l10t1775r239b1865],
3	degree	NN	O	degree	nsubjpass	16	SENT_268	[p18l266t1775r494b1865],
4	of	IN	O	of	_	0	SENT_268	[p18l523t1775r603b1842],
5	platelet	NN	O	platelet	nn	6	SENT_268	[p18l618t1775r879b1865],
6	inhibition	NN	O	inhibition	prep_of	3	SENT_268	[p18l905t1775r1256b1842],
7	resulting	VBG	O	result	partmod	6	SENT_268	[p18l1283t1775r1592b1865],
8	in	IN	O	in	_	0	SENT_268	[p18l1618t1778r1686b1841],
9	a	DT	O	a	det	11	SENT_268	[p18l1715t1802r1749b1842],
10	significant	JJ	O	significant	amod	11	SENT_268	[p18l1777t1775r2142b1865],
11	reduction	NN	O	reduction	prep_in	7	SENT_268	[p18l10t1880r346b1946],
12	of	IN	O	of	_	0	SENT_268	[p18l372t1880r452b1946],
13	ischemic	JJ	O	ischemic	amod	14	SENT_268	[p18l465t1880r772b1946],
14	events	NNS	O	event	prep_of	11	SENT_268	[p18l797t1897r1013b1946],
15	was	VBD	O	be	auxpass	16	SENT_268	[p18l1036t1906r1165b1946],
16	associated	VBN	O	associate	_	0	SENT_268	[p18l1194t1880r1546b1946],
17	with	IN	O	with	_	0	SENT_268	[p18l1567t1880r1728b1946],
18	an	DT	O	a	det	19	SENT_268	[p18l1755t1906r1835b1946],
19	increase	NN	O	increase	prep_with	16	SENT_268	[p18l1861t1883r2139b1946],
20	of	IN	O	of	_	0	SENT_268	[p18l11t1986r90b2053],
21	bleeding	VBG	O	bleed	amod	22	SENT_268	[p18l107t1986r411b2076],
22	complications	NNS	O	complication	prep_of	19	SENT_268	[p18l442t1987r930b2076],
23	in	IN	O	in	_	0	SENT_268	[p18l963t1989r1030b2052],
24	the	DT	O	the	det	26	SENT_268	[p18l1061t1986r1171b2053],
25	TRITON	NNP	ORGANIZATION	TRITON	nn	26	SENT_268	[p18l1200t1985r1561b2053],
26	TIMI	NNP	O	TIMI	prep_in	22	SENT_268	[p18l1591t1985r1804b2052],
27	38	CD	NUMBER	38	num	28	SENT_268	[p18l1837t1990r1919b2053],
28	study	NN	O	study	dep	26	SENT_268	[p18l1955t1986r2144b2076],
29	(	CD	NUMBER	(	number	30	SENT_268	[p18l13t2090r172b2173],
30	12	CD	NUMBER	12	num	31	SENT_268	[p18l13t2090r172b2173],
31	)	NN	O	)	dep	28	SENT_268	[p18l13t2090r172b2173],
32	.	.	O	.	_	0	SENT_268	[p18l13t2090r172b2173],

1	Indeed	RB	O	indeed	advmod	9	SENT_269	[p18l224t2092r489b2173],
2	,	,	O	,	_	0	SENT_269	[p18l224t2092r489b2173],
3	in	IN	O	in	_	0	SENT_269	[p18l541t2095r609b2158],
4	the	DT	O	the	det	6	SENT_269	[p18l656t2092r767b2159],
5	present	JJ	DATE	present	amod	6	SENT_269	[p18l814t2110r1073b2182],
6	study	NN	O	study	prep_in	9	SENT_269	[p18l1121t2092r1326b2182],
7	,	,	O	,	_	0	SENT_269	[p18l1121t2092r1326b2182],
8	we	PRP	O	we	nsubj	9	SENT_269	[p18l1373t2119r1472b2159],
9	observed	VBD	O	observe	_	0	SENT_269	[p18l1521t2092r1829b2159],
10	a	DT	O	a	det	14	SENT_269	[p18l1879t2119r1913b2159],
11	more	RBR	O	more	advmod	12	SENT_269	[p18l1961t2118r2139b2159],
12	Cuisset	JJ	O	cuisset	amod	14	SENT_269	[p18l1467t2196r1658b2240],
13	et	FW	O	et	nn	14	SENT_269	[p18l1684t2199r1736b2240],
14	al.	FW	O	al.	dobj	9	SENT_269	[p18l1759t2197r1817b2240],
15	1285	CD	DATE	1285	dep	14	SENT_269	[p18l1998t2196r2139b2240],

1	Genetic	JJ	O	genetic	nsubj	22	SENT_270	[p18l945t2278r1145b2321],
2	and	CC	O	and	_	0	SENT_270	[p18l1168t2279r1263b2321],
3	Prasugrel	NNP	O	Prasugrel	nn	6	SENT_270	[p18l1291t2279r1537b2332],
4	Response	NNP	O	Response	nn	6	SENT_270	[p18l1564t2279r1820b2331],
5	predictable	JJ	O	predictable	amod	6	SENT_270	[p18l9t2492r398b2581],
6	degree	NN	O	degree	conj_and	1	SENT_270	[p18l428t2492r656b2581],
7	of	IN	O	of	_	0	SENT_270	[p18l686t2492r766b2558],
8	platelet	NN	O	platelet	nn	9	SENT_270	[p18l780t2492r1042b2581],
9	inhibition	NN	O	inhibition	prep_of	6	SENT_270	[p18l1068t2492r1419b2558],
10	with	IN	O	with	_	0	SENT_270	[p18l1444t2492r1605b2558],
11	prasugrel	NN	O	prasugrel	prep_with	6	SENT_270	[p18l1632t2492r1956b2581],
12	with	IN	O	with	_	0	SENT_270	[p18l1979t2492r2140b2558],
13	a	DT	O	a	det	15	SENT_270	[p18l12t2624r46b2664],
14	low	JJ	O	low	amod	15	SENT_270	[p18l86t2598r215b2664],
15	rate	NN	O	rate	prep_with	6	SENT_270	[p18l253t2615r384b2664],
16	of	IN	O	of	_	0	SENT_270	[p18l428t2598r508b2664],
17	patients	NNS	O	patient	prep_of	15	SENT_270	[p18l537t2601r813b2687],
18	with	IN	O	with	_	0	SENT_270	[p18l854t2598r1015b2664],
19	residual	JJ	O	residual	amod	20	SENT_270	[p18l1057t2598r1331b2664],
20	HTPR	NN	O	htpr	prep_with	17	SENT_270	[p18l1372t2596r1625b2663],
21	while	IN	O	while	advmod	22	SENT_270	[p18l1661t2598r1854b2664],
22	treated	VBN	O	treat	_	0	SENT_270	[p18l1896t2598r2141b2664],
23	with	IN	O	with	_	0	SENT_270	[p18l7t2704r168b2770],
24	prasugrel	NN	O	prasugrel	prep_with	22	SENT_270	[p18l215t2704r555b2793],
25	.	.	O	.	_	0	SENT_270	[p18l215t2704r555b2793],

1	These	DT	O	these	det	2	SENT_271	[p18l604t2702r821b2770],
2	results	NNS	O	result	nsubj	3	SENT_271	[p18l869t2704r1092b2770],
3	are	VBP	O	be	_	0	SENT_271	[p18l1143t2729r1243b2770],
4	not	RB	O	not	neg	3	SENT_271	[p18l1293t2721r1410b2770],
5	in	IN	O	in	_	0	SENT_271	[p18l1456t2707r1524b2769],
6	line	NN	O	line	prep_in	3	SENT_271	[p18l1571t2704r1700b2770],
7	with	IN	O	with	_	0	SENT_271	[p18l1745t2704r1906b2770],
8	those	DT	O	those	prep_with	3	SENT_271	[p18l1954t2704r2140b2770],
9	previously	RB	DATE	previously	advmod	10	SENT_271	[p18l9t2810r369b2899],
10	published	VBN	O	publish	partmod	8	SENT_271	[p18l422t2810r766b2899],
11	by	IN	O	by	_	0	SENT_271	[p18l821t2810r906b2899],
12	Bonello	NNP	PERSON	Bonello	agent	10	SENT_271	[p18l961t2810r1234b2876],
13	et	FW	O	et	nn	15	SENT_271	[p18l1293t2827r1357b2876],
14	al.	FW	O	al.	nn	15	SENT_271	[p18l1415t2810r1488b2876],
15	(	FW	O	(	dobj	10	SENT_271	[p18l1553t2808r1691b2890],
16	16	CD	NUMBER	16	num	17	SENT_271	[p18l1553t2808r1691b2890],
17	)	CD	NUMBER	)	npadvmod	10	SENT_271	[p18l1553t2808r1691b2890],
18	showing	VBG	O	show	partmod	17	SENT_271	[p18l1754t2810r2050b2899],
19	a	DT	O	a	det	21	SENT_271	[p18l2107t2836r2141b2876],
20	signiﬁcant	JJ	O	signiﬁcant	amod	21	SENT_271	[p18l11t2916r376b3005],
21	proportion	NN	O	proportion	dobj	18	SENT_271	[p18l408t2919r790b3005],
22	of	IN	O	of	_	0	SENT_271	[p18l825t2916r905b2982],
23	patients	NNS	O	patient	prep_of	21	SENT_271	[p18l926t2919r1203b3005],
24	with	IN	O	with	_	0	SENT_271	[p18l1236t2916r1397b2982],
25	HTPR	NN	O	htpr	prep_with	23	SENT_271	[p18l1432t2914r1685b2981],
26	after	IN	O	after	_	0	SENT_271	[p18l1718t2916r1877b2982],
27	the	DT	O	the	det	31	SENT_271	[p18l1909t2916r2019b2982],
28	60	CD	NUMBER	60	num	31	SENT_271	[p18l2056t2919r2139b2982],
29	mg	NN	O	mg	nn	31	SENT_271	[p18l11t3048r123b3111],
30	loading	NN	O	loading	nn	31	SENT_271	[p18l147t3022r412b3111],
31	dose	NN	O	dose	prep_after	10	SENT_271	[p18l438t3022r612b3088],
32	.	.	O	.	_	0	SENT_271	[p18l438t3022r612b3088],

1	This	DT	O	this	det	2	SENT_272	[p18l640t3020r804b3088],
2	discrepancy	NN	O	discrepancy	nsubj	3	SENT_272	[p18l833t3022r1245b3111],
3	illustrates	VBZ	O	illustrate	_	0	SENT_272	[p18l1268t3022r1603b3088],
4	that	IN	O	that	complm	14	SENT_272	[p18l1631t3022r1772b3088],
5	a	DT	O	a	det	8	SENT_272	[p18l1799t3048r1833b3088],
6	remaining	VBG	O	remain	amod	8	SENT_272	[p18l1859t3025r2137b3088, p18l10t3132r122b3218],
7	critical	JJ	O	critical	amod	8	SENT_272	[p18l156t3129r393b3195],
8	issue	NN	O	issue	nsubj	14	SENT_272	[p18l427t3132r593b3195],
9	of	IN	O	of	_	0	SENT_272	[p18l629t3129r709b3195],
10	platelet	NN	O	platelet	nn	11	SENT_272	[p18l730t3129r991b3218],
11	testing	NN	O	testing	prep_of	8	SENT_272	[p18l1024t3132r1263b3218],
12	is	VBZ	O	be	cop	14	SENT_272	[p18l1296t3132r1346b3195],
13	the	DT	O	the	det	14	SENT_272	[p18l1383t3129r1493b3195],
14	timing	NN	O	timing	ccomp	3	SENT_272	[p18l1528t3132r1764b3218],
15	and	CC	O	and	_	0	SENT_272	[p18l1799t3129r1926b3195],
16	delay	NN	O	delay	conj_and	14	SENT_272	[p18l1961t3129r2145b3218],
17	from	IN	O	from	_	0	SENT_272	[p18l10t3273r180b3339],
18	loading	VBG	O	load	prepc_from	14	SENT_272	[p18l235t3273r500b3362],
19	dose	NN	O	dose	dobj	18	SENT_272	[p18l556t3273r711b3339],
20	to	TO	O	to	_	0	SENT_272	[p18l767t3290r836b3339],
21	sampling	NN	O	sampling	prep_to	18	SENT_272	[p18l895t3273r1216b3362],
22	for	IN	O	for	_	0	SENT_272	[p18l1270t3273r1370b3339],
23	antiplatelet	JJ	O	antiplatelet	amod	25	SENT_272	[p18l1427t3273r1822b3362],
24	therapy	NN	O	therapy	nn	25	SENT_272	[p18l1877t3273r2144b3362],
25	monitoring	NN	O	monitoring	prep_for	21	SENT_272	[p19l11t37r429b123],
26	.	.	O	.	_	0	SENT_272	[p19l11t37r429b123],

1	A	DT	O	a	det	3	SENT_273	[p19l457t32r524b99],
2	possible	JJ	O	possible	amod	3	SENT_273	[p19l548t34r827b123],
3	explanation	NN	O	explanation	nsubj	12	SENT_273	[p19l855t34r1263b123],
4	of	IN	O	of	_	0	SENT_273	[p19l1290t34r1370b100],
5	the	DT	O	the	det	7	SENT_273	[p19l1384t34r1494b100],
6	observed	VBN	O	observe	amod	7	SENT_273	[p19l1522t34r1830b100],
7	ﬁndings	NNS	O	ﬁndings	prep_of	3	SENT_273	[p19l1855t34r2138b123],
8	(	CD	NUMBER	(	num	10	SENT_273	[p19l13t138r174b221],
9	16	CD	NUMBER	16	num	10	SENT_273	[p19l13t138r174b221],
10	)	NN	O	)	dep	7	SENT_273	[p19l13t138r174b221],
11	,	,	O	,	_	0	SENT_273	[p19l13t138r174b221],
12	is	VBZ	O	be	_	0	SENT_273	[p19l213t143r263b206],
13	that	IN	O	that	complm	23	SENT_273	[p19l300t140r441b206],
14	the	DT	O	the	det	15	SENT_273	[p19l475t140r585b206],
15	delay	NN	O	delay	nsubj	23	SENT_273	[p19l623t140r806b229],
16	between	IN	O	between	_	0	SENT_273	[p19l836t140r1129b206],
17	loading	VBG	O	load	prepc_between	15	SENT_273	[p19l1164t140r1429b229],
18	dose	NN	O	dose	dobj	17	SENT_273	[p19l1464t140r1619b206],
19	and	CC	O	and	_	0	SENT_273	[p19l1657t140r1785b206],
20	sampling	NN	O	sampling	conj_and	18	SENT_273	[p19l1821t140r2142b229],
21	was	VBD	O	be	cop	23	SENT_273	[p19l7t273r135b313],
22	too	RB	O	too	advmod	23	SENT_273	[p19l192t264r304b313],
23	short	JJ	O	short	ccomp	12	SENT_273	[p19l362t247r541b313],
24	to	TO	O	to	aux	25	SENT_273	[p19l594t264r662b313],
25	allow	VB	O	allow	xcomp	23	SENT_273	[p19l720t247r907b313],
26	appropriate	JJ	O	appropriate	amod	27	SENT_273	[p19l960t250r1363b336],
27	effectiveness	NN	O	effectiveness	dobj	25	SENT_273	[p19l1419t247r1849b313],
28	of	IN	O	of	_	0	SENT_273	[p19l1907t247r1987b313],
29	the	DT	O	the	det	30	SENT_273	[p19l2029t247r2139b313],
30	treatment	NN	O	treatment	prep_of	27	SENT_273	[p19l10t370r373b419],
31	.	.	O	.	_	0	SENT_273	[p19l10t370r373b419],

1	In	IN	O	in	_	0	SENT_274	[p19l402t354r480b418],
2	a	DT	O	a	det	3	SENT_274	[p19l507t379r541b419],
3	substudy	NN	O	substudy	pobj	1	SENT_274	[p19l567t353r878b442],
4	of	IN	O	of	_	0	SENT_274	[p19l900t353r980b419],
5	TRITON	NNP	ORGANIZATION	TRITON	prep_of	3	SENT_274	[p19l991t351r1603b419],
6	.	.	O	.	_	0	SENT_274	[p19l991t351r1603b419],

1	—	NN	O	—	_	0	SENT_275	[p19l991t351r1603b419],
2	.	.	O	.	_	0	SENT_275	[p19l991t351r1603b419],

1	TIMI	NNP	ORGANIZATION	TIMI	nsubj	10	SENT_276	[p19l991t351r1603b419],
2	38	CD	NUMBER	38	num	1	SENT_276	[p19l1631t356r1736b434],
3	,	,	O	,	_	0	SENT_276	[p19l1631t356r1736b434],
4	Michelson	NNP	PERSON	Michelson	appos	1	SENT_276	[p19l1763t353r2140b419],
5	et	FW	O	et	dep	4	SENT_276	[p19l11t476r74b525],
6	al.	FW	O	al.	nn	9	SENT_276	[p19l106t459r180b525],
7	(	FW	O	(	dep	9	SENT_276	[p19l219t457r356b539],
8	20	CD	NUMBER	20	num	9	SENT_276	[p19l219t457r356b539],
9	)	NN	O	)	advmod	10	SENT_276	[p19l219t457r356b539],
10	found	VBD	O	find	_	0	SENT_276	[p19l392t459r600b525],
11	that	IN	O	that	complm	15	SENT_276	[p19l630t459r771b525],
12	24	CD	PERCENT	24	number	13	SENT_276	[p19l799t462r953b526],
13	%	NN	PERCENT	%	amod	14	SENT_276	[p19l799t462r953b526],
14	patients	NNS	O	patient	nsubj	15	SENT_276	[p19l984t462r1261b548],
15	had	VBD	O	have	ccomp	10	SENT_276	[p19l1294t459r1424b525],
16	HTPR	NN	O	htpr	dobj	15	SENT_276	[p19l1455t457r1708b524],
17	at	IN	O	at	_	0	SENT_276	[p19l1739t476r1802b525],
18	1	CD	DURATION	1	prep_at	16	SENT_276	[p19l1836t462r1867b524],
19	month	NN	NUMBER	month	tmod	15	SENT_276	[p19l1905t459r2140b525],
20	on	IN	O	on	_	0	SENT_276	[p19l11t592r98b632],
21	prasugrel	NN	O	prasugrel	nn	23	SENT_276	[p19l159t566r482b655],
22	10	CD	NUMBER	10	num	23	SENT_276	[p19l547t569r627b632],
23	mg	NN	O	mg	prep_on	15	SENT_276	[p19l691t592r803b655],
24	daily	RB	SET	daily	advmod	15	SENT_276	[p19l864t566r1047b655],
25	.	.	O	.	_	0	SENT_276	[p19l864t566r1047b655],

1	This	DT	O	this	det	2	SENT_277	[p19l1110t564r1273b632],
2	discrepancy	NN	O	discrepancy	nsubjpass	5	SENT_277	[p19l1338t566r1750b655],
3	could	MD	O	could	aux	5	SENT_277	[p19l1809t566r2000b632],
4	be	VB	O	be	auxpass	5	SENT_277	[p19l2059t566r2139b632],
5	explained	VBN	O	explain	_	0	SENT_277	[p19l11t708r346b797],
6	by	IN	O	by	_	0	SENT_277	[p19l383t708r470b797],
7	the	DT	O	the	det	9	SENT_277	[p19l506t708r616b774],
8	patient	NN	O	patient	nn	9	SENT_277	[p19l657t711r905b797],
9	characteristics	NNS	O	characteristic	agent	5	SENT_277	[p19l945t708r1460b789],
10	,	,	O	,	_	0	SENT_277	[p19l945t708r1460b789],
11	with	IN	O	with	_	0	SENT_277	[p19l1500t708r1661b774],
12	higher	JJR	O	higher	amod	15	SENT_277	[p19l1702t708r1931b797],
13	body	NN	O	body	nn	15	SENT_277	[p19l1967t708r2145b797],
14	mass	NN	O	mass	nn	15	SENT_277	[p19l11t839r178b879],
15	index	NN	O	index	prep_with	9	SENT_277	[p19l223t814r416b879],
16	and	CC	O	and	_	0	SENT_277	[p19l460t814r587b879],
17	incidence	NN	O	incidence	npadvmod	9	SENT_277	[p19l631t814r963b879],
18	of	IN	O	of	_	0	SENT_277	[p19l1009t814r1089b879],
19	diabetes	NN	O	diabetes	prep_of	17	SENT_277	[p19l1122t814r1404b879],
20	in	IN	O	in	_	0	SENT_277	[p19l1450t817r1518b878],
21	the	DT	O	the	det	22	SENT_277	[p19l1561t814r1671b879],
22	Michelson	NNP	PERSON	Michelson	poss	24	SENT_277	[p19l1714t814r2139b879],
23	’s	POS	O	’s	_	0	SENT_277	[p19l1714t814r2139b879],
24	study	NN	O	study	prep_in	9	SENT_277	[p19l11t920r200b1009],
25	(	CD	NUMBER	(	number	26	SENT_277	[p19l230t918r389b1000],
26	20	CD	NUMBER	20	num	27	SENT_277	[p19l230t918r389b1000],
27	)	NN	O	)	dep	9	SENT_277	[p19l230t918r389b1000],
28	.	.	O	.	_	0	SENT_277	[p19l230t918r389b1000],

1	Recently	RB	DATE	recently	dep	3	SENT_278	[p19l425t920r751b1009],
2	,	,	O	,	_	0	SENT_278	[p19l425t920r751b1009],
3	results	VBZ	O	result	_	0	SENT_278	[p19l783t920r1006b986],
4	from	IN	O	from	_	0	SENT_278	[p19l1037t920r1207b986],
5	several	JJ	O	several	amod	6	SENT_278	[p19l1239t920r1473b986],
6	studies	NNS	O	study	nsubj	8	SENT_278	[p19l1503t920r1741b986],
7	performed	VBN	O	perform	partmod	6	SENT_278	[p19l1771t920r2141b1009],
8	were	VBD	O	be	dep	35	SENT_278	[p19l7t1050r173b1090],
9	in	IN	O	in	_	0	SENT_278	[p19l215t1028r282b1089],
10	line	NN	O	line	prep_in	8	SENT_278	[p19l321t1025r450b1090],
11	with	IN	O	with	_	0	SENT_278	[p19l488t1025r650b1090],
12	our	PRP$	O	we	poss	13	SENT_278	[p19l691t1050r808b1090],
13	results	NNS	O	result	prep_with	8	SENT_278	[p19l847t1025r1091b1105],
14	,	,	O	,	_	0	SENT_278	[p19l847t1025r1091b1105],
15	with	IN	O	with	_	0	SENT_278	[p19l1131t1025r1292b1090],
16	a	DT	O	a	det	19	SENT_278	[p19l1335t1051r1369b1090],
17	low	JJ	O	low	amod	19	SENT_278	[p19l1407t1025r1537b1090],
18	rate	NN	O	rate	nn	19	SENT_278	[p19l1574t1042r1704b1090],
19	(	NN	O	(	dep	20	SENT_278	[p19l1749t1023r2027b1105],
20	<	JJR	O	<	prep_with	8	SENT_278	[p19l1749t1023r2027b1105],
21	10	CD	PERCENT	10	number	22	SENT_278	[p19l1749t1023r2027b1105],
22	%	NN	PERCENT	%	amod	20	SENT_278	[p19l1749t1023r2027b1105],
23	)	CD	NUMBER	)	dep	8	SENT_278	[p19l1749t1023r2027b1105],
24	of	IN	O	of	_	0	SENT_278	[p19l2073t1025r2152b1090],
25	patients	NNS	O	patient	prep_of	23	SENT_278	[p19l9t1134r286b1220],
26	with	IN	O	with	_	0	SENT_278	[p19l326t1131r487b1197],
27	HTPR	NN	O	htpr	prep_with	25	SENT_278	[p19l530t1129r782b1196],
28	while	IN	O	while	mark	29	SENT_278	[p19l818t1131r1011b1197],
29	treated	VBN	O	treat	dep	23	SENT_278	[p19l1053t1131r1298b1197],
30	with	IN	O	with	_	0	SENT_278	[p19l1335t1131r1496b1197],
31	prasugrel	NN	O	prasugrel	nn	33	SENT_278	[p19l1537t1131r1861b1220],
32	10	CD	NUMBER	10	num	33	SENT_278	[p19l1905t1134r1986b1197],
33	mg	NN	O	mg	prep_with	29	SENT_278	[p19l2029t1157r2142b1220],
34	daily	JJ	SET	daily	amod	35	SENT_278	[p19l11t1237r180b1326],
35	(	NN	O	(	prep_from	3	SENT_278	[p19l236t1235r529b1317],
36	21-23	CD	NUMBER	21-23	num	37	SENT_278	[p19l236t1235r529b1317],
37	)	NN	O	)	nsubj	3	SENT_278	[p19l236t1235r529b1317],
38	.	.	O	.	_	0	SENT_278	[p19l236t1235r529b1317],

1	However	RB	O	however	advmod	10	SENT_279	[p19l590t1238r932b1318],
2	,	,	O	,	_	0	SENT_279	[p19l590t1238r932b1318],
3	in	IN	O	in	_	0	SENT_279	[p19l991t1240r1059b1302],
4	the	DT	O	the	det	6	SENT_279	[p19l1115t1237r1226b1303],
5	present	JJ	DATE	present	amod	6	SENT_279	[p19l1282t1254r1541b1326],
6	study	NN	O	study	prep_in	10	SENT_279	[p19l1597t1237r1802b1326],
7	,	,	O	,	_	0	SENT_279	[p19l1597t1237r1802b1326],
8	we	PRP	O	we	nsubj	10	SENT_279	[p19l1858t1263r1956b1303],
9	still	RB	O	still	advmod	10	SENT_279	[p19l2015t1237r2141b1303],
10	observed	VBD	O	observe	_	0	SENT_279	[p19l11t1343r319b1409],
11	variability	NN	O	variability	dobj	10	SENT_279	[p19l341t1343r695b1432],
12	of	IN	O	of	_	0	SENT_279	[p19l717t1343r797b1409],
13	response	NN	O	response	prep_of	11	SENT_279	[p19l811t1368r1113b1432],
14	to	TO	O	to	_	0	SENT_279	[p19l1140t1360r1207b1409],
15	prasugrel	NN	O	prasugrel	prep_to	10	SENT_279	[p19l1233t1343r1575b1432],
16	,	,	O	,	_	0	SENT_279	[p19l1233t1343r1575b1432],
17	which	WDT	O	which	nsubjpass	20	SENT_279	[p19l1600t1343r1818b1409],
18	could	MD	O	could	aux	20	SENT_279	[p19l1845t1343r2036b1409],
19	be	VB	O	be	auxpass	20	SENT_279	[p19l2059t1343r2139b1409],
20	explained	VBN	O	explain	rcmod	15	SENT_279	[p19l11t1449r346b1538],
21	by	IN	O	by	_	0	SENT_279	[p19l375t1449r461b1538],
22	the	DT	O	the	det	25	SENT_279	[p19l488t1449r599b1515],
23	relatively	RB	O	relatively	advmod	24	SENT_279	[p19l631t1449r950b1538],
24	high	JJ	O	high	amod	25	SENT_279	[p19l978t1449r1138b1538],
25	incidence	NN	O	incidence	agent	20	SENT_279	[p19l1169t1449r1502b1515],
26	of	IN	O	of	_	0	SENT_279	[p19l1535t1449r1616b1515],
27	factors	NNS	O	factor	prep_of	25	SENT_279	[p19l1635t1449r1866b1515],
28	known	VBN	O	know	partmod	27	SENT_279	[p19l1900t1449r2140b1515],
29	to	TO	O	to	_	0	SENT_279	[p19l10t1573r78b1622],
30	inﬂuence	NN	O	inﬂuence	nn	32	SENT_279	[p19l117t1556r437b1622],
31	thienopyridine	NN	O	thienopyridine	nn	32	SENT_279	[p19l475t1556r994b1645],
32	metabolism	NN	O	metabolism	prep_to	28	SENT_279	[p19l1033t1556r1463b1637],
33	,	,	O	,	_	0	SENT_279	[p19l1033t1556r1463b1637],
34	including	VBG	O	include	_	0	SENT_279	[p19l1504t1556r1838b1645],
35	prasugrel	NN	O	prasugrel	prep_including	27	SENT_279	[p19l1873t1581r2137b1645, p19l10t1662r117b1743],
36	,	,	O	,	_	0	SENT_279	[p19l1873t1581r2137b1645, p19l10t1662r117b1743],
37	such	JJ	O	such	_	0	SENT_279	[p19l182t1662r339b1728],
38	as	IN	O	as	_	0	SENT_279	[p19l401t1688r464b1728],
39	acute	JJ	O	acute	amod	41	SENT_279	[p19l528t1679r708b1728],
40	myocardial	JJ	O	myocardial	amod	41	SENT_279	[p19l770t1662r1157b1751],
41	infarction	NN	O	infarction	prep_such_as	35	SENT_279	[p19l1216t1662r1580b1743],
42	,	,	O	,	_	0	SENT_279	[p19l1216t1662r1580b1743],
43	diabetes	NN	O	diabetes	conj_and	41	SENT_279	[p19l1644t1662r1948b1742],
44	,	,	O	,	_	0	SENT_279	[p19l1644t1662r1948b1742],
45	and	CC	O	and	_	0	SENT_279	[p19l2014t1662r2141b1728],
46	patients	NNS	O	patient	conj_and	41	SENT_279	[p19l9t1772r286b1858],
47	with	IN	O	with	_	0	SENT_279	[p19l317t1769r478b1835],
48	a	DT	O	a	det	52	SENT_279	[p19l512t1795r547b1835],
49	high	JJ	O	high	amod	52	SENT_279	[p19l579t1769r738b1858],
50	body	NN	O	body	nn	52	SENT_279	[p19l769t1769r946b1858],
51	mass	NN	O	mass	nn	52	SENT_279	[p19l975t1795r1142b1835],
52	index	NN	O	index	prep_with	46	SENT_279	[p19l1177t1769r1386b1835],
53	.	.	O	.	_	0	SENT_279	[p19l1177t1769r1386b1835],

1	Like	IN	O	like	_	0	SENT_280	[p19l100t1913r259b1979],
2	clopidogrel	NN	O	clopidogrel	prep_like	7	SENT_280	[p19l296t1913r709b2002],
3	,	,	O	,	_	0	SENT_280	[p19l296t1913r709b2002],
4	prasugrel	NN	O	prasugrel	nsubj	7	SENT_280	[p19l746t1913r1070b2002],
5	is	VBZ	O	be	cop	7	SENT_280	[p19l1104t1916r1155b1979],
6	a	DT	O	a	det	7	SENT_280	[p19l1193t1939r1227b1979],
7	prodrug	NN	O	prodrug	_	0	SENT_280	[p19l1260t1913r1545b2002],
8	that	WDT	O	that	nsubj	10	SENT_280	[p19l1578t1913r1719b1979],
9	irreversibly	RB	O	irreversibly	advmod	10	SENT_280	[p19l1753t1913r2144b2002],
10	blocks	VBZ	O	block	rcmod	7	SENT_280	[p19l8t2019r229b2085],
11	the	DT	O	the	det	14	SENT_280	[p19l255t2019r366b2085],
12	P2Y12	NN	O	p2y12	nn	14	SENT_280	[p19l392t2020r633b2086],
13	platelet	NN	O	platelet	nn	14	SENT_280	[p19l659t2019r920b2108],
14	receptor	NN	O	receptor	dobj	10	SENT_280	[p19l943t2036r1233b2108],
15	after	IN	O	after	_	0	SENT_280	[p19l1258t2019r1417b2085],
16	hepatic	JJ	O	hepatic	amod	17	SENT_280	[p19l1440t2019r1696b2108],
17	transformation	NN	O	transformation	prep_after	10	SENT_280	[p19l1720t2019r2137b2085, p19l10t2128r150b2191],
18	and	CC	O	and	_	0	SENT_280	[p19l200t2125r327b2191],
19	could	MD	O	could	aux	21	SENT_280	[p19l376t2125r567b2191],
20	be	VB	O	be	auxpass	21	SENT_280	[p19l613t2125r693b2191],
21	affected	VBN	O	affect	conj_and	10	SENT_280	[p19l744t2125r1012b2191],
22	by	IN	O	by	_	0	SENT_280	[p19l1058t2125r1144b2214],
23	CYP45O	NN	O	cyp45o	nn	25	SENT_280	[p19l1190t2125r1496b2191],
24	genetic	JJ	O	genetic	amod	25	SENT_280	[p19l1545t2128r1798b2214],
25	variants	NNS	O	variant	agent	21	SENT_280	[p19l1842t2128r2136b2191],
26	.	.	O	.	_	0	SENT_280	[p19l1842t2128r2136b2191],

1	Previous	JJ	O	previous	amod	2	SENT_281	[p19l10t2232r310b2297],
2	studies	NNS	O	study	nsubj	3	SENT_281	[p19l373t2231r611b2297],
3	found	VBD	O	find	_	0	SENT_281	[p19l671t2231r880b2297],
4	a	DT	O	a	det	6	SENT_281	[p19l940t2257r974b2297],
5	signiﬁcant	JJ	O	signiﬁcant	amod	6	SENT_281	[p19l1034t2231r1399b2320],
6	inﬂuence	NN	O	inﬂuence	dobj	3	SENT_281	[p19l1456t2231r1776b2297],
7	of	IN	O	of	_	0	SENT_281	[p19l1837t2231r1917b2297],
8	CYP	NNP	O	CYP	nn	10	SENT_281	[p19l1966t2231r2140b2297],
9	genetic	JJ	O	genetic	amod	10	SENT_281	[p19l9t2341r262b2427],
10	variants	NNS	O	variant	prep_of	6	SENT_281	[p19l288t2341r562b2404],
11	on	IN	O	on	_	0	SENT_281	[p19l594t2364r681b2404],
12	pharmacokinetic	JJ	O	pharmacokinetic	amod	15	SENT_281	[p19l710t2338r1302b2427],
13	and	CC	O	and	_	0	SENT_281	[p19l1333t2338r1460b2404],
14	pharmacodynamic	JJ	O	pharmacodynamic	conj_and	12	SENT_281	[p19l1488t2338r2141b2427],
15	response	NN	O	response	prep_on	3	SENT_281	[p19l10t2469r312b2533],
16	to	TO	O	to	prep	15	SENT_281	[p19l357t2461r424b2510],
17	clopidogrel	NN	O	clopidogrel	pobj	16	SENT_281	[p19l470t2444r883b2533],
18	,	,	O	,	_	0	SENT_281	[p19l470t2444r883b2533],
19	but	CC	O	but	_	0	SENT_281	[p19l927t2444r1046b2510],
20	not	RB	O	not	conj_but	16	SENT_281	[p19l1089t2461r1206b2510],
21	to	TO	O	to	dep	16	SENT_281	[p19l1247t2461r1316b2510],
22	prasugrel	NN	O	prasugrel	pobj	21	SENT_281	[p19l1359t2444r1683b2533],
23	(	CD	NUMBER	(	num	22	SENT_281	[p19l1728t2442r2001b2525],
24	13,14	CD	NUMBER	13,14	num	25	SENT_281	[p19l1728t2442r2001b2525],
25	)	NN	O	)	tmod	3	SENT_281	[p19l1728t2442r2001b2525],
26	,	,	O	,	_	0	SENT_281	[p19l1728t2442r2001b2525],
27	although	IN	O	although	mark	31	SENT_281	[p19l2048t2444r2137b2510, p19l10t2550r263b2639],
28	a	DT	O	a	det	29	SENT_281	[p19l296t2576r330b2616],
29	trend	NN	O	trend	nsubjpass	31	SENT_281	[p19l360t2550r548b2616],
30	was	VBD	O	be	auxpass	31	SENT_281	[p19l574t2576r704b2616],
31	observed	VBN	O	observe	dep	25	SENT_281	[p19l737t2550r1045b2616],
32	in	IN	O	in	_	0	SENT_281	[p19l1076t2553r1143b2615],
33	the	DT	O	the	det	37	SENT_281	[p19l1175t2550r1285b2616],
34	Mega	JJ	O	mega	amod	37	SENT_281	[p19l1315t2551r1521b2639],
35	et	FW	O	et	nn	37	SENT_281	[p19l1551t2567r1615b2616],
36	al.	FW	O	al.	nn	37	SENT_281	[p19l1646t2550r1720b2616],
37	study	NN	O	study	prep_in	31	SENT_281	[p19l1757t2550r1946b2639],
38	(	CD	NUMBER	(	number	39	SENT_281	[p19l1977t2548r2137b2631],
39	13	CD	NUMBER	13	num	40	SENT_281	[p19l1977t2548r2137b2631],
40	)	NN	O	)	dep	37	SENT_281	[p19l1977t2548r2137b2631],
41	,	,	O	,	_	0	SENT_281	[p19l1977t2548r2137b2631],
42	suggesting	VBG	O	suggest	xcomp	31	SENT_281	[p19l11t2659r383b2745],
43	that	IN	O	that	complm	50	SENT_281	[p19l412t2656r553b2722],
44	the	DT	O	the	det	45	SENT_281	[p19l582t2656r692b2722],
45	absence	NN	O	absence	nsubj	50	SENT_281	[p19l725t2656r994b2722],
46	of	IN	O	of	_	0	SENT_281	[p19l1026t2656r1106b2722],
47	diﬁerence	NN	O	diﬁerence	prep_of	45	SENT_281	[p19l1125t2656r1465b2722],
48	might	MD	O	might	aux	50	SENT_281	[p19l1497t2656r1709b2745],
49	be	VB	O	be	cop	50	SENT_281	[p19l1736t2656r1817b2722],
50	due	JJ	O	due	ccomp	42	SENT_281	[p19l1850t2656r1973b2722],
51	to	TO	O	to	_	0	SENT_281	[p19l2005t2673r2073b2722],
52	a	DT	O	a	det	53	SENT_281	[p19l2107t2682r2141b2722],
53	lack	NN	O	lack	prep_to	50	SENT_281	[p19l9t2762r152b2828],
54	of	IN	O	of	_	0	SENT_281	[p19l183t2762r262b2828],
55	power	NN	O	power	prep_of	53	SENT_281	[p19l282t2787r501b2851],
56	in	IN	O	in	mark	60	SENT_281	[p19l533t2765r600b2827],
57	238	CD	NUMBER	238	num	59	SENT_281	[p19l632t2765r761b2829],
58	healthy	JJ	O	healthy	amod	59	SENT_281	[p19l798t2762r1060b2851],
59	volunteers	NNS	O	volunteer	nsubj	60	SENT_281	[p19l1086t2762r1448b2828],
60	(	VBP	O	(	advcl	50	SENT_281	[p19l1486t2760r1757b2843],
61	13,14	CD	NUMBER	13,14	number	62	SENT_281	[p19l1486t2760r1757b2843],
62	)	CD	NUMBER	)	dobj	60	SENT_281	[p19l1486t2760r1757b2843],
63	.	.	O	.	_	0	SENT_281	[p19l1486t2760r1757b2843],

1	However	RB	O	however	advmod	5	SENT_282	[p19l1796t2763r2137b2843],
2	,	,	O	,	_	0	SENT_282	[p19l1796t2763r2137b2843],
3	these	DT	O	these	det	4	SENT_282	[p19l10t2868r190b2934],
4	studies	NNS	O	study	nsubj	5	SENT_282	[p19l247t2868r485b2934],
5	included	VBD	O	include	_	0	SENT_282	[p19l541t2868r844b2934],
6	mainly	RB	O	mainly	advmod	5	SENT_282	[p19l900t2868r1141b2957],
7	healthy	JJ	O	healthy	amod	8	SENT_282	[p19l1192t2868r1454b2957],
8	subjects	NNS	O	subject	dobj	5	SENT_282	[p19l1507t2868r1799b2957],
9	,	,	O	,	_	0	SENT_282	[p19l1507t2868r1799b2957],
10	assessed	VBN	O	assess	partmod	8	SENT_282	[p19l1859t2868r2141b2934],
11	biological	JJ	O	biological	amod	12	SENT_282	[p19l8t2975r352b3064],
12	response	NN	O	response	dobj	10	SENT_282	[p19l392t3000r694b3064],
13	to	TO	O	to	_	0	SENT_282	[p19l736t2992r804b3041],
14	60	CD	NUMBER	60	number	15	SENT_282	[p19l849t2978r1085b3064],
15	—	CD	NUMBER	—	num	17	SENT_282	[p19l849t2978r1085b3064],
16	mg	NN	O	mg	nn	17	SENT_282	[p19l849t2978r1085b3064],
17	prasugrel	NN	O	prasugrel	prep_to	10	SENT_282	[p19l1124t2975r1448b3064],
18	loading	VBG	O	load	xcomp	10	SENT_282	[p19l1486t2975r1752b3064],
19	dose	NN	O	dose	dobj	18	SENT_282	[p19l1792t2975r1968b3056],
20	,	,	O	,	_	0	SENT_282	[p19l1792t2975r1968b3056],
21	and	CC	O	and	advmod	8	SENT_282	[p19l2014t2975r2141b3041],

1	E	NN	O	e	_	0	SENT_283	[p20l163t278r226b323],

1	I	PRP	O	I	_	0	SENT_284	[p20l1460t662r1556b720],
2	-	:	O	-	_	0	SENT_284	[p20l1460t662r1556b720],
3	*	SYM	O	*	dep	5	SENT_284	[p20l1594t666r1687b714],
4	-	:	O	-	_	0	SENT_284	[p20l1594t666r1687b714],
5	'17	CD	NUMBER	'17	dep	1	SENT_284	[p20l1594t666r1687b714],
6	Carriers	NNS	O	carrier	nn	7	SENT_284	[p20l1709t666r1937b714],
7	E	NN	O	e	dep	1	SENT_284	[p20l1460t752r1556b807],
8	*	CD	NUMBER	*	number	9	SENT_284	[p20l1594t752r1687b800],
9	1	CD	NUMBER	1	num	10	SENT_284	[p20l1594t752r1687b800],
10	]	NN	O	]	dep	7	SENT_284	[p20l1594t752r1687b800],
11	?	.	O	?	_	0	SENT_284	[p20l1594t752r1687b800],

1	Non	NN	O	non	_	0	SENT_285	[p20l1712t752r1815b800],
2	Carrier	NN	O	carrier	dep	1	SENT_285	[p20l1838t752r2065b800],
3	's	POS	O	's	possessive	2	SENT_285	[p20l1838t752r2065b800],

1	.1	NN	NUMBER	.1	nn	2	SENT_286	[p20l166t717r188b762],
2	GI	NN	O	gi	_	0	SENT_286	[p20l195t717r229b762],

1	10	CD	NUMBER	10	num	2	SENT_287	[p20l166t935r224b979],
2	lncidenvce	NN	O	lncidenvce	_	0	SENT_287	[p20l82t1162r128b1440],
3	of	IN	O	of	_	0	SENT_287	[p20l82t1081r128b1142],
4	Bleeding	VBG	O	bleed	prepc_of	2	SENT_287	[p20l82t816r141b1063],
5	Compllicatlons	NNS	O	compllicatlon	dobj	4	SENT_287	[p20l82t374r141b791],
6	(	CD	NUMBER	(	number	7	SENT_287	[p20l82t253r141b352],
7	“	CD	NUMBER	“	dep	8	SENT_287	[p20l82t253r141b352],
8	M	NN	O	m	dep	5	SENT_287	[p20l82t253r141b352],

1	DI	NNP	O	DI	_	0	SENT_288	[p20l195t1155r226b1200],

1	Q	NNP	O	Q	_	0	SENT_289	[p20l195t1372r224b1417],

1	*	NN	O	*	_	0	SENT_290	[p20l377t1430r460b1475],
2	1	CD	NUMBER	1	dep	1	SENT_290	[p20l377t1430r460b1475],
3	?	.	O	?	_	0	SENT_290	[p20l377t1430r460b1475],

1	Carriers	NNS	O	carrier	nsubj	2	SENT_291	[p20l479t1430r697b1475],
2	*	VBP	O	*	_	0	SENT_291	[p20l879t1430r927b1475],
3	1	CD	NUMBER	1	number	4	SENT_291	[p20l879t1430r927b1475],
4	7	CD	NUMBER	7	num	6	SENT_291	[p20l937t1430r966b1475],
5	Ma-n	NN	O	ma-n	nn	6	SENT_291	[p20l988t1430r1095b1475],
6	Carriers	NNS	O	carrier	dobj	2	SENT_291	[p20l1111t1430r1332b1475],

1	Figure	NN	O	figure	_	0	SENT_292	[p20l65t1612r233b1667],
2	7	CD	NUMBER	7	dep	1	SENT_292	[p20l259t1612r307b1656],
3	.	.	O	.	_	0	SENT_292	[p20l259t1612r307b1656],

1	Bleeding	NN	O	bleeding	_	0	SENT_293	[p20l335t1612r575b1667],
2	and	CC	O	and	_	0	SENT_293	[p20l597t1612r693b1656],
3	CYP2C19	NN	O	cyp2c19	conj_and	1	SENT_293	[p20l721t1612r1105b1656],
4	*	CD	NUMBER	*	number	5	SENT_293	[p20l721t1612r1105b1656],
5	17	CD	NUMBER	17	num	1	SENT_293	[p20l721t1612r1105b1656],
6	Status	NNP	O	Status	nn	7	SENT_293	[p20l1119t1612r1301b1656],
7	Incidence	NN	O	incidence	dep	1	SENT_293	[p20l66t1744r311b1790],
8	of	IN	O	of	_	0	SENT_293	[p20l336t1743r389b1790],
9	bleeding	VBG	O	bleed	prepc_of	7	SENT_293	[p20l411t1744r634b1802],
10	complications	NNS	O	complication	dobj	9	SENT_293	[p20l661t1744r1022b1801],
11	according	VBG	O	accord	_	0	SENT_293	[p20l1047t1744r1300b1802],
12	to	TO	O	to	prepc_according_to	9	SENT_293	[p20l1325t1751r1377b1790],
13	CYP2C19	NN	O	cyp2c19	pobj	9	SENT_293	[p20l1403t1746r1714b1790],
14	*	CD	NUMBER	*	num	13	SENT_293	[p20l1403t1746r1714b1790],
15	77	CD	NUMBER	77	num	16	SENT_293	[p20l1403t1746r1714b1790],
16	status	NN	O	status	dep	13	SENT_293	[p20l1735t1751r1898b1790],
17	.	.	O	.	_	0	SENT_293	[p20l1735t1751r1898b1790],

1	1286	CD	DATE	1286	num	2	SENT_294	[p20l12t2026r154b2070],
2	Cuisset	NNP	O	Cuisset	_	0	SENT_294	[p20l332t2026r523b2070],
3	et	FW	O	et	nn	4	SENT_294	[p20l544t2028r596b2070],
4	al.	FW	O	al.	dep	2	SENT_294	[p20l614t2027r672b2070],
5	.	.	O	.	_	0	SENT_294	[p20l614t2027r672b2070],

1	Genetic	JJ	O	genetic	nsubj	5	SENT_295	[p20l332t2108r533b2152],
2	and	CC	O	and	_	0	SENT_295	[p20l554t2109r649b2152],
3	Prasugrel	NNP	O	Prasugrel	nn	4	SENT_295	[p20l675t2109r922b2163],
4	Response	NNP	O	Response	conj_and	1	SENT_295	[p20l948t2109r1204b2162],
5	used	VBD	O	use	_	0	SENT_295	[p20l10t2325r170b2392],
6	LTA	NNP	ORGANIZATION	LTA	dobj	5	SENT_295	[p20l194t2324r379b2391],
7	as	IN	O	as	_	0	SENT_295	[p20l404t2352r467b2392],
8	platelet	NN	O	platelet	nn	9	SENT_295	[p20l492t2325r754b2415],
9	test	NN	O	test	prep_as	5	SENT_295	[p20l777t2342r918b2392],
10	.	.	O	.	_	0	SENT_295	[p20l777t2342r918b2392],

1	Moreover	RB	O	moreover	advmod	11	SENT_296	[p20l946t2326r1315b2406],
2	,	,	O	,	_	0	SENT_296	[p20l946t2326r1315b2406],
3	the	DT	O	the	det	8	SENT_296	[p20l1342t2325r1453b2392],
4	CYP2C19	NN	O	cyp2c19	nn	8	SENT_296	[p20l1485t2329r1896b2393],
5	*	CD	NUMBER	*	num	8	SENT_296	[p20l1485t2329r1896b2393],
6	J	NN	O	j	nn	8	SENT_296	[p20l1485t2329r1896b2393],
7	7	CD	NUMBER	7	num	8	SENT_296	[p20l1912t2330r1949b2392],
8	allele	NN	O	allele	nsubjpass	11	SENT_296	[p20l1970t2325r2147b2392],
9	was	VBD	O	be	auxpass	11	SENT_296	[p20l7t2460r137b2500],
10	not	RB	O	not	neg	11	SENT_296	[p20l165t2450r282b2500],
11	included	VBN	O	include	_	0	SENT_296	[p20l306t2433r610b2500],
12	in	IN	O	in	_	0	SENT_296	[p20l634t2436r702b2499],
13	the	DT	O	the	det	15	SENT_296	[p20l727t2433r837b2500],
14	genetic	JJ	O	genetic	amod	15	SENT_296	[p20l863t2436r1116b2523],
15	subanalysis	NN	O	subanalysis	prep_in	11	SENT_296	[p20l1142t2433r1530b2523],
16	of	IN	O	of	_	0	SENT_296	[p20l1558t2433r1638b2500],
17	the	DT	O	the	det	19	SENT_296	[p20l1650t2433r1761b2500],
18	TRITON	NNP	ORGANIZATION	TRITON	nn	19	SENT_296	[p20l1784t2432r2146b2500],
19	study	NN	O	study	prep_of	15	SENT_296	[p20l12t2541r202b2631],
20	(	CD	NUMBER	(	num	22	SENT_296	[p20l258t2539r418b2622],
21	13	CD	NUMBER	13	num	22	SENT_296	[p20l258t2539r418b2622],
22	)	NN	O	)	dobj	11	SENT_296	[p20l258t2539r418b2622],
23	.	.	O	.	_	0	SENT_296	[p20l258t2539r418b2622],

1	Our	PRP$	O	we	poss	3	SENT_297	[p20l481t2541r626b2608],
2	present	JJ	DATE	present	amod	3	SENT_297	[p20l680t2558r939b2631],
3	results	NNS	O	result	nsubj	4	SENT_297	[p20l994t2541r1217b2608],
4	are	VBP	O	be	_	0	SENT_297	[p20l1278t2567r1378b2608],
5	in	IN	O	in	_	0	SENT_297	[p20l1436t2544r1504b2607],
6	line	NN	O	line	prep_in	4	SENT_297	[p20l1559t2541r1688b2608],
7	with	IN	O	with	mark	12	SENT_297	[p20l1742t2542r1904b2608],
8	those	DT	O	those	det	11	SENT_297	[p20l1960t2541r2147b2608],
9	previously	RB	DATE	previously	advmod	10	SENT_297	[p20l10t2650r371b2739],
10	published	VBN	O	publish	amod	11	SENT_297	[p20l390t2649r736b2739],
11	studies	NNS	O	study	nsubj	12	SENT_297	[p20l760t2649r999b2716],
12	(	VBP	O	(	advcl	4	SENT_297	[p20l1028t2647r1278b2730],
13	13,14	CD	NUMBER	13,14	number	14	SENT_297	[p20l1028t2647r1278b2730],
14	)	CD	NUMBER	)	dobj	12	SENT_297	[p20l1028t2647r1278b2730],
15	observing	VBG	O	observe	xcomp	12	SENT_297	[p20l1307t2650r1647b2739],
16	no	DT	O	no	det	18	SENT_297	[p20l1670t2676r1756b2716],
17	signiﬁcant	JJ	O	signiﬁcant	amod	18	SENT_297	[p20l1784t2649r2150b2739],
18	association	NN	O	association	dobj	15	SENT_297	[p20l12t2761r396b2825],
19	between	IN	O	between	_	0	SENT_297	[p20l423t2758r718b2825],
20	on-prasugrel	JJ	O	on-prasugrel	amod	22	SENT_297	[p20l747t2758r1198b2848],
21	platelet	NN	O	platelet	nn	22	SENT_297	[p20l1224t2758r1486b2848],
22	reactivity	NN	O	reactivity	prep_between	18	SENT_297	[p20l1513t2761r1839b2848],
23	assessed	VBN	O	assess	partmod	22	SENT_297	[p20l1865t2758r2149b2825],
24	by	IN	O	by	_	0	SENT_297	[p20l9t2866r95b2956],
25	ADP	NN	O	adp	agent	23	SENT_297	[p20l149t2865r489b2956],
26	.	.	O	.	_	0	SENT_297	[p20l149t2865r489b2956],

1	—	NN	O	—	_	0	SENT_298	[p20l149t2865r489b2956],
2	.	.	O	.	_	0	SENT_298	[p20l149t2865r489b2956],

1	Ag	NN	O	ag	_	0	SENT_299	[p20l149t2865r489b2956],
2	and	CC	O	and	_	0	SENT_299	[p20l549t2866r676b2933],
3	these	DT	O	these	det	5	SENT_299	[p20l736t2866r916b2933],
4	genetic	JJ	O	genetic	amod	5	SENT_299	[p20l976t2869r1230b2956],
5	variants	NNS	O	variant	conj_and	1	SENT_299	[p20l1286t2869r1581b2933],
6	.	.	O	.	_	0	SENT_299	[p20l1286t2869r1581b2933],

1	However	RB	O	however	advmod	5	SENT_300	[p20l1647t2867r1989b2947],
2	,	,	O	,	_	0	SENT_300	[p20l1647t2867r1989b2947],
3	We	PRP	O	we	nsubj	5	SENT_300	[p20l2048t2893r2147b2933],
4	originally	RB	O	originally	advmod	5	SENT_300	[p20l12t2974r347b3064],
5	observed	VBD	O	observe	_	0	SENT_300	[p20l381t2974r690b3041],
6	a	DT	O	a	det	8	SENT_300	[p20l728t3001r762b3041],
7	significant	JJ	O	significant	amod	8	SENT_300	[p20l799t2974r1166b3064],
8	effect	NN	O	effect	dobj	5	SENT_300	[p20l1202t2974r1387b3041],
9	of	IN	O	of	_	0	SENT_300	[p20l1423t2974r1504b3041],
10	CYPZCI9	NN	O	cypzci9	nn	11	SENT_300	[p20l1530t2974r1903b3042],
11	genotypes	NNS	O	genotype	prep_of	8	SENT_300	[p20l1941t3001r2145b3064, p20l11t3099r189b3172],
12	on	IN	O	on	_	0	SENT_300	[p20l218t3109r305b3149],
13	prasugrel	NN	O	prasugrel	nn	14	SENT_300	[p20l331t3083r655b3172],
14	response	NN	O	response	prep_on	5	SENT_300	[p20l680t3108r984b3172],
15	assessed	VBN	O	assess	partmod	14	SENT_300	[p20l1012t3082r1295b3149],
16	by	IN	O	by	_	0	SENT_300	[p20l1319t3083r1405b3172],
17	PRI	NNP	ORGANIZATION	PRI	nn	18	SENT_300	[p20l1429t3083r1572b3148],
18	VASP	NN	ORGANIZATION	vasp	agent	15	SENT_300	[p20l1601t3081r1847b3149],
19	.	.	O	.	_	0	SENT_300	[p20l1601t3081r1847b3149],

1	Among	IN	O	among	_	0	SENT_301	[p20l1876t3081r2150b3172],
2	each	DT	O	each	det	3	SENT_301	[p20l12t3191r169b3257],
3	genotype	NN	O	genotype	prep_among	7	SENT_301	[p20l192t3208r534b3280],
4	,	,	O	,	_	0	SENT_301	[p20l192t3208r534b3280],
5	We	PRP	O	we	nsubj	7	SENT_301	[p20l558t3217r657b3257],
6	still	RB	O	still	advmod	7	SENT_301	[p20l684t3190r810b3257],
7	observed	VBD	O	observe	_	0	SENT_301	[p20l835t3190r1144b3257],
8	a	DT	O	a	det	10	SENT_301	[p20l1170t3217r1204b3257],
9	large	JJ	O	large	amod	10	SENT_301	[p20l1227t3191r1396b3280],
10	variability	NN	O	variability	dobj	7	SENT_301	[p20l1419t3190r1774b3280],
11	of	IN	O	of	_	0	SENT_301	[p20l1796t3190r1876b3257],
12	platelet	NN	O	platelet	nn	13	SENT_301	[p20l1888t3190r2150b3280],
13	response	NN	O	response	prep_of	10	SENT_301	[p20l11t3325r314b3389],
14	to	TO	O	to	_	0	SENT_301	[p20l348t3316r416b3366],
15	prasugrel	NN	O	prasugrel	prep_to	7	SENT_301	[p20l450t3300r791b3389],
16	.	.	O	.	_	0	SENT_301	[p20l450t3300r791b3389],

1	This	DT	O	this	npadvmod	2	SENT_302	[p20l826t3298r990b3366],
2	ﬁnding	JJ	O	ﬁnding	dep	3	SENT_302	[p20l1025t3299r1281b3389],
3	highlights	VBZ	O	highlight	_	0	SENT_302	[p20l1312t3299r1669b3389],
4	the	DT	O	the	det	5	SENT_302	[p20l1703t3300r1814b3366],
5	fact	NN	O	fact	dobj	3	SENT_302	[p20l1847t3299r1977b3366],
6	that	IN	O	that	dep	19	SENT_302	[p20l2008t3300r2150b3366],
7	prasugrel	NN	O	prasugrel	nn	8	SENT_302	[p21l10t35r334b125],
8	response	NN	O	response	nsubj	19	SENT_302	[p21l364t61r688b125],
9	,	,	O	,	_	0	SENT_302	[p21l364t61r688b125],
10	as	IN	O	as	mark	11	SENT_302	[p21l723t62r786b102],
11	described	VBN	O	describe	dep	8	SENT_302	[p21l820t35r1152b102],
12	for	IN	O	for	_	0	SENT_302	[p21l1182t35r1283b102],
13	clopidogrel	NN	O	clopidogrel	nn	14	SENT_302	[p21l1313t35r1709b125],
14	response	NN	O	response	prep_for	11	SENT_302	[p21l1738t61r2062b125],
15	,	,	O	,	_	0	SENT_302	[p21l1738t61r2062b125],
16	is	VBZ	O	be	cop	19	SENT_302	[p21l2096t38r2147b102],
17	a	DT	O	a	det	19	SENT_302	[p21l12t170r47b210],
18	multifactorial	JJ	O	multifactorial	amod	19	SENT_302	[p21l73t143r553b210],
19	process	NN	O	process	dep	5	SENT_302	[p21l577t169r832b233],
20	and	CC	O	and	_	0	SENT_302	[p21l862t143r989b210],
21	that	IN	O	that	dep	28	SENT_302	[p21l1015t144r1156b210],
22	genetic	JJ	O	genetic	amod	23	SENT_302	[p21l1180t146r1434b233],
23	modulation	NN	O	modulation	nsubj	28	SENT_302	[p21l1461t143r1870b210],
24	is	VBZ	O	be	cop	28	SENT_302	[p21l1896t146r1947b210],
25	only	RB	O	only	advmod	28	SENT_302	[p21l1976t143r2145b233],
26	,	,	O	,	_	0	SENT_302	[p21l1976t143r2145b233],
27	although	IN	O	although	dep	28	SENT_302	[p21l12t252r326b342],
28	strong	JJ	O	strong	dep	5	SENT_302	[p21l362t269r603b342],
29	,	,	O	,	_	0	SENT_302	[p21l362t269r603b342],
30	1	CD	NUMBER	1	num	31	SENT_302	[p21l645t256r677b318],
31	factor	NN	O	factor	appos	5	SENT_302	[p21l717t252r922b319],
32	explaining	VBG	O	explain	partmod	31	SENT_302	[p21l956t252r1323b342],
33	variability	NN	O	variability	dobj	32	SENT_302	[p21l1353t252r1708b342],
34	of	IN	O	of	_	0	SENT_302	[p21l1741t252r1821b319],
35	response	NN	O	response	prep_of	33	SENT_302	[p21l1844t278r2147b342],
36	(	CD	NUMBER	(	num	35	SENT_302	[p21l14t358r174b441],
37	24	CD	NUMBER	24	num	38	SENT_302	[p21l14t358r174b441],
38	)	NN	O	)	nsubj	3	SENT_302	[p21l14t358r174b441],
39	.	.	O	.	_	0	SENT_302	[p21l14t358r174b441],

1	We	PRP	O	we	nsubj	3	SENT_303	[p21l219t361r349b427],
2	thus	RB	O	thus	advmod	3	SENT_303	[p21l394t360r542b427],
3	observed	VBD	O	observe	_	0	SENT_303	[p21l589t361r898b427],
4	in	IN	O	in	_	0	SENT_303	[p21l942t363r1010b426],
5	our	PRP$	O	we	poss	6	SENT_303	[p21l1054t386r1172b427],
6	study	NN	O	study	prep_in	3	SENT_303	[p21l1216t360r1405b450],
7	a	DT	O	a	det	9	SENT_303	[p21l1447t387r1481b427],
8	clear	JJ	O	clear	amod	9	SENT_303	[p21l1525t360r1689b427],
9	discordance	NN	O	discordance	dobj	3	SENT_303	[p21l1732t360r2147b427],
10	between	IN	O	between	_	0	SENT_303	[p21l9t469r304b536],
11	the	DT	O	the	det	12	SENT_303	[p21l339t469r449b536],
12	effect	NN	O	effect	prep_between	9	SENT_303	[p21l487t469r673b536],
13	of	IN	O	of	_	0	SENT_303	[p21l707t469r787b536],
14	genetic	JJ	O	genetic	amod	15	SENT_303	[p21l810t472r1064b559],
15	variants	NNS	O	variant	prep_of	12	SENT_303	[p21l1095t472r1370b536],
16	on	IN	O	on	_	0	SENT_303	[p21l1408t496r1496b536],
17	platelet	NN	O	platelet	nn	18	SENT_303	[p21l1530t469r1792b559],
18	reactivity	NN	O	reactivity	prep_on	12	SENT_303	[p21l1826t472r2152b559],
19	(	CD	NUMBER	(	num	20	SENT_303	[p21l14t575r401b667],
20	ADP	NN	O	adp	dep	12	SENT_303	[p21l14t575r401b667],
21	.	.	O	.	_	0	SENT_303	[p21l14t575r401b667],

1	—	NN	O	—	_	0	SENT_304	[p21l14t575r401b667],
2	.	.	O	.	_	0	SENT_304	[p21l14t575r401b667],

1	Ag	NN	O	ag	nn	2	SENT_305	[p21l14t575r401b667],
2	)	NN	O	)	_	0	SENT_305	[p21l14t575r401b667],
3	and	CC	O	and	_	0	SENT_305	[p21l437t577r564b644],
4	prasugrel	NN	O	prasugrel	nn	5	SENT_305	[p21l592t577r917b667],
5	response	NN	O	response	conj_and	2	SENT_305	[p21l946t603r1249b667],
6	(	CD	NUMBER	(	num	8	SENT_305	[p21l1283t575r1454b658],
7	PR1	NN	O	pr1	nn	8	SENT_305	[p21l1283t575r1454b658],
8	VASP	NN	ORGANIZATION	vasp	dep	2	SENT_305	[p21l1486t575r1762b658],
9	)	CD	NUMBER	)	dep	8	SENT_305	[p21l1486t575r1762b658],
10	.	.	O	.	_	0	SENT_305	[p21l1486t575r1762b658],

1	For	IN	O	for	_	0	SENT_306	[p21l1797t578r1923b644],
2	years	NNS	DURATION	year	prep_for	9	SENT_306	[p21l1949t603r2145b667],
3	,	,	O	,	_	0	SENT_306	[p21l1949t603r2145b667],
4	several	JJ	O	several	amod	6	SENT_306	[p21l12t686r247b753],
5	platelet	NN	O	platelet	nn	6	SENT_306	[p21l277t686r540b776],
6	tests	NNS	O	test	nsubjpass	9	SENT_306	[p21l571t703r724b753],
7	have	VBP	O	have	aux	9	SENT_306	[p21l759t686r918b753],
8	been	VBN	O	be	auxpass	9	SENT_306	[p21l950t687r1117b753],
9	proposed	VBN	O	propose	_	0	SENT_306	[p21l1149t686r1475b776],
10	to	TO	O	to	aux	11	SENT_306	[p21l1508t703r1576b753],
11	assess	VB	O	assess	xcomp	9	SENT_306	[p21l1612t713r1808b753],
12	response	NN	O	response	dobj	11	SENT_306	[p21l1844t712r2147b776],
13	to	TO	O	to	_	0	SENT_306	[p21l11t848r79b898],
14	thienopyridine	NN	O	thienopyridine	prep_to	11	SENT_306	[p21l114t831r654b921],
15	.	.	O	.	_	0	SENT_306	[p21l114t831r654b921],

1	In	IN	O	in	_	0	SENT_307	[p21l692t832r769b897],
2	clopidogrel-treated	JJ	O	clopidogrel-treated	amod	3	SENT_307	[p21l805t831r1484b921],
3	patients	NNS	O	patient	prep_in	7	SENT_307	[p21l1515t834r1814b921],
4	,	,	O	,	_	0	SENT_307	[p21l1515t834r1814b921],
5	different	JJ	O	different	amod	6	SENT_307	[p21l1852t831r2150b898],
6	tests	NNS	O	test	nsubj	7	SENT_307	[p21l11t956r164b1006],
7	have	VBP	O	have	_	0	SENT_307	[p21l217t940r375b1006],
8	signiﬁcant	JJ	O	signiﬁcant	amod	9	SENT_307	[p21l428t939r795b1029],
9	correlation	NN	O	correlation	dobj	7	SENT_307	[p21l844t939r1225b1006],
10	but	CC	O	but	prep	9	SENT_307	[p21l1273t940r1392b1006],
11	their	PRP$	O	they	poss	12	SENT_307	[p21l1441t939r1609b1006],
12	agreement	NN	O	agreement	dep	10	SENT_307	[p21l1659t956r2029b1029],
13	to	TO	O	to	aux	14	SENT_307	[p21l2078t956r2146b1006],
14	identify	VB	O	identify	infmod	12	SENT_307	[p21l11t1048r286b1137],
15	speciﬁc	NN	O	speciﬁc	nn	16	SENT_307	[p21l312t1048r569b1138],
16	patients	NNS	O	patient	dobj	14	SENT_307	[p21l596t1051r874b1138],
17	as	IN	O	as	_	0	SENT_307	[p21l905t1074r968b1114],
18	responders	NNS	O	responder	prep_as	14	SENT_307	[p21l999t1048r1378b1138],
19	or	CC	O	or	_	0	SENT_307	[p21l1409t1074r1481b1114],
20	not	RB	O	not	conj_or	7	SENT_307	[p21l1509t1065r1627b1114],
21	are	VBP	O	be	dep	7	SENT_307	[p21l1655t1074r1755b1114],
22	rather	RB	O	rather	prep	21	SENT_307	[p21l1785t1048r1996b1114],
23	low	JJ	O	low	amod	26	SENT_307	[p21l2022t1048r2151b1115],
24	(	NN	O	(	nn	26	SENT_307	[p21l14t1154r174b1237],
25	25	CD	NUMBER	25	num	26	SENT_307	[p21l14t1154r174b1237],
26	)	NN	O	)	pobj	22	SENT_307	[p21l14t1154r174b1237],
27	.	.	O	.	_	0	SENT_307	[p21l14t1154r174b1237],

1	Accordingly	RB	O	accordingly	advmod	14	SENT_308	[p21l207t1155r663b1245],
2	,	,	O	,	_	0	SENT_308	[p21l207t1155r663b1245],
3	the	DT	O	the	det	6	SENT_308	[p21l697t1156r807b1222],
4	gold	JJ	O	gold	amod	6	SENT_308	[p21l838t1156r993b1245],
5	standard	JJ	O	standard	amod	6	SENT_308	[p21l1025t1156r1328b1222],
6	test	NN	O	test	nsubj	14	SENT_308	[p21l1358t1173r1484b1222],
7	to	TO	O	to	aux	8	SENT_308	[p21l1512t1173r1581b1222],
8	assess	VB	O	assess	infmod	6	SENT_308	[p21l1615t1183r1811b1222],
9	response	NN	O	response	dobj	8	SENT_308	[p21l1844t1182r2147b1246],
10	to	TO	O	to	_	0	SENT_308	[p21l11t1281r79b1330],
11	thienopyridine	NN	O	thienopyridine	prep_to	8	SENT_308	[p21l104t1264r625b1353],
12	is	VBZ	O	be	cop	14	SENT_308	[p21l649t1267r699b1330],
13	still	RB	O	still	advmod	14	SENT_308	[p21l727t1264r852b1330],
14	controversial	JJ	O	controversial	_	0	SENT_308	[p21l876t1264r1346b1345],
15	,	,	O	,	_	0	SENT_308	[p21l876t1264r1346b1345],
16	and	CC	O	and	_	0	SENT_308	[p21l1375t1264r1503b1330],
17	the	DT	O	the	det	19	SENT_308	[p21l1525t1264r1636b1330],
18	best	JJS	O	best	amod	19	SENT_308	[p21l1658t1264r1802b1330],
19	option	NN	O	option	nsubj	49	SENT_308	[p21l1824t1267r2055b1353],
20	to	TO	O	to	aux	21	SENT_308	[p21l2078t1281r2146b1330],
21	predict	VB	O	predict	infmod	19	SENT_308	[p21l10t1373r259b1462],
22	clinical	JJ	O	clinical	amod	23	SENT_308	[p21l281t1373r530b1439],
23	outcomes	NNS	O	outcome	dobj	21	SENT_308	[p21l553t1390r887b1439],
24	between	IN	O	between	_	0	SENT_308	[p21l910t1373r1204b1439],
25	a	DT	O	a	det	32	SENT_308	[p21l1229t1399r1263b1439],
26	speciﬁc	JJ	O	speciﬁc	amod	32	SENT_308	[p21l1287t1373r1544b1463],
27	pharmacological	JJ	O	pharmacological	amod	32	SENT_308	[p21l1565t1373r2149b1463],
28	test	NN	O	test	nn	32	SENT_308	[p21l11t1498r136b1547],
29	(	NN	O	(	nn	32	SENT_308	[p21l172t1479r343b1562],
30	PR1	NN	O	pr1	nn	32	SENT_308	[p21l172t1479r343b1562],
31	VASP	NN	ORGANIZATION	vasp	nn	32	SENT_308	[p21l380t1479r634b1561],
32	)	NN	O	)	prep_between	23	SENT_308	[p21l380t1479r634b1561],
33	and	CC	O	and	_	0	SENT_308	[p21l674t1481r802b1547],
34	more	JJR	O	more	amod	35	SENT_308	[p21l837t1507r1017b1547],
35	“	NN	O	“	dobj	21	SENT_308	[p21l1053t1481r1329b1570],
36	global	JJ	O	global	amod	38	SENT_308	[p21l1053t1481r1329b1570],
37	”	NN	O	”	nn	38	SENT_308	[p21l1053t1481r1329b1570],
38	assessment	NN	O	assessment	dep	35	SENT_308	[p21l1367t1498r1752b1547],
39	of	IN	O	of	_	0	SENT_308	[p21l1786t1481r1866b1547],
40	platelet	NN	O	platelet	nn	41	SENT_308	[p21l1888t1481r2150b1571],
41	reactivity	NN	O	reactivity	prep_of	38	SENT_308	[p21l11t1592r337b1678],
42	(	CD	NUMBER	(	num	41	SENT_308	[p21l368t1587r599b1670],
43	LTA	NNP	ORGANIZATION	LTA	nn	45	SENT_308	[p21l368t1587r599b1670],
44	,	,	O	,	_	0	SENT_308	[p21l368t1587r599b1670],
45	VerifyNow	NNP	O	VerifyNow	dep	38	SENT_308	[p21l635t1587r1055b1678],
46	)	CD	NUMBER	)	num	45	SENT_308	[p21l635t1587r1055b1678],
47	is	VBZ	O	be	cop	49	SENT_308	[p21l1091t1592r1141b1655],
48	still	RB	O	still	advmod	49	SENT_308	[p21l1177t1589r1304b1655],
49	unclear	JJ	O	unclear	conj_and	14	SENT_308	[p21l1334t1589r1608b1655],
50	.	.	O	.	_	0	SENT_308	[p21l1334t1589r1608b1655],

1	In	IN	O	in	_	0	SENT_309	[p21l1645t1590r1722b1654],
2	the	DT	O	the	det	4	SENT_309	[p21l1755t1589r1865b1655],
3	important	JJ	O	important	amod	4	SENT_309	[p21l1899t1592r2145b1678, p21l11t1714r152b1762],
4	POPULAR	NN	O	popular	prep_in	6	SENT_309	[p21l182t1695r617b1763],
5	(	CD	NUMBER	(	nsubj	6	SENT_309	[p21l649t1695r787b1777],
6	Do	VBP	O	do	_	0	SENT_309	[p21l649t1695r787b1777],
7	Point	NN	O	point	dobj	6	SENT_309	[p21l820t1697r1331b1763],
8	.	.	O	.	_	0	SENT_309	[p21l820t1697r1331b1763],

1	—	NN	O	—	_	0	SENT_310	[p21l820t1697r1331b1763],
2	.	.	O	.	_	0	SENT_310	[p21l820t1697r1331b1763],

1	of	IN	O	of	_	0	SENT_311	[p21l820t1697r1331b1763],
2	.	.	O	.	_	0	SENT_311	[p21l820t1697r1331b1763],

1	—	NN	O	—	_	0	SENT_312	[p21l820t1697r1331b1763],
2	.	.	O	.	_	0	SENT_312	[p21l820t1697r1331b1763],

1	Care	NNP	O	Care	nn	4	SENT_313	[p21l820t1697r1331b1763],
2	Platelet	NN	O	platelet	nn	4	SENT_313	[p21l1363t1697r1632b1762],
3	Function	NN	O	function	nn	4	SENT_313	[p21l1663t1698r1985b1762],
4	Assays	NNS	O	assay	nsubj	5	SENT_313	[p21l2015t1695r2145b1762, p21l12t1832r146b1895],
5	Predict	VB	O	predict	_	0	SENT_313	[p21l177t1806r433b1872],
6	Clinical	JJ	O	clinical	amod	7	SENT_313	[p21l461t1806r739b1872],
7	Outcomes	NNS	O	outcome	dobj	5	SENT_313	[p21l768t1806r1130b1872],
8	in	IN	O	in	_	0	SENT_313	[p21l1161t1809r1229b1871],
9	Clopidogrel	NNP	O	Clopidogrel	nn	10	SENT_313	[p21l1259t1806r1684b1895],
10	Pre	NNP	O	Pre	prep_in	5	SENT_313	[p21l1711t1804r2149b1872],
11	.	.	O	.	_	0	SENT_313	[p21l1711t1804r2149b1872],

1	—	NN	O	—	_	0	SENT_314	[p21l1711t1804r2149b1872],
2	.	.	O	.	_	0	SENT_314	[p21l1711t1804r2149b1872],

1	Treated	VBN	O	treat	partmod	16	SENT_315	[p21l1711t1804r2149b1872],
2	Patients	NNPS	O	Patients	nsubj	3	SENT_315	[p21l11t1915r296b1980],
3	Undergoing	VBG	O	undergo	dep	1	SENT_315	[p21l355t1914r786b2003],
4	Elective	JJ	O	elective	amod	7	SENT_315	[p21l845t1914r1127b1980],
5	PCI	NN	O	pcus	nn	7	SENT_315	[p21l1188t1912r1363b1994],
6	)	NN	O	)	nn	7	SENT_315	[p21l1188t1912r1363b1994],
7	study	NN	O	study	dobj	3	SENT_315	[p21l1428t1914r1617b2003],
8	(	CD	NUMBER	(	num	10	SENT_315	[p21l1676t1912r1837b1995],
9	26	CD	NUMBER	26	num	10	SENT_315	[p21l1676t1912r1837b1995],
10	)	NN	O	)	dep	7	SENT_315	[p21l1676t1912r1837b1995],
11	,	,	O	,	_	0	SENT_315	[p21l1676t1912r1837b1995],
12	various	JJ	O	various	amod	14	SENT_315	[p21l1896t1917r2146b1980],
13	platelet	NN	O	platelet	nn	14	SENT_315	[p21l10t2021r272b2111],
14	tests	NNS	O	test	nsubjpass	16	SENT_315	[p21l306t2038r460b2088],
15	were	VBD	O	be	auxpass	16	SENT_315	[p21l495t2047r662b2088],
16	tested	VBN	O	test	_	0	SENT_315	[p21l699t2021r908b2088],
17	to	TO	O	to	aux	18	SENT_315	[p21l944t2039r1012b2088],
18	assess	VB	O	assess	xcomp	16	SENT_315	[p21l1052t2048r1248b2088],
19	clinical	JJ	O	clinical	amod	20	SENT_315	[p21l1288t2021r1537b2088],
20	outcomes	NNS	O	outcome	dobj	18	SENT_315	[p21l1573t2038r1928b2088],
21	.	.	O	.	_	0	SENT_315	[p21l1573t2038r1928b2088],

1	Only	RB	O	only	quantmod	2	SENT_316	[p21l1971t2021r2152b2111],
2	some	DT	O	some	nsubj	8	SENT_316	[p21l12t2156r193b2196],
3	of	IN	O	of	_	0	SENT_316	[p21l224t2129r304b2196],
4	the	DT	O	the	det	5	SENT_316	[p21l321t2129r431b2196],
5	tests	NNS	O	test	prep_of	2	SENT_316	[p21l461t2146r615b2196],
6	used	VBN	O	use	partmod	5	SENT_316	[p21l644t2129r804b2196],
7	were	VBD	O	be	cop	8	SENT_316	[p21l829t2155r996b2196],
8	able	JJ	O	able	_	0	SENT_316	[p21l1028t2129r1166b2196],
9	to	TO	O	to	aux	10	SENT_316	[p21l1196t2147r1264b2196],
10	predict	VB	O	predict	xcomp	8	SENT_316	[p21l1294t2129r1543b2219],
11	ischemic	JJ	O	ischemic	amod	12	SENT_316	[p21l1570t2129r1878b2196],
12	events	NNS	O	event	dobj	10	SENT_316	[p21l1908t2147r2145b2210],
13	,	,	O	,	_	0	SENT_316	[p21l1908t2147r2145b2210],
14	suggesting	VBG	O	suggest	partmod	10	SENT_316	[p21l12t2241r385b2328],
15	different	JJ	O	different	amod	16	SENT_316	[p21l412t2238r709b2305],
16	performances	NNS	O	performance	dobj	14	SENT_316	[p21l734t2238r1210b2328],
17	of	IN	O	of	_	0	SENT_316	[p21l1240t2238r1321b2305],
18	platelet	NN	O	platelet	nn	19	SENT_316	[p21l1335t2238r1597b2328],
19	tests	NNS	O	test	prep_of	16	SENT_316	[p21l1622t2256r1776b2305],
20	to	TO	O	to	aux	21	SENT_316	[p21l1804t2255r1873b2305],
21	predict	VB	O	predict	xcomp	14	SENT_316	[p21l1900t2238r2150b2328],
22	clinical	JJ	O	clinical	amod	23	SENT_316	[p21l12t2381r261b2447],
23	outcome	NN	O	outcome	dobj	21	SENT_316	[p21l290t2398r613b2447],
24	.	.	O	.	_	0	SENT_316	[p21l290t2398r613b2447],

1	Our	PRP$	O	we	poss	2	SENT_317	[p21l649t2381r793b2448],
2	results	NNS	O	result	nsubj	11	SENT_317	[p21l821t2381r1065b2462],
3	,	,	O	,	_	0	SENT_317	[p21l821t2381r1065b2462],
4	focusing	VBG	O	focus	partmod	2	SENT_317	[p21l1098t2381r1396b2470],
5	on	IN	O	on	_	0	SENT_317	[p21l1424t2407r1512b2447],
6	prasugrel	NN	O	prasugrel	nn	7	SENT_317	[p21l1541t2381r2148b2471],
7	—	NN	O	—	prep_on	4	SENT_317	[p21l1541t2381r2148b2471],
8	treated	VBN	O	treat	partmod	7	SENT_317	[p21l1541t2381r2148b2471],
9	patients	NNS	O	patient	dobj	8	SENT_317	[p21l10t2492r309b2579],
10	,	,	O	,	_	0	SENT_317	[p21l10t2492r309b2579],
11	are	VBP	O	be	_	0	SENT_317	[p21l352t2515r453b2555],
12	in	IN	O	in	_	0	SENT_317	[p21l492t2492r560b2555],
13	line	NN	O	line	prep_in	11	SENT_317	[p21l597t2489r727b2555],
14	with	IN	O	with	_	0	SENT_317	[p21l762t2489r924b2556],
15	this	DT	O	this	det	16	SENT_317	[p21l963t2489r1090b2555],
16	study	NN	O	study	prep_with	13	SENT_317	[p21l1132t2489r1337b2578],
17	;	:	O	;	_	0	SENT_317	[p21l1132t2489r1337b2578],
18	only	RB	O	only	advmod	23	SENT_317	[p21l1380t2489r1533b2578],
19	PR1	NN	O	pr1	nn	20	SENT_317	[p21l1568t2490r1712b2555],
20	VASP	NN	ORGANIZATION	vasp	nsubjpass	23	SENT_317	[p21l1753t2488r1981b2556],
21	was	VBD	O	be	auxpass	23	SENT_317	[p21l2016t2516r2146b2556],
22	signiﬁcantly	RB	O	signiﬁcantly	advmod	23	SENT_317	[p21l12t2598r443b2687],
23	associated	VBN	O	associate	parataxis	11	SENT_317	[p21l497t2598r850b2664],
24	with	IN	O	with	_	0	SENT_317	[p21l902t2598r1063b2664],
25	bleeding	JJ	O	bleeding	amod	26	SENT_317	[p21l1118t2598r1423b2687],
26	events	NNS	O	event	prep_with	23	SENT_317	[p21l1478t2615r1716b2679],
27	,	,	O	,	_	0	SENT_317	[p21l1478t2615r1716b2679],
28	suggesting	VBG	O	suggest	xcomp	23	SENT_317	[p21l1776t2601r2149b2687],
29	PR1	NN	O	pr1	nn	30	SENT_317	[p21l11t2707r155b2772],
30	VASP	NN	ORGANIZATION	vasp	dobj	28	SENT_317	[p21l193t2705r422b2773],
31	as	IN	O	as	_	0	SENT_317	[p21l459t2732r523b2772],
32	the	DT	O	the	det	34	SENT_317	[p21l560t2706r671b2772],
33	best	JJS	O	best	amod	34	SENT_317	[p21l706t2706r849b2772],
34	option	NN	O	option	prep_as	28	SENT_317	[p21l884t2709r1114b2796],
35	for	IN	O	for	_	0	SENT_317	[p21l1150t2706r1251b2772],
36	bleeding	VBG	O	bleed	prepc_for	34	SENT_317	[p21l1284t2706r1589b2795],
37	risk	NN	O	risk	nn	38	SENT_317	[p21l1623t2706r1754b2772],
38	prediction	NN	O	prediction	dobj	36	SENT_317	[p21l1785t2706r2148b2796],
39	with	IN	O	with	_	0	SENT_317	[p21l7t2814r171b2880],
40	prasugrel	NN	O	prasugrel	prep_with	36	SENT_317	[p21l233t2814r578b2904],
41	.	.	O	.	_	0	SENT_317	[p21l233t2814r578b2904],

1	Indeed	RB	O	indeed	advmod	5	SENT_318	[p21l645t2814r914b2895],
2	,	,	O	,	_	0	SENT_318	[p21l645t2814r914b2895],
3	it	PRP	O	it	nsubj	5	SENT_318	[p21l980t2817r1032b2880],
4	is	VBZ	O	be	cop	5	SENT_318	[p21l1093t2817r1144b2880],
5	interesting	JJ	O	interesting	_	0	SENT_318	[p21l1208t2817r1593b2903],
6	to	TO	O	to	aux	7	SENT_318	[p21l1653t2831r1722b2880],
7	note	VB	O	note	xcomp	5	SENT_318	[p21l1788t2831r1942b2880],
8	that	IN	O	that	complm	9	SENT_318	[p21l2006t2814r2149b2880],
9	ADP	NN	O	adp	dep	7	SENT_318	[p21l9t2920r348b3011],
10	.	.	O	.	_	0	SENT_318	[p21l9t2920r348b3011],

1	—	NN	O	—	_	0	SENT_319	[p21l9t2920r348b3011],
2	.	.	O	.	_	0	SENT_319	[p21l9t2920r348b3011],

1	Ag	NN	O	ag	nsubj	4	SENT_320	[p21l9t2920r348b3011],
2	is	VBZ	O	be	cop	4	SENT_320	[p21l385t2925r435b2988],
3	scarcely	RB	O	scarcely	advmod	4	SENT_320	[p21l478t2922r750b3011],
4	lower	JJR	O	lower	_	0	SENT_320	[p21l784t2922r980b2988],
5	than	IN	O	than	_	0	SENT_320	[p21l1017t2922r1176b2988],
6	20	CD	PERCENT	20	num	7	SENT_320	[p21l1213t2925r1387b3003],
7	%	NN	PERCENT	%	prep_than	4	SENT_320	[p21l1213t2925r1387b3003],
8	,	,	O	,	_	0	SENT_320	[p21l1213t2925r1387b3003],
9	in	IN	O	in	_	0	SENT_320	[p21l1429t2925r1497b2987],
10	contrast	NN	O	contrast	prep_in	4	SENT_320	[p21l1537t2939r1820b2988],
11	to	TO	O	to	_	0	SENT_320	[p21l1857t2939r1925b2988],
12	PR1VASP	NN	O	pr1vasp	prep_to	4	SENT_320	[p21l1966t2923r2144b2987, p21l11t3028r260b3111],
13	,	,	O	,	_	0	SENT_320	[p21l1966t2923r2144b2987, p21l11t3028r260b3111],
14	which	WDT	O	which	nsubj	16	SENT_320	[p21l286t3030r504b3096],
15	may	MD	O	may	aux	16	SENT_320	[p21l532t3056r681b3119],
16	reach	VB	O	reach	rcmod	12	SENT_320	[p21l704t3030r892b3096],
17	o	NN	PERCENT	o	nn	18	SENT_320	[p21l919t3033r1047b3111],
18	%	NN	PERCENT	%	dobj	16	SENT_320	[p21l919t3033r1047b3111],
19	,	,	O	,	_	0	SENT_320	[p21l919t3033r1047b3111],
20	indicating	VBG	O	indicate	xcomp	4	SENT_320	[p21l1077t3030r1434b3119],
21	a	DT	O	a	det	22	SENT_320	[p21l1462t3056r1496b3096],
22	limit	NN	O	limit	dobj	20	SENT_320	[p21l1521t3030r1691b3096],
23	of	IN	O	of	_	0	SENT_320	[p21l1717t3030r1797b3096],
24	ADP	NN	O	adp	prep_of	22	SENT_320	[p21l1810t3028r2149b3119],
25	.	.	O	.	_	0	SENT_320	[p21l1810t3028r2149b3119],

1	—	NN	O	—	_	0	SENT_321	[p21l1810t3028r2149b3119],
2	.	.	O	.	_	0	SENT_321	[p21l1810t3028r2149b3119],

1	Ag	NN	O	ag	nsubj	19	SENT_322	[p21l1810t3028r2149b3119],
2	to	TO	O	to	aux	3	SENT_322	[p21l11t3156r79b3205],
3	detect	VB	O	detect	infmod	1	SENT_322	[p21l106t3139r319b3205],
4	strong	JJ	O	strong	amod	5	SENT_322	[p21l344t3156r566b3228],
5	degree	NN	O	degree	dobj	3	SENT_322	[p21l590t3139r818b3228],
6	of	IN	O	of	_	0	SENT_322	[p21l844t3139r924b3205],
7	P2Y12	NN	O	p2y12	nn	8	SENT_322	[p21l937t3140r1179b3206],
8	inhibition	NN	O	inhibition	prep_of	5	SENT_322	[p21l1205t3139r1577b3220],
9	,	,	O	,	_	0	SENT_322	[p21l1205t3139r1577b3220],
10	suggesting	VBG	O	suggest	partmod	3	SENT_322	[p21l1606t3142r1979b3228],
11	PR1	NN	O	pr1	nn	12	SENT_322	[p21l2002t3140r2146b3204],
12	VASP	NN	ORGANIZATION	vasp	dobj	10	SENT_322	[p21l11t3245r240b3314],
13	as	IN	O	as	_	0	SENT_322	[p21l285t3273r348b3313],
14	the	DT	O	the	det	16	SENT_322	[p21l392t3247r503b3313],
15	best	JJS	O	best	amod	16	SENT_322	[p21l545t3247r688b3313],
16	option	NN	O	option	prep_as	10	SENT_322	[p21l731t3250r961b3336],
17	in	IN	O	in	_	0	SENT_322	[p21l1004t3250r1072b3312],
18	patients	NNS	O	patient	prep_in	16	SENT_322	[p21l1114t3250r1392b3336],
19	treated	VBN	O	treat	_	0	SENT_322	[p21l1437t3247r1682b3313],
20	with	IN	O	with	_	0	SENT_322	[p21l1721t3247r1883b3313],
21	strong	JJ	O	strong	amod	23	SENT_322	[p21l1927t3264r2150b3336],
22	P2Y12	NN	O	p2y12	nn	23	SENT_322	[p21l11t3355r253b3422],
23	inhibitors	NNS	O	inhibitor	prep_with	19	SENT_322	[p21l296t3354r637b3421],
24	to	TO	O	to	aux	25	SENT_322	[p21l680t3371r748b3421],
25	assess	VB	O	assess	xcomp	19	SENT_322	[p21l792t3381r989b3421],
26	platelet	NN	O	platelet	nn	27	SENT_322	[p21l1031t3354r1292b3444],
27	response	NN	O	response	dobj	25	SENT_322	[p21l1331t3380r1635b3444],
28	and	CC	O	and	_	0	SENT_322	[p21l1678t3354r1806b3421],
29	bleeding	NN	O	bleeding	nn	30	SENT_322	[p21l1845t3354r2150b3444],
30	risk	NN	O	risk	conj_and	27	SENT_322	[p21l11t3462r156b3529],
31	.	.	O	.	_	0	SENT_322	[p21l11t3462r156b3529],

1	Accordingly	RB	O	accordingly	advmod	27	SENT_323	[p21l189t3461r645b3552],
2	,	,	O	,	_	0	SENT_323	[p21l189t3461r645b3552],
3	although	IN	O	although	mark	5	SENT_323	[p21l680t3462r994b3552],
4	ADP-Ag	NN	O	adp-ag	nsubj	5	SENT_323	[p21l1022t3461r1361b3552],
5	has	VBZ	O	have	advcl	27	SENT_323	[p21l1390t3462r1503b3529],
6	a	DT	O	a	det	8	SENT_323	[p21l1538t3489r1572b3529],
7	greater	JJR	O	greater	amod	8	SENT_323	[p21l1601t3479r1846b3552],
8	amount	NN	O	amount	dobj	5	SENT_323	[p21l1877t3479r2150b3529],
9	of	IN	O	of	_	0	SENT_323	[p21l12t3570r92b3637],
10	evidence	NN	O	evidence	prep_of	8	SENT_323	[p21l110t3570r411b3637],
11	for	IN	O	for	mark	17	SENT_323	[p21l441t3570r541b3637],
12	a	DT	O	a	det	13	SENT_323	[p21l570t3597r604b3637],
13	relationship	NN	O	relationship	nsubj	17	SENT_323	[p21l632t3570r1050b3660],
14	with	IN	O	with	_	0	SENT_323	[p21l1077t3571r1239b3637],
15	ischemic	JJ	O	ischemic	amod	16	SENT_323	[p21l1267t3570r1575b3637],
16	events	NNS	O	event	prep_with	13	SENT_323	[p21l1604t3588r1820b3637],
17	(	VBP	O	(	advcl	5	SENT_323	[p21l1853t3568r1970b3651],
18	4	CD	NUMBER	4	number	19	SENT_323	[p21l1853t3568r1970b3651],
19	)	CD	NUMBER	)	dobj	17	SENT_323	[p21l1853t3568r1970b3651],
20	,	,	O	,	_	0	SENT_323	[p21l1853t3568r1970b3651],
21	PR1	NN	O	pr1	nn	22	SENT_323	[p21l2002t3571r2146b3636],
22	VASP	NN	ORGANIZATION	vasp	nsubj	27	SENT_323	[p21l11t3677r240b3745],
23	might	MD	O	might	aux	27	SENT_323	[p21l264t3678r477b3767],
24	be	VB	O	be	cop	27	SENT_323	[p21l496t3678r577b3744],
25	a	DT	O	a	det	27	SENT_323	[p21l603t3705r637b3744],
26	better	JJR	O	better	amod	27	SENT_323	[p21l657t3678r865b3744],
27	test	NN	O	test	_	0	SENT_323	[p21l886t3695r1012b3744],
28	to	TO	O	to	aux	29	SENT_323	[p21l1033t3695r1101b3744],
29	assess	VB	O	assess	infmod	27	SENT_323	[p21l1127t3705r1323b3744],
30	bleeding	JJ	O	bleeding	amod	31	SENT_323	[p21l1346t3678r1652b3767],
31	risk	NN	O	risk	dobj	29	SENT_323	[p21l1673t3678r1804b3744],
32	with	IN	O	with	_	0	SENT_323	[p21l1819t3678r1981b3745],
33	new	JJ	O	new	prep_with	29	SENT_323	[p21l2005t3705r2151b3745],

1	P2Y12	NN	O	p2y12	nn	2	SENT_324	[p22l11t17r253b84],
2	blockers	NNS	O	blocker	_	0	SENT_324	[p22l286t16r576b82],
3	providing	VBG	O	provide	partmod	2	SENT_324	[p22l611t16r954b106],
4	a	DT	O	a	det	6	SENT_324	[p22l988t42r1022b82],
5	strong	JJ	O	strong	amod	6	SENT_324	[p22l1056t33r1279b105],
6	degree	NN	O	degree	dobj	3	SENT_324	[p22l1312t16r1540b105],
7	of	IN	O	of	_	0	SENT_324	[p22l1575t16r1656b82],
8	P2Y12	NN	O	p2y12	nn	10	SENT_324	[p22l1678t17r1919b83],
9	pathway	NN	O	pathway	nn	10	SENT_324	[p22l1954t16r2145b106, p22l7t150r149b213],
10	inhibition	NN	O	inhibition	prep_of	6	SENT_324	[p22l173t124r544b190],
11	.	.	O	.	_	0	SENT_324	[p22l173t124r544b190],

1	In	IN	O	in	_	0	SENT_325	[p22l575t125r653b189],
2	the	DT	O	the	det	4	SENT_325	[p22l681t124r791b190],
3	present	JJ	DATE	present	amod	4	SENT_325	[p22l818t141r1077b214],
4	study	NN	O	study	prep_in	8	SENT_325	[p22l1105t124r1310b213],
5	,	,	O	,	_	0	SENT_325	[p22l1105t124r1310b213],
6	we	PRP	O	we	nsubj	8	SENT_325	[p22l1337t150r1435b190],
7	also	RB	O	also	advmod	8	SENT_325	[p22l1465t124r1596b190],
8	introduced	VBD	O	introduce	_	0	SENT_325	[p22l1625t124r2010b190],
9	the	DT	O	the	det	10	SENT_325	[p22l2036t124r2147b190],
10	notion	NN	O	notion	dobj	8	SENT_325	[p22l12t236r244b299],
11	of	IN	O	of	_	0	SENT_325	[p22l276t233r356b299],
12	hyper	JJ	O	hyper	amod	14	SENT_325	[p22l375t233r916b323],
13	—	NN	O	—	nn	14	SENT_325	[p22l375t233r916b323],
14	response	NN	O	response	prep_of	10	SENT_325	[p22l375t233r916b323],
15	to	TO	O	to	_	0	SENT_325	[p22l948t250r1016b299],
16	prasugrel	NN	O	prasugrel	prep_to	8	SENT_325	[p22l1048t233r1391b323],
17	,	,	O	,	_	0	SENT_325	[p22l1048t233r1391b323],
18	incorporating	VBG	O	incorporate	dep	8	SENT_325	[p22l1425t236r1908b322],
19	a	DT	O	a	det	21	SENT_325	[p22l1939t259r1974b299],
20	new	JJ	O	new	amod	21	SENT_325	[p22l2005t259r2151b299],
21	concept	NN	O	concept	dobj	18	SENT_325	[p22l12t358r287b430],
22	with	IN	O	with	_	0	SENT_325	[p22l316t341r478b408],
23	a	DT	O	a	det	25	SENT_325	[p22l514t367r549b407],
24	threshold	NN	O	threshold	nn	25	SENT_325	[p22l582t341r918b407],
25	value	NN	O	value	prep_with	18	SENT_325	[p22l948t341r1130b407],
26	for	IN	O	for	_	0	SENT_325	[p22l1165t341r1266b407],
27	PRI	NNP	ORGANIZATION	PRI	nn	28	SENT_325	[p22l1300t342r1444b406],
28	VASP	NN	ORGANIZATION	vasp	prep_for	25	SENT_325	[p22l1480t340r1709b408],
29	and	CC	O	and	_	0	SENT_325	[p22l1745t341r1873b407],
30	identifying	VBG	O	identify	conj_and	18	SENT_325	[p22l1907t341r2145b407, p22l11t450r190b539],
31	hyper	JJ	O	hyper	amod	34	SENT_325	[p22l216t450r804b539],
32	—	NN	O	—	nn	34	SENT_325	[p22l216t450r804b539],
33	responder	NN	O	responder	nn	34	SENT_325	[p22l216t450r804b539],
34	patients	NNS	O	patient	dobj	30	SENT_325	[p22l828t453r1106b539],
35	with	IN	O	with	_	0	SENT_325	[p22l1131t450r1293b516],
36	high	JJ	O	high	amod	38	SENT_325	[p22l1320t450r1480b539],
37	bleeding	NN	O	bleeding	nn	38	SENT_325	[p22l1505t450r1810b539],
38	risk	NN	O	risk	prep_with	30	SENT_325	[p22l1835t450r1966b516],
39	with	IN	O	with	_	0	SENT_325	[p22l1986t450r2148b516],
40	new	JJ	O	new	amod	42	SENT_325	[p22l12t584r158b624],
41	P2Y12	NN	O	p2y12	nn	42	SENT_325	[p22l194t559r436b625],
42	blockers	NNS	O	blocker	prep_with	38	SENT_325	[p22l475t558r785b624],
43	.	.	O	.	_	0	SENT_325	[p22l475t558r785b624],

1	Together	RB	O	together	_	0	SENT_326	[p22l826t556r1161b647],
2	with	IN	O	with	_	0	SENT_326	[p22l1195t558r1357b624],
3	HTPR	NN	O	htpr	prep_together_with	19	SENT_326	[p22l1398t556r1651b623],
4	deﬁned	VBN	O	deﬁned	partmod	3	SENT_326	[p22l1689t558r1951b624],
5	with	IN	O	with	_	0	SENT_326	[p22l1986t558r2148b624],
6	clopidogrel	NN	O	clopidogrel	prep_with	4	SENT_326	[p22l12t667r408b756],
7	as	IN	O	as	_	0	SENT_326	[p22l433t693r496b733],
8	PRI	NNP	ORGANIZATION	PRI	nn	9	SENT_326	[p22l523t668r667b732],
9	VASP	NN	ORGANIZATION	vasp	dep	10	SENT_326	[p22l694t665r923b733],
10	>	JJR	O	>	prep_as	4	SENT_326	[p22l953t667r1174b733],
11	50	CD	PERCENT	50	number	12	SENT_326	[p22l953t667r1174b733],
12	%	NN	PERCENT	%	amod	10	SENT_326	[p22l953t667r1174b733],
13	(	CD	NUMBER	(	number	14	SENT_326	[p22l1203t665r1364b748],
14	16	CD	NUMBER	16	num	15	SENT_326	[p22l1203t665r1364b748],
15	)	NN	O	)	dep	10	SENT_326	[p22l1203t665r1364b748],
16	,	,	O	,	_	0	SENT_326	[p22l1203t665r1364b748],
17	this	DT	O	this	nsubj	19	SENT_326	[p22l1392t667r1519b733],
18	might	MD	O	might	aux	19	SENT_326	[p22l1546t667r1759b756],
19	suggest	VB	O	suggest	_	0	SENT_326	[p22l1784t684r2043b756],
20	an	DT	O	a	det	24	SENT_326	[p22l2067t693r2148b733],
21	optimal	JJ	O	optimal	amod	24	SENT_326	[p22l12t775r284b864],
22	therapeutic	JJ	O	therapeutic	amod	24	SENT_326	[p22l336t775r735b864],
23	window	NN	O	window	nn	24	SENT_326	[p22l784t775r1072b841],
24	(	NN	O	(	dobj	19	SENT_326	[p22l1125t773r1304b855],
25	17	CD	PERCENT	17	number	29	SENT_326	[p22l1125t773r1304b855],
26	%	NN	PERCENT	%	dep	29	SENT_326	[p22l1125t773r1304b855],
27	to	TO	O	to	dep	29	SENT_326	[p22l1358t792r1426b841],
28	50	CD	PERCENT	50	number	29	SENT_326	[p22l1481t773r1659b855],
29	%	NN	PERCENT	%	dep	24	SENT_326	[p22l1481t773r1659b855],
30	)	CD	NUMBER	)	dep	29	SENT_326	[p22l1481t773r1659b855],
31	for	IN	O	for	_	0	SENT_326	[p22l1717t775r1817b841],
32	patients	NNS	O	patient	prep_for	19	SENT_326	[p22l1868t778r2146b864],
33	treated	VBN	O	treat	partmod	32	SENT_326	[p22l11t881r256b947],
34	with	IN	O	with	_	0	SENT_326	[p22l285t881r447b947],
35	P2Y12	NN	O	p2y12	nn	36	SENT_326	[p22l480t882r722b948],
36	inhibitors	NNS	O	inhibitor	prep_with	33	SENT_326	[p22l757t881r1118b947],
37	.	.	O	.	_	0	SENT_326	[p22l757t881r1118b947],

1	JACC	NN	O	jacc	_	0	SENT_327	[p22l317t1107r466b1138],
2	:	:	O	:	_	0	SENT_327	[p22l317t1107r466b1138],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_327	[p22l503t1107r1001b1138],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_327	[p22l1039t1107r1497b1143],
5	,	,	O	,	_	0	SENT_327	[p22l1039t1107r1497b1143],
6	VOL	NNP	O	VOL	appos	4	SENT_327	[p22l1533t1107r1655b1138],
7	.	.	O	.	_	0	SENT_327	[p22l1533t1107r1655b1138],

1	5	CD	NUMBER	5	_	0	SENT_328	[p22l1692t1109r1735b1143],
2	,	,	O	,	_	0	SENT_328	[p22l1692t1109r1735b1143],
3	NO.	NNP	DATE	NO.	appos	1	SENT_328	[p22l1773t1107r1863b1138],
4	12	CD	DATE	12	num	3	SENT_328	[p22l1902t1108r1977b1143],
5	,	,	DATE	,	_	0	SENT_328	[p22l1902t1108r1977b1143],
6	2012	CD	DATE	2012	num	3	SENT_328	[p22l2014t1108r2139b1138],
7	DECEMBER	NNP	DATE	DECEMBER	dep	1	SENT_328	[p22l1463t1171r1747b1203],
8	2012:1280	CD	NUMBER	2012:1280	num	7	SENT_328	[p22l1784t1172r2139b1203],
9	—	CD	NUMBER	—	number	10	SENT_328	[p22l1784t1172r2139b1203],
10	7	CD	NUMBER	7	dep	7	SENT_328	[p22l1784t1172r2139b1203],

1	Also	RB	O	also	advmod	9	SENT_329	[p22l98t1363r282b1445],
2	,	,	O	,	_	0	SENT_329	[p22l98t1363r282b1445],
3	results	VBZ	O	result	csubj	9	SENT_329	[p22l309t1364r531b1431],
4	on	IN	O	on	_	0	SENT_329	[p22l559t1391r646b1431],
5	LTA	NN	ORGANIZATION	lta	prep_on	3	SENT_329	[p22l672t1363r856b1430],
6	might	MD	O	might	aux	9	SENT_329	[p22l881t1365r1093b1454],
7	have	VB	O	have	aux	9	SENT_329	[p22l1116t1365r1274b1431],
8	been	VBN	O	be	cop	9	SENT_329	[p22l1297t1365r1463b1431],
9	due	JJ	O	due	_	0	SENT_329	[p22l1489t1364r1613b1431],
10	to	TO	O	to	_	0	SENT_329	[p22l1639t1382r1707b1431],
11	the	DT	O	the	det	12	SENT_329	[p22l1733t1364r1843b1431],
12	amount	NN	O	amount	prep_to	9	SENT_329	[p22l1870t1382r2141b1431],
13	of	IN	O	of	_	0	SENT_329	[p22l13t1473r92b1538],
14	ADP	NN	ORGANIZATION	adp	prep_of	12	SENT_329	[p22l106t1471r297b1538],
15	used	VBD	O	use	rcmod	14	SENT_329	[p22l324t1473r483b1538],
16	(	CD	NUMBER	(	number	17	SENT_329	[p22l513t1471r624b1553],
17	10	CD	NUMBER	10	num	19	SENT_329	[p22l513t1471r624b1553],
18	p.	NN	O	p.	nn	19	SENT_329	[p22l656t1470r950b1555],
19	mol/l	NN	O	mol/l	dobj	15	SENT_329	[p22l656t1470r950b1555],
20	)	NN	O	)	tmod	15	SENT_329	[p22l656t1470r950b1555],
21	,	,	O	,	_	0	SENT_329	[p22l656t1470r950b1555],
22	which	WDT	O	which	nsubj	26	SENT_329	[p22l977t1472r1194b1538],
23	is	VBZ	O	be	cop	26	SENT_329	[p22l1222t1475r1272b1537],
24	an	DT	O	a	det	26	SENT_329	[p22l1303t1498r1383b1537],
25	intermediate	JJ	O	intermediate	amod	26	SENT_329	[p22l1412t1472r1858b1537],
26	dose	NN	O	dose	rcmod	20	SENT_329	[p22l1888t1472r2042b1537],
27	of	IN	O	of	_	0	SENT_329	[p22l2072t1472r2151b1537],
28	ADP	NN	ORGANIZATION	adp	prep_of	26	SENT_329	[p22l10t1580r201b1646],
29	to	TO	O	to	aux	30	SENT_329	[p22l245t1598r313b1647],
30	stimulate	VB	O	stimulate	infmod	26	SENT_329	[p22l361t1581r682b1647],
31	platelets	NNS	O	platelet	dobj	30	SENT_329	[p22l727t1581r1015b1671],
32	highly	RB	O	highly	advmod	33	SENT_329	[p22l1062t1581r1286b1670],
33	inhibited	VBN	O	inhibit	amod	31	SENT_329	[p22l1327t1581r1648b1647],
34	by	IN	O	by	_	0	SENT_329	[p22l1690t1581r1776b1670],
35	a	DT	O	a	det	37	SENT_329	[p22l1818t1607r1853b1647],
36	P2Y12	NN	O	p2y12	nn	37	SENT_329	[p22l1897t1582r2137b1648],
37	antagonist	NN	O	antagonist	prep_by	9	SENT_329	[p22l14t1694r396b1780],
38	.	.	O	.	_	0	SENT_329	[p22l14t1694r396b1780],

1	The	DT	O	the	det	4	SENT_330	[p22l426t1690r573b1757],
2	20	CD	NUMBER	20	num	4	SENT_330	[p22l601t1695r687b1758],
3	umol/l	NN	O	umol/l	nn	4	SENT_330	[p22l719t1691r966b1775],
4	dose	NN	O	dose	nsubj	8	SENT_330	[p22l994t1691r1149b1757],
5	might	MD	O	might	aux	8	SENT_330	[p22l1179t1691r1391b1780],
6	be	VB	O	be	cop	8	SENT_330	[p22l1416t1691r1497b1757],
7	more	RBR	O	more	advmod	8	SENT_330	[p22l1527t1717r1706b1757],
8	appropriate	JJ	O	appropriate	_	0	SENT_330	[p22l1737t1694r2138b1781],
9	as	IN	O	as	mark	10	SENT_330	[p22l13t1827r76b1867],
10	shown	VBN	O	show	ccomp	8	SENT_330	[p22l105t1801r332b1867],
11	in	IN	O	in	_	0	SENT_330	[p22l357t1803r425b1866],
12	the	DT	O	the	det	15	SENT_330	[p22l450t1801r560b1867],
13	ALBION	NNP	ORGANIZATION	ALBION	nn	15	SENT_330	[p22l583t1799r940b1867],
14	(	CD	NUMBER	(	num	15	SENT_330	[p22l971t1798r1410b1881],
15	Assessment	NNP	O	Assessment	prep_in	10	SENT_330	[p22l971t1798r1410b1881],
16	of	IN	O	of	_	0	SENT_330	[p22l1434t1800r1514b1867],
17	the	DT	O	the	det	20	SENT_330	[p22l1527t1801r1637b1867],
18	Best	JJS	O	best	amod	20	SENT_330	[p22l1664t1801r1818b1867],
19	Loading	NN	O	loading	nn	20	SENT_330	[p22l1842t1800r2141b1890],
20	Dose	NN	O	dose	prep_of	15	SENT_330	[p22l12t1911r194b1976],
21	of	IN	O	of	_	0	SENT_330	[p22l232t1910r312b1976],
22	Clopidogrel	NNP	O	Clopidogrel	prep_of	20	SENT_330	[p22l338t1910r760b1999],
23	to	TO	O	to	_	0	SENT_330	[p22l795t1927r863b1976],
24	Blunt	NNP	O	Blunt	nn	26	SENT_330	[p22l902t1910r1101b1976],
25	Platelet	NN	O	platelet	nn	26	SENT_330	[p22l1137t1910r1404b1976],
26	Activation	NN	O	activation	prep_to	10	SENT_330	[p22l1436t1908r1829b1991],
27	,	,	O	,	_	0	SENT_330	[p22l1436t1908r1829b1991],
28	Inﬂammation	NN	O	inﬂammation	prep_to	10	SENT_330	[p22l1868t1910r2136b1976, p22l13t2021r262b2084],
29	and	CC	O	and	_	0	SENT_330	[p22l291t2018r418b2084],
30	Ongoing	JJ	O	ongoing	amod	33	SENT_330	[p22l448t2018r765b2107],
31	Necrosis	NN	O	necrosis	nn	33	SENT_330	[p22l791t2016r1120b2098],
32	)	NN	O	)	nn	33	SENT_330	[p22l791t2016r1120b2098],
33	study	NN	O	study	prep_to	10	SENT_330	[p22l1153t2018r1342b2107],
34	with	IN	O	with	_	0	SENT_330	[p22l1362t2018r1523b2084],
35	clopidogrel	NN	O	clopidogrel	prep_with	10	SENT_330	[p22l1552t2018r1946b2107],
36	(	CD	NUMBER	(	number	37	SENT_330	[p22l1976t2016r2135b2098],
37	27	CD	NUMBER	27	num	38	SENT_330	[p22l1976t2016r2135b2098],
38	)	NN	O	)	dep	10	SENT_330	[p22l1976t2016r2135b2098],
39	.	.	O	.	_	0	SENT_330	[p22l1976t2016r2135b2098],

1	In	IN	O	in	_	0	SENT_331	[p22l11t2127r89b2191],
2	addition	NN	O	addition	prep_in	11	SENT_331	[p22l149t2126r461b2206],
3	,	,	O	,	_	0	SENT_331	[p22l149t2126r461b2206],
4	for	IN	O	for	dep	10	SENT_331	[p22l523t2126r623b2192],
5	prasugrel	NN	O	prasugrel	nn	6	SENT_331	[p22l679t2126r1002b2215],
6	metabolism	NN	O	metabolism	pobj	4	SENT_331	[p22l1061t2126r1490b2206],
7	,	,	O	,	_	0	SENT_331	[p22l1061t2126r1490b2206],
8	in	FW	O	in	nn	9	SENT_331	[p22l1552t2129r1619b2191],
9	vitro	FW	O	vitro	dep	4	SENT_331	[p22l1675t2129r1838b2192],
10	studies	NNS	O	study	nsubj	11	SENT_331	[p22l1900t2126r2137b2192],
11	indicate	VBP	O	indicate	_	0	SENT_331	[p22l12t2235r289b2301],
12	the	DT	O	the	det	16	SENT_331	[p22l332t2235r442b2301],
13	active	JJ	O	active	amod	16	SENT_331	[p22l485t2238r682b2301],
14	prasugrel	NN	O	prasugrel	nn	16	SENT_331	[p22l724t2235r1047b2324],
15	metabolite	NN	O	metabolite	nn	16	SENT_331	[p22l1088t2235r1460b2301],
16	generation	NN	O	generation	nsubj	17	SENT_331	[p22l1502t2238r1877b2324],
17	occurs	VBZ	O	occur	ccomp	11	SENT_331	[p22l1920t2261r2137b2301],
18	primarily	RB	O	primarily	advmod	17	SENT_331	[p22l11t2345r337b2434],
19	by	IN	O	by	_	0	SENT_331	[p22l356t2345r442b2434],
20	CYP3A	NN	O	cyp3a	prep_by	17	SENT_331	[p22l464t2343r750b2411],
21	and	CC	O	and	_	0	SENT_331	[p22l774t2345r902b2411],
22	CYPZB6	NN	O	cypzb6	prep_by	17	SENT_331	[p22l927t2345r1246b2412],
23	with	IN	O	with	_	0	SENT_331	[p22l1269t2345r1430b2411],
24	lesser	JJR	O	lesser	amod	25	SENT_331	[p22l1453t2345r1645b2411],
25	contributions	NNS	O	contribution	prep_with	17	SENT_331	[p22l1668t2345r2137b2411],
26	by	IN	O	by	_	0	SENT_331	[p22l10t2453r96b2542],
27	CYPZC9	NN	O	cypzc9	prep_by	25	SENT_331	[p22l141t2453r468b2520],
28	and	CC	O	and	_	0	SENT_331	[p22l519t2453r646b2519],
29	CYPZC19	NN	O	cypzc19	conj_and	25	SENT_331	[p22l695t2453r1066b2520],
30	(	CD	NUMBER	(	number	31	SENT_331	[p22l1118t2451r1277b2534],
31	28	CD	NUMBER	28	num	32	SENT_331	[p22l1118t2451r1277b2534],
32	)	NN	O	)	dep	29	SENT_331	[p22l1118t2451r1277b2534],
33	.	.	O	.	_	0	SENT_331	[p22l1118t2451r1277b2534],

1	However	RB	O	however	advmod	6	SENT_332	[p22l1330t2454r1670b2534],
2	,	,	O	,	_	0	SENT_332	[p22l1330t2454r1670b2534],
3	our	PRP$	O	we	poss	5	SENT_332	[p22l1721t2479r1838b2519],
4	present	JJ	DATE	present	amod	5	SENT_332	[p22l1883t2470r2141b2542],
5	results	NNS	O	result	nsubj	6	SENT_332	[p22l12t2561r234b2627],
6	suggest	VBP	O	suggest	_	0	SENT_332	[p22l267t2578r524b2649],
7	that	IN	O	that	complm	9	SENT_332	[p22l552t2561r693b2627],
8	CYPZC19	NN	O	cypzc19	nsubj	9	SENT_332	[p22l723t2561r1094b2628],
9	participates	VBZ	O	participate	ccomp	6	SENT_332	[p22l1125t2564r1528b2650],
10	in	IN	O	in	_	0	SENT_332	[p22l1560t2564r1627b2626],
11	active	JJ	O	active	amod	13	SENT_332	[p22l1659t2564r1856b2627],
12	metabolite	NN	O	metabolite	nn	13	SENT_332	[p22l1887t2561r2136b2627, p22l13t2670r165b2736],
13	formation	NN	O	formation	prep_in	9	SENT_332	[p22l198t2670r568b2736],
14	.	.	O	.	_	0	SENT_332	[p22l198t2670r568b2736],

1	Clinical	JJ	O	clinical	amod	2	SENT_333	[p22l103t2779r379b2844],
2	relevance	NN	O	relevance	nsubj	7	SENT_333	[p22l440t2779r762b2844],
3	of	IN	O	of	_	0	SENT_333	[p22l826t2779r905b2844],
4	such	JJ	O	such	amod	5	SENT_333	[p22l956t2779r1113b2844],
5	findings	NNS	O	finding	prep_of	2	SENT_333	[p22l1174t2779r1457b2867],
6	will	MD	O	will	aux	7	SENT_333	[p22l1516t2779r1648b2844],
7	have	VB	O	have	_	0	SENT_333	[p22l1709t2779r1866b2844],
8	to	TO	O	to	aux	10	SENT_333	[p22l1929t2796r1997b2844],
9	be	VB	O	be	auxpass	10	SENT_333	[p22l2058t2779r2138b2844],
10	addressed	VBN	O	address	xcomp	7	SENT_333	[p22l13t2886r355b2951],
11	in	IN	O	in	_	0	SENT_333	[p22l391t2889r459b2951],
12	further	JJ	O	further	amod	14	SENT_333	[p22l496t2886r742b2951],
13	clinical	JJ	O	clinical	amod	14	SENT_333	[p22l778t2886r1026b2951],
14	trials	NNS	O	trial	prep_in	10	SENT_333	[p22l1061t2886r1252b2966],
15	,	,	O	,	_	0	SENT_333	[p22l1061t2886r1252b2966],
16	including	VBG	O	include	_	0	SENT_333	[p22l1292t2886r1626b2974],
17	high-risk	JJ	O	high-risk	amod	18	SENT_333	[p22l1662t2886r1990b2974],
18	patients	NNS	O	patient	prep_including	14	SENT_333	[p22l2022t2912r2136b2975, p22l12t2997r204b3060],
19	and	CC	O	and	_	0	SENT_333	[p22l243t2994r370b3060],
20	all	DT	O	all	det	22	SENT_333	[p22l406t2994r486b3060],
21	genetic	JJ	O	genetic	amod	22	SENT_333	[p22l519t2997r772b3082],
22	variants	NNS	O	variant	nsubj	23	SENT_333	[p22l804t2997r1077b3060],
23	thought	VBD	O	think	conj_and	7	SENT_333	[p22l1114t2994r1397b3082],
24	to	TO	O	to	_	0	SENT_333	[p22l1431t3011r1499b3060],
25	inﬂuence	NN	O	inﬂuence	nn	27	SENT_333	[p22l1536t2994r1855b3060],
26	clinical	JJ	O	clinical	amod	27	SENT_333	[p22l1893t2994r2140b3060],
27	prognosis	NN	O	prognosis	prep_to	23	SENT_333	[p22l11t3105r368b3191],
28	.	.	O	.	_	0	SENT_333	[p22l11t3105r368b3191],

1	Indeed	RB	O	indeed	advmod	25	SENT_334	[p22l411t3102r676b3183],
2	,	,	O	,	_	0	SENT_334	[p22l411t3102r676b3183],
3	the	DT	O	the	det	5	SENT_334	[p22l718t3102r827b3168],
4	potential	JJ	O	potential	amod	5	SENT_334	[p22l866t3102r1181b3191],
5	eﬂect	NN	O	eﬂect	nsubj	25	SENT_334	[p22l1220t3102r1404b3168],
6	of	IN	O	of	_	0	SENT_334	[p22l1442t3102r1522b3168],
7	CYP2CZ9	NN	O	cyp2cz9	nn	9	SENT_334	[p22l1555t3106r2017b3169],
8	*	CD	NUMBER	*	num	9	SENT_334	[p22l1555t3106r2017b3169],
9	J7	NN	O	j7	prep_of	5	SENT_334	[p22l1555t3106r2017b3169],
10	on	IN	O	on	_	0	SENT_334	[p22l2052t3128r2139b3168],
11	bleeding	VBG	O	bleed	amod	12	SENT_334	[p22l10t3212r314b3300],
12	risk	NN	O	risk	prep_on	9	SENT_334	[p22l342t3212r472b3277],
13	in	IN	O	in	_	0	SENT_334	[p22l498t3215r566b3276],
14	prasugrel	NN	O	prasugrel	nn	15	SENT_334	[p22l595t3212r1200b3300],
15	—	NN	O	—	prep_in	12	SENT_334	[p22l595t3212r1200b3300],
16	treated	VBN	O	treat	partmod	15	SENT_334	[p22l595t3212r1200b3300],
17	patients	NNS	O	patient	dobj	16	SENT_334	[p22l1228t3215r1505b3300],
18	could	MD	O	could	aux	25	SENT_334	[p22l1537t3212r1728b3277],
19	be	VB	O	be	aux	25	SENT_334	[p22l1756t3212r1836b3277],
20	of	IN	O	of	_	0	SENT_334	[p22l1868t3212r1948b3277],
21	great	JJ	O	great	amod	23	SENT_334	[p22l1964t3229r2141b3300],
22	clinical	JJ	O	clinical	amod	23	SENT_334	[p23l13t33r261b98],
23	interest	NN	O	interest	prep_of	25	SENT_334	[p23l294t36r576b113],
24	,	,	O	,	_	0	SENT_334	[p23l294t36r576b113],
25	aiming	VBG	O	aim	_	0	SENT_334	[p23l615t36r859b121],
26	to	TO	O	to	aux	27	SENT_334	[p23l892t50r959b98],
27	provide	VB	O	provide	xcomp	25	SENT_334	[p23l994t33r1258b121],
28	genetic	JJ	O	genetic	amod	29	SENT_334	[p23l1292t33r1779b121],
29	—	NN	O	—	dobj	27	SENT_334	[p23l1292t33r1779b121],
30	based	VBN	O	base	partmod	29	SENT_334	[p23l1292t33r1779b121],
31	individualized	JJ	O	individualized	amod	32	SENT_334	[p23l1813t33r2136b99, p23l13t142r217b208],
32	therapy	NN	O	therapy	dobj	30	SENT_334	[p23l249t142r530b232],
33	.	.	O	.	_	0	SENT_334	[p23l249t142r530b232],

1	In	IN	O	in	_	0	SENT_335	[p23l567t143r644b208],
2	the	DT	O	the	det	4	SENT_335	[p23l678t142r787b208],
3	present	JJ	DATE	present	amod	4	SENT_335	[p23l820t159r1079b232],
4	study	NN	O	study	prep_in	7	SENT_335	[p23l1111t142r1316b231],
5	,	,	O	,	_	0	SENT_335	[p23l1111t142r1316b231],
6	we	PRP	O	we	nsubj	7	SENT_335	[p23l1348t169r1446b209],
7	included	VBD	O	include	_	0	SENT_335	[p23l1481t142r1783b208],
8	BARC	NNP	ORGANIZATION	BARC	nn	10	SENT_335	[p23l1816t141r2063b209],
9	1	CD	NUMBER	1	num	10	SENT_335	[p23l2102t146r2134b208],
10	bleedings	NNS	O	bleeding	dobj	7	SENT_335	[p23l10t251r342b341],
11	in	IN	O	in	_	0	SENT_335	[p23l390t254r458b317],
12	the	DT	O	the	det	13	SENT_335	[p23l505t251r614b318],
13	analysis	NN	O	analysis	prep_in	7	SENT_335	[p23l664t251r949b341],
14	.	.	O	.	_	0	SENT_335	[p23l664t251r949b341],

1	These	DT	O	these	det	2	SENT_336	[p23l997t250r1213b318],
2	bleedings	NNS	O	bleeding	nsubjpass	13	SENT_336	[p23l1258t251r1590b341],
3	might	MD	O	might	aux	7	SENT_336	[p23l1640t251r1852b341],
4	not	RB	O	not	neg	7	SENT_336	[p23l1898t268r2015b318],
5	be	VB	O	be	cop	7	SENT_336	[p23l2058t251r2138b318],
6	clinically	RB	O	clinically	advmod	7	SENT_336	[p23l13t360r325b448],
7	meaningful	JJ	O	meaningful	_	0	SENT_336	[p23l348t360r748b448],
8	by	IN	O	by	_	0	SENT_336	[p23l770t360r856b448],
9	themselves	PRP	O	themselves	prep_by	7	SENT_336	[p23l878t360r1259b425],
10	and	CC	O	and	_	0	SENT_336	[p23l1287t360r1414b425],
11	could	MD	O	could	aux	13	SENT_336	[p23l1440t360r1631b425],
12	be	VB	O	be	auxpass	13	SENT_336	[p23l1654t360r1735b425],
13	considered	VBN	O	consider	conj_and	7	SENT_336	[p23l1762t360r2140b425],
14	as	IN	O	as	_	0	SENT_336	[p23l13t493r76b532],
15	minimal	JJ	O	minimal	amod	18	SENT_336	[p23l121t467r417b532],
16	or	CC	O	or	_	0	SENT_336	[p23l458t492r530b532],
17	nuisance	NN	O	nuisance	conj_or	15	SENT_336	[p23l572t470r874b532],
18	bleedings	NNS	O	bleeding	prep_as	13	SENT_336	[p23l914t467r1266b555],
19	.	.	O	.	_	0	SENT_336	[p23l914t467r1266b555],

1	However	RB	O	however	advmod	6	SENT_337	[p23l1314t468r1654b547],
2	,	,	O	,	_	0	SENT_337	[p23l1314t468r1654b547],
3	these	DT	O	these	det	4	SENT_337	[p23l1699t467r1879b532],
4	events	NNS	O	event	nsubj	6	SENT_337	[p23l1923t484r2138b533],
5	might	MD	O	might	aux	6	SENT_337	[p23l13t575r225b663],
6	lead	VB	O	lead	_	0	SENT_337	[p23l246t575r390b640],
7	to	TO	O	to	_	0	SENT_337	[p23l413t592r481b640],
8	premature	JJ	O	premature	amod	9	SENT_337	[p23l506t592r867b664],
9	discontinuation	NN	O	discontinuation	prep_to	6	SENT_337	[p23l893t575r1444b640],
10	of	IN	O	of	_	0	SENT_337	[p23l1469t575r1549b640],
11	the	DT	O	the	det	12	SENT_337	[p23l1561t575r1671b640],
12	drug	NN	O	drug	prep_of	9	SENT_337	[p23l1697t575r1859b663],
13	in	IN	O	in	_	0	SENT_337	[p23l1881t578r1949b640],
14	daily	JJ	SET	daily	amod	15	SENT_337	[p23l1974t575r2143b663],
15	practice	NN	O	practice	prep_in	6	SENT_337	[p23l11t687r284b773],
16	as	IN	O	as	amod	15	SENT_337	[p23l342t710r405b749],
17	shown	VBN	O	show	partmod	15	SENT_337	[p23l464t684r690b750],
18	in	IN	O	in	_	0	SENT_337	[p23l745t687r813b749],
19	clopidogrel	NN	O	clopidogrel	prep_in	17	SENT_337	[p23l869t684r1295b773],
20	-	:	O	-	_	0	SENT_337	[p23l869t684r1295b773],
21	and	CC	O	and	_	0	SENT_337	[p23l1354t684r1481b749],
22	prasugrel	NN	O	prasugrel	nn	23	SENT_337	[p23l1535t684r2140b772],
23	—	NN	O	—	prep_in	6	SENT_337	[p23l1535t684r2140b772],
24	treated	VBN	O	treat	partmod	23	SENT_337	[p23l1535t684r2140b772],
25	patients	NNS	O	patient	nsubj	28	SENT_337	[p23l11t796r287b883],
26	(	CD	NUMBER	(	number	27	SENT_337	[p23l329t791r600b874],
27	29,30	CD	NUMBER	29,30	num	28	SENT_337	[p23l329t791r600b874],
28	)	NN	O	)	xcomp	24	SENT_337	[p23l329t791r600b874],
29	.	.	O	.	_	0	SENT_337	[p23l329t791r600b874],

1	Also	RB	O	also	advmod	5	SENT_338	[p23l639t792r822b874],
2	,	,	O	,	_	0	SENT_338	[p23l639t792r822b874],
3	this	DT	O	this	det	4	SENT_338	[p23l862t793r988b859],
4	study	NN	O	study	nsubj	5	SENT_338	[p23l1029t793r1218b882],
5	emphasizes	VBZ	O	emphasize	_	0	SENT_338	[p23l1252t793r1650b883],
6	the	DT	O	the	det	7	SENT_338	[p23l1689t793r1799b859],
7	fact	NN	O	fact	dobj	5	SENT_338	[p23l1836t793r1965b860],
8	that	IN	O	that	complm	16	SENT_338	[p23l2000t793r2141b859],
9	platelet	NN	O	platelet	nn	11	SENT_338	[p23l11t903r271b992],
10	function	NN	O	function	nn	11	SENT_338	[p23l306t903r603b969],
11	test	NN	O	test	nsubj	16	SENT_338	[p23l639t920r763b969],
12	and	CC	O	and	_	0	SENT_338	[p23l800t903r927b969],
13	genotyping	NN	O	genotyping	conj_and	11	SENT_338	[p23l962t906r1360b992],
14	may	MD	O	may	aux	16	SENT_338	[p23l1396t929r1544b991],
15	be	VB	O	be	cop	16	SENT_338	[p23l1574t903r1655b969],
16	complementary	JJ	O	complementary	ccomp	5	SENT_338	[p23l1693t903r2136b992, p23l12t1028r148b1100],
17	to	TO	O	to	aux	18	SENT_338	[p23l172t1028r239b1077],
18	assess	VB	O	assess	xcomp	16	SENT_338	[p23l270t1037r466b1077],
19	both	CC	O	both	preconj	20	SENT_338	[p23l494t1011r658b1077],
20	ischemic	JJ	O	ischemic	amod	23	SENT_338	[p23l685t1011r992b1077],
21	and	CC	O	and	_	0	SENT_338	[p23l1021t1011r1148b1077],
22	bleeding	JJ	O	bleeding	conj_and	20	SENT_338	[p23l1173t1011r1477b1100],
23	risk	NN	O	risk	dobj	18	SENT_338	[p23l1503t1011r1647b1077],
24	.	.	O	.	_	0	SENT_338	[p23l1503t1011r1647b1077],

1	It	PRP	O	it	nsubj	3	SENT_339	[p23l1679t1012r1739b1077],
2	also	RB	O	also	advmod	3	SENT_339	[p23l1767t1011r1897b1077],
3	shows	VBZ	O	show	_	0	SENT_339	[p23l1928t1011r2137b1077],
4	that	IN	O	that	complm	7	SENT_339	[p23l12t1120r153b1186],
5	genetics	NNS	O	genetics	nsubj	7	SENT_339	[p23l192t1123r474b1209],
6	are	VBP	O	be	cop	7	SENT_339	[p23l520t1146r620b1186],
7	important	JJ	O	important	ccomp	3	SENT_339	[p23l663t1123r1018b1209],
8	when	WRB	O	when	advmod	9	SENT_339	[p23l1055t1120r1249b1186],
9	using	VBG	O	use	ccomp	7	SENT_339	[p23l1290t1123r1480b1209],
10	a	DT	O	a	det	11	SENT_339	[p23l1522t1146r1557b1186],
11	thienopyridine	NN	O	thienopyridine	dobj	9	SENT_339	[p23l1597t1120r2136b1209],
12	,	,	O	,	_	0	SENT_339	[p23l1597t1120r2136b1209],

1	either	DT	O	either	preconj	2	SENT_340	[p23l13t1263r216b1329],
2	clopidogrel	NN	O	clopidogrel	_	0	SENT_340	[p23l255t1263r648b1352],
3	or	CC	O	or	_	0	SENT_340	[p23l687t1289r759b1329],
4	prasugrel	NN	O	prasugrel	conj_or	2	SENT_340	[p23l795t1264r1137b1352],
5	,	,	O	,	_	0	SENT_340	[p23l795t1264r1137b1352],
6	and	CC	O	and	_	0	SENT_340	[p23l1181t1263r1308b1329],
7	that	IN	O	that	dep	15	SENT_340	[p23l1346t1263r1487b1329],
8	risk	NN	O	risk	nsubj	9	SENT_340	[p23l1524t1263r1655b1329],
9	scoring	VBG	O	score	dep	15	SENT_340	[p23l1691t1266r1944b1352],
10	with	IN	O	with	_	0	SENT_340	[p23l1978t1264r2139b1329],
11	genetic	JJ	O	genetic	amod	12	SENT_340	[p23l11t1375r264b1460],
12	information	NN	O	information	prep_with	9	SENT_340	[p23l289t1372r711b1437],
13	might	MD	O	might	aux	15	SENT_340	[p23l738t1372r950b1460],
14	be	VB	O	be	cop	15	SENT_340	[p23l972t1372r1053b1437],
15	useful	JJ	O	useful	conj_and	2	SENT_340	[p23l1078t1372r1287b1437],
16	also	RB	O	also	advmod	15	SENT_340	[p23l1313t1372r1443b1437],
17	for	IN	O	for	_	0	SENT_340	[p23l1470t1372r1571b1437],
18	bleeding	VBG	O	bleed	prepc_for	15	SENT_340	[p23l1593t1372r1897b1460],
19	risk	NN	O	risk	dobj	18	SENT_340	[p23l1921t1372r2051b1437],
20	as	IN	O	as	mark	21	SENT_340	[p23l2074t1397r2137b1437],
21	shown	VBN	O	show	advcl	15	SENT_340	[p23l13t1480r240b1545],
22	for	IN	O	for	_	0	SENT_340	[p23l271t1480r371b1545],
23	stent	JJ	O	stent	amod	24	SENT_340	[p23l402t1497r572b1545],
24	thrombosis	NN	O	thrombosis	prep_for	21	SENT_340	[p23l601t1480r994b1545],
25	in	IN	O	in	_	0	SENT_340	[p23l1026t1483r1094b1544],
26	the	DT	O	the	det	29	SENT_340	[p23l1124t1480r1234b1545],
27	recently	RB	DATE	recently	advmod	28	SENT_340	[p23l1266t1480r1546b1568],
28	published	VBN	O	publish	amod	29	SENT_340	[p23l1571t1480r1915b1568],
29	paper	NN	O	paper	prep_in	21	SENT_340	[p23l1944t1505r2141b1568],
30	by	IN	O	by	_	0	SENT_340	[p23l10t1588r96b1677],
31	Cayla	NNP	PERSON	Cayla	prep_by	29	SENT_340	[p23l127t1588r327b1677],
32	et	FW	O	et	nn	34	SENT_340	[p23l360t1605r423b1654],
33	al.	FW	O	al.	nn	34	SENT_340	[p23l456t1588r530b1654],
34	(	FW	O	(	dobj	15	SENT_340	[p23l571t1586r730b1668],
35	31	CD	NUMBER	31	num	36	SENT_340	[p23l571t1586r730b1668],
36	)	NN	O	)	nsubj	15	SENT_340	[p23l571t1586r730b1668],
37	.	.	O	.	_	0	SENT_340	[p23l571t1586r730b1668],

1	Accordingly	RB	O	accordingly	advmod	8	SENT_341	[p23l765t1586r1219b1677],
2	,	,	O	,	_	0	SENT_341	[p23l765t1586r1219b1677],
3	genetically	RB	O	genetically	advmod	4	SENT_341	[p23l1254t1588r1632b1677],
4	tailored	VBN	O	tailor	amod	5	SENT_341	[p23l1661t1588r1930b1654],
5	therapy	NN	O	therapy	nsubjpass	8	SENT_341	[p23l1962t1588r2136b1654, p23l13t1721r135b1784],
6	could	MD	O	could	aux	8	SENT_341	[p23l177t1696r367b1761],
7	be	VB	O	be	auxpass	8	SENT_341	[p23l410t1696r490b1761],
8	tested	VBN	O	test	_	0	SENT_341	[p23l536t1696r743b1761],
9	with	IN	O	with	_	0	SENT_341	[p23l784t1696r945b1761],
10	switching	NN	O	switching	nn	12	SENT_341	[p23l991t1696r1331b1784],
11	poor	JJ	O	poor	amod	12	SENT_341	[p23l1372t1721r1536b1784],
12	metabolizers	NNS	O	metabolizer	prep_with	8	SENT_341	[p23l1580t1696r2023b1761],
13	to	TO	O	to	_	0	SENT_341	[p23l2070t1713r2137b1761],
14	prasugrel	NN	O	prasugrel	nn	17	SENT_341	[p23l11t1804r334b1893],
15	and	CC	O	and	_	0	SENT_341	[p23l359t1804r486b1869],
16	fast	JJ	O	fast	conj_and	14	SENT_341	[p23l509t1804r633b1869],
17	metabolizers	NNS	O	metabolizer	prep_to	8	SENT_341	[p23l657t1804r1100b1869],
18	to	TO	O	to	_	0	SENT_341	[p23l1126t1821r1194b1869],
19	clopidogrel	NN	O	clopidogrel	prep_to	8	SENT_341	[p23l1221t1804r1631b1892],
20	.	.	O	.	_	0	SENT_341	[p23l1221t1804r1631b1892],

1	However	RB	O	however	advmod	12	SENT_342	[p23l1661t1805r2002b1884],
2	,	,	O	,	_	0	SENT_342	[p23l1661t1805r2002b1884],
3	the	DT	O	the	det	5	SENT_342	[p23l2029t1804r2139b1869],
4	clinical	JJ	O	clinical	amod	5	SENT_342	[p23l13t1912r261b1977],
5	beneﬁt	NN	O	beneﬁt	nsubjpass	12	SENT_342	[p23l285t1912r530b1977],
6	of	IN	O	of	_	0	SENT_342	[p23l556t1912r636b1977],
7	such	PDT	O	such	predet	9	SENT_342	[p23l653t1912r809b1977],
8	a	DT	O	a	det	9	SENT_342	[p23l838t1938r872b1977],
9	strategy	NN	O	strategy	prep_of	5	SENT_342	[p23l899t1929r1174b2000],
10	should	MD	O	should	aux	12	SENT_342	[p23l1200t1912r1433b1977],
11	be	VB	O	be	auxpass	12	SENT_342	[p23l1457t1912r1538b1977],
12	tested	VBN	O	test	_	0	SENT_342	[p23l1566t1912r1774b1977],
13	in	IN	O	in	_	0	SENT_342	[p23l1800t1915r1868b1977],
14	further	JJ	O	further	prep_in	12	SENT_342	[p23l1895t1912r2141b1977],
15	randomized	VBN	O	randomize	partmod	14	SENT_342	[p23l12t2020r433b2085],
16	clinical	JJ	O	clinical	amod	17	SENT_342	[p23l460t2020r708b2085],
17	trials	NNS	O	trial	dobj	15	SENT_342	[p23l733t2020r923b2100],
18	,	,	O	,	_	0	SENT_342	[p23l733t2020r923b2100],
19	whereas	IN	O	whereas	mark	26	SENT_342	[p23l949t2020r1232b2086],
20	data	NNS	O	datum	nsubj	26	SENT_342	[p23l1261t2020r1408b2086],
21	on	IN	O	on	_	0	SENT_342	[p23l1434t2046r1522b2085],
22	a	DT	O	a	det	23	SENT_342	[p23l1549t2046r1584b2085],
23	switch	NN	O	switch	prep_on	20	SENT_342	[p23l1611t2020r1835b2086],
24	are	VBP	O	be	cop	26	SENT_342	[p23l1862t2045r1963b2085],
25	only	RB	O	only	advmod	26	SENT_342	[p23l1991t2020r2143b2108],
26	available	JJ	O	available	advcl	15	SENT_342	[p23l13t2129r312b2196],
27	from	IN	O	from	_	0	SENT_342	[p23l345t2129r515b2196],
28	biological	JJ	O	biological	amod	29	SENT_342	[p23l547t2129r890b2218],
29	studies	NNS	O	study	prep_from	26	SENT_342	[p23l923t2129r1161b2196],
30	(	VBP	O	(	rcmod	29	SENT_342	[p23l1198t2127r1468b2210],
31	32,33	CD	NUMBER	32,33	number	32	SENT_342	[p23l1198t2127r1468b2210],
32	)	CD	NUMBER	)	dobj	30	SENT_342	[p23l1198t2127r1468b2210],
33	.	.	O	.	_	0	SENT_342	[p23l1198t2127r1468b2210],

1	Study	NNP	O	Study	_	0	SENT_343	[p23l13t2246r211b2321],
2	limitations	NNS	O	limitation	dep	1	SENT_343	[p23l242t2246r624b2304],
3	.	.	O	.	_	0	SENT_343	[p23l242t2246r624b2304],

1	The	DT	O	the	det	3	SENT_344	[p23l670t2237r817b2305],
2	main	JJ	O	main	amod	3	SENT_344	[p23l848t2241r1024b2305],
3	limitation	NN	O	limitation	nsubj	12	SENT_344	[p23l1052t2238r1401b2305],
4	of	IN	O	of	_	0	SENT_344	[p23l1431t2238r1511b2305],
5	the	DT	O	the	det	7	SENT_344	[p23l1528t2239r1638b2305],
6	present	JJ	DATE	present	amod	7	SENT_344	[p23l1667t2256r1925b2328],
7	study	NN	O	study	prep_of	3	SENT_344	[p23l1955t2238r2143b2328],
8	is	VBZ	O	be	cop	12	SENT_344	[p23l12t2349r62b2412],
9	its	PRP$	O	its	poss	12	SENT_344	[p23l93t2349r171b2412],
10	limited	JJ	O	limited	amod	12	SENT_344	[p23l201t2346r454b2412],
11	sample	NN	O	sample	nn	12	SENT_344	[p23l484t2346r725b2435],
12	size	NN	O	size	_	0	SENT_344	[p23l757t2349r883b2412],
13	and	CC	O	and	_	0	SENT_344	[p23l914t2346r1041b2412],
14	the	DT	O	the	det	15	SENT_344	[p23l1070t2347r1180b2412],
15	lack	NN	O	lack	conj_and	12	SENT_344	[p23l1208t2346r1351b2412],
16	of	IN	O	of	_	0	SENT_344	[p23l1377t2346r1457b2412],
17	power	NN	O	power	prep_of	15	SENT_344	[p23l1472t2372r1691b2435],
18	to	TO	O	to	aux	19	SENT_344	[p23l1718t2363r1786b2412],
19	detect	VB	O	detect	infmod	17	SENT_344	[p23l1817t2346r2030b2412],
20	an	DT	O	a	det	21	SENT_344	[p23l2059t2372r2139b2412],
21	effect	NN	O	effect	dobj	19	SENT_344	[p23l13t2454r198b2520],
22	on	IN	O	on	_	0	SENT_344	[p23l236t2480r323b2520],
23	endpoint	NN	O	endpoint	prep_on	19	SENT_344	[p23l363t2454r699b2543],
24	,	,	O	,	_	0	SENT_344	[p23l363t2454r699b2543],
25	such	JJ	O	such	_	0	SENT_344	[p23l742t2454r898b2520],
26	as	IN	O	as	_	0	SENT_344	[p23l939t2480r1002b2520],
27	mortality	NN	O	mortality	nn	30	SENT_344	[p23l1043t2454r1368b2543],
28	or	CC	O	or	_	0	SENT_344	[p23l1404t2480r1476b2520],
29	stent	NN	O	stent	nn	30	SENT_344	[p23l1515t2471r1685b2520],
30	thrombosis	NN	O	thrombosis	prep_such_as	15	SENT_344	[p23l1722t2454r2135b2520],
31	.	.	O	.	_	0	SENT_344	[p23l1722t2454r2135b2520],

1	Also	RB	O	also	advmod	7	SENT_345	[p23l10t2562r193b2645],
2	,	,	O	,	_	0	SENT_345	[p23l10t2562r193b2645],
3	effect	NN	O	effect	nsubjpass	7	SENT_345	[p23l246t2564r431b2630],
4	on	IN	O	on	_	0	SENT_345	[p23l479t2590r566b2630],
5	bleeding	NN	O	bleeding	prep_on	3	SENT_345	[p23l613t2564r917b2653],
6	was	VBD	O	be	auxpass	7	SENT_345	[p23l960t2590r1089b2630],
7	observed	VBN	O	observe	_	0	SENT_345	[p23l1141t2564r1449b2630],
8	with	IN	O	with	_	0	SENT_345	[p23l1494t2564r1655b2630],
9	inclusion	NN	O	inclusion	prep_with	7	SENT_345	[p23l1703t2564r2022b2630],
10	of	IN	O	of	_	0	SENT_345	[p23l2072t2564r2151b2630],
11	minimal	JJ	O	minimal	amod	12	SENT_345	[p23l13t2673r308b2739],
12	BARC	NN	ORGANIZATION	barc	prep_of	9	SENT_345	[p23l332t2671r578b2739],
13	1	CD	NUMBER	1	num	14	SENT_345	[p23l609t2676r640b2738],
14	bleedings	NNS	O	bleeding	dep	12	SENT_345	[p23l667t2673r1019b2762],
15	.	.	O	.	_	0	SENT_345	[p23l667t2673r1019b2762],

1	Finally	RB	O	finally	advmod	13	SENT_346	[p23l1048t2673r1310b2762],
2	,	,	O	,	_	0	SENT_346	[p23l1048t2673r1310b2762],
3	assessment	NN	O	assessment	nsubjpass	13	SENT_346	[p23l1338t2690r1722b2739],
4	of	IN	O	of	_	0	SENT_346	[p23l1745t2673r1825b2739],
5	response	NN	O	response	prep_of	3	SENT_346	[p23l1837t2698r2139b2762],
6	to	TO	O	to	_	0	SENT_346	[p23l12t2797r80b2845],
7	chronic	JJ	O	chronic	amod	9	SENT_346	[p23l117t2780r379b2845],
8	antiplatelet	JJ	O	antiplatelet	amod	9	SENT_346	[p23l415t2780r809b2868],
9	therapy	NN	O	therapy	prep_to	5	SENT_346	[p23l842t2780r1109b2868],
10	may	MD	O	may	aux	13	SENT_346	[p23l1140t2805r1288b2868],
11	have	VB	O	have	aux	13	SENT_346	[p23l1319t2780r1477b2845],
12	been	VBN	O	be	auxpass	13	SENT_346	[p23l1510t2780r1676b2845],
13	modiﬁed	VBN	O	modiﬁed	_	0	SENT_346	[p23l1711t2780r2026b2845],
14	by	IN	O	by	_	0	SENT_346	[p23l2057t2780r2143b2868],
15	lack	NN	O	lack	agent	13	SENT_346	[p23l11t2888r154b2953],
16	of	IN	O	of	_	0	SENT_346	[p23l188t2888r267b2953],
17	compliance	NN	O	compliance	prep_of	15	SENT_346	[p23l293t2888r711b2976],
18	.	.	O	.	_	0	SENT_346	[p23l293t2888r711b2976],

1	However	RB	O	however	advmod	10	SENT_347	[p23l753t2889r1093b2968],
2	,	,	O	,	_	0	SENT_347	[p23l753t2889r1093b2968],
3	in	IN	O	in	_	0	SENT_347	[p23l1133t2891r1201b2953],
4	the	DT	O	the	det	6	SENT_347	[p23l1238t2888r1348b2953],
5	present	JJ	DATE	present	amod	6	SENT_347	[p23l1384t2905r1642b2976],
6	study	NN	O	study	prep_in	10	SENT_347	[p23l1679t2888r1884b2976],
7	,	,	O	,	_	0	SENT_347	[p23l1679t2888r1884b2976],
8	efforts	NNS	O	effort	nsubjpass	10	SENT_347	[p23l1925t2888r2138b2953],
9	were	VBD	O	be	auxpass	10	SENT_347	[p23l9t3022r175b3063],
10	made	VBN	O	make	_	0	SENT_347	[p23l212t2997r400b3062],
11	to	TO	O	to	aux	12	SENT_347	[p23l437t3014r504b3062],
12	improve	VB	O	improve	ccomp	10	SENT_347	[p23l541t3000r829b3085],
13	compliance	NN	O	compliance	dobj	12	SENT_347	[p23l866t2997r1265b3085],
14	and	CC	O	and	_	0	SENT_347	[p23l1302t2997r1429b3062],
15	to	TO	O	to	aux	16	SENT_347	[p23l1464t3014r1532b3062],
16	detect	VB	O	detect	conj_and	12	SENT_347	[p23l1570t2997r1782b3062],
17	noncompliant	JJ	O	noncompliant	acomp	16	SENT_347	[p23l1817t3023r2136b3062, p23l11t3141r216b3229],

1	patients	NNS	O	patient	_	0	SENT_348	[p23l246t3144r543b3229],
2	.	.	O	.	_	0	SENT_348	[p23l246t3144r543b3229],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	4	SENT_349	[p23l7t3390r631b3471],
2	The	DT	O	the	det	3	SENT_349	[p23l9t3492r156b3559],
3	authors	NNS	O	author	dep	1	SENT_349	[p23l209t3493r468b3559],
4	thank	VBP	O	thank	_	0	SENT_349	[p23l520t3493r727b3559],
5	the	DT	O	the	det	6	SENT_349	[p23l774t3493r884b3559],
6	nurses	NNS	O	nurse	nsubj	7	SENT_349	[p23l937t3493r1171b3559],
7	’	VBP	O	’	ccomp	4	SENT_349	[p23l937t3493r1171b3559],
8	team	NN	O	team	dobj	7	SENT_349	[p23l1223t3510r1395b3559],
9	and	CC	O	and	_	0	SENT_349	[p23l1448t3493r1575b3559],
10	technicians	NNS	O	technician	dobj	7	SENT_349	[p23l1626t3493r2019b3559],
11	in	IN	O	in	_	0	SENT_349	[p23l2072t3496r2139b3558],
12	executing	VBG	O	execute	prepc_in	7	SENT_349	[p23l13t3606r349b3692],
13	this	DT	O	this	det	14	SENT_349	[p23l381t3604r507b3669],
14	study	NN	O	study	dobj	12	SENT_349	[p23l544t3603r748b3692],
15	,	,	O	,	_	0	SENT_349	[p23l544t3603r748b3692],
16	and	CC	O	and	_	0	SENT_349	[p23l786t3603r913b3669],
17	the	DT	O	the	det	19	SENT_349	[p23l946t3603r1056b3669],
18	hematology	NN	O	hematology	nn	19	SENT_349	[p23l1091t3603r1507b3692],
19	laboratory	NN	O	laboratory	dobj	12	SENT_349	[p23l1536t3603r1912b3692],
20	,	,	O	,	_	0	SENT_349	[p23l1536t3603r1912b3692],
21	Conception	NN	O	conception	nn	22	SENT_349	[p23l1951t3603r2136b3669, p23l13t3715r272b3802],
22	Hospital	NN	O	hospital	appos	19	SENT_349	[p23l306t3713r613b3802],
23	for	IN	O	for	_	0	SENT_349	[p23l644t3712r744b3779],
24	VASP	NN	ORGANIZATION	vasp	nn	25	SENT_349	[p23l776t3711r1004b3779],
25	analysis	NN	O	analysis	prep_for	22	SENT_349	[p23l1038t3712r1322b3802],
26	.	.	O	.	_	0	SENT_349	[p23l1038t3712r1322b3802],

1	JACC	NN	O	jacc	_	0	SENT_350	[p24l7t151r157b182],
2	:	:	O	:	_	0	SENT_350	[p24l7t151r157b182],
3	CARDIOVASCULAR	NN	O	cardiovascular	nn	4	SENT_350	[p24l192t151r692b182],
4	INTERVENTIONS	NNS	O	intervention	dep	1	SENT_350	[p24l728t151r1188b187],
5	,	,	O	,	_	0	SENT_350	[p24l728t151r1188b187],
6	VOL	NNP	O	VOL	appos	4	SENT_350	[p24l1222t151r1345b182],
7	.	.	O	.	_	0	SENT_350	[p24l1222t151r1345b182],

1	5	CD	NUMBER	5	_	0	SENT_351	[p24l1380t152r1423b187],
2	,	,	O	,	_	0	SENT_351	[p24l1380t152r1423b187],
3	NO.	NNP	O	NO.	appos	1	SENT_351	[p24l1460t151r1550b182],
4	12	CD	NUMBER	12	num	3	SENT_351	[p24l1588t152r1664b187],
5	,	,	O	,	_	0	SENT_351	[p24l1588t152r1664b187],
6	2012	CD	DATE	2012	num	3	SENT_351	[p24l1699t152r1824b182],

1	DECEMBER	NNP	DATE	DECEMBER	_	0	SENT_352	[p24l10t239r295b271],
2	2012:1280	CD	NUMBER	2012:1280	num	3	SENT_352	[p24l326t240r682b271],
3	-7	CD	NUMBER	-7	dep	1	SENT_352	[p24l326t240r682b271],

1	Reprint	JJ	MISC	reprint	amod	2	SENT_353	[p24l10t493r271b572],
2	requests	NNS	O	request	_	0	SENT_353	[p24l318t506r593b572],
3	and	CC	O	and	_	0	SENT_353	[p24l644t491r767b551],
4	correspondence	NN	O	correspondence	conj_and	2	SENT_353	[p24l816t491r1361b572],
5	:	:	O	:	_	0	SENT_353	[p24l816t491r1361b572],
6	Dr.	NNP	O	Dr.	nn	8	SENT_353	[p24l1414t492r1520b551],
7	Thomas	NNP	PERSON	Thomas	nn	8	SENT_353	[p24l1571t490r1836b551],
8	Cuisset	NNP	PERSON	Cuisset	dep	2	SENT_353	[p24l1889t492r2140b564],
9	,	,	O	,	_	0	SENT_353	[p24l1889t492r2140b564],
10	Aix	NNP	LOCATION	Aix	appos	8	SENT_353	[p24l7t587r453b648],
11	.	.	O	.	_	0	SENT_353	[p24l7t587r453b648],

1	—	NN	O	—	_	0	SENT_354	[p24l7t587r453b648],
2	.	.	O	.	_	0	SENT_354	[p24l7t587r453b648],

1	Marseille	NNP	ORGANIZATION	Marseille	nn	2	SENT_355	[p24l7t587r453b648],
2	Université	NNP	ORGANIZATION	Université	_	0	SENT_355	[p24l485t589r831b661],
3	,	,	O	,	_	0	SENT_355	[p24l485t589r831b661],
4	Faculté	NNP	O	Faculté	nn	6	SENT_355	[p24l868t589r1099b648],
5	de	IN	O	de	amod	6	SENT_355	[p24l1135t588r1206b648],
6	Médecine	NNP	O	Médecine	appos	2	SENT_355	[p24l1239t588r1574b661],
7	,	,	O	,	_	0	SENT_355	[p24l1239t588r1574b661],
8	Departement	NNP	O	Departement	nn	10	SENT_355	[p24l1611t589r2038b669],
9	de	IN	O	de	amod	10	SENT_355	[p24l2071t588r2142b648],
10	Cardiologie	NNP	O	Cardiologie	appos	2	SENT_355	[p24l10t685r402b765],
11	,	,	O	,	_	0	SENT_355	[p24l10t685r402b765],
12	CHU	NNP	ORGANIZATION	CHU	nn	13	SENT_355	[p24l437t685r621b745],
13	Timone	NNP	ORGANIZATION	Timone	appos	2	SENT_355	[p24l647t683r923b758],
14	,	,	O	,	_	0	SENT_355	[p24l647t683r923b758],
15	264	CD	NUMBER	264	num	16	SENT_355	[p24l954t688r1073b745],
16	rue	NN	O	rue	appos	2	SENT_355	[p24l1102t708r1201b744],
17	Saint	NNP	O	Saint	nn	18	SENT_355	[p24l1234t685r1397b745],
18	Pierre	NNP	PERSON	Pierre	dep	16	SENT_355	[p24l1426t686r1633b758],
19	,	,	O	,	_	0	SENT_355	[p24l1426t686r1633b758],
20	F-13385	NNP	O	F-13385	nn	21	SENT_355	[p24l1666t685r1940b745],
21	Marseille	NNP	ORGANIZATION	Marseille	appos	2	SENT_355	[p24l1971t686r2140b744, p24l10t783r182b855],
22	,	,	O	,	_	0	SENT_355	[p24l1971t686r2140b744, p24l10t783r182b855],
23	France	NNP	LOCATION	France	appos	2	SENT_355	[p24l215t783r447b842],
24	.	.	O	.	_	0	SENT_355	[p24l215t783r447b842],

1	E	NN	O	e	nn	3	SENT_356	[p24l483t783r723b842],
2	—	CD	NUMBER	—	num	3	SENT_356	[p24l483t783r723b842],
3	mail	NN	O	mail	_	0	SENT_356	[p24l483t783r723b842],
4	:	:	O	:	_	0	SENT_356	[p24l483t783r723b842],
5	thomas.cuisset@ap—hm.fr	NN	O	thomas.cuisset@ap—hm.fr	dep	3	SENT_356	[p24l757t783r1588b863],
6	.	.	O	.	_	0	SENT_356	[p24l757t783r1588b863],

1	REFERENCES	NNS	O	reference	_	0	SENT_357	[p24l10t1084r399b1129],

1	1	LS	NUMBER	1	_	0	SENT_358	[p24l47t1239r92b1289],
2	.	.	O	.	_	0	SENT_358	[p24l47t1239r92b1289],

1	Bertrand	NNP	PERSON	Bertrand	nn	2	SENT_359	[p24l116t1236r368b1289],
2	ME	NNP	PERSON	ME	_	0	SENT_359	[p24l414t1236r547b1301],
3	,	,	O	,	_	0	SENT_359	[p24l414t1236r547b1301],
4	Rupprecht	NNP	PERSON	Rupprecht	nn	5	SENT_359	[p24l599t1236r899b1308],
5	HJ	NNP	O	HJ	appos	2	SENT_359	[p24l947t1236r1043b1304],
6	,	,	O	,	_	0	SENT_359	[p24l947t1236r1043b1304],
7	Urban	NNP	MISC	Urban	nn	8	SENT_359	[p24l1092t1236r1272b1289],
8	P	NN	O	p	appos	2	SENT_359	[p24l1320t1236r1376b1301],
9	,	,	O	,	_	0	SENT_359	[p24l1320t1236r1376b1301],
10	Gershlick	NNP	O	Gershlick	nn	11	SENT_359	[p24l1428t1236r1706b1289],
11	AH	NNP	O	AH	appos	2	SENT_359	[p24l1748t1235r1877b1301],
12	,	,	O	,	_	0	SENT_359	[p24l1748t1235r1877b1301],
13	for	IN	O	for	_	0	SENT_359	[p24l1926t1236r2007b1289],
14	the	DT	O	the	det	16	SENT_359	[p24l2053t1236r2142b1289],
15	CLASSICS	NNP	O	CLASSICS	nn	16	SENT_359	[p24l117t1315r461b1369],
16	Investigators	NNS	O	investigator	prep_for	2	SENT_359	[p24l486t1316r864b1387],
17	.	.	O	.	_	0	SENT_359	[p24l486t1316r864b1387],

1	Double	JJ	O	double	amod	4	SENT_360	[p24l891t1316r1295b1369],
2	—	NN	O	—	nn	4	SENT_360	[p24l891t1316r1295b1369],
3	blind	JJ	O	blind	amod	4	SENT_360	[p24l891t1316r1295b1369],
4	study	NN	O	study	_	0	SENT_360	[p24l1321t1316r1478b1387],
5	of	IN	O	of	_	0	SENT_360	[p24l1501t1316r1566b1369],
6	the	DT	O	the	det	7	SENT_360	[p24l1581t1316r1672b1369],
7	safety	NN	O	safety	prep_of	4	SENT_360	[p24l1699t1316r1867b1387],
8	of	IN	O	of	_	0	SENT_360	[p24l1890t1316r1956b1369],
9	clopidogrel	NN	O	clopidogrel	prep_of	7	SENT_360	[p24l1971t1316r2140b1388, p24l117t1396r301b1467],
10	with	IN	O	with	prep	9	SENT_360	[p24l322t1396r456b1449],
11	and	CC	O	and	_	0	SENT_360	[p24l481t1396r586b1449],
12	without	IN	O	without	prep	9	SENT_360	[p24l607t1396r840b1449],
13	a	DT	O	a	det	15	SENT_360	[p24l865t1416r892b1449],
14	loading	VBG	O	load	amod	15	SENT_360	[p24l914t1396r1135b1467],
15	dose	NN	O	dose	pobj	12	SENT_360	[p24l1159t1396r1288b1449],
16	in	IN	O	in	_	0	SENT_360	[p24l1312t1398r1368b1448],
17	combination	NN	O	combination	prep_in	15	SENT_360	[p24l1393t1396r1765b1449],
18	with	IN	O	with	_	0	SENT_360	[p24l1786t1396r1920b1449],
19	aspirin	NN	O	aspirin	prep_with	17	SENT_360	[p24l1946t1398r2143b1468],
20	compared	VBN	O	compare	_	0	SENT_360	[p24l117t1477r405b1549],
21	with	IN	O	with	prepc_compared_with	19	SENT_360	[p24l432t1477r566b1530],
22	ticlopidine	NN	O	ticlopidine	pobj	19	SENT_360	[p24l596t1477r912b1549],
23	in	IN	O	in	_	0	SENT_360	[p24l943t1479r999b1529],
24	combination	NN	O	combination	prep_in	22	SENT_360	[p24l1030t1477r1401b1530],
25	with	IN	O	with	_	0	SENT_360	[p24l1430t1477r1563b1530],
26	aspirin	NN	O	aspirin	prep_with	24	SENT_360	[p24l1595t1479r1792b1549],
27	after	IN	O	after	_	0	SENT_360	[p24l1824t1477r1957b1530],
28	coronary	JJ	O	coronary	amod	29	SENT_360	[p24l1987t1497r2140b1530, p24l117t1577r244b1628],
29	stenting	NN	O	stenting	prep_after	26	SENT_360	[p24l268t1559r521b1628],
30	:	:	O	:	_	0	SENT_360	[p24l268t1559r521b1628],
31	the	DT	O	the	det	39	SENT_360	[p24l551t1557r642b1610],
32	Clopidogrel	NNP	O	Clopidogrel	nn	39	SENT_360	[p24l670t1557r1024b1629],
33	Aspirin	NNP	O	Aspirin	nn	39	SENT_360	[p24l1047t1556r1270b1629],
34	Stent	NNP	O	Stent	nn	39	SENT_360	[p24l1299t1557r1453b1610],
35	International	NNP	O	International	nn	39	SENT_360	[p24l1478t1557r1867b1610],
36	Cooperative	NNP	O	Cooperative	nn	39	SENT_360	[p24l1894t1557r2140b1629, p24l117t1639r252b1690],
37	Study	NNP	O	Study	nn	39	SENT_360	[p24l284t1637r454b1708],
38	(	CD	NUMBER	(	num	39	SENT_360	[p24l482t1635r902b1701],
39	CLASSICS	NNS	MISC	classic	dep	4	SENT_360	[p24l482t1635r902b1701],
40	)	CD	NUMBER	)	dep	39	SENT_360	[p24l482t1635r902b1701],
41	.	.	O	.	_	0	SENT_360	[p24l482t1635r902b1701],

1	Circulation	NN	O	circulation	_	0	SENT_361	[p24l937t1637r1272b1690],
2	2000	CD	DATE	2000	num	1	SENT_361	[p24l1300t1639r1805b1702],
3	;	:	O	;	_	0	SENT_361	[p24l1300t1639r1805b1702],
4	102:624	CD	NUMBER	102:624	number	5	SENT_361	[p24l1300t1639r1805b1702],
5	—	CD	NUMBER	—	dep	1	SENT_361	[p24l1300t1639r1805b1702],
6	9	CD	NUMBER	9	dep	5	SENT_361	[p24l1300t1639r1805b1702],
7	.	.	O	.	_	0	SENT_361	[p24l1300t1639r1805b1702],

1	2	LS	NUMBER	2	_	0	SENT_362	[p24l43t1719r92b1771],
2	.	.	O	.	_	0	SENT_362	[p24l43t1719r92b1771],

1	Yusuf	NNP	PERSON	Yusuf	nn	2	SENT_363	[p24l113t1717r290b1770],
2	S	NNP	PERSON	S	_	0	SENT_363	[p24l305t1717r354b1782],
3	,	,	O	,	_	0	SENT_363	[p24l305t1717r354b1782],
4	Zhao	NNP	PERSON	Zhao	nn	5	SENT_363	[p24l379t1717r528b1770],
5	F	NN	PERSON	f	appos	2	SENT_363	[p24l552t1717r607b1782],
6	,	,	O	,	_	0	SENT_363	[p24l552t1717r607b1782],
7	Mehta	NNP	ORGANIZATION	Mehta	nn	8	SENT_363	[p24l630t1717r821b1770],
8	SR	NN	ORGANIZATION	sr	appos	2	SENT_363	[p24l844t1717r943b1782],
9	,	,	O	,	_	0	SENT_363	[p24l844t1717r943b1782],
10	et	FW	O	et	nn	11	SENT_363	[p24l968t1730r1019b1770],
11	al.	FW	O	al.	appos	2	SENT_363	[p24l1041t1717r1100b1770],
12	.	.	O	.	_	0	SENT_363	[p24l1041t1717r1100b1770],

1	Effects	NNS	O	effect	_	0	SENT_364	[p24l1126t1717r1316b1770],
2	of	IN	O	of	_	0	SENT_364	[p24l1339t1717r1403b1770],
3	clopidogrel	NN	O	clopidogrel	prep_of	1	SENT_364	[p24l1416t1717r1732b1789],
4	in	IN	O	in	_	0	SENT_364	[p24l1753t1719r1807b1769],
5	addition	NN	O	addition	_	0	SENT_364	[p24l1830t1717r2065b1770],
6	to	TO	O	to	_	0	SENT_364	[p24l2087t1731r2141b1770],
7	aspirin	NN	O	aspirin	prep_in_addition_to	1	SENT_364	[p24l117t1799r306b1869],
8	in	IN	O	in	_	0	SENT_364	[p24l326t1799r381b1849],
9	patients	NNS	O	patient	prep_in	1	SENT_364	[p24l401t1799r622b1869],
10	with	IN	O	with	_	0	SENT_364	[p24l642t1797r771b1850],
11	acute	JJ	O	acute	amod	13	SENT_364	[p24l793t1811r938b1850],
12	coronary	JJ	O	coronary	amod	13	SENT_364	[p24l960t1817r1208b1868],
13	syndromes	NNS	O	syndrome	prep_with	9	SENT_364	[p24l1226t1797r1525b1868],
14	without	IN	O	without	_	0	SENT_364	[p24l1544t1797r1770b1850],
15	ST-segment	NN	O	st-segment	nn	16	SENT_364	[p24l1792t1795r2144b1868],
16	elevation	NN	O	elevation	prep_without	13	SENT_364	[p24l117t1877r383b1930],
17	.	.	O	.	_	0	SENT_364	[p24l117t1877r383b1930],

1	N	NN	O	n	nn	2	SENT_365	[p24l413t1877r465b1930],
2	EnglJ	NN	O	englj	nsubj	3	SENT_365	[p24l494t1877r678b1948],
3	Med	VBD	O	med	_	0	SENT_365	[p24l702t1877r839b1930],
4	2001	CD	DATE	2001	dobj	3	SENT_365	[p24l864t1877r1420b1942],
5	;	:	O	;	_	0	SENT_365	[p24l864t1877r1420b1942],
6	345:494	CD	NUMBER	345:494	num	7	SENT_365	[p24l864t1877r1420b1942],
7	—	NN	O	—	dep	4	SENT_365	[p24l864t1877r1420b1942],
8	502	CD	NUMBER	502	dep	7	SENT_365	[p24l864t1877r1420b1942],
9	.	.	O	.	_	0	SENT_365	[p24l864t1877r1420b1942],

1	3	LS	NUMBER	3	_	0	SENT_366	[p24l45t1959r92b2010],
2	.	.	O	.	_	0	SENT_366	[p24l45t1959r92b2010],

1	Mehta	NNP	ORGANIZATION	Mehta	nn	2	SENT_367	[p24l115t1957r306b2010],
2	SR	NN	ORGANIZATION	sr	_	0	SENT_367	[p24l329t1957r428b2022],
3	,	,	O	,	_	0	SENT_367	[p24l329t1957r428b2022],
4	Yusuf	NNP	PERSON	Yusuf	nn	5	SENT_367	[p24l448t1957r625b2010],
5	S	NNP	PERSON	S	appos	2	SENT_367	[p24l638t1957r688b2022],
6	,	,	O	,	_	0	SENT_367	[p24l638t1957r688b2022],
7	Peters	NNP	PERSON	Peters	nn	8	SENT_367	[p24l711t1957r883b2010],
8	RJ	NN	PERSON	rj	appos	2	SENT_367	[p24l907t1957r992b2025],
9	,	,	O	,	_	0	SENT_367	[p24l907t1957r992b2025],
10	et	FW	O	et	nn	11	SENT_367	[p24l1015t1970r1067b2010],
11	al.	FW	O	al.	appos	2	SENT_367	[p24l1087t1957r1147b2010],
12	.	.	O	.	_	0	SENT_367	[p24l1087t1957r1147b2010],

1	Clopidogrel	NNP	O	Clopidogrel	_	0	SENT_368	[p24l1172t1957r1512b2029],
2	in	IN	O	in	_	0	SENT_368	[p24l1531t1959r1586b2009],
3	Unstable	JJ	O	unstable	amod	4	SENT_368	[p24l1605t1957r1857b2010],
4	angina	NN	O	angina	prep_in	1	SENT_368	[p24l1880t1959r2067b2028],
5	to	TO	O	to	aux	6	SENT_368	[p24l2087t1971r2141b2010],
6	prevent	VB	O	prevent	infmod	1	SENT_368	[p24l115t2050r328b2108],
7	Recurrent	JJ	O	recurrent	amod	8	SENT_368	[p24l357t2036r639b2089],
8	Events	NNS	O	event	dobj	6	SENT_368	[p24l668t2036r859b2089],
9	trial	NN	O	trial	nn	11	SENT_368	[p24l890t2036r1003b2089],
10	(	CD	NUMBER	(	num	11	SENT_368	[p24l1033t2034r1277b2100],
11	CURE	NN	O	cure	tmod	6	SENT_368	[p24l1033t2034r1277b2100],
12	)	CD	NUMBER	)	num	13	SENT_368	[p24l1033t2034r1277b2100],
13	Investigators	NNS	O	investigator	dep	11	SENT_368	[p24l1309t2036r1687b2107],
14	.	.	O	.	_	0	SENT_368	[p24l1309t2036r1687b2107],

1	Effects	NNS	O	effect	nsubj	8	SENT_369	[p24l1721t2036r1911b2089],
2	of	IN	O	of	_	0	SENT_369	[p24l1941t2036r2006b2089],
3	pretreatment	NN	O	pretreatment	prep_of	1	SENT_369	[p24l2024t2056r2140b2108, p24l116t2130r393b2170],
4	with	IN	O	with	_	0	SENT_369	[p24l415t2117r545b2170],
5	clopidogrel	NN	O	clopidogrel	prep_with	3	SENT_369	[p24l572t2117r888b2189],
6	and	CC	O	and	_	0	SENT_369	[p24l914t2117r1016b2170],
7	aspirin	NN	O	aspirin	conj_and	5	SENT_369	[p24l1043t2119r1232b2189],
8	followed	VBN	O	follow	_	0	SENT_369	[p24l1258t2117r1502b2170],
9	by	IN	O	by	_	0	SENT_369	[p24l1526t2117r1595b2188],
10	long	JJ	O	long	amod	13	SENT_369	[p24l1618t2117r1905b2188],
11	—	JJ	O	—	amod	13	SENT_369	[p24l1618t2117r1905b2188],
12	term	NN	O	term	nn	13	SENT_369	[p24l1618t2117r1905b2188],
13	therapy	NN	O	therapy	prep_by	8	SENT_369	[p24l1932t2117r2146b2189],
14	in	IN	O	in	_	0	SENT_369	[p24l116t2227r170b2277],
15	patients	NNS	O	patient	prep_in	13	SENT_369	[p24l199t2227r421b2297],
16	undergoing	VBG	O	undergo	partmod	15	SENT_369	[p24l451t2225r777b2296],
17	percutaneous	JJ	O	percutaneous	amod	19	SENT_369	[p24l805t2239r1176b2297],
18	coronary	JJ	O	coronary	amod	19	SENT_369	[p24l1208t2245r1456b2296],
19	intervention	NN	O	intervention	dobj	16	SENT_369	[p24l1482t2227r1842b2278],
20	:	:	O	:	_	0	SENT_369	[p24l1482t2227r1842b2278],
21	the	DT	O	the	det	25	SENT_369	[p24l1875t2225r1963b2278],
22	PCI	NN	O	pcus	nn	25	SENT_369	[p24l1994t2225r2140b2278],
23	—	CD	NUMBER	—	num	25	SENT_369	[p24l1994t2225r2140b2278],
24	CURE	NN	O	cure	nn	25	SENT_369	[p24l117t2305r317b2358],
25	study	NN	O	study	dep	19	SENT_369	[p24l346t2305r509b2376],
26	.	.	O	.	_	0	SENT_369	[p24l346t2305r509b2376],

1	Lancet	NNP	O	Lancet	_	0	SENT_370	[p24l540t2305r735b2358],
2	2001	CD	DATE	2001	num	1	SENT_370	[p24l759t2305r1271b2370],
3	;	:	O	;	_	0	SENT_370	[p24l759t2305r1271b2370],
4	358:527	CD	NUMBER	358:527	number	5	SENT_370	[p24l759t2305r1271b2370],
5	-33	CD	NUMBER	-33	dep	1	SENT_370	[p24l759t2305r1271b2370],
6	.	.	O	.	_	0	SENT_370	[p24l759t2305r1271b2370],

1	4	LS	NUMBER	4	_	0	SENT_371	[p24l43t2387r92b2438],
2	.	.	O	.	_	0	SENT_371	[p24l43t2387r92b2438],

1	Angiolillo	JJ	O	angiolillo	amod	2	SENT_372	[p24l114t2384r401b2456],
2	DJ	NNP	O	DJ	_	0	SENT_372	[p24l435t2385r530b2453],
3	,	,	O	,	_	0	SENT_372	[p24l435t2385r530b2453],
4	Fernandez	NNP	PERSON	Fernandez	appos	2	SENT_372	[p24l565t2385r1051b2438],
5	.	.	O	.	_	0	SENT_372	[p24l565t2385r1051b2438],

1	—	NN	O	—	_	0	SENT_373	[p24l565t2385r1051b2438],
2	.	.	O	.	_	0	SENT_373	[p24l565t2385r1051b2438],

1	Ortiz	NNP	PERSON	Ortiz	nn	2	SENT_374	[p24l565t2385r1051b2438],
2	A	NNP	O	A	_	0	SENT_374	[p24l1079t2384r1147b2450],
3	,	,	O	,	_	0	SENT_374	[p24l1079t2384r1147b2450],
4	Bernardo	NNP	PERSON	Bernardo	nn	5	SENT_374	[p24l1183t2385r1446b2438],
5	E	NNP	PERSON	E	appos	2	SENT_374	[p24l1481t2385r1542b2450],
6	,	,	O	,	_	0	SENT_374	[p24l1481t2385r1542b2450],
7	et	FW	O	et	nn	8	SENT_374	[p24l1578t2399r1629b2438],
8	al.	FW	O	al.	appos	5	SENT_374	[p24l1662t2385r1721b2438],
9	.	.	O	.	_	0	SENT_374	[p24l1662t2385r1721b2438],

1	Variability	NN	O	variability	_	0	SENT_375	[p24l1758t2385r2058b2456],
2	in	IN	O	in	_	0	SENT_375	[p24l2089t2387r2143b2437],
3	individual	JJ	O	individual	amod	4	SENT_375	[p24l116t2466r399b2519],
4	responsiveness	NN	O	responsiveness	prep_in	1	SENT_375	[p24l419t2468r830b2538],
5	to	TO	O	to	_	0	SENT_375	[p24l854t2480r908b2519],
6	clopidogrel	NN	O	clopidogrel	prep_to	4	SENT_375	[p24l932t2466r1261b2538],
7	:	:	O	:	_	0	SENT_375	[p24l932t2466r1261b2538],
8	clinical	JJ	O	clinical	amod	9	SENT_375	[p24l1288t2466r1487b2519],
9	implications	NNS	O	implication	dep	1	SENT_375	[p24l1508t2466r1871b2538],
10	,	,	O	,	_	0	SENT_375	[p24l1508t2466r1871b2538],
11	management	NN	O	management	conj_and	9	SENT_375	[p24l1896t2486r2140b2537, p24l117t2559r277b2610],
12	,	,	O	,	_	0	SENT_375	[p24l1896t2486r2140b2537, p24l117t2559r277b2610],
13	and	CC	O	and	_	0	SENT_375	[p24l307t2545r409b2598],
14	future	JJ	DATE	future	amod	15	SENT_375	[p24l435t2545r603b2598],
15	perspectives	NNS	O	perspective	dep	1	SENT_375	[p24l630t2547r983b2617],
16	.	.	O	.	_	0	SENT_375	[p24l630t2547r983b2617],

1	J	NNP	O	J	nn	4	SENT_376	[p24l1006t2545r1035b2613],
2	Am	NNP	O	Am	nn	4	SENT_376	[p24l1059t2543r1168b2597],
3	Coll	NNP	O	Coll	nn	4	SENT_376	[p24l1196t2545r1318b2598],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_376	[p24l1345t2545r1559b2598],
5	2007	CD	DATE	2007	num	4	SENT_376	[p24l1583t2545r2096b2610],
6	;	:	O	;	_	0	SENT_376	[p24l1583t2545r2096b2610],
7	49:1505	CD	NUMBER	49:1505	number	8	SENT_376	[p24l1583t2545r2096b2610],
8	—	CD	NUMBER	—	dep	4	SENT_376	[p24l1583t2545r2096b2610],
9	16	CD	NUMBER	16	dep	8	SENT_376	[p24l1583t2545r2096b2610],
10	.	.	O	.	_	0	SENT_376	[p24l1583t2545r2096b2610],

1	5	CD	NUMBER	5	_	0	SENT_377	[p24l44t2625r92b2678],
2	.	.	O	.	_	0	SENT_377	[p24l44t2625r92b2678],

1	Frere	NNP	ORGANIZATION	Frere	nn	2	SENT_378	[p24l116t2625r265b2678],
2	C	NNP	ORGANIZATION	C	_	0	SENT_378	[p24l298t2625r363b2690],
3	,	,	O	,	_	0	SENT_378	[p24l298t2625r363b2690],
4	Cuisset	NNP	O	Cuisset	nn	5	SENT_378	[p24l399t2625r608b2678],
5	T	NN	O	t	appos	2	SENT_378	[p24l636t2623r702b2690],
6	,	,	O	,	_	0	SENT_378	[p24l636t2623r702b2690],
7	Morange	NNP	ORGANIZATION	Morange	nn	8	SENT_378	[p24l735t2625r996b2696],
8	PE	NNP	ORGANIZATION	PE	appos	2	SENT_378	[p24l1028t2625r1134b2690],
9	,	,	O	,	_	0	SENT_378	[p24l1028t2625r1134b2690],
10	et	FW	O	et	nn	11	SENT_378	[p24l1169t2639r1220b2678],
11	al.	FW	O	al.	appos	2	SENT_378	[p24l1252t2625r1311b2678],
12	.	.	O	.	_	0	SENT_378	[p24l1252t2625r1311b2678],

1	Effect	NN	O	effect	_	0	SENT_379	[p24l1348t2625r1514b2678],
2	of	IN	O	of	_	0	SENT_379	[p24l1546t2625r1610b2678],
3	cytochrome	NN	O	cytochrome	nn	5	SENT_379	[p24l1633t2625r1962b2696],
4	P450	NN	O	p450	nn	5	SENT_379	[p24l1995t2625r2142b2678],
5	polymorphisms	NNS	O	polymorphism	prep_of	1	SENT_379	[p24l115t2706r553b2778],
6	on	IN	O	on	_	0	SENT_379	[p24l574t2726r644b2759],
7	platelet	NN	O	platelet	nn	8	SENT_379	[p24l662t2706r871b2778],
8	reactivity	NN	O	reactivity	prep_on	5	SENT_379	[p24l889t2708r1149b2777],
9	after	IN	O	after	_	0	SENT_379	[p24l1167t2706r1294b2759],
10	treatment	NN	O	treatment	prep_after	8	SENT_379	[p24l1312t2719r1589b2759],
11	with	IN	O	with	_	0	SENT_379	[p24l1605t2706r1734b2759],
12	clopidogrel	NN	O	clopidogrel	prep_with	1	SENT_379	[p24l1754t2706r2070b2778],
13	in	IN	O	in	_	0	SENT_379	[p24l2089t2708r2143b2758],
14	acute	JJ	O	acute	amod	16	SENT_379	[p24l117t2800r261b2839],
15	coronary	JJ	O	coronary	amod	16	SENT_379	[p24l289t2806r537b2857],
16	syndrome	NN	O	syndrome	prep_in	1	SENT_379	[p24l561t2786r851b2857],
17	.	.	O	.	_	0	SENT_379	[p24l561t2786r851b2857],

1	AmJ	NN	O	amj	nn	2	SENT_380	[p24l879t2785r1036b2854],
2	Cardiol	NN	O	cardiol	_	0	SENT_380	[p24l1064t2786r1278b2839],
3	2008	CD	DATE	2008	dep	2	SENT_380	[p24l1302t2788r1859b2851],
4	;	:	O	;	_	0	SENT_380	[p24l1302t2788r1859b2851],
5	101:1088	CD	NUMBER	101:1088	number	6	SENT_380	[p24l1302t2788r1859b2851],
6	—	CD	NUMBER	—	dep	2	SENT_380	[p24l1302t2788r1859b2851],
7	93	CD	NUMBER	93	dep	6	SENT_380	[p24l1302t2788r1859b2851],
8	.	.	O	.	_	0	SENT_380	[p24l1302t2788r1859b2851],

1	6	CD	NUMBER	6	_	0	SENT_381	[p24l45t2868r92b2919],
2	.	.	O	.	_	0	SENT_381	[p24l45t2868r92b2919],

1	Collet	NNP	ORGANIZATION	Collet	nn	2	SENT_382	[p24l117t2866r292b2919],
2	JP	NNP	ORGANIZATION	JP	_	0	SENT_382	[p24l309t2866r396b2934],
3	,	,	O	,	_	0	SENT_382	[p24l309t2866r396b2934],
4	Hulot	NNP	PERSON	Hulot	nn	5	SENT_382	[p24l424t2866r595b2919],
5	JS	NNP	O	JS	appos	2	SENT_382	[p24l611t2866r695b2934],
6	,	,	O	,	_	0	SENT_382	[p24l611t2866r695b2934],
7	Pena	NNP	PERSON	Pena	nn	8	SENT_382	[p24l722t2866r862b2919],
8	A	NNP	O	A	appos	2	SENT_382	[p24l884t2865r952b2931],
9	,	,	O	,	_	0	SENT_382	[p24l884t2865r952b2931],
10	et	FW	O	et	nn	11	SENT_382	[p24l980t2880r1031b2919],
11	al.	FW	O	al.	appos	2	SENT_382	[p24l1056t2866r1115b2919],
12	.	.	O	.	_	0	SENT_382	[p24l1056t2866r1115b2919],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_383	[p24l1145t2866r1497b2937],
2	P450	NN	O	p450	nn	4	SENT_383	[p24l1523t2866r1669b2919],
3	2C19	NN	O	2c19	nn	4	SENT_383	[p24l1694t2866r1851b2920],
4	polymorphism	NN	O	polymorphism	_	0	SENT_383	[p24l1876t2866r2140b2938, p24l115t2947r289b3019],
5	in	IN	O	in	_	0	SENT_383	[p24l331t2949r385b2999],
6	young	JJ	O	young	amod	7	SENT_383	[p24l424t2967r600b3018],
7	patients	NNS	O	patient	prep_in	4	SENT_383	[p24l639t2949r861b3019],
8	treated	VBN	O	treat	partmod	7	SENT_383	[p24l903t2947r1099b3000],
9	with	IN	O	with	_	0	SENT_383	[p24l1137t2947r1266b3000],
10	clopidogrel	NN	O	clopidogrel	prep_with	8	SENT_383	[p24l1308t2947r1624b3019],
11	after	IN	O	after	_	0	SENT_383	[p24l1665t2947r1793b3000],
12	myocardial	JJ	O	myocardial	amod	13	SENT_383	[p24l1833t2947r2144b3018],
13	infarction	NN	O	infarction	prep_after	8	SENT_383	[p24l116t3027r406b3080],
14	:	:	O	:	_	0	SENT_383	[p24l116t3027r406b3080],
15	a	DT	O	a	det	16	SENT_383	[p24l437t3047r464b3080],
16	cohort	NN	O	cohort	dep	4	SENT_383	[p24l491t3027r674b3080],
17	study	NN	O	study	dep	16	SENT_383	[p24l700t3027r863b3098],
18	.	.	O	.	_	0	SENT_383	[p24l700t3027r863b3098],

1	Lancet	NNP	O	Lancet	_	0	SENT_384	[p24l894t3027r1089b3080],
2	2009	CD	DATE	2009	num	1	SENT_384	[p24l1113t3028r1634b3092],
3	;	:	O	;	_	0	SENT_384	[p24l1113t3028r1634b3092],
4	373:309	CD	NUMBER	373:309	number	5	SENT_384	[p24l1113t3028r1634b3092],
5	—	CD	NUMBER	—	dep	1	SENT_384	[p24l1113t3028r1634b3092],
6	17	CD	NUMBER	17	dep	5	SENT_384	[p24l1113t3028r1634b3092],
7	.	.	O	.	_	0	SENT_384	[p24l1113t3028r1634b3092],

1	7	CD	NUMBER	7	_	0	SENT_385	[p24l45t3108r92b3160],
2	.	.	O	.	_	0	SENT_385	[p24l45t3108r92b3160],

1	Hulot	NNP	PERSON	Hulot	nn	2	SENT_386	[p24l116t3107r288b3160],
2	JS	NNP	O	JS	_	0	SENT_386	[p24l302t3107r385b3175],
3	,	,	O	,	_	0	SENT_386	[p24l302t3107r385b3175],
4	Collet	NNP	ORGANIZATION	Collet	nn	5	SENT_386	[p24l412t3107r587b3160],
5	JP	NNP	ORGANIZATION	JP	appos	2	SENT_386	[p24l602t3107r689b3175],
6	,	,	O	,	_	0	SENT_386	[p24l602t3107r689b3175],
7	Silvain	NNP	PERSON	Silvain	nn	8	SENT_386	[p24l717t3107r906b3160],
8	J	NNP	PERSON	J	appos	2	SENT_386	[p24l922t3107r966b3175],
9	,	,	O	,	_	0	SENT_386	[p24l922t3107r966b3175],
10	et	FW	O	et	nn	11	SENT_386	[p24l992t3121r1043b3160],
11	al.	FW	O	al.	appos	2	SENT_386	[p24l1066t3107r1125b3160],
12	.	.	O	.	_	0	SENT_386	[p24l1066t3107r1125b3160],

1	Cardiovascular	NNP	O	Cardiovascular	nsubj	2	SENT_387	[p24l1153t3107r1575b3160],
2	risk	NN	O	risk	_	0	SENT_387	[p24l1596t3107r1701b3160],
3	in	IN	O	in	_	0	SENT_387	[p24l1720t3109r1775b3159],
4	clopidogreltreated	JJ	O	clopidogreltreated	amod	5	SENT_387	[p24l1798t3107r2140b3179, p24l116t3187r312b3240],
5	patients	NNS	O	patient	prep_in	2	SENT_387	[p24l328t3189r551b3259],
6	according	VBG	O	accord	_	0	SENT_387	[p24l572t3187r847b3258],
7	to	TO	O	to	prepc_according_to	5	SENT_387	[p24l864t3201r918b3240],
8	cytochrome	NN	O	cytochrome	nn	11	SENT_387	[p24l938t3187r1268b3258],
9	P450	NN	O	p450	nn	11	SENT_387	[p24l1287t3187r1433b3240],
10	2C19	NN	O	2c19	nn	11	SENT_387	[p24l1451t3187r1667b3241],
11	*	NN	O	*	pobj	5	SENT_387	[p24l1451t3187r1667b3241],
12	2	CD	NUMBER	2	num	13	SENT_387	[p24l1451t3187r1667b3241],
13	loss	NN	O	loss	dep	11	SENT_387	[p24l1684t3187r2143b3240],
14	—	CD	NUMBER	—	num	16	SENT_387	[p24l1684t3187r2143b3240],
15	of-function	JJ	O	of-function	amod	16	SENT_387	[p24l1684t3187r2143b3240],
16	allele	NN	O	allele	dep	11	SENT_387	[p24l117t3268r258b3321],
17	or	CC	O	or	_	0	SENT_387	[p24l290t3288r347b3321],
18	proton	NN	O	proton	nn	21	SENT_387	[p24l375t3282r566b3340],
19	pump	NN	O	pump	nn	21	SENT_387	[p24l595t3288r758b3340],
20	inhibitor	NN	O	inhibitor	nn	21	SENT_387	[p24l790t3268r1040b3321],
21	coadministration	NN	O	coadministration	pobj	5	SENT_387	[p24l1069t3268r1564b3321],
22	:	:	O	:	_	0	SENT_387	[p24l1069t3268r1564b3321],
23	a	DT	O	a	det	25	SENT_387	[p24l1598t3288r1626b3321],
24	systematic	JJ	O	systematic	amod	25	SENT_387	[p24l1656t3270r1946b3339],
25	metaanalysis	NN	O	metaanalysis	dep	21	SENT_387	[p24l1977t3282r2140b3321, p24l117t3348r346b3419],
26	.	.	O	.	_	0	SENT_387	[p24l1977t3282r2140b3321, p24l117t3348r346b3419],

1	J	NNP	O	J	nn	4	SENT_388	[p24l368t3348r397b3416],
2	Am	NNP	O	Am	nn	4	SENT_388	[p24l420t3346r530b3400],
3	Coll	NNP	O	Coll	nn	4	SENT_388	[p24l558t3348r680b3401],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_388	[p24l707t3348r922b3401],
5	2010	CD	DATE	2010	num	4	SENT_388	[p24l946t3348r1439b3413],
6	;	:	O	;	_	0	SENT_388	[p24l946t3348r1439b3413],
7	56:134	CD	NUMBER	56:134	number	8	SENT_388	[p24l946t3348r1439b3413],
8	—	CD	NUMBER	—	dep	4	SENT_388	[p24l946t3348r1439b3413],
9	43	CD	NUMBER	43	dep	8	SENT_388	[p24l946t3348r1439b3413],
10	.	.	O	.	_	0	SENT_388	[p24l946t3348r1439b3413],

1	8	CD	NUMBER	8	_	0	SENT_389	[p24l48t3430r95b3480],
2	.	.	O	.	_	0	SENT_389	[p24l48t3430r95b3480],

1	Frére	NN	O	frére	nn	2	SENT_390	[p24l122t3428r275b3480],
2	C	NN	O	c	_	0	SENT_390	[p24l330t3428r396b3492],
3	,	,	O	,	_	0	SENT_390	[p24l330t3428r396b3492],
4	Cuisset	NN	O	cuisset	nn	5	SENT_390	[p24l452t3428r670b3480],
5	T	NN	O	t	appos	2	SENT_390	[p24l718t3426r785b3492],
6	,	,	O	,	_	0	SENT_390	[p24l718t3426r785b3492],
7	Gaborit	NN	O	gaborit	nn	8	SENT_390	[p24l841t3428r1073b3480],
8	B	NN	O	b	appos	2	SENT_390	[p24l1124t3428r1185b3492],
9	,	,	O	,	_	0	SENT_390	[p24l1124t3428r1185b3492],
10	Alessi	NNP	PERSON	Alessi	nn	11	SENT_390	[p24l1238t3427r1415b3480],
11	MC	NNP	O	MC	appos	2	SENT_390	[p24l1466t3428r1607b3492],
12	,	,	O	,	_	0	SENT_390	[p24l1466t3428r1607b3492],
13	Hulot	NNP	PERSON	Hulot	nn	14	SENT_390	[p24l1662t3428r1839b3480],
14	JS	NNP	O	JS	appos	2	SENT_390	[p24l1883t3428r1967b3495],
15	.	.	O	.	_	0	SENT_390	[p24l1883t3428r1967b3495],

1	The	DT	O	the	det	5	SENT_391	[p24l2021t3426r2141b3480],
2	CYP2C19	NN	O	cyp2c19	nn	5	SENT_391	[p24l117t3507r512b3561],
3	*	NN	O	*	nn	5	SENT_391	[p24l117t3507r512b3561],
4	17	CD	NUMBER	17	num	5	SENT_391	[p24l117t3507r512b3561],
5	allele	NN	O	allele	nsubjpass	7	SENT_391	[p24l559t3507r700b3560],
6	is	VBZ	O	be	auxpass	7	SENT_391	[p24l746t3509r787b3560],
7	associated	VBN	O	associate	_	0	SENT_391	[p24l836t3507r1118b3560],
8	with	IN	O	with	_	0	SENT_391	[p24l1160t3507r1290b3560],
9	better	JJR	O	better	amod	11	SENT_391	[p24l1334t3507r1500b3560],
10	platelet	NN	O	platelet	nn	11	SENT_391	[p24l1544t3507r1754b3579],
11	response	NN	O	response	prep_with	7	SENT_391	[p24l1798t3527r2040b3579],
12	to	TO	O	to	_	0	SENT_391	[p24l2087t3521r2141b3560],
13	clopidogrel	NN	O	clopidogrel	prep_to	11	SENT_391	[p24l117t3587r433b3659],
14	in	IN	O	in	_	0	SENT_391	[p24l455t3589r509b3639],
15	patients	NNS	O	patient	prep_in	7	SENT_391	[p24l532t3589r754b3659],
16	admitted	VBN	O	admit	partmod	15	SENT_391	[p24l780t3587r1034b3640],
17	for	IN	O	for	_	0	SENT_391	[p24l1057t3587r1137b3640],
18	non-ST	JJ	O	non-st	amod	21	SENT_391	[p24l1161t3585r1387b3640],
19	acute	JJ	O	acute	amod	21	SENT_391	[p24l1411t3601r1555b3640],
20	coronary	JJ	O	coronary	amod	21	SENT_391	[p24l1580t3607r1828b3658],
21	syndrome	NN	O	syndrome	prep_for	16	SENT_391	[p24l1849t3587r2139b3658],
22	.	.	O	.	_	0	SENT_391	[p24l1849t3587r2139b3658],

1	J	NNP	O	J	nn	3	SENT_392	[p24l108t3667r137b3734],
2	Thromb	NNP	O	Thromb	nn	3	SENT_392	[p24l161t3665r400b3719],
3	Haemost	NNP	O	Haemost	_	0	SENT_392	[p24l429t3667r690b3719],
4	2009	CD	DATE	2009	num	3	SENT_392	[p24l713t3668r1198b3731],
5	;	:	O	;	_	0	SENT_392	[p24l713t3668r1198b3731],
6	7:1409	CD	DATE	7:1409	number	7	SENT_392	[p24l713t3668r1198b3731],
7	-11	CD	DATE	-11	dep	3	SENT_392	[p24l713t3668r1198b3731],
8	.	.	O	.	_	0	SENT_392	[p24l713t3668r1198b3731],

1	9	CD	NUMBER	9	_	0	SENT_393	[p24l45t3748r92b3799],
2	.	.	O	.	_	0	SENT_393	[p24l45t3748r92b3799],

1	Sibbing	VBG	O	sibb	_	0	SENT_394	[p24l119t3746r336b3817],
2	D	NN	O	d	dobj	1	SENT_394	[p24l363t3746r434b3811],
3	,	,	O	,	_	0	SENT_394	[p24l363t3746r434b3811],
4	Koch	NNP	PERSON	Koch	nn	5	SENT_394	[p24l467t3746r616b3799],
5	W	NNP	O	W	appos	2	SENT_394	[p24l641t3746r732b3811],
6	,	,	O	,	_	0	SENT_394	[p24l641t3746r732b3811],
7	Gebhard	NNP	PERSON	Gebhard	nn	8	SENT_394	[p24l765t3746r1016b3799],
8	D	NNP	O	D	appos	2	SENT_394	[p24l1044t3746r1115b3811],
9	,	,	O	,	_	0	SENT_394	[p24l1044t3746r1115b3811],
10	et	FW	O	et	nn	11	SENT_394	[p24l1147t3760r1197b3799],
11	al.	FW	O	al.	appos	2	SENT_394	[p24l1226t3746r1285b3799],
12	.	.	O	.	_	0	SENT_394	[p24l1226t3746r1285b3799],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_395	[p24l1319t3746r1671b3817],
2	2C19	NN	O	2c19	_	0	SENT_395	[p24l1699t3746r1953b3800],
3	*	CD	NUMBER	*	number	4	SENT_395	[p24l1699t3746r1953b3800],
4	17	CD	NUMBER	17	num	6	SENT_395	[p24l1699t3746r1953b3800],
5	allelic	JJ	O	allelic	amod	6	SENT_395	[p24l1982t3746r2143b3799],
6	variant	NN	O	variant	dep	2	SENT_395	[p25l113t14r324b77],
7	,	,	O	,	_	0	SENT_395	[p25l113t14r324b77],
8	platelet	NN	O	platelet	nn	9	SENT_395	[p25l353t12r562b84],
9	aggregation	NN	O	aggregation	appos	2	SENT_395	[p25l589t14r935b83],
10	,	,	O	,	_	0	SENT_395	[p25l589t14r935b83],
11	bleeding	VBG	O	bleed	amod	12	SENT_395	[p25l963t12r1206b83],
12	events	NNS	O	event	appos	2	SENT_395	[p25l1232t25r1422b77],
13	,	,	O	,	_	0	SENT_395	[p25l1232t25r1422b77],
14	and	CC	O	and	_	0	SENT_395	[p25l1453t12r1555b65],
15	stent	NN	O	stent	nn	16	SENT_395	[p25l1582t26r1719b65],
16	thrombosis	NN	O	thrombosis	appos	2	SENT_395	[p25l1745t12r2060b65],
17	in	IN	O	in	_	0	SENT_395	[p25l2088t14r2143b64],
18	clopidogrel	NN	O	clopidogrel	nn	19	SENT_395	[p25l117t120r659b192],
19	—	NN	O	—	prep_in	16	SENT_395	[p25l117t120r659b192],
20	treated	VBN	O	treat	partmod	19	SENT_395	[p25l117t120r659b192],
21	patients	NNS	O	patient	dobj	20	SENT_395	[p25l678t122r900b192],
22	with	IN	O	with	_	0	SENT_395	[p25l919t120r1048b173],
23	coronary	JJ	O	coronary	amod	25	SENT_395	[p25l1069t140r1317b191],
24	stent	NN	O	stent	nn	25	SENT_395	[p25l1335t133r1472b173],
25	placement	NN	O	placement	prep_with	20	SENT_395	[p25l1490t120r1796b192],
26	.	.	O	.	_	0	SENT_395	[p25l1490t120r1796b192],

1	Circulation	NN	O	circulation	_	0	SENT_396	[p25l1822t120r2143b173],
2	2010	CD	DATE	2010	num	1	SENT_396	[p25l114t201r600b265],
3	;	:	O	;	_	0	SENT_396	[p25l114t201r600b265],
4	121:512	CD	NUMBER	121:512	number	5	SENT_396	[p25l114t201r600b265],
5	—	CD	NUMBER	—	dep	1	SENT_396	[p25l114t201r600b265],
6	8	CD	NUMBER	8	dep	5	SENT_396	[p25l114t201r600b265],
7	.	.	O	.	_	0	SENT_396	[p25l114t201r600b265],

1	10	CD	NUMBER	10	_	0	SENT_397	[p25l12t281r92b332],
2	.	.	O	.	_	0	SENT_397	[p25l12t281r92b332],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_398	[p25l113t279r339b332],
2	SD	NN	O	sd	_	0	SENT_398	[p25l362t279r469b344],
3	,	,	O	,	_	0	SENT_398	[p25l362t279r469b344],
4	Antman	NNP	ORGANIZATION	Antman	nn	5	SENT_398	[p25l491t277r729b332],
5	EM	NNP	ORGANIZATION	EM	appos	2	SENT_398	[p25l752t279r883b344],
6	,	,	O	,	_	0	SENT_398	[p25l752t279r883b344],
7	Winters	NNP	DATE	Winters	nn	9	SENT_398	[p25l904t279r1137b332],
8	K	NNP	O	K	nn	9	SENT_398	[p25l1163t279r1248b347],
9	]	NNP	O	]	appos	2	SENT_398	[p25l1163t279r1248b347],
10	,	,	O	,	_	0	SENT_398	[p25l1163t279r1248b347],
11	et	FW	O	et	nn	12	SENT_398	[p25l1273t293r1323b332],
12	al.	FW	O	al.	appos	2	SENT_398	[p25l1345t279r1404b332],
13	.	.	O	.	_	0	SENT_398	[p25l1345t279r1404b332],

1	Randomized	VBN	O	randomize	partmod	37	SENT_399	[p25l1432t279r1793b332],
2	comparison	NN	O	comparison	dobj	1	SENT_399	[p25l1815t281r2143b351],
3	of	IN	O	of	_	0	SENT_399	[p25l117t358r180b411],
4	prasugrel	NN	O	prasugrel	nn	7	SENT_399	[p25l214t358r474b430],
5	(	CD	NUMBER	(	num	7	SENT_399	[p25l520t356r782b423],
6	CS	NNP	O	CS	nn	7	SENT_399	[p25l520t356r782b423],
7	—	NN	O	—	prep_of	2	SENT_399	[p25l520t356r782b423],
8	747	CD	NUMBER	747	num	7	SENT_399	[p25l520t356r782b423],
9	,	,	O	,	_	0	SENT_399	[p25l520t356r782b423],
10	LY640315	CD	NUMBER	ly640315	num	11	SENT_399	[p25l829t356r1173b423],
11	)	NN	O	)	nsubj	37	SENT_399	[p25l829t356r1173b423],
12	,	,	O	,	_	0	SENT_399	[p25l829t356r1173b423],
13	a	DT	O	a	det	17	SENT_399	[p25l1221t379r1249b411],
14	novel	JJ	O	novel	amod	17	SENT_399	[p25l1293t358r1443b411],
15	thienopyridine	NN	O	thienopyridine	nn	17	SENT_399	[p25l1487t358r1903b430],
16	P2Y12	NN	O	p2y12	nn	17	SENT_399	[p25l1948t358r2142b412],
17	antagonist	NN	O	antagonist	appos	11	SENT_399	[p25l117t441r425b510],
18	,	,	O	,	_	0	SENT_399	[p25l117t441r425b510],
19	with	IN	O	with	_	0	SENT_399	[p25l464t439r594b492],
20	clopidogrel	NN	O	clopidogrel	prep_with	11	SENT_399	[p25l634t439r950b511],
21	in	IN	O	in	_	0	SENT_399	[p25l989t441r1043b491],
22	percutaneous	JJ	O	percutaneous	amod	24	SENT_399	[p25l1081t453r1453b511],
23	coronary	JJ	O	coronary	amod	24	SENT_399	[p25l1495t459r1742b510],
24	intervention	NN	O	intervention	prep_in	20	SENT_399	[p25l1779t441r2139b492],
25	:	:	O	:	_	0	SENT_399	[p25l1779t441r2139b492],
26	results	NNS	O	result	dep	20	SENT_399	[p25l116t519r294b571],
27	of	IN	O	of	_	0	SENT_399	[p25l340t519r404b571],
28	the	DT	O	the	det	30	SENT_399	[p25l438t519r526b571],
29	Joint	NNP	O	Joint	nn	30	SENT_399	[p25l564t519r709b586],
30	Utilization	NN	O	utilization	prep_of	26	SENT_399	[p25l749t519r1057b571],
31	of	IN	O	of	_	0	SENT_399	[p25l1102t519r1166b571],
32	Medications	NNS	O	medication	prep_of	30	SENT_399	[p25l1198t519r1552b571],
33	to	TO	O	to	_	0	SENT_399	[p25l1597t532r1652b571],
34	Block	NNP	O	Block	nn	35	SENT_399	[p25l1697t519r1863b571],
35	Platelets	NNS	O	platelet	prep_to	32	SENT_399	[p25l1904t519r2141b571],
36	Optimally	RB	O	optimally	advmod	37	SENT_399	[p25l117t597r409b669],
37	(	VBP	O	(	_	0	SENT_399	[p25l434t595r928b665],
38	JUMBO	NNP	O	JUMBO	dobj	37	SENT_399	[p25l434t595r928b665],
39	)	CD	NUMBER	)	num	38	SENT_399	[p25l434t595r928b665],
40	.	.	O	.	_	0	SENT_399	[p25l434t595r928b665],

1	—	NN	O	—	_	0	SENT_400	[p25l434t595r928b665],
2	.	.	O	.	_	0	SENT_400	[p25l434t595r928b665],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_401	[p25l434t595r928b665],
2	26	CD	NUMBER	26	num	3	SENT_401	[p25l955t599r1023b651],
3	trial	NN	O	trial	dep	1	SENT_401	[p25l1051t597r1178b650],
4	.	.	O	.	_	0	SENT_401	[p25l1051t597r1178b650],

1	Circulation	NN	O	circulation	_	0	SENT_402	[p25l1209t597r1530b650],
2	2005	CD	DATE	2005	num	1	SENT_402	[p25l1555t597r2112b662],
3	;	:	O	;	_	0	SENT_402	[p25l1555t597r2112b662],
4	111:3366	CD	NUMBER	111:3366	number	5	SENT_402	[p25l1555t597r2112b662],
5	—	CD	NUMBER	—	dep	1	SENT_402	[p25l1555t597r2112b662],
6	73	CD	NUMBER	73	dep	5	SENT_402	[p25l1555t597r2112b662],
7	.	.	O	.	_	0	SENT_402	[p25l1555t597r2112b662],

1	11	CD	NUMBER	11	_	0	SENT_403	[p25l12t679r92b729],
2	.	.	O	.	_	0	SENT_403	[p25l12t679r92b729],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_404	[p25l116t676r314b729],
2	JT	NNP	O	JT	_	0	SENT_404	[p25l333t674r427b744],
3	,	,	O	,	_	0	SENT_404	[p25l333t674r427b744],
4	Payne	NNP	PERSON	Payne	nn	5	SENT_404	[p25l457t676r627b747],
5	CD	NNP	O	CD	appos	2	SENT_404	[p25l656t676r779b741],
6	,	,	O	,	_	0	SENT_404	[p25l656t676r779b741],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_404	[p25l806t676r1032b729],
8	SD	NN	O	sd	appos	2	SENT_404	[p25l1061t676r1168b741],
9	,	,	O	,	_	0	SENT_404	[p25l1061t676r1168b741],
10	et	FW	O	et	nn	11	SENT_404	[p25l1199t690r1250b729],
11	al.	FW	O	al.	appos	2	SENT_404	[p25l1278t676r1337b729],
12	.	.	O	.	_	0	SENT_404	[p25l1278t676r1337b729],

1	A	DT	O	a	det	2	SENT_405	[p25l1367t675r1420b728],
2	comparison	NN	O	comparison	nsubjpass	18	SENT_405	[p25l1447t678r1775b748],
3	of	IN	O	of	_	0	SENT_405	[p25l1804t676r1867b729],
4	prasugrel	NN	O	prasugrel	prep_of	2	SENT_405	[p25l1884t676r2144b748],
5	and	CC	O	and	_	0	SENT_405	[p25l117t756r219b809],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_405	[p25l264t756r580b828],
7	loading	NN	O	loading	nn	8	SENT_405	[p25l622t756r835b827],
8	doses	NNS	O	dose	conj_and	2	SENT_405	[p25l879t756r1027b809],
9	on	IN	O	on	_	0	SENT_405	[p25l1074t776r1144b809],
10	platelet	NN	O	platelet	nn	11	SENT_405	[p25l1187t756r1397b828],
11	function	NN	O	function	prep_on	8	SENT_405	[p25l1439t756r1692b809],
12	:	:	O	:	_	0	SENT_405	[p25l1439t756r1692b809],
13	magnitude	NN	O	magnitude	dep	8	SENT_405	[p25l1741t756r2042b827],
14	of	IN	O	of	_	0	SENT_405	[p25l2088t756r2152b809],
15	platelet	NN	O	platelet	nn	16	SENT_405	[p25l115t835r324b907],
16	inhibition	NN	O	inhibition	prep_of	13	SENT_405	[p25l342t835r624b888],
17	is	VBZ	O	be	auxpass	18	SENT_405	[p25l643t837r684b888],
18	related	VBN	O	relate	_	0	SENT_405	[p25l704t835r896b888],
19	to	TO	O	to	_	0	SENT_405	[p25l915t849r970b888],
20	active	JJ	O	active	amod	22	SENT_405	[p25l992t837r1150b888],
21	metabolite	NN	O	metabolite	nn	22	SENT_405	[p25l1170t835r1469b888],
22	formation	NN	O	formation	prep_to	18	SENT_405	[p25l1489t835r1786b888],
23	.	.	O	.	_	0	SENT_405	[p25l1489t835r1786b888],

1	Am	VBP	O	be	dep	2	SENT_406	[p25l1807t833r1916b887],
2	HeartJ	JJ	O	heartj	_	0	SENT_406	[p25l1937t835r2143b903],
3	2007	CD	DATE	2007	tmod	2	SENT_406	[p25l114t915r564b979],
4	;	:	O	;	_	0	SENT_406	[p25l114t915r564b979],
5	153:9	CD	NUMBER	153:9	dep	2	SENT_406	[p25l114t915r564b979],
6	-16	CD	NUMBER	-16	dep	5	SENT_406	[p25l114t915r564b979],
7	.	.	O	.	_	0	SENT_406	[p25l114t915r564b979],

1	12	CD	NUMBER	12	_	0	SENT_407	[p25l12t996r92b1048],
2	.	.	O	.	_	0	SENT_407	[p25l12t996r92b1048],

1	Wiviott	NNP	PERSON	Wiviott	nn	2	SENT_408	[p25l113t994r339b1047],
2	SD	NN	O	sd	_	0	SENT_408	[p25l384t994r491b1059],
3	,	,	O	,	_	0	SENT_408	[p25l384t994r491b1059],
4	Braunwald	NNP	PERSON	Braunwald	nn	5	SENT_408	[p25l538t994r846b1047],
5	E	NNP	O	E	appos	2	SENT_408	[p25l891t994r952b1059],
6	,	,	O	,	_	0	SENT_408	[p25l891t994r952b1059],
7	McCabe	NNP	PERSON	McCabe	nn	8	SENT_408	[p25l997t994r1244b1047],
8	CH	NN	O	ch	appos	2	SENT_408	[p25l1290t994r1416b1059],
9	,	,	O	,	_	0	SENT_408	[p25l1290t994r1416b1059],
10	et	FW	O	et	nn	11	SENT_408	[p25l1463t1008r1514b1047],
11	al.	FW	O	al.	appos	2	SENT_408	[p25l1558t994r1617b1047],
12	.	.	O	.	_	0	SENT_408	[p25l1558t994r1617b1047],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_409	[p25l1665t994r1930b1065],
2	versus	CC	O	versus	prep	1	SENT_409	[p25l1970t1014r2141b1047],
3	clopidogrel	NN	O	clopidogrel	dep	2	SENT_409	[p25l117t1074r433b1146],
4	in	IN	O	in	_	0	SENT_409	[p25l457t1076r511b1126],
5	patients	NNS	O	patient	prep_in	1	SENT_409	[p25l535t1076r757b1146],
6	with	IN	O	with	_	0	SENT_409	[p25l780t1074r910b1127],
7	acute	JJ	O	acute	amod	9	SENT_409	[p25l936t1087r1080b1127],
8	coronary	JJ	O	coronary	amod	9	SENT_409	[p25l1107t1094r1354b1145],
9	syndromes	NNS	O	syndrome	prep_with	5	SENT_409	[p25l1377t1074r1693b1145],
10	.	.	O	.	_	0	SENT_409	[p25l1377t1074r1693b1145],

1	N	NN	O	n	nn	2	SENT_410	[p25l1720t1074r1773b1127],
2	EnglJ	NN	O	englj	nsubj	3	SENT_410	[p25l1801t1074r1983b1145],
3	Med	VBD	O	med	_	0	SENT_410	[p25l2007t1074r2143b1127],
4	2007	CD	DATE	2007	dobj	3	SENT_410	[p25l114t1154r662b1218],
5	;	:	O	;	_	0	SENT_410	[p25l114t1154r662b1218],
6	357:2001	CD	NUMBER	357:2001	number	7	SENT_410	[p25l114t1154r662b1218],
7	—	CD	NUMBER	—	dep	4	SENT_410	[p25l114t1154r662b1218],
8	15	CD	NUMBER	15	dep	7	SENT_410	[p25l114t1154r662b1218],
9	.	.	O	.	_	0	SENT_410	[p25l114t1154r662b1218],

1	13	CD	NUMBER	13	_	0	SENT_411	[p25l12t1235r92b1286],
2	.	.	O	.	_	0	SENT_411	[p25l12t1235r92b1286],

1	Mega	JJ	O	mega	amod	2	SENT_412	[p25l115t1233r279b1304],
2	JL	NN	O	jl	_	0	SENT_412	[p25l307t1233r398b1301],
3	,	,	O	,	_	0	SENT_412	[p25l307t1233r398b1301],
4	Close	NNP	O	Close	nn	5	SENT_412	[p25l439t1233r597b1286],
5	SL	NNP	O	SL	appos	2	SENT_412	[p25l637t1233r733b1298],
6	,	,	O	,	_	0	SENT_412	[p25l637t1233r733b1298],
7	Wiviott	NNP	PERSON	Wiviott	nn	8	SENT_412	[p25l768t1233r994b1286],
8	SD	NN	O	sd	appos	2	SENT_412	[p25l1032t1233r1140b1298],
9	,	,	O	,	_	0	SENT_412	[p25l1032t1233r1140b1298],
10	et	FW	O	et	nn	11	SENT_412	[p25l1179t1247r1230b1286],
11	al.	FW	O	al.	appos	2	SENT_412	[p25l1266t1233r1326b1286],
12	.	.	O	.	_	0	SENT_412	[p25l1266t1233r1326b1286],

1	Cytochrome	NN	O	cytochrome	nn	2	SENT_413	[p25l1367t1233r1720b1304],
2	P450	NN	O	p450	_	0	SENT_413	[p25l1757t1233r1903b1286],
3	genetic	JJ	O	genetic	amod	4	SENT_413	[p25l1940t1235r2143b1304],
4	polymorphisms	NNS	O	polymorphism	dep	2	SENT_413	[p25l115t1314r553b1386],
5	and	CC	O	and	_	0	SENT_413	[p25l579t1314r681b1367],
6	the	DT	O	the	det	7	SENT_413	[p25l704t1314r792b1367],
7	response	NN	O	response	conj_and	2	SENT_413	[p25l816t1334r1058b1386],
8	to	TO	O	to	_	0	SENT_413	[p25l1083t1328r1137b1367],
9	prasugrel	NN	O	prasugrel	prep_to	7	SENT_413	[p25l1161t1314r1434b1386],
10	:	:	O	:	_	0	SENT_413	[p25l1161t1314r1434b1386],
11	relationship	NN	O	relationship	dep	2	SENT_413	[p25l1461t1314r1795b1386],
12	to	TO	O	to	_	0	SENT_413	[p25l1820t1328r1874b1367],
13	pharmacokinetic	JJ	O	pharmacokinetic	prep_to	11	SENT_413	[p25l1898t1314r2140b1386, p25l117t1394r387b1459],
14	,	,	O	,	_	0	SENT_413	[p25l1898t1314r2140b1386, p25l117t1394r387b1459],
15	pharmacodynamic	JJ	O	pharmacodynamic	prep_to	11	SENT_413	[p25l413t1394r951b1466],
16	,	,	O	,	_	0	SENT_413	[p25l413t1394r951b1466],
17	and	CC	O	and	_	0	SENT_413	[p25l978t1394r1081b1447],
18	clinical	JJ	O	clinical	amod	19	SENT_413	[p25l1105t1394r1304b1447],
19	outcomes	NNS	O	outcome	conj_and	13	SENT_413	[p25l1327t1408r1610b1447],
20	.	.	O	.	_	0	SENT_413	[p25l1327t1408r1610b1447],

1	Circulation	NN	O	circulation	_	0	SENT_414	[p25l1639t1394r1961b1447],
2	2009	CD	DATE	2009	num	1	SENT_414	[p25l1983t1396r2140b1459],
3	;	:	O	;	_	0	SENT_414	[p25l1983t1396r2140b1459],
4	119:2553	CD	NUMBER	119:2553	number	5	SENT_414	[p25l119t1474r510b1527],
5	—	CD	NUMBER	—	dep	1	SENT_414	[p25l119t1474r510b1527],
6	60	CD	NUMBER	60	dep	5	SENT_414	[p25l119t1474r510b1527],
7	.	.	O	.	_	0	SENT_414	[p25l119t1474r510b1527],

1	14	CD	NUMBER	14	_	0	SENT_415	[p25l12t1554r92b1605],
2	.	.	O	.	_	0	SENT_415	[p25l12t1554r92b1605],

1	Brandt	NNP	PERSON	Brandt	nn	2	SENT_416	[p25l116t1552r314b1605],
2	JT	NNP	O	JT	_	0	SENT_416	[p25l339t1550r433b1620],
3	,	,	O	,	_	0	SENT_416	[p25l339t1550r433b1620],
4	Close	NNP	O	Close	nn	5	SENT_416	[p25l471t1552r629b1605],
5	SL	NNP	O	SL	appos	2	SENT_416	[p25l666t1552r762b1617],
6	,	,	O	,	_	0	SENT_416	[p25l666t1552r762b1617],
7	Iturria	NNP	PERSON	Iturria	nn	9	SENT_416	[p25l798t1552r980b1605],
8	S	NNP	O	S	nn	9	SENT_416	[p25l1016t1552r1089b1620],
9	]	NN	O	]	appos	2	SENT_416	[p25l1016t1552r1089b1620],
10	,	,	O	,	_	0	SENT_416	[p25l1016t1552r1089b1620],
11	et	FW	O	et	nn	12	SENT_416	[p25l1126t1566r1177b1605],
12	al.	FW	O	al.	appos	2	SENT_416	[p25l1211t1552r1270b1605],
13	.	.	O	.	_	0	SENT_416	[p25l1211t1552r1270b1605],

1	Common	JJ	O	common	amod	2	SENT_417	[p25l1309t1552r1582b1605],
2	polymorphisms	NNS	O	polymorphism	nsubj	7	SENT_417	[p25l1615t1552r2052b1624],
3	of	IN	O	of	_	0	SENT_417	[p25l2088t1552r2152b1605],
4	CYP2C19	NN	O	cyp2c19	prep_of	2	SENT_417	[p25l117t1632r415b1686],
5	and	CC	O	and	_	0	SENT_417	[p25l442t1632r544b1685],
6	CYP2C9	NN	O	cyp2c9	conj_and	4	SENT_417	[p25l569t1632r831b1686],
7	affect	VBP	O	affect	_	0	SENT_417	[p25l858t1632r1006b1685],
8	the	DT	O	the	det	12	SENT_417	[p25l1029t1632r1117b1685],
9	pharmacokinetic	JJ	O	pharmacokinetic	amod	12	SENT_417	[p25l1141t1632r1616b1704],
10	and	CC	O	and	_	0	SENT_417	[p25l1640t1632r1742b1685],
11	pharmacodynamic	JJ	O	pharmacodynamic	amod	12	SENT_417	[p25l1765t1632r2140b1704, p25l117t1714r288b1765],
12	response	NN	O	response	dobj	7	SENT_417	[p25l316t1732r558b1784],
13	to	TO	O	to	_	0	SENT_417	[p25l588t1725r642b1765],
14	clopidogrel	NN	O	clopidogrel	prep_to	12	SENT_417	[p25l673t1712r989b1784],
15	but	CC	O	but	_	0	SENT_417	[p25l1015t1712r1111b1765],
16	not	RB	O	not	_	0	SENT_417	[p25l1139t1726r1233b1765],
17	prasugrel	NN	O	prasugrel	dobj	7	SENT_417	[p25l1260t1712r1533b1784],
18	.	.	O	.	_	0	SENT_417	[p25l1260t1712r1533b1784],

1	J	NNP	O	J	nn	3	SENT_418	[p25l1558t1712r1586b1780],
2	Thromb	NNP	O	Thromb	nn	3	SENT_418	[p25l1613t1710r1852b1765],
3	Haemost	NNP	O	Haemost	_	0	SENT_418	[p25l1883t1712r2144b1765],
4	2007	CD	DATE	2007	num	3	SENT_418	[p25l114t1793r600b1857],
5	;	:	O	;	_	0	SENT_418	[p25l114t1793r600b1857],
6	5:2429	CD	NUMBER	5:2429	number	7	SENT_418	[p25l114t1793r600b1857],
7	—	CD	NUMBER	—	dep	3	SENT_418	[p25l114t1793r600b1857],
8	36	CD	NUMBER	36	dep	7	SENT_418	[p25l114t1793r600b1857],
9	.	.	O	.	_	0	SENT_418	[p25l114t1793r600b1857],

1	15	CD	NUMBER	15	_	0	SENT_419	[p25l12t1872r92b1925],
2	.	.	O	.	_	0	SENT_419	[p25l12t1872r92b1925],

1	Schwarz	NNP	PERSON	Schwarz	nn	2	SENT_420	[p25l119t1872r356b1925],
2	UR	NNP	O	UR	_	0	SENT_420	[p25l389t1872r507b1937],
3	,	,	O	,	_	0	SENT_420	[p25l389t1872r507b1937],
4	Geiger	NNP	PERSON	Geiger	nn	5	SENT_420	[p25l547t1872r741b1943],
5	J	NNP	PERSON	J	appos	2	SENT_420	[p25l769t1872r813b1940],
6	,	,	O	,	_	0	SENT_420	[p25l769t1872r813b1940],
7	Walter	NNP	PERSON	Walter	nn	8	SENT_420	[p25l849t1872r1051b1925],
8	U	NNP	PERSON	U	appos	2	SENT_420	[p25l1085t1872r1152b1937],
9	,	,	O	,	_	0	SENT_420	[p25l1085t1872r1152b1937],
10	Eigenthaler	NNP	PERSON	Eigenthaler	nn	11	SENT_420	[p25l1192t1872r1525b1943],
11	M.	NNP	PERSON	M.	appos	2	SENT_420	[p25l1559t1872r1642b1925],
12	Flow	NN	PERSON	flow	nn	14	SENT_420	[p25l1682t1872r1827b1925],
13	cytometry	NN	O	cytometry	nn	14	SENT_420	[p25l1861t1885r2146b1943],
14	analysis	NN	O	analysis	dep	11	SENT_420	[p25l117t1952r330b2023],
15	of	IN	O	of	_	0	SENT_420	[p25l362t1952r426b2005],
16	intracellular	JJ	O	intracellular	amod	18	SENT_420	[p25l447t1952r785b2005],
17	VASP	NN	ORGANIZATION	vasp	nn	18	SENT_420	[p25l814t1951r997b2005],
18	phosphorylation	NN	O	phosphorylation	prep_of	2	SENT_420	[p25l1026t1952r1490b2024],
19	for	IN	O	for	_	0	SENT_420	[p25l1520t1952r1601b2005],
20	the	DT	O	the	det	21	SENT_420	[p25l1630t1952r1718b2005],
21	assessment	NN	O	assessment	prep_for	2	SENT_420	[p25l1750t1966r2058b2005],
22	of	IN	O	of	_	0	SENT_420	[p25l2089t1952r2152b2005],
23	activating	VBG	O	activate	nn	28	SENT_420	[p25l117t2035r392b2104],
24	and	CC	O	and	_	0	SENT_420	[p25l440t2033r541b2086],
25	inhibitory	JJ	O	inhibitory	nn	28	SENT_420	[p25l589t2033r873b2104],
26	signal	NN	O	signal	nn	28	SENT_420	[p25l919t2033r1082b2104],
27	transduction	NN	O	transduction	nn	28	SENT_420	[p25l1129t2033r1485b2086],
28	pathways	NNS	O	pathway	prep_of	21	SENT_420	[p25l1532t2033r1793b2105],
29	in	IN	O	in	_	0	SENT_420	[p25l1842t2035r1897b2085],
30	human	JJ	O	human	amod	31	SENT_420	[p25l1945t2033r2143b2086],
31	platelets	NNS	O	platelet	prep_in	21	SENT_420	[p25l115t2113r363b2185],
32	:	:	O	:	_	0	SENT_420	[p25l115t2113r363b2185],
33	deﬁnition	NN	O	deﬁnition	dep	2	SENT_420	[p25l407t2113r682b2166],
34	and	CC	O	and	_	0	SENT_420	[p25l725t2113r827b2166],
35	detection	NN	O	detection	dep	2	SENT_420	[p25l868t2113r1129b2166],
36	of	IN	O	of	_	0	SENT_420	[p25l1170t2113r1234b2166],
37	ticlopidine/clopidogrel	JJ	O	ticlopidine/clopidogrel	amod	38	SENT_420	[p25l1265t2113r1912b2185],
38	effects	NNS	O	effect	prep_of	33	SENT_420	[p25l1952t2113r2139b2166],
39	.	.	O	.	_	0	SENT_420	[p25l1952t2113r2139b2166],

1	Thromb	NNP	O	Thromb	nn	2	SENT_421	[p25l114t2191r353b2245],
2	Haemost	NNP	O	Haemost	_	0	SENT_421	[p25l382t2193r642b2245],
3	1999	CD	DATE	1999	num	2	SENT_421	[p25l670t2193r1178b2256],
4	;	:	O	;	_	0	SENT_421	[p25l670t2193r1178b2256],
5	82:1145	CD	NUMBER	82:1145	number	6	SENT_421	[p25l670t2193r1178b2256],
6	—	CD	NUMBER	—	dep	2	SENT_421	[p25l670t2193r1178b2256],
7	52	CD	NUMBER	52	dep	6	SENT_421	[p25l670t2193r1178b2256],
8	.	.	O	.	_	0	SENT_421	[p25l670t2193r1178b2256],

1	Cuisset	NNP	O	Cuisset	_	0	SENT_422	[p25l1469t2283r1660b2327],
2	et	FW	O	et	nn	3	SENT_422	[p25l1686t2286r1737b2327],
3	al.	FW	O	al.	dep	1	SENT_422	[p25l1760t2284r1819b2327],
4	1287	CD	DATE	1287	dep	1	SENT_422	[p25l2000t2283r2140b2327],

1	Genetic	JJ	O	genetic	_	0	SENT_423	[p25l946t2365r1146b2408],
2	and	CC	O	and	_	0	SENT_423	[p25l1169t2366r1264b2408],
3	Prasugrel	NNP	O	Prasugrel	nn	4	SENT_423	[p25l1292t2366r1538b2419],
4	Response	NN	O	response	conj_and	1	SENT_423	[p25l1565t2366r1822b2418],

1	16	CD	NUMBER	16	_	0	SENT_424	[p25l12t2582r92b2632],
2	.	.	O	.	_	0	SENT_424	[p25l12t2582r92b2632],

1	Bonello	NNP	PERSON	Bonello	nn	2	SENT_425	[p25l116t2579r335b2632],
2	L	NNP	PERSON	L	_	0	SENT_425	[p25l367t2580r426b2644],
3	,	,	O	,	_	0	SENT_425	[p25l367t2580r426b2644],
4	Pansieri	NNP	O	Pansieri	nn	5	SENT_425	[p25l459t2580r686b2632],
5	M	NNP	O	M	appos	2	SENT_425	[p25l715t2580r799b2644],
6	,	,	O	,	_	0	SENT_425	[p25l715t2580r799b2644],
7	Mancini	NNP	PERSON	Mancini	nn	8	SENT_425	[p25l830t2580r1072b2632],
8	J	NNP	PERSON	J	appos	2	SENT_425	[p25l1095t2580r1139b2647],
9	,	,	O	,	_	0	SENT_425	[p25l1095t2580r1139b2647],
10	et	FW	O	et	nn	11	SENT_425	[p25l1172t2593r1223b2632],
11	al.	FW	O	al.	appos	2	SENT_425	[p25l1253t2579r1313b2632],
12	.	.	O	.	_	0	SENT_425	[p25l1253t2579r1313b2632],

1	High	JJ	O	high	_	0	SENT_426	[p25l1347t2579r1497b2651],
2	on	IN	O	on	_	0	SENT_426	[p25l1527t2593r1906b2632],
3	—	NN	O	—	nn	6	SENT_426	[p25l1527t2593r1906b2632],
4	treatment	NN	O	treatment	nn	6	SENT_426	[p25l1527t2593r1906b2632],
5	platelet	NN	O	platelet	nn	6	SENT_426	[p25l1934t2579r2144b2651],
6	reactivity	NN	O	reactivity	prep_on	1	SENT_426	[p25l116t2661r376b2731],
7	after	IN	O	after	_	0	SENT_426	[p25l405t2659r532b2712],
8	prasugrel	NN	O	prasugrel	prep_after	6	SENT_426	[p25l561t2659r820b2731],
9	loading	VBG	O	load	partmod	1	SENT_426	[p25l849t2659r1062b2731],
10	dose	NN	O	dose	nn	13	SENT_426	[p25l1092t2659r1216b2712],
11	and	CC	O	and	_	0	SENT_426	[p25l1249t2659r1351b2712],
12	cardiovascular	JJ	O	cardiovascular	conj_and	10	SENT_426	[p25l1382t2659r1780b2712],
13	events	NNS	O	event	dobj	9	SENT_426	[p25l1811t2673r1983b2712],
14	after	IN	O	after	_	0	SENT_426	[p25l2017t2659r2144b2712],
15	percutaneous	JJ	O	percutaneous	amod	17	SENT_426	[p25l115t2754r487b2812],
16	coronary	JJ	O	coronary	amod	17	SENT_426	[p25l510t2760r758b2812],
17	intervention	NN	O	intervention	prep_after	9	SENT_426	[p25l776t2742r1121b2793],
18	in	IN	O	in	_	0	SENT_426	[p25l1142t2742r1197b2793],
19	acute	JJ	O	acute	amod	21	SENT_426	[p25l1219t2754r1364b2793],
20	coronary	JJ	O	coronary	amod	21	SENT_426	[p25l1386t2760r1634b2812],
21	syndromes	NNS	O	syndrome	prep_in	17	SENT_426	[p25l1653t2740r1968b2812],
22	.	.	O	.	_	0	SENT_426	[p25l1653t2740r1968b2812],

1	J	NNP	O	J	nn	4	SENT_427	[p25l1985t2741r2014b2808],
2	Am	NNP	O	Am	nn	4	SENT_427	[p25l2033t2739r2142b2793],
3	Coll	NNP	O	Coll	nn	4	SENT_427	[p25l117t2821r239b2874],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_427	[p25l266t2821r481b2874],
5	2011	CD	DATE	2011	num	4	SENT_427	[p25l505t2821r981b2885],
6	;	:	O	;	_	0	SENT_427	[p25l505t2821r981b2885],
7	58:467	CD	NUMBER	58:467	number	8	SENT_427	[p25l505t2821r981b2885],
8	—	CD	NUMBER	—	dep	4	SENT_427	[p25l505t2821r981b2885],
9	73	CD	NUMBER	73	dep	8	SENT_427	[p25l505t2821r981b2885],
10	.	.	O	.	_	0	SENT_427	[p25l505t2821r981b2885],

1	17	CD	NUMBER	17	_	0	SENT_428	[p25l12t2901r92b2953],
2	.	.	O	.	_	0	SENT_428	[p25l12t2901r92b2953],

1	Mehran	NNP	MISC	Mehran	nn	2	SENT_429	[p25l115t2900r345b2953],
2	R	NNP	O	R	_	0	SENT_429	[p25l367t2901r428b2965],
3	,	,	O	,	_	0	SENT_429	[p25l367t2901r428b2965],
4	Rao	NNP	PERSON	Rao	nn	5	SENT_429	[p25l452t2901r563b2953],
5	SV	NNP	O	SV	appos	2	SENT_429	[p25l587t2900r687b2965],
6	,	,	O	,	_	0	SENT_429	[p25l587t2900r687b2965],
7	Bhatt	NNP	PERSON	Bhatt	nn	8	SENT_429	[p25l710t2900r869b2953],
8	DL	NNP	O	DL	appos	2	SENT_429	[p25l889t2901r1007b2965],
9	,	,	O	,	_	0	SENT_429	[p25l889t2901r1007b2965],
10	et	FW	O	et	nn	11	SENT_429	[p25l1031t2914r1082b2953],
11	al.	FW	O	al.	appos	2	SENT_429	[p25l1102t2900r1162b2953],
12	.	.	O	.	_	0	SENT_429	[p25l1102t2900r1162b2953],

1	Standardized	JJ	O	standardized	amod	3	SENT_430	[p25l1189t2900r1560b2953],
2	bleeding	NN	O	bleeding	nn	3	SENT_430	[p25l1578t2900r1822b2972],
3	deﬁnitions	NNS	O	deﬁnitions	_	0	SENT_430	[p25l1842t2900r2141b2953],
4	for	IN	O	for	_	0	SENT_430	[p25l116t2980r196b3033],
5	cardiovascular	JJ	O	cardiovascular	amod	7	SENT_430	[p25l222t2980r620b3033],
6	clinical	JJ	O	clinical	amod	7	SENT_430	[p25l647t2980r846b3033],
7	trials	NNS	O	trial	prep_for	3	SENT_430	[p25l871t2980r1023b3033],
8	:	:	O	:	_	0	SENT_430	[p25l871t2980r1023b3033],
9	a	DT	O	a	det	11	SENT_430	[p25l1054t3001r1082b3033],
10	consensus	NN	O	consensus	nn	11	SENT_430	[p25l1108t3001r1386b3033],
11	report	NN	O	report	dep	3	SENT_430	[p25l1414t2994r1587b3052],
12	from	IN	O	from	_	0	SENT_430	[p25l1612t2980r1748b3033],
13	the	DT	O	the	det	17	SENT_430	[p25l1775t2980r1864b3033],
14	Bleeding	NNP	ORGANIZATION	Bleeding	nn	17	SENT_430	[p25l1891t2980r2144b3052],
15	Academic	NNP	ORGANIZATION	Academic	nn	17	SENT_430	[p25l114t3059r399b3113],
16	Research	NNP	ORGANIZATION	Research	nn	17	SENT_430	[p25l427t3060r681b3113],
17	Consortium	NNP	ORGANIZATION	Consortium	prep_from	11	SENT_430	[p25l709t3060r1066b3113],
18	.	.	O	.	_	0	SENT_430	[p25l709t3060r1066b3113],

1	Circulation	NN	O	circulation	_	0	SENT_431	[p25l1097t3060r1418b3113],
2	2011	CD	DATE	2011	num	1	SENT_431	[p25l1443t3061r2008b3124],
3	;	:	O	;	_	0	SENT_431	[p25l1443t3061r2008b3124],
4	123:2736	CD	NUMBER	123:2736	number	5	SENT_431	[p25l1443t3061r2008b3124],
5	—	CD	NUMBER	—	dep	1	SENT_431	[p25l1443t3061r2008b3124],
6	47	CD	NUMBER	47	dep	5	SENT_431	[p25l1443t3061r2008b3124],
7	.	.	O	.	_	0	SENT_431	[p25l1443t3061r2008b3124],

1	18	CD	NUMBER	18	_	0	SENT_432	[p25l12t3142r92b3192],
2	.	.	O	.	_	0	SENT_432	[p25l12t3142r92b3192],

1	Cutlip	NNP	PERSON	Cutlip	nn	2	SENT_433	[p25l117t3139r298b3211],
2	DE	NN	PERSON	de	_	0	SENT_433	[p25l335t3140r455b3204],
3	,	,	O	,	_	0	SENT_433	[p25l335t3140r455b3204],
4	Windecker	NNP	PERSON	Windecker	nn	5	SENT_433	[p25l489t3139r809b3193],
5	S	NNP	O	S	appos	2	SENT_433	[p25l846t3139r895b3204],
6	,	,	O	,	_	0	SENT_433	[p25l846t3139r895b3204],
7	Mehran	NNP	ORGANIZATION	Mehran	nn	8	SENT_433	[p25l932t3139r1161b3192],
8	R	NNP	ORGANIZATION	R	appos	2	SENT_433	[p25l1198t3140r1259b3204],
9	,	,	O	,	_	0	SENT_433	[p25l1198t3140r1259b3204],
10	et	FW	O	et	nn	11	SENT_433	[p25l1298t3153r1349b3192],
11	al.	FW	O	al.	appos	2	SENT_433	[p25l1384t3139r1444b3192],
12	.	.	O	.	_	0	SENT_433	[p25l1384t3139r1444b3192],

1	Clinical	JJ	O	clinical	amod	3	SENT_434	[p25l1484t3139r1706b3192],
2	end	NN	O	end	nn	3	SENT_434	[p25l1741t3139r1844b3192],
3	points	NNS	O	point	_	0	SENT_434	[p25l1877t3141r2052b3211],
4	in	IN	O	in	_	0	SENT_434	[p25l2089t3141r2143b3192],
5	coronary	JJ	O	coronary	amod	7	SENT_434	[p25l117t3239r364b3291],
6	stent	NN	O	stent	nn	7	SENT_434	[p25l396t3233r533b3272],
7	trials	NNS	O	trial	prep_in	3	SENT_434	[p25l565t3219r716b3272],
8	:	:	O	:	_	0	SENT_434	[p25l565t3219r716b3272],
9	a	DT	O	a	det	10	SENT_434	[p25l755t3240r782b3272],
10	case	NN	O	case	dep	3	SENT_434	[p25l816t3240r927b3272],
11	for	IN	O	for	_	0	SENT_434	[p25l961t3219r1041b3272],
12	standardized	JJ	O	standardized	amod	13	SENT_434	[p25l1075t3219r1434b3272],
13	deﬁnitions	NNS	O	deﬁnitions	prep_for	10	SENT_434	[p25l1468t3219r1783b3272],
14	.	.	O	.	_	0	SENT_434	[p25l1468t3219r1783b3272],

1	Circulation	NN	O	circulation	_	0	SENT_435	[p25l1822t3219r2143b3272],
2	2007	CD	DATE	2007	num	1	SENT_435	[p25l115t3299r618b3363],
3	;	:	O	;	_	0	SENT_435	[p25l115t3299r618b3363],
4	115:2344	CD	NUMBER	115:2344	number	5	SENT_435	[p25l115t3299r618b3363],
5	—	CD	NUMBER	—	num	7	SENT_435	[p25l115t3299r618b3363],
6	5	CD	NUMBER	5	number	7	SENT_435	[p25l115t3299r618b3363],
7	1	CD	NUMBER	1	dep	1	SENT_435	[p25l627t3302r671b3352],
8	.	.	O	.	_	0	SENT_435	[p25l627t3302r671b3352],

1	19	CD	NUMBER	19	_	0	SENT_436	[p25l12t3382r92b3432],
2	.	.	O	.	_	0	SENT_436	[p25l12t3382r92b3432],

1	Thygesen	NNP	PERSON	Thygesen	nn	2	SENT_437	[p25l114t3378r391b3451],
2	K	NNP	PERSON	K	_	0	SENT_437	[p25l419t3380r480b3444],
3	,	,	O	,	_	0	SENT_437	[p25l419t3380r480b3444],
4	Alpert	NNP	PERSON	Alpert	nn	5	SENT_437	[p25l507t3378r692b3451],
5	JS	NNP	O	JS	appos	2	SENT_437	[p25l709t3379r792b3447],
6	,	,	O	,	_	0	SENT_437	[p25l709t3379r792b3447],
7	White	NNP	O	White	nn	8	SENT_437	[p25l817t3379r1002b3433],
8	HD	NNP	O	HD	appos	2	SENT_437	[p25l1028t3380r1160b3444],
9	,	,	O	,	_	0	SENT_437	[p25l1028t3380r1160b3444],
10	et	FW	O	et	nn	11	SENT_437	[p25l1188t3393r1239b3432],
11	al.	FW	O	al.	appos	8	SENT_437	[p25l1265t3379r1343b3444],
12	,	,	O	,	_	0	SENT_437	[p25l1265t3379r1343b3444],
13	for	IN	O	for	_	0	SENT_437	[p25l1371t3379r1452b3432],
14	the	DT	O	the	det	16	SENT_437	[p25l1476t3379r1564b3432],
15	Joint	NNP	O	Joint	nn	16	SENT_437	[p25l1583t3380r1728b3447],
16	ESC/ACCF	NN	O	esc/accf	prep_for	8	SENT_437	[p25l1753t3378r2144b3433],
17	/	:	O	/	punct	2	SENT_437	[p25l1753t3378r2144b3433],
18	AHA/W	NNP	O	AHA/W	nn	21	SENT_437	[p25l114t3458r382b3513],
19	HF	NN	O	hf	nn	21	SENT_437	[p25l383t3460r485b3512],
20	Task	NNP	O	Task	nn	21	SENT_437	[p25l500t3458r644b3512],
21	Force	NNP	O	Force	dep	2	SENT_437	[p25l662t3460r820b3512],
22	for	IN	O	for	_	0	SENT_437	[p25l840t3459r921b3512],
23	the	DT	O	the	det	24	SENT_437	[p25l939t3459r1028b3512],
24	Redeﬁnition	NN	O	redeﬁnition	prep_for	21	SENT_437	[p25l1050t3459r1404b3512],
25	of	IN	O	of	_	0	SENT_437	[p25l1425t3459r1489b3512],
26	Myocardial	JJ	O	myocardial	amod	27	SENT_437	[p25l1498t3459r1823b3531],
27	Infarction	NN	O	infarction	prep_of	24	SENT_437	[p25l1841t3459r2139b3512],
28	.	.	O	.	_	0	SENT_437	[p25l1841t3459r2139b3512],

1	Universal	NNP	O	Universal	nn	2	SENT_438	[p25l115t3539r383b3592],
2	deﬁnition	NN	O	deﬁnition	_	0	SENT_438	[p25l419t3539r694b3592],
3	of	IN	O	of	_	0	SENT_438	[p25l730t3539r794b3592],
4	myocardial	JJ	O	myocardial	amod	5	SENT_438	[p25l821t3539r1131b3611],
5	infarction	NN	O	infarction	prep_of	2	SENT_438	[p25l1166t3539r1456b3592],
6	.	.	O	.	_	0	SENT_438	[p25l1166t3539r1456b3592],

1	Eur	NNP	MISC	Eur	nn	2	SENT_439	[p25l1496t3540r1603b3592],
2	HeartJ	NNP	O	HeartJ	_	0	SENT_439	[p25l1638t3540r1860b3607],
3	2007	CD	DATE	2007	num	2	SENT_439	[p25l1894t3540r2139b3604],
4	;	:	O	;	_	0	SENT_439	[p25l1894t3540r2139b3604],
5	28	CD	NUMBER	28	num	7	SENT_439	[p25l1894t3540r2139b3604],
6	:	:	O	:	_	0	SENT_439	[p25l1894t3540r2139b3604],
7	2525-38	CD	NUMBER	2525-38	dep	2	SENT_439	[p25l115t3619r377b3672],
8	.	.	O	.	_	0	SENT_439	[p25l115t3619r377b3672],

1	Michelson	NNP	PERSON	Michelson	nn	2	SENT_440	[p26l115t20r417b73],
2	AD	NN	O	ad	_	0	SENT_440	[p26l463t19r588b85],
3	,	,	O	,	_	0	SENT_440	[p26l463t19r588b85],
4	Frelinger	NNP	PERSON	Frelinger	nn	6	SENT_440	[p26l639t20r899b92],
5	AL	NNP	PERSON	AL	nn	6	SENT_440	[p26l943t19r1042b73],
6	III	NNP	PERSON	III	appos	2	SENT_440	[p26l1089t21r1182b85],
7	,	,	O	,	_	0	SENT_440	[p26l1089t21r1182b85],
8	Braunwald	NNP	PERSON	Braunwald	nn	9	SENT_440	[p26l1232t20r1540b73],
9	E	NNP	O	E	appos	2	SENT_440	[p26l1589t21r1649b85],
10	,	,	O	,	_	0	SENT_440	[p26l1589t21r1649b85],
11	et	FW	O	et	nn	12	SENT_440	[p26l1700t34r1751b73],
12	al.	FW	O	al.	appos	2	SENT_440	[p26l1798t20r1877b85],
13	,	,	O	,	_	0	SENT_440	[p26l1798t20r1877b85],
14	for	IN	O	for	_	0	SENT_440	[p26l1927t20r2008b73],
15	the	DT	O	the	det	16	SENT_440	[p26l2054t20r2142b73],
16	TRITON	NNP	ORGANIZATION	TRITON	prep_for	2	SENT_440	[p26l114t99r604b153],
17	.	.	O	.	_	0	SENT_440	[p26l114t99r604b153],

1	—	NN	O	—	_	0	SENT_441	[p26l114t99r604b153],
2	.	.	O	.	_	0	SENT_441	[p26l114t99r604b153],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_442	[p26l114t99r604b153],
2	38	CD	NUMBER	38	num	3	SENT_442	[p26l646t103r711b153],
3	Investigators	NNS	O	investigator	dep	1	SENT_442	[p26l752t101r1130b172],
4	.	.	O	.	_	0	SENT_442	[p26l752t101r1130b172],

1	Pharmacodynamic	JJ	O	pharmacodynamic	amod	2	SENT_443	[p26l1173t100r1702b172],
2	assessment	NN	O	assessment	_	0	SENT_443	[p26l1742t114r2050b153],
3	of	IN	O	of	_	0	SENT_443	[p26l2089t100r2152b153],
4	platelet	NN	O	platelet	nn	5	SENT_443	[p26l115t180r324b252],
5	inhibition	NN	O	inhibition	prep_of	2	SENT_443	[p26l347t180r629b233],
6	by	IN	O	by	_	0	SENT_443	[p26l652t180r721b252],
7	prasugrel	NN	O	prasugrel	prep_by	2	SENT_443	[p26l741t180r1000b252],
8	vs.	CC	O	vs.	prep	2	SENT_443	[p26l1021t201r1092b233],
9	clopidogrel	NN	O	clopidogrel	dep	8	SENT_443	[p26l1121t180r1437b252],
10	in	IN	O	in	_	0	SENT_443	[p26l1460t182r1514b233],
11	the	DT	O	the	det	12	SENT_443	[p26l1539t180r1627b233],
12	TRITON	NNP	ORGANIZATION	TRITON	prep_in	9	SENT_443	[p26l1650t179r2140b233],
13	.	.	O	.	_	0	SENT_443	[p26l1650t179r2140b233],

1	—	NN	O	—	_	0	SENT_444	[p26l1650t179r2140b233],
2	.	.	O	.	_	0	SENT_444	[p26l1650t179r2140b233],

1	TIMI	NNP	ORGANIZATION	TIMI	_	0	SENT_445	[p26l1650t179r2140b233],
2	38	CD	NUMBER	38	num	3	SENT_445	[p26l117t263r182b313],
3	trial	NN	O	trial	dep	1	SENT_445	[p26l211t260r337b312],
4	.	.	O	.	_	0	SENT_445	[p26l211t260r337b312],

1	Eur	NNP	O	Eur	nn	2	SENT_446	[p26l369t261r475b312],
2	Heart	NNP	O	Heart	_	0	SENT_446	[p26l501t261r714b327],
3	]	CD	NUMBER	]	num	4	SENT_446	[p26l501t261r714b327],
4	2009	CD	DATE	2009	dep	2	SENT_446	[p26l738t260r1166b324],
5	;	:	O	;	_	0	SENT_446	[p26l738t260r1166b324],
6	30:1753	CD	NUMBER	30:1753	num	8	SENT_446	[p26l738t260r1166b324],
7	-	:	O	-	_	0	SENT_446	[p26l738t260r1166b324],
8	63	CD	DATE	63	dep	2	SENT_446	[p26l1178t263r1259b313],
9	.	.	O	.	_	0	SENT_446	[p26l1178t263r1259b313],

1	Angiolillo	NN	O	angiolillo	nn	2	SENT_447	[p26l114t338r401b411],
2	D	NN	O	d	_	0	SENT_447	[p26l437t340r532b407],
3	]	CD	NUMBER	]	dep	2	SENT_447	[p26l437t340r532b407],
4	,	,	O	,	_	0	SENT_447	[p26l437t340r532b407],
5	Badimon	NNP	PERSON	Badimon	appos	3	SENT_447	[p26l570t339r831b392],
6	]	CD	NUMBER	]	number	7	SENT_447	[p26l859t340r927b407],
7	]	CD	NUMBER	]	num	11	SENT_447	[p26l859t340r927b407],
8	,	,	O	,	_	0	SENT_447	[p26l859t340r927b407],
9	Saucedo	NNP	PERSON	Saucedo	dep	11	SENT_447	[p26l967t339r1198b392],
10	]	CD	NUMBER	]	num	11	SENT_447	[p26l1227t340r1314b407],
11	F	NN	O	f	dep	2	SENT_447	[p26l1227t340r1314b407],
12	,	,	O	,	_	0	SENT_447	[p26l1227t340r1314b407],
13	et	FW	O	et	nn	14	SENT_447	[p26l1352t353r1402b392],
14	al.	FW	O	al.	appos	11	SENT_447	[p26l1438t339r1497b392],
15	.	.	O	.	_	0	SENT_447	[p26l1438t339r1497b392],

1	A	DT	O	a	det	3	SENT_448	[p26l1534t338r1587b392],
2	pharmacodynamic	JJ	O	pharmacodynamic	amod	3	SENT_448	[p26l1620t339r2143b411],
3	comparison	NN	O	comparison	_	0	SENT_448	[p26l117t422r444b492],
4	of	IN	O	of	_	0	SENT_448	[p26l466t420r530b473],
5	prasugrel	NN	O	prasugrel	prep_of	3	SENT_448	[p26l541t420r801b492],
6	vs.	CC	O	vs.	_	0	SENT_448	[p26l818t441r889b473],
7	high	JJ	O	high	amod	10	SENT_448	[p26l914t420r1198b492],
8	—	NN	O	—	nn	10	SENT_448	[p26l914t420r1198b492],
9	dose	NN	O	dose	nn	10	SENT_448	[p26l914t420r1198b492],
10	clopidogrel	NN	O	clopidogrel	conj_vs.	3	SENT_448	[p26l1221t420r1537b492],
11	in	IN	O	in	_	0	SENT_448	[p26l1557t422r1611b473],
12	patients	NNS	O	patient	prep_in	10	SENT_448	[p26l1632t422r1854b492],
13	with	IN	O	with	_	0	SENT_448	[p26l1874t420r2003b473],
14	type	NN	O	type	nn	17	SENT_448	[p26l2024t434r2142b492],
15	2	CD	NUMBER	2	num	17	SENT_448	[p26l115t503r147b554],
16	diabetes	NN	O	diabetes	nn	17	SENT_448	[p26l172t500r398b553],
17	mellitus	NN	O	mellitus	prep_with	12	SENT_448	[p26l423t500r646b553],
18	and	CC	O	and	_	0	SENT_448	[p26l671t500r773b553],
19	coronary	JJ	O	coronary	amod	21	SENT_448	[p26l795t520r1043b572],
20	artery	NN	O	artery	nn	21	SENT_448	[p26l1064t514r1226b572],
21	disease	NN	O	disease	conj_and	3	SENT_448	[p26l1247t500r1456b553],
22	:	:	O	:	_	0	SENT_448	[p26l1247t500r1456b553],
23	results	NNS	O	result	dep	3	SENT_448	[p26l1481t500r1660b553],
24	of	IN	O	of	_	0	SENT_448	[p26l1684t500r1748b553],
25	the	DT	O	the	prep_of	23	SENT_448	[p26l1761t500r1849b553],
26	Optimizing	VBG	O	optimize	amod	25	SENT_448	[p26l1874t500r2140b572, p26l116t581r206b651],
27	anti	JJ	O	anti	amod	25	SENT_448	[p26l236t579r588b632],
28	.	.	O	.	_	0	SENT_448	[p26l236t579r588b632],

1	—	NN	O	—	_	0	SENT_449	[p26l236t579r588b632],
2	.	.	O	.	_	0	SENT_449	[p26l236t579r588b632],

1	Platelet	NN	O	platelet	nn	2	SENT_450	[p26l236t579r588b632],
2	Therapy	NN	O	therapy	_	0	SENT_450	[p26l615t578r859b651],
3	In	IN	O	in	dep	2	SENT_450	[p26l885t580r947b632],
4	diabetes	NN	O	diabetes	nn	5	SENT_450	[p26l978t579r1204b632],
5	MellitUS	NN	O	mellitus	pobj	3	SENT_450	[p26l1234t579r1501b632],
6	(	CD	NUMBER	(	num	7	SENT_450	[p26l1536t578r1979b644],
7	OPTIMUS	NNP	O	OPTIMUS	dep	5	SENT_450	[p26l1536t578r1979b644],
8	)	CD	NUMBER	)	num	7	SENT_450	[p26l1536t578r1979b644],
9	.	.	O	.	_	0	SENT_450	[p26l1536t578r1979b644],

1	—	NN	O	—	_	0	SENT_451	[p26l1536t578r1979b644],
2	.	.	O	.	_	0	SENT_451	[p26l1536t578r1979b644],

1	3	CD	NUMBER	3	_	0	SENT_452	[p26l1536t578r1979b644],
2	trial	NN	O	trial	dep	1	SENT_452	[p26l2012t579r2139b632],
3	.	.	O	.	_	0	SENT_452	[p26l2012t579r2139b632],

1	Eur	NNP	O	Eur	nn	2	SENT_453	[p26l117t660r224b711],
2	Heart	NNP	O	Heart	_	0	SENT_453	[p26l249t660r462b726],
3	]	CD	NUMBER	]	num	4	SENT_453	[p26l249t660r462b726],
4	2011	CD	DATE	2011	dep	2	SENT_453	[p26l487t662r981b723],
5	;	:	O	;	_	0	SENT_453	[p26l487t662r981b723],
6	32:838	CD	NUMBER	32:838	number	7	SENT_453	[p26l487t662r981b723],
7	—	CD	NUMBER	—	dep	2	SENT_453	[p26l487t662r981b723],
8	46	CD	NUMBER	46	dep	7	SENT_453	[p26l487t662r981b723],
9	.	.	O	.	_	0	SENT_453	[p26l487t662r981b723],

1	Alexopoulos	NNP	PERSON	Alexopoulos	nn	2	SENT_454	[p26l114t737r467b810],
2	D	NNP	PERSON	D	_	0	SENT_454	[p26l499t739r570b803],
3	,	,	O	,	_	0	SENT_454	[p26l499t739r570b803],
4	Xanthopoulou	NNP	O	Xanthopoulou	nn	5	SENT_454	[p26l599t738r1012b810],
5	I	NNP	O	I	appos	2	SENT_454	[p26l1042t739r1082b803],
6	,	,	O	,	_	0	SENT_454	[p26l1042t739r1082b803],
7	Davlouros	NNP	PERSON	Davlouros	nn	8	SENT_454	[p26l1115t738r1405b791],
8	P	NN	O	p	appos	2	SENT_454	[p26l1437t739r1493b803],
9	,	,	O	,	_	0	SENT_454	[p26l1437t739r1493b803],
10	et	FW	O	et	nn	11	SENT_454	[p26l1527t752r1577b791],
11	al.	FW	O	al.	appos	2	SENT_454	[p26l1608t738r1667b791],
12	.	.	O	.	_	0	SENT_454	[p26l1608t738r1667b791],

1	Prasugrel	NNP	O	Prasugrel	nsubj	2	SENT_455	[p26l1701t738r1966b810],
2	overcomes	VBZ	O	overcome	_	0	SENT_455	[p26l1996t758r2140b791, p26l117t840r290b872],
3	high	JJ	O	high	acomp	2	SENT_455	[p26l312t819r440b891],
4	on	IN	O	on	_	0	SENT_455	[p26l462t819r881b891],
5	—	CD	NUMBER	—	num	8	SENT_455	[p26l462t819r881b891],
6	clopidogrel	NN	O	clopidogrel	nn	8	SENT_455	[p26l462t819r881b891],
7	platelet	NN	O	platelet	nn	8	SENT_455	[p26l900t819r1109b891],
8	reactivity	NN	O	reactivity	prep_on	3	SENT_455	[p26l1129t821r1389b891],
9	in	IN	O	in	_	0	SENT_455	[p26l1407t821r1462b872],
10	chronic	JJ	O	chronic	amod	14	SENT_455	[p26l1484t819r1695b872],
11	coronary	JJ	O	coronary	amod	14	SENT_455	[p26l1716t839r1964b891],
12	artery	NN	O	artery	nn	14	SENT_455	[p26l1983t833r2146b891],
13	disease	NN	O	disease	nn	14	SENT_455	[p26l117t898r311b951],
14	patients	NNS	O	patient	prep_in	8	SENT_455	[p26l336t900r558b970],
15	more	RBR	O	more	advmod	16	SENT_455	[p26l586t918r729b951],
16	effectively	RB	O	effectively	advmod	2	SENT_455	[p26l757t898r1036b970],
17	than	IN	O	than	_	0	SENT_455	[p26l1059t898r1186b951],
18	high	JJ	O	high	amod	20	SENT_455	[p26l1212t898r1339b970],
19	dose	NN	O	dose	nn	20	SENT_455	[p26l1366t898r1490b951],
20	(	NN	O	(	prep_than	16	SENT_455	[p26l1519t897r1644b963],
21	150	CD	NUMBER	150	num	24	SENT_455	[p26l1519t897r1644b963],
22	mg	NN	O	mg	nn	24	SENT_455	[p26l1671t897r1780b970],
23	)	NN	O	)	nn	24	SENT_455	[p26l1671t897r1780b970],
24	clopidogrel	NN	O	clopidogrel	dep	20	SENT_455	[p26l1809t898r2139b970],
25	.	.	O	.	_	0	SENT_455	[p26l1809t898r2139b970],

1	Am	VBP	O	be	dep	2	SENT_456	[p26l114t977r223b1030],
2	Heart	NNP	O	Heart	_	0	SENT_456	[p26l250t979r463b1045],
3	]	CD	NUMBER	]	number	4	SENT_456	[p26l250t979r463b1045],
4	2011	CD	DATE	2011	amod	2	SENT_456	[p26l488t979r965b1042],
5	;	:	O	;	_	0	SENT_456	[p26l488t979r965b1042],
6	162:733	CD	NUMBER	162:733	dep	4	SENT_456	[p26l488t979r965b1042],
7	—	CD	NUMBER	—	num	8	SENT_456	[p26l488t979r965b1042],
8	9	CD	NUMBER	9	dep	6	SENT_456	[p26l488t979r965b1042],
9	.	.	O	.	_	0	SENT_456	[p26l488t979r965b1042],

1	Parodi	NNP	PERSON	Parodi	nn	2	SENT_457	[p26l116t1057r303b1110],
2	G	NNP	PERSON	G	_	0	SENT_457	[p26l338t1057r407b1122],
3	,	,	O	,	_	0	SENT_457	[p26l338t1057r407b1122],
4	Bellandi	NNP	PERSON	Bellandi	nn	5	SENT_457	[p26l444t1057r679b1110],
5	B	NNP	PERSON	B	appos	2	SENT_457	[p26l712t1058r772b1122],
6	,	,	O	,	_	0	SENT_457	[p26l712t1058r772b1122],
7	Venditti	NNP	PERSON	Venditti	nn	8	SENT_457	[p26l808t1057r1044b1111],
8	F	NN	O	f	appos	2	SENT_457	[p26l1078t1058r1133b1122],
9	,	,	O	,	_	0	SENT_457	[p26l1078t1058r1133b1122],
10	et	FW	O	et	nn	11	SENT_457	[p26l1170t1071r1221b1110],
11	al.	FW	O	al.	appos	2	SENT_457	[p26l1254t1057r1313b1110],
12	.	.	O	.	_	0	SENT_457	[p26l1254t1057r1313b1110],

1	Residual	JJ	O	residual	amod	3	SENT_458	[p26l1352t1057r1595b1110],
2	platelet	NN	O	platelet	nn	3	SENT_458	[p26l1626t1057r1835b1129],
3	reactivity	NN	O	reactivity	_	0	SENT_458	[p26l1867t1059r2140b1129],
4	,	,	O	,	_	0	SENT_458	[p26l1867t1059r2140b1129],
5	bleedings	NNS	O	bleeding	conj_and	3	SENT_458	[p26l114t1138r398b1210],
6	,	,	O	,	_	0	SENT_458	[p26l114t1138r398b1210],
7	and	CC	O	and	_	0	SENT_458	[p26l420t1138r523b1191],
8	adherence	NN	O	adherence	conj_and	3	SENT_458	[p26l543t1138r827b1191],
9	to	TO	O	to	_	0	SENT_458	[p26l847t1152r901b1191],
10	treatment	NN	O	treatment	prep_to	8	SENT_458	[p26l922t1152r1199b1191],
11	in	IN	O	in	_	0	SENT_458	[p26l1218t1140r1272b1191],
12	patients	NNS	O	patient	prep_in	10	SENT_458	[p26l1291t1140r1512b1210],
13	having	VBG	O	have	partmod	12	SENT_458	[p26l1533t1138r1723b1210],
14	coronary	JJ	O	coronary	amod	16	SENT_458	[p26l1742t1158r1990b1210],
15	stent	NN	O	stent	nn	16	SENT_458	[p26l2008t1152r2144b1191],
16	implantation	NN	O	implantation	dobj	13	SENT_458	[p26l116t1218r481b1290],
17	treated	VBN	O	treat	partmod	3	SENT_458	[p26l507t1218r703b1271],
18	with	IN	O	with	_	0	SENT_458	[p26l726t1218r855b1271],
19	prasugrel	NN	O	prasugrel	prep_with	17	SENT_458	[p26l881t1218r1153b1290],
20	.	.	O	.	_	0	SENT_458	[p26l881t1218r1153b1290],

1	Am	VBP	O	be	dep	3	SENT_459	[p26l1182t1217r1339b1286],
2	]	CD	NUMBER	]	num	3	SENT_459	[p26l1182t1217r1339b1286],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_459	[p26l1366t1218r1581b1271],
4	2012	CD	DATE	2012	num	3	SENT_459	[p26l1605t1221r2099b1283],
5	;	:	O	;	_	0	SENT_459	[p26l1605t1221r2099b1283],
6	109:214	CD	NUMBER	109:214	dep	3	SENT_459	[p26l1605t1221r2099b1283],
7	—	CD	NUMBER	—	num	8	SENT_459	[p26l1605t1221r2099b1283],
8	8	CD	NUMBER	8	dep	6	SENT_459	[p26l1605t1221r2099b1283],
9	.	.	O	.	_	0	SENT_459	[p26l1605t1221r2099b1283],

1	Cuisset	JJ	MISC	cuisset	amod	2	SENT_460	[p26l117t1298r327b1351],
2	T	NN	O	t	_	0	SENT_460	[p26l347t1297r413b1363],
3	,	,	O	,	_	0	SENT_460	[p26l347t1297r413b1363],
4	Morange	NNP	ORGANIZATION	Morange	nn	5	SENT_460	[p26l438t1299r699b1370],
5	PE	NNP	ORGANIZATION	PE	appos	2	SENT_460	[p26l724t1299r829b1363],
6	,	,	O	,	_	0	SENT_460	[p26l724t1299r829b1363],
7	Alessi	NNP	PERSON	Alessi	nn	8	SENT_460	[p26l854t1297r1024b1351],
8	MC	NNP	O	MC	appos	5	SENT_460	[p26l1047t1298r1184b1351],
9	.	.	O	.	_	0	SENT_460	[p26l1047t1298r1184b1351],

1	Recent	JJ	O	recent	amod	2	SENT_461	[p26l1213t1299r1411b1351],
2	advances	NNS	O	advance	_	0	SENT_461	[p26l1435t1298r1681b1351],
3	in	IN	O	in	_	0	SENT_461	[p26l1707t1300r1761b1351],
4	the	DT	O	the	det	5	SENT_461	[p26l1785t1298r1874b1351],
5	pharmacogenetics	NNS	O	pharmacogenetic	prep_in	2	SENT_461	[p26l1898t1298r2140b1370, p26l117t1380r406b1450],
6	of	IN	O	of	_	0	SENT_461	[p26l434t1378r498b1431],
7	clopidogrel	NN	O	clopidogrel	prep_of	2	SENT_461	[p26l515t1378r845b1450],
8	.	.	O	.	_	0	SENT_461	[p26l515t1378r845b1450],

1	Hum	NNP	O	Hum	nn	2	SENT_462	[p26l876t1379r1026b1431],
2	Genet	NNP	O	Genet	_	0	SENT_462	[p26l1055t1378r1231b1431],
3	2012	CD	DATE	2012	num	2	SENT_462	[p26l1255t1378r1683b1443],
4	;	:	O	;	_	0	SENT_462	[p26l1255t1378r1683b1443],
5	131:653	CD	NUMBER	131:653	number	6	SENT_462	[p26l1255t1378r1683b1443],
6	—	CD	NUMBER	—	dep	2	SENT_462	[p26l1255t1378r1683b1443],
7	64	CD	NUMBER	64	dep	6	SENT_462	[p26l1694t1381r1776b1431],
8	.	.	O	.	_	0	SENT_462	[p26l1694t1381r1776b1431],

1	Cuisset	JJ	MISC	cuisset	amod	2	SENT_463	[p26l117t1458r327b1511],
2	T	NN	O	t	_	0	SENT_463	[p26l343t1457r409b1523],
3	,	,	O	,	_	0	SENT_463	[p26l343t1457r409b1523],
4	Frere	NNP	ORGANIZATION	Frere	nn	5	SENT_463	[p26l433t1459r581b1511],
5	C	NNP	ORGANIZATION	C	appos	2	SENT_463	[p26l604t1458r668b1523],
6	,	,	O	,	_	0	SENT_463	[p26l604t1458r668b1523],
7	Poyet	NNP	PERSON	Poyet	nn	8	SENT_463	[p26l692t1459r853b1530],
8	R	NNP	O	R	appos	2	SENT_463	[p26l874t1459r935b1523],
9	,	,	O	,	_	0	SENT_463	[p26l874t1459r935b1523],
10	et	FW	O	et	nn	11	SENT_463	[p26l959t1472r1010b1511],
11	al.	FW	O	al.	appos	2	SENT_463	[p26l1031t1458r1090b1511],
12	.	.	O	.	_	0	SENT_463	[p26l1031t1458r1090b1511],

1	Clopidogrel	NNP	O	Clopidogrel	nn	2	SENT_464	[p26l1116t1458r1455b1530],
2	response	NN	O	response	_	0	SENT_464	[p26l1475t1478r1732b1530],
3	:	:	O	:	_	0	SENT_464	[p26l1475t1478r1732b1530],
4	head	NN	O	head	dep	2	SENT_464	[p26l1757t1458r2143b1511],
5	—	CD	NUMBER	—	number	7	SENT_464	[p26l1757t1458r2143b1511],
6	to	TO	O	to	dep	7	SENT_464	[p26l1757t1458r2143b1511],
7	—	CD	NUMBER	—	num	9	SENT_464	[p26l1757t1458r2143b1511],
8	head	NN	O	head	nn	9	SENT_464	[p26l1757t1458r2143b1511],
9	comparison	NN	O	comparison	nsubj	15	SENT_464	[p26l117t1541r444b1611],
10	of	IN	O	of	_	0	SENT_464	[p26l487t1539r551b1592],
11	different	JJ	O	different	amod	13	SENT_464	[p26l585t1539r822b1592],
12	platelet	NN	O	platelet	nn	13	SENT_464	[p26l862t1539r1071b1611],
13	assays	NNS	O	assay	prep_of	9	SENT_464	[p26l1113t1560r1276b1611],
14	to	TO	O	to	aux	15	SENT_464	[p26l1319t1553r1374b1592],
15	identify	VB	O	identify	infmod	4	SENT_464	[p26l1417t1539r1637b1611],
16	clopidogrel	NN	O	clopidogrel	nn	19	SENT_464	[p26l1677t1539r1993b1611],
17	non	JJ	O	non	amod	19	SENT_464	[p26l2035t1560r2143b1592],
18	responder	NN	O	responder	nn	19	SENT_464	[p26l116t1619r396b1691],
19	patients	NNS	O	patient	dobj	15	SENT_464	[p26l418t1621r640b1691],
20	after	IN	O	after	_	0	SENT_464	[p26l667t1619r794b1672],
21	coronary	JJ	O	coronary	amod	22	SENT_464	[p26l818t1639r1066b1691],
22	stenting	NN	O	stenting	prep_after	15	SENT_464	[p26l1088t1621r1330b1691],
23	.	.	O	.	_	0	SENT_464	[p26l1088t1621r1330b1691],

1	Arch	NNP	O	Arch	nn	3	SENT_465	[p26l1355t1618r1499b1672],
2	Cardiovasc	NNP	O	Cardiovasc	nn	3	SENT_465	[p26l1525t1619r1837b1672],
3	Dis	NNP	O	Dis	_	0	SENT_465	[p26l1861t1620r1959b1672],
4	2010	CD	DATE	2010	num	3	SENT_465	[p26l1983t1622r2140b1684],
5	;	:	O	;	_	0	SENT_465	[p26l1983t1622r2140b1684],
6	103:39	CD	NUMBER	103:39	number	7	SENT_465	[p26l119t1699r448b1752],
7	-45	CD	NUMBER	-45	dep	3	SENT_465	[p26l119t1699r448b1752],
8	.	.	O	.	_	0	SENT_465	[p26l119t1699r448b1752],

1	Breet	NNP	O	Breet	nn	3	SENT_466	[p26l116t1779r269b1831],
2	N	NNP	O	N	nn	3	SENT_466	[p26l290t1779r383b1846],
3	]	NN	O	]	_	0	SENT_466	[p26l290t1779r383b1846],
4	,	,	O	,	_	0	SENT_466	[p26l290t1779r383b1846],
5	van	NN	O	van	nn	8	SENT_466	[p26l405t1799r504b1831],
6	Werkum	NNP	O	Werkum	nn	8	SENT_466	[p26l523t1778r781b1832],
7	]	CD	NUMBER	]	num	8	SENT_466	[p26l796t1779r915b1846],
8	VV	NNP	O	VV	appos	3	SENT_466	[p26l796t1779r915b1846],
9	,	,	O	,	_	0	SENT_466	[p26l796t1779r915b1846],
10	Bouman	NNP	PERSON	Bouman	nn	12	SENT_466	[p26l939t1779r1181b1831],
11	H	NNP	O	H	nn	12	SENT_466	[p26l1204t1779r1301b1846],
12	]	NN	O	]	appos	3	SENT_466	[p26l1204t1779r1301b1846],
13	,	,	O	,	_	0	SENT_466	[p26l1204t1779r1301b1846],
14	et	FW	O	et	nn	15	SENT_466	[p26l1326t1792r1377b1831],
15	al.	FW	O	al.	appos	3	SENT_466	[p26l1399t1778r1458b1831],
16	.	.	O	.	_	0	SENT_466	[p26l1399t1778r1458b1831],

1	Comparison	NN	O	comparison	_	0	SENT_467	[p26l1485t1778r1836b1850],
2	of	IN	O	of	_	0	SENT_467	[p26l1859t1778r1923b1831],
3	platelet	NN	O	platelet	prep_of	4	SENT_467	[p26l1935t1778r2144b1850],
4	function	NN	O	function	amod	5	SENT_467	[p26l116t1859r353b1912],
5	tests	NNS	O	test	dobj	6	SENT_467	[p26l388t1873r511b1912],
6	in	IN	O	in	dep	1	SENT_467	[p26l547t1861r601b1912],
7	predicting	VBG	O	predict	dep	6	SENT_467	[p26l635t1859r926b1931],
8	clinical	JJ	O	clinical	amod	9	SENT_467	[p26l960t1859r1159b1912],
9	outcome	NN	O	outcome	dobj	7	SENT_467	[p26l1193t1873r1436b1912],
10	in	IN	O	in	dep	9	SENT_467	[p26l1471t1861r1526b1912],
11	patients	NNS	O	patient	nsubj	12	SENT_467	[p26l1560t1861r1781b1931],
12	undergoing	VBG	O	undergo	pcomp	10	SENT_467	[p26l1817t1859r2144b1931],
13	coronary	JJ	O	coronary	amod	15	SENT_467	[p26l117t1959r364b2011],
14	stent	NN	O	stent	nn	15	SENT_467	[p26l389t1953r525b1992],
15	implantation	NN	O	implantation	dobj	12	SENT_467	[p26l550t1939r930b2011],
16	.	.	O	.	_	0	SENT_467	[p26l550t1939r930b2011],
17	]	SYM	O	]	dep	1	SENT_467	[p26l952t1938r1158b2007],

1	AMA	NNP	O	AMA	_	0	SENT_468	[p26l952t1938r1158b2007],
2	2010	CD	DATE	2010	num	1	SENT_468	[p26l1182t1939r1711b2004],
3	;	:	O	;	_	0	SENT_468	[p26l1182t1939r1711b2004],
4	303:754	CD	NUMBER	303:754	number	5	SENT_468	[p26l1182t1939r1711b2004],
5	—	CD	NUMBER	—	dep	1	SENT_468	[p26l1182t1939r1711b2004],
6	62	CD	NUMBER	62	dep	5	SENT_468	[p26l1182t1939r1711b2004],
7	.	.	O	.	_	0	SENT_468	[p26l1182t1939r1711b2004],

1	Montalescot	NNP	O	Montalescot	nn	2	SENT_469	[p26l115t2019r472b2072],
2	G	NNP	O	G	_	0	SENT_469	[p26l493t2019r563b2083],
3	,	,	O	,	_	0	SENT_469	[p26l493t2019r563b2083],
4	Sideris	NNP	PERSON	Sideris	nn	5	SENT_469	[p26l589t2019r776b2072],
5	G	NNP	PERSON	G	appos	2	SENT_469	[p26l800t2019r870b2083],
6	,	,	O	,	_	0	SENT_469	[p26l800t2019r870b2083],
7	Meuleman	NNP	PERSON	Meuleman	nn	8	SENT_469	[p26l892t2019r1201b2072],
8	C	NNP	O	C	appos	2	SENT_469	[p26l1224t2019r1289b2083],
9	,	,	O	,	_	0	SENT_469	[p26l1224t2019r1289b2083],
10	et	FW	O	et	nn	11	SENT_469	[p26l1312t2033r1364b2072],
11	al.	FW	O	al.	appos	2	SENT_469	[p26l1384t2019r1463b2083],
12	,	,	O	,	_	0	SENT_469	[p26l1384t2019r1463b2083],
13	for	IN	O	for	_	0	SENT_469	[p26l1486t2019r1567b2072],
14	the	DT	O	the	det	17	SENT_469	[p26l1587t2019r1675b2072],
15	ALBION	NNP	ORGANIZATION	ALBION	nn	17	SENT_469	[p26l1694t2018r1980b2072],
16	Trial	NNP	O	Trial	nn	17	SENT_469	[p26l2001t2018r2144b2072],
17	Investigators	NNS	O	investigator	prep_for	2	SENT_469	[p26l115t2100r493b2171],
18	.	.	O	.	_	0	SENT_469	[p26l115t2100r493b2171],

1	A	DT	O	a	det	3	SENT_470	[p26l526t2098r580b2152],
2	randomized	VBN	O	randomize	amod	3	SENT_470	[p26l610t2099r948b2152],
3	comparison	NN	O	comparison	_	0	SENT_470	[p26l980t2101r1307b2171],
4	of	IN	O	of	_	0	SENT_470	[p26l1340t2099r1404b2152],
5	high	JJ	O	high	amod	6	SENT_470	[p26l1426t2099r1553b2171],
6	clopidogrel	NN	O	clopidogrel	prep_of	3	SENT_470	[p26l1586t2099r1902b2171],
7	loading	VBG	O	load	partmod	6	SENT_470	[p26l1932t2099r2144b2171],
8	doses	NNS	O	dose	dobj	7	SENT_470	[p26l117t2179r266b2232],
9	in	IN	O	in	_	0	SENT_470	[p26l315t2181r369b2232],
10	patients	NNS	O	patient	prep_in	8	SENT_470	[p26l416t2181r638b2251],
11	with	IN	O	with	_	0	SENT_470	[p26l684t2179r814b2232],
12	non	JJ	O	non	prep_with	7	SENT_470	[p26l862t2178r1356b2251],
13	.	.	O	.	_	0	SENT_470	[p26l862t2178r1356b2251],

1	—	NN	O	—	_	0	SENT_471	[p26l862t2178r1356b2251],
2	.	.	O	.	_	0	SENT_471	[p26l862t2178r1356b2251],

1	ST	JJ	O	st	_	0	SENT_472	[p26l862t2178r1356b2251],
2	.	.	O	.	_	0	SENT_472	[p26l862t2178r1356b2251],

1	—	NN	O	—	_	0	SENT_473	[p26l862t2178r1356b2251],
2	.	.	O	.	_	0	SENT_473	[p26l862t2178r1356b2251],

1	segment	NN	O	segment	nn	5	SENT_474	[p26l862t2178r1356b2251],
2	elevation	NN	O	elevation	nn	5	SENT_474	[p26l1404t2179r1655b2232],
3	acute	JJ	O	acute	amod	5	SENT_474	[p26l1704t2193r1849b2232],
4	coronary	JJ	O	coronary	amod	5	SENT_474	[p26l1898t2199r2146b2251],
5	syndromes	NNS	O	syndrome	_	0	SENT_474	[p26l117t2258r432b2330],
6	:	:	O	:	_	0	SENT_474	[p26l117t2258r432b2330],
7	the	DT	O	the	det	10	SENT_474	[p26l466t2258r554b2311],
8	ALBION	NNP	ORGANIZATION	ALBION	nn	10	SENT_474	[p26l583t2257r869b2311],
9	(	CD	NUMBER	(	num	10	SENT_474	[p26l903t2257r1256b2323],
10	Assessment	NNP	O	Assessment	dep	5	SENT_474	[p26l903t2257r1256b2323],
11	of	IN	O	of	_	0	SENT_474	[p26l1285t2258r1350b2311],
12	the	DT	O	the	det	15	SENT_474	[p26l1370t2258r1458b2311],
13	Best	JJS	O	best	amod	15	SENT_474	[p26l1489t2259r1613b2311],
14	Loading	NN	O	loading	nn	15	SENT_474	[p26l1643t2258r1882b2330],
15	Dose	NN	O	dose	prep_of	10	SENT_474	[p26l1911t2259r2057b2311],
16	of	IN	O	of	_	0	SENT_474	[p26l2088t2258r2152b2311],
17	Clopidogrel	NNP	O	Clopidogrel	prep_of	15	SENT_474	[p26l117t2338r457b2410],
18	to	TO	O	to	_	0	SENT_474	[p26l483t2352r538b2391],
19	Blunt	NNP	O	Blunt	nn	21	SENT_474	[p26l567t2338r727b2391],
20	Platelet	NN	O	platelet	nn	21	SENT_474	[p26l754t2338r968b2391],
21	Activation	NN	O	activation	prep_to	17	SENT_474	[p26l993t2337r1308b2403],
22	,	,	O	,	_	0	SENT_474	[p26l993t2337r1308b2403],
23	Inﬂammation	NN	LOCATION	inﬂammation	appos	21	SENT_474	[p26l1338t2338r1729b2391],
24	and	CC	O	and	_	0	SENT_474	[p26l1758t2338r1860b2391],
25	Ongoing	JJ	O	ongoing	amod	28	SENT_474	[p26l1889t2338r2144b2410],
26	Necrosis	NN	O	necrosis	nn	28	SENT_474	[p26l116t2417r380b2482],
27	)	NN	O	)	nn	28	SENT_474	[p26l116t2417r380b2482],
28	trial	NN	O	trial	appos	21	SENT_474	[p26l409t2418r535b2470],
29	.	.	O	.	_	0	SENT_474	[p26l409t2418r535b2470],
30	]	SYM	O	]	dep	5	SENT_474	[p26l558t2419r586b2485],

1	Am	VBP	O	be	dep	3	SENT_475	[p26l610t2417r720b2470],
2	Coll	NNP	O	Coll	nn	3	SENT_475	[p26l748t2418r870b2471],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_475	[p26l897t2418r1112b2471],
4	2006	CD	DATE	2006	num	3	SENT_475	[p26l1135t2421r1585b2482],
5	;	:	O	;	_	0	SENT_475	[p26l1135t2421r1585b2482],
6	48:931	CD	NUMBER	48:931	dep	3	SENT_475	[p26l1135t2421r1585b2482],
7	—	CD	NUMBER	—	num	8	SENT_475	[p26l1135t2421r1585b2482],
8	8	CD	NUMBER	8	dep	6	SENT_475	[p26l1135t2421r1585b2482],
9	.	.	O	.	_	0	SENT_475	[p26l1135t2421r1585b2482],

1	Rehmel	NNP	O	Rehmel	nn	3	SENT_476	[p26l118t2497r338b2550],
2	]	CD	NUMBER	]	num	3	SENT_476	[p26l360t2498r451b2565],
3	L	NN	O	l	_	0	SENT_476	[p26l360t2498r451b2565],
4	,	,	O	,	_	0	SENT_476	[p26l360t2498r451b2565],
5	Eckstein	NN	PERSON	eckstein	nn	7	SENT_476	[p26l485t2497r730b2550],
6	]	NN	O	]	nn	7	SENT_476	[p26l753t2496r850b2565],
7	A	NN	O	a	appos	3	SENT_476	[p26l753t2496r850b2565],
8	,	,	O	,	_	0	SENT_476	[p26l753t2496r850b2565],
9	Farid	NNP	PERSON	Farid	nn	10	SENT_476	[p26l882t2497r1033b2550],
10	NA	NNP	O	NA	appos	3	SENT_476	[p26l1062t2496r1185b2562],
11	,	,	O	,	_	0	SENT_476	[p26l1062t2496r1185b2562],
12	et	FW	O	et	nn	13	SENT_476	[p26l1218t2511r1269b2550],
13	al.	FW	O	al.	appos	3	SENT_476	[p26l1299t2497r1358b2550],
14	.	.	O	.	_	0	SENT_476	[p26l1299t2497r1358b2550],

1	Interactions	NNS	O	interaction	_	0	SENT_477	[p26l1391t2498r1729b2550],
2	of	IN	O	of	_	0	SENT_477	[p26l1761t2497r1825b2550],
3	two	CD	NUMBER	two	num	5	SENT_477	[p26l1845t2511r1949b2550],
4	major	JJ	O	major	amod	5	SENT_477	[p26l1981t2498r2144b2569],
5	metabolites	NNS	O	metabolite	prep_of	1	SENT_477	[p26l117t2578r440b2631],
6	of	IN	O	of	_	0	SENT_477	[p26l472t2578r536b2631],
7	prasugrel	NN	O	prasugrel	prep_of	5	SENT_477	[p26l555t2578r830b2650],
8	,	,	O	,	_	0	SENT_477	[p26l555t2578r830b2650],
9	a	DT	O	a	det	12	SENT_477	[p26l863t2599r891b2631],
10	thienopyridine	NN	O	thienopyridine	nn	12	SENT_477	[p26l920t2578r1336b2650],
11	antiplatelet	JJ	O	antiplatelet	amod	12	SENT_477	[p26l1368t2578r1685b2650],
12	agent	NN	O	agent	appos	1	SENT_477	[p26l1715t2592r1868b2650],
13	with	IN	O	with	_	0	SENT_477	[p26l1894t2578r2024b2631],
14	the	DT	O	the	det	16	SENT_477	[p26l2054t2578r2142b2631],
15	cytochromes	NNS	O	cytochrome	nn	16	SENT_477	[p26l117t2658r471b2730],
16	P450	NN	O	p450	prep_with	12	SENT_477	[p26l499t2658r661b2711],
17	.	.	O	.	_	0	SENT_477	[p26l499t2658r661b2711],

1	Drug	NN	O	drug	nn	3	SENT_478	[p26l690t2659r842b2730],
2	Metab	NNP	O	Metab	nn	3	SENT_478	[p26l866t2658r1052b2711],
3	Dispos	NNP	O	Dispos	_	0	SENT_478	[p26l1080t2659r1275b2730],
4	2006	CD	DATE	2006	num	3	SENT_478	[p26l1302t2661r1656b2723],
5	;	:	O	;	_	0	SENT_478	[p26l1302t2661r1656b2723],
6	34:600	CD	NUMBER	34:600	number	7	SENT_478	[p26l1302t2661r1656b2723],
7	-7	CD	NUMBER	-7	dep	3	SENT_478	[p26l1667t2659r1751b2711],
8	.	.	O	.	_	0	SENT_478	[p26l1667t2659r1751b2711],

1	Roy	NNP	PERSON	Roy	nn	2	SENT_479	[p26l118t2739r233b2810],
2	P	NN	PERSON	p	_	0	SENT_479	[p26l251t2739r307b2803],
3	,	,	O	,	_	0	SENT_479	[p26l251t2739r307b2803],
4	Bonello	NNP	PERSON	Bonello	nn	5	SENT_479	[p26l331t2738r549b2791],
5	L	NNP	PERSON	L	appos	2	SENT_479	[p26l573t2739r632b2803],
6	,	,	O	,	_	0	SENT_479	[p26l573t2739r632b2803],
7	Torguson	NNP	PERSON	Torguson	nn	8	SENT_479	[p26l653t2737r932b2810],
8	R	NNP	PERSON	R	appos	2	SENT_479	[p26l955t2739r1016b2803],
9	,	,	O	,	_	0	SENT_479	[p26l955t2739r1016b2803],
10	et	FW	O	et	nn	11	SENT_479	[p26l1040t2752r1091b2791],
11	al.	FW	O	al.	appos	2	SENT_479	[p26l1112t2738r1172b2791],
12	.	.	O	.	_	0	SENT_479	[p26l1112t2738r1172b2791],

1	Impact	NN	O	impact	nsubj	4	SENT_480	[p26l1196t2739r1398b2810],
2	of	IN	O	of	_	0	SENT_480	[p26l1418t2738r1482b2791],
3	“	CD	NUMBER	“	prep_of	1	SENT_480	[p26l1494t2738r1788b2791],
4	nuisance	NN	O	nuisance	_	0	SENT_480	[p26l1494t2738r1788b2791],
5	”	CD	NUMBER	”	num	6	SENT_480	[p26l1494t2738r1788b2791],
6	bleeding	NN	O	bleeding	dobj	4	SENT_480	[p26l1808t2738r2052b2810],
7	on	IN	O	on	_	0	SENT_480	[p26l2073t2759r2142b2791],
8	clopidogrel	NN	O	clopidogrel	nn	9	SENT_480	[p26l117t2819r433b2891],
9	compliance	NN	O	compliance	prep_on	6	SENT_480	[p26l474t2819r794b2891],
10	in	IN	O	in	_	0	SENT_480	[p26l837t2821r891b2872],
11	patients	NNS	O	patient	prep_in	9	SENT_480	[p26l932t2821r1153b2891],
12	undergoing	VBG	O	undergo	xcomp	4	SENT_480	[p26l1196t2819r1523b2891],
13	intracoronary	JJ	O	intracoronary	amod	16	SENT_480	[p26l1563t2821r1946b2891],
14	drugeluting	NN	O	drugeluting	nn	16	SENT_480	[p26l1985t2819r2140b2891, p26l117t2899r314b2971],
15	stent	NN	O	stent	nn	16	SENT_480	[p26l339t2913r476b2952],
16	implantation	NN	O	implantation	dobj	12	SENT_480	[p26l501t2899r881b2971],
17	.	.	O	.	_	0	SENT_480	[p26l501t2899r881b2971],

1	Am	VBP	O	be	dep	3	SENT_481	[p26l908t2898r1066b2967],
2	]	CD	NUMBER	]	num	3	SENT_481	[p26l908t2898r1066b2967],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_481	[p26l1093t2899r1308b2953],
4	2008	CD	DATE	2008	num	3	SENT_481	[p26l1332t2900r1853b2964],
5	;	:	O	;	_	0	SENT_481	[p26l1332t2900r1853b2964],
6	102:1614	CD	NUMBER	102:1614	num	7	SENT_481	[p26l1332t2900r1853b2964],
7	—	NN	O	—	dep	3	SENT_481	[p26l1332t2900r1853b2964],
8	7	CD	NUMBER	7	dep	7	SENT_481	[p26l1332t2900r1853b2964],
9	.	.	O	.	_	0	SENT_481	[p26l1332t2900r1853b2964],

1	Armero	NNP	LOCATION	Armero	nn	2	SENT_482	[p26l114t2978r337b3032],
2	S	NNP	O	S	_	0	SENT_482	[p26l369t2979r418b3044],
3	,	,	O	,	_	0	SENT_482	[p26l369t2979r418b3044],
4	Bonello	NNP	PERSON	Bonello	nn	5	SENT_482	[p26l449t2979r667b3032],
5	L	NNP	PERSON	L	appos	2	SENT_482	[p26l697t2980r757b3044],
6	,	,	O	,	_	0	SENT_482	[p26l697t2980r757b3044],
7	Berbis	NNP	O	Berbis	appos	2	SENT_482	[p26l788t2979r965b3032],
8	]	CD	NUMBER	]	num	7	SENT_482	[p26l987t2980r1031b3047],
9	,	,	O	,	_	0	SENT_482	[p26l987t2980r1031b3047],
10	et	FW	O	et	nn	11	SENT_482	[p26l1062t2993r1113b3032],
11	al.	FW	O	al.	appos	2	SENT_482	[p26l1141t2979r1200b3032],
12	.	.	O	.	_	0	SENT_482	[p26l1141t2979r1200b3032],

1	Rate	NN	O	rate	_	0	SENT_483	[p26l1234t2980r1362b3032],
2	of	IN	O	of	_	0	SENT_483	[p26l1391t2979r1456b3032],
3	nuisance	NN	O	nuisance	nn	4	SENT_483	[p26l1475t2981r1716b3032],
4	bleedings	NNS	O	bleeding	prep_of	1	SENT_483	[p26l1744t2979r2010b3051],
5	and	CC	O	and	_	0	SENT_483	[p26l2041t2979r2143b3032],
6	impact	NN	O	impact	prep_of	1	SENT_483	[p26l116t3062r310b3132],
7	on	IN	O	on	_	0	SENT_483	[p26l333t3081r403b3113],
8	compliance	NN	O	compliance	prep_on	4	SENT_483	[p26l427t3060r747b3132],
9	to	TO	O	to	_	0	SENT_483	[p26l771t3074r825b3113],
10	prasugrel	NN	O	prasugrel	prep_to	1	SENT_483	[p26l849t3060r1108b3132],
11	in	IN	O	in	_	0	SENT_483	[p26l1131t3062r1185b3113],
12	acute	JJ	O	acute	amod	14	SENT_483	[p26l1210t3074r1354b3113],
13	coronary	JJ	O	coronary	amod	14	SENT_483	[p26l1379t3080r1627b3132],
14	syndromes	NNS	O	syndrome	prep_in	1	SENT_483	[p26l1649t3060r1964b3132],
15	.	.	O	.	_	0	SENT_483	[p26l1649t3060r1964b3132],

1	Am	VBP	O	be	dep	3	SENT_484	[p26l1988t3059r2143b3128],
2	]	CD	NUMBER	]	num	3	SENT_484	[p26l1988t3059r2143b3128],
3	Cardiol	NNP	O	Cardiol	_	0	SENT_484	[p26l117t3141r332b3194],
4	2011	CD	DATE	2011	num	3	SENT_484	[p26l356t3142r877b3205],
5	;	:	O	;	_	0	SENT_484	[p26l356t3142r877b3205],
6	108:1710	CD	NUMBER	108:1710	dep	3	SENT_484	[p26l356t3142r877b3205],
7	—	CD	NUMBER	—	num	8	SENT_484	[p26l356t3142r877b3205],
8	3	CD	NUMBER	3	dep	6	SENT_484	[p26l356t3142r877b3205],
9	.	.	O	.	_	0	SENT_484	[p26l356t3142r877b3205],

1	Cayla	NNP	PERSON	Cayla	nn	2	SENT_485	[p26l117t3220r277b3292],
2	G	NNP	PERSON	G	_	0	SENT_485	[p26l308t3220r378b3285],
3	,	,	O	,	_	0	SENT_485	[p26l308t3220r378b3285],
4	Hulot	NNP	PERSON	Hulot	nn	6	SENT_485	[p26l411t3220r582b3273],
5	]	CD	NUMBER	]	num	6	SENT_485	[p26l603t3220r686b3288],
6	S	NN	O	s	appos	2	SENT_485	[p26l603t3220r686b3288],
7	,	,	O	,	_	0	SENT_485	[p26l603t3220r686b3288],
8	O’Connor	NNP	O	O’Connor	nn	9	SENT_485	[p26l720t3220r1013b3273],
9	SA	NNP	O	SA	appos	2	SENT_485	[p26l1045t3219r1147b3285],
10	,	,	O	,	_	0	SENT_485	[p26l1045t3219r1147b3285],
11	et	FW	O	et	nn	12	SENT_485	[p26l1180t3234r1231b3273],
12	al.	FW	O	al.	appos	2	SENT_485	[p26l1261t3220r1320b3273],
13	.	.	O	.	_	0	SENT_485	[p26l1261t3220r1320b3273],

1	Clinical	JJ	O	clinical	amod	3	SENT_486	[p26l1355t3220r1592b3285],
2	,	,	O	,	_	0	SENT_486	[p26l1355t3220r1592b3285],
3	angiographic	JJ	O	angiographic	_	0	SENT_486	[p26l1625t3220r2007b3292],
4	,	,	O	,	_	0	SENT_486	[p26l1625t3220r2007b3292],
5	and	CC	O	and	_	0	SENT_486	[p26l2041t3220r2142b3273],
6	genetic	JJ	O	genetic	amod	7	SENT_486	[p26l115t3302r318b3372],
7	factors	NNS	O	factor	conj_and	3	SENT_486	[p26l340t3300r526b3353],
8	associated	VBN	O	associate	rcmod	7	SENT_486	[p26l552t3300r834b3353],
9	with	IN	O	with	dobj	8	SENT_486	[p26l853t3300r983b3353],
10	early	JJ	O	early	dep	9	SENT_486	[p26l1007t3300r1140b3372],
11	coronary	JJ	O	coronary	iobj	10	SENT_486	[p26l1161t3320r1409b3372],
12	stent	NN	O	stent	dobj	10	SENT_486	[p26l1430t3314r1567b3353],
13	thrombosis	NN	O	thrombosis	dep	12	SENT_486	[p26l1588t3300r1919b3353],
14	.	.	O	.	_	0	SENT_486	[p26l1588t3300r1919b3353],
15	]	SYM	O	]	dep	9	SENT_486	[p26l1939t3299r2144b3368],

1	AMA	NNP	O	AMA	_	0	SENT_487	[p26l1939t3299r2144b3368],
2	2011	CD	DATE	2011	num	1	SENT_487	[p26l115t3380r663b3444],
3	;	:	O	;	_	0	SENT_487	[p26l115t3380r663b3444],
4	306:1765	CD	NUMBER	306:1765	number	5	SENT_487	[p26l115t3380r663b3444],
5	-74	CD	NUMBER	-74	dep	1	SENT_487	[p26l115t3380r663b3444],
6	.	.	O	.	_	0	SENT_487	[p26l115t3380r663b3444],

1	Montalescot	NNP	O	Montalescot	nn	2	SENT_488	[p26l115t3459r486b3512],
2	G	NNP	O	G	_	0	SENT_488	[p26l510t3459r581b3524],
3	,	,	O	,	_	0	SENT_488	[p26l510t3459r581b3524],
4	Sideris	NNP	PERSON	Sideris	nn	5	SENT_488	[p26l609t3459r805b3512],
5	G	NNP	PERSON	G	appos	2	SENT_488	[p26l831t3459r902b3524],
6	,	,	O	,	_	0	SENT_488	[p26l831t3459r902b3524],
7	Cohen	NNP	PERSON	Cohen	nn	8	SENT_488	[p26l929t3459r1126b3512],
8	R	NNP	O	R	appos	2	SENT_488	[p26l1150t3460r1213b3524],
9	,	,	O	,	_	0	SENT_488	[p26l1150t3460r1213b3524],
10	et	FW	O	et	nn	11	SENT_488	[p26l1239t3473r1291b3512],
11	al.	FW	O	al.	appos	2	SENT_488	[p26l1314t3459r1376b3512],
12	.	.	O	.	_	0	SENT_488	[p26l1314t3459r1376b3512],

1	Prasugrel	NNP	O	Prasugrel	_	0	SENT_489	[p26l1403t3459r1679b3531],
2	compared	VBN	O	compare	_	0	SENT_489	[p26l1702t3459r1990b3531],
3	with	IN	O	with	prepc_compared_with	1	SENT_489	[p26l2010t3459r2143b3512],
4	high	JJ	O	high	amod	7	SENT_489	[p26l116t3539r411b3611],
5	—	NN	O	—	nn	7	SENT_489	[p26l116t3539r411b3611],
6	dose	NN	O	dose	nn	7	SENT_489	[p26l116t3539r411b3611],
7	clopidogrel	NN	O	clopidogrel	pobj	1	SENT_489	[p26l434t3539r764b3611],
8	in	IN	O	in	_	0	SENT_489	[p26l784t3541r840b3592],
9	acute	JJ	O	acute	amod	11	SENT_489	[p26l863t3553r1013b3592],
10	coronary	JJ	O	coronary	amod	11	SENT_489	[p26l1035t3559r1293b3611],
11	syndrome	NN	O	syndrome	prep_in	7	SENT_489	[p26l1312t3539r1613b3611],
12	.	.	O	.	_	0	SENT_489	[p26l1312t3539r1613b3611],

1	The	DT	O	the	nsubj	2	SENT_490	[p26l1636t3538r1757b3592],
2	randomised	VBN	O	randomise	_	0	SENT_490	[p26l1778t3539r2140b3604],
3	,	,	O	,	_	0	SENT_490	[p26l1778t3539r2140b3604],
4	double	JJ	O	double	dep	8	SENT_490	[p26l117t3619r499b3672],
5	—	RB	O	—	advmod	6	SENT_490	[p26l117t3619r499b3672],
6	blind	JJ	O	blind	amod	4	SENT_490	[p26l117t3619r499b3672],
7	ACAPULCO	NNP	ORGANIZATION	ACAPULCO	nn	8	SENT_490	[p26l544t3618r966b3672],
8	study	NN	O	study	ccomp	2	SENT_490	[p26l1017t3619r1187b3691],
9	.	.	O	.	_	0	SENT_490	[p26l1017t3619r1187b3691],

1	Thromb	NNP	O	Thromb	nn	2	SENT_491	[p26l1236t3618r1483b3672],
2	Haemost	NNP	O	Haemost	_	0	SENT_491	[p26l1532t3620r1802b3672],
3	2010	CD	DATE	2010	num	2	SENT_491	[p26l1847t3622r2139b3684],
4	;	:	O	;	_	0	SENT_491	[p26l1847t3622r2139b3684],
5	103	CD	NUMBER	103	num	7	SENT_491	[p26l1847t3622r2139b3684],
6	:	:	O	:	_	0	SENT_491	[p26l1847t3622r2139b3684],
7	213-23	CD	NUMBER	213-23	dep	2	SENT_491	[p26l115t3702r350b3752],
8	.	.	O	.	_	0	SENT_491	[p26l115t3702r350b3752],

1	33	CD	NUMBER	33	_	0	SENT_492	[p27l9t23r92b73],
2	.	.	O	.	_	0	SENT_492	[p27l9t23r92b73],

1	Angiolillo	NN	O	angiolillo	nn	3	SENT_493	[p27l114t19r401b92],
2	D	NN	O	d	nn	3	SENT_493	[p27l428t21r522b88],
3	]	NN	O	]	_	0	SENT_493	[p27l428t21r522b88],
4	,	,	O	,	_	0	SENT_493	[p27l428t21r522b88],
5	Saucedo	NNP	PERSON	Saucedo	nn	6	SENT_493	[p27l553t20r784b73],
6	JF	NNP	O	JF	appos	3	SENT_493	[p27l804t21r890b88],
7	,	,	O	,	_	0	SENT_493	[p27l804t21r890b88],
8	Deraad	NNP	PERSON	Deraad	nn	9	SENT_493	[p27l918t20r1126b73],
9	R	NNP	PERSON	R	appos	3	SENT_493	[p27l1153t21r1214b85],
10	,	,	O	,	_	0	SENT_493	[p27l1153t21r1214b85],
11	et	FW	O	et	nn	12	SENT_493	[p27l1243t34r1293b73],
12	al.	FW	O	al.	appos	3	SENT_493	[p27l1319t20r1378b73],
13	for	IN	O	for	_	0	SENT_493	[p27l1407t20r1488b73],
14	the	DT	O	the	det	16	SENT_493	[p27l1512t20r1600b73],
15	SWAP	NNP	O	SWAP	nn	16	SENT_493	[p27l1629t19r1833b74],
16	Investigators	NNS	O	investigator	prep_for	12	SENT_493	[p27l1858t21r2140b92, p27l116t114r236b153],
17	.	.	O	.	_	0	SENT_493	[p27l1858t21r2140b92, p27l116t114r236b153],

1	Increased	VBN	O	increase	amod	3	SENT_494	[p27l274t100r544b153],
2	platelet	NN	O	platelet	nn	3	SENT_494	[p27l578t100r787b172],
3	inhibition	NN	O	inhibition	_	0	SENT_494	[p27l822t100r1103b153],
4	after	IN	O	after	_	0	SENT_494	[p27l1140t100r1267b153],
5	switching	VBG	O	switch	prepc_after	3	SENT_494	[p27l1303t100r1575b172],
6	from	IN	O	from	_	0	SENT_494	[p27l1609t100r1745b153],
7	maintenance	NN	O	maintenance	nn	8	SENT_494	[p27l1782t102r2142b153],
8	clopidogrel	NN	O	clopidogrel	prep_from	5	SENT_494	[p27l117t181r433b253],
9	to	TO	O	to	_	0	SENT_494	[p27l467t195r522b234],
10	prasugrel	NN	O	prasugrel	prep_to	5	SENT_494	[p27l557t181r817b253],
11	in	IN	O	in	_	0	SENT_494	[p27l851t183r905b234],
12	patients	NNS	O	patient	prep_in	10	SENT_494	[p27l940t183r1162b253],
13	with	IN	O	with	_	0	SENT_494	[p27l1196t181r1325b234],
14	acute	JJ	O	acute	amod	16	SENT_494	[p27l1362t195r1506b234],
15	coronary	JJ	O	coronary	amod	16	SENT_494	[p27l1543t201r1791b253],
16	syndromes	NNS	O	syndrome	prep_with	12	SENT_494	[p27l1824t181r2139b253],
17	:	:	O	:	_	0	SENT_494	[p27l1824t181r2139b253],
18	results	NNS	O	result	dep	3	SENT_494	[p27l116t260r294b313],
19	of	IN	O	of	_	0	SENT_494	[p27l334t260r398b313],
20	the	DT	O	the	det	23	SENT_494	[p27l426t260r514b313],
21	SWAP	NN	O	swap	nn	23	SENT_494	[p27l555t259r759b314],
22	(	CD	NUMBER	(	num	23	SENT_494	[p27l799t259r1133b332],
23	SWitching	NN	O	switching	prep_of	18	SENT_494	[p27l799t259r1133b332],
24	Anti	NNP	O	Anti	nn	27	SENT_494	[p27l1167t259r1299b313],
25	Platelet	NN	O	platelet	nn	27	SENT_494	[p27l1337t259r1571b325],
26	)	NN	O	)	nn	27	SENT_494	[p27l1337t259r1571b325],
27	study	NN	O	study	dep	18	SENT_494	[p27l1612t260r1775b332],
28	.	.	O	.	_	0	SENT_494	[p27l1612t260r1775b332],

1	J	NNP	O	J	nn	4	SENT_495	[p27l1809t261r1837b328],
2	Am	NNP	O	Am	nn	4	SENT_495	[p27l1873t259r1982b313],
3	Coll	NNP	O	Coll	nn	4	SENT_495	[p27l2021t260r2143b313],
4	Cardiol	NNP	O	Cardiol	_	0	SENT_495	[p27l117t356r332b409],
5	2010	CD	DATE	2010	num	4	SENT_495	[p27l356t356r868b420],
6	;	:	O	;	_	0	SENT_495	[p27l356t356r868b420],
7	56:1017	CD	NUMBER	56:1017	number	8	SENT_495	[p27l356t356r868b420],
8	—	CD	NUMBER	—	dep	4	SENT_495	[p27l356t356r868b420],
9	23	CD	NUMBER	23	dep	8	SENT_495	[p27l356t356r868b420],
10	.	.	O	.	_	0	SENT_495	[p27l356t356r868b420],

1	Key	NN	O	key	nn	2	SENT_496	[p27l11t573r155b661],
2	Words	NNS	O	word	_	0	SENT_496	[p27l181t571r457b639],
3	:	:	O	:	_	0	SENT_496	[p27l181t571r457b639],
4	acute	JJ	O	acute	amod	6	SENT_496	[p27l525t589r705b638],
5	coronary	JJ	O	coronary	amod	6	SENT_496	[p27l740t598r1050b661],
6	syndrome	NN	O	syndrome	dep	2	SENT_496	[p27l1080t572r1423b661],
7	I	PRP	O	I	nsubj	8	SENT_496	[p27l9t691r54b736],
8	bleeding	VBG	O	bleed	rcmod	6	SENT_496	[p27l86t679r391b768],
9	I	PRP	O	I	nsubj	10	SENT_496	[p27l422t691r467b736],
10	genotyping	VBG	O	genotype	dep	8	SENT_496	[p27l500t682r899b768],
11	I	PRP	O	I	nsubj	13	SENT_496	[p27l931t691r976b736],
12	platelet	NN	O	platelet	nn	13	SENT_496	[p27l1009t679r1270b768],
13	testing	NN	O	testing	xcomp	10	SENT_496	[p27l1301t682r1541b768],
14	I	PRP	O	I	nsubj	15	SENT_496	[p27l1572t691r1617b736],
15	prasugrel	VBP	O	prasugrel	rcmod	13	SENT_496	[p27l1650t679r1991b768],
16	.	.	O	.	_	0	SENT_496	[p27l1650t679r1991b768],

